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I 
Abstract 
The PhD thesis herein presented deal with the synthesis, characterization and catalytic application of new 
ruthenium transition metal complexes which exhibit unprecedented combination of ligands: 
cyclopentadienones and N-heterocyclic carbenes (NHC). In the first year of the PhD work it was developed a 
straightforward and efficient synthetic route to novel Ru N-heterocyclic carbenes (NHC) complexes by 
transmetallation of non-bulky imidazolylidene silver complexes to ruthenium dicarbonyl 
tetraarylcyclopentadienone. The same procedure with sterically demanding NHC resulted in the formation of 
unprecedented heterobimetallic Ru-Ag(NHC) complexes. During the second year six months (from March to 
September 2014) have been spent at the UCD School of Chemistry and Chemical Biology, University College 
of Dublin, under the supervision of Professor Martin Albrecht investigating the steric and electronic tunability 
of the catalyst precursors by replacing imidazolylidenes with triazolylidenes. Triazolylidenes are stronger 
donors than imidazolylidenes, and hence they further activate the ruthenium(0) oxidation state in dicarbonyl 
tetraarylcyclopentadienone Ru (NHC) complexes, which resulted to be beneficial in catalytic applications. 
During the second and third year the novel classes of ruthenium complexes were successfully employed as 
catalyst precursors in the transfer hydrogenation of ketones and aldehydes using iPrOH as hydrogen source. 
Fine tuning of several molecular parameters and reaction conditions allowed to improve catalytic 
performances. Furthermore, the catalysts were employed for the oxidation of alcohol with promising results. 
Heterogenization of the catalyst on polypropylene imine dendrimers has been also developed, moreover ionic 
ruthenium complexes have been also exploited as potential catalyst in ionic liquids. Greener synthetic 
conditions have been found both for the synthesis of ruthenium complexes under microwave irradiation and 
for the acid catalysed transformation of the bio-based bis-hydroxymethylfuran. Preliminary electrochemical 
measurements have been carried out on a triazolylidene Ru(0) complex. Its redox behaviour could be exploited 
in the development of electrocatalysis. 
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CHAPTER I 
General Introduction 
The development of highly efficient and selective catalysts is one of the major research goals in chemistry and 
is expected to provide a significant contribution to the issue of sustainability. New catalysts need to be 
developed, and the demand for more selective and efficient synthetic methods has led to renewed interest 
toward homogeneous catalysis, particularly in the development of new ligands which can be tuned to specific 
needs. Indeed, the properties of a metal complex are the result of the interaction of the metal center and its 
surrounding ligands. In traditional approaches, the steric and electronic properties of the ligands are used to 
control the performance of the catalyst, but the ligands play a spectator role (the reactivity takes place at the 
metal center). Recent new approaches deviate from this concept, and make use of more reactive (actor) 
ligands, that can play a much more prominent role in the elementary bond activation steps in a catalytic cycle. 
The central idea is that the metal and the ligand can cooperate in a synergistic manner, and their interplay 
facilitates the chemical process.1 Starting from this idea, the main goal of this thesis concerned the design of 
a new class of ruthenium carbonylic bifunctional catalyst that combine two versatile and popular class of 
ligands such as cyclopentadienone/hydroxycyclopentadienyl and N-Heterocyclic carbenes, in order to exploit 
this new metal-ligand combination for application in homogeneous catalysis. The unique features of the both 
ligands will be considered in details in the following paragraphs. 
1. N-heterocyclic carbenes (NHCs) as spectator ligands
N-heterocyclic carbenes (NHCs) are probably the class of ligands that has attracted the most attention during
the past decade, and has also witnessed the most impressive advances, which had produced a wider 
availability, applicability and a deeper understanding of their properties.  
The first complex with a heteroatom-stabilized carbene ligand dates back to almost a century ago by 
Tschugajeff (Chugaev),2 even though the molecular structure was only solved decades later providing 
evidence for the formation of the diaminocarbene complexes. 
Discussions about N-heterocyclic carbenes were initialized by Wanzlick’s report in the early 1960s; shortly 
thereafter, in 1968, Wanzlick and Öfele3 independently published the first transition metal-carbene complexes 
(Hg and Cr respectively) predating the isolation of a free NHC by over 20 years (Figure 1.1). 
Nevertheless, the ﬁeld of N-heterocyclic carbenes as ligands in transition metal chemistry remained a lab 
curiosity until 1991 when a report on the extraordinary stability, isolation and storability of crystalline NHC IAd 
by Arduengo et al.4 ignited a rapidly growing research ﬁeld. The discovery that some carbenes could be 
isolated and easily handled trigged a true explosion of interest in their coordination ability. A few years later, 
this new class of ligands exploded in the literature, so that NHCs have become a ubiquitous class of ligands 
(Figure 1.1).  
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Figure 1.1. Number of publications (N-heterocyclic carbene as research topic).5 
As excellent ligands for transition metals, NHCs have found multiple applications in some of the most important 
catalytic transformations in the chemical industry, while their reactivity upon coordination to main group 
elements and as organocatalysts has opened up new areas of research. 
However, the largest application of NHC-transition metal complexes is in homogeneous catalysis directed to 
organic synthesis. The success encountered by NHC spectator ligands in this transformation is often attributed 
to their strong σ-electron donating properties, which allow a very strong NHC-metal bonds preventing 
decomposition of the catalyst and improving the catalytic activity. 
1.1 Attractive Features of NHC 
In many reviews the NHC are defined as heterocyclic species containing a carbene carbon and at least one 
nitrogen atom in the ring structure. Within these criteria fall many different classes of carbene compound with 
various substituent patterns, ring size and degrees of heteroatom stabilization (Figure 1.2). Nowadays the 
most common NHC used in catalysis are five-membered ring imidazolylidene, imidazolinylidenes and 
triazolylidenes that probably constitute the largest group of stable heterocyclic carbenes.6  
Figure 1.2. Common five-membered heterocyclic carbenes. 
A representation of the general structures of NHCs is shown in Figure 1.3a for the first reported compound IAd 
by Arduengo. The remarkable stability of the carbene centre C2 is explained by the combination of electronic 
and steric effects of these structural features. As demonstrated in IAd by the two adamantyl groups bound to 
the nitrogen atoms, NHCs generally include bulky substituents adjacent to the carbene carbon, which help to 
kinetically stabilize the species by sterically disfavouring dimerization to the corresponding olefin (the Wanzlick 
equilibrium).  
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1.1.1 Electronic and Steric Properties of NHC 
The most important factor in the NHC ligands is the electronic stabilization provided by the nitrogen atoms.  
In contrast to classical carbenes, the NHCs such as IAd contain an sp2-hybridized C2 carbon in a singlet 
ground-state electronic configuration with the σ molecular orbital filled with two electrons in antiparallel spin 
orientation at highest energy and an unoccupied p-orbital at lowest energy (Figure 1.3b).7 
Figure 1.3. (a) General structural features of IAd. (b) Ground-state electronic structure of imidazol-2-ylidenes. The 
mesomeric (red) and inductive (blue) effects help to stabilize the singlet carbene structure.7 
The adjacent σ -electron-withdrawing and π-electron-donating nitrogen atoms stabilize this structure both 
inductively by lowering the energy of the occupied σ-orbital (HOMO) and mesomerically by donating electron 
density into the empty p-orbital (LUMO). Furthermore, the cyclic nature of NHCs also helps to favour the singlet 
state by forcing the carbene carbon into a bent, more sp2-like arrangement.  
This ground state electronic structure, and in particular the presence of a lone pair on the plane of the 
heterocyclic ring of NHC, makes these compound nucleophilic with the tendency to act as σ-donors and bind 
to a wide range of metallic and non-metallic compound. This peculiarity influences the stability, structure and 
reactivity of the resulting complexes. 
Although σ-donation is the most important component of metal–ligand binding, the contribution of both π-back-
bonding into the carbene p-orbital and π-donation from the carbene p-orbital can be relevant (Figure 1.4). The 
degree of π-acceptor power of N-heterocyclic carbenes is still disputed and unclear. From experimental and 
theoretical results, Frenking and co-workers calculated that π-contributions account for about 20% of the 
complexes’ overall orbital interaction.4 
Figure 1.4. Diagram illustrates the σ→ d (a), the d →π* (b), and the π→ d (c) bonding modes occurring between NHCs 
and transition metals.6 
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The strong σ-donor and comparatively weak π-acceptor properties of NHCs bear similarities to the 
coordination characteristics of phosphines, so that NHCs were initially considered as mimics for this ubiquitous 
class of ancillary ligand in transition-metal coordination chemistry. There are, however, a number of differences 
between the two classes of ligands.8 
As indicated by their lower TEP (Tolman Electronic Parameter) values (evaluation of the electron-donating 
ability of ligand by measuring the infrared-stretching frequencies of carbonyl ligands in model transition metal 
carbonyl complexes), NHCs are in general more electron-donating than phosphines. This leads to 
thermodynamically stronger metal–ligand bonds and is reflected in the typically greater bond dissociation 
energies and shorter metal–ligand bond lengths observed for NHC complexes over their phosphine 
counterparts. As a rule, the stronger metal–ligand interaction renders NHC–metal coordination less labile than 
metal–phosphine binding and the complexes are more thermally and oxidatively stable. Therefore, the 
equilibrium between the free carbene and the carbene metal complex lies far more on the side of the complex 
than in the case for phosphines (Figure 1.5b)9 
Figure 1.5. Comparison between the steric (a) and electronic (b) properties of phosphine and NHC metal complexes. 
A comparison of the steric properties of NHCs and phosphines also reveals significant differences. Whereas 
the sp3-hybridization of phosphines results in a cone-shaped spatial arrangement of the steric bulk, most 
classes of NHCs, including the most commonly employed imidazole-derived types, can be better described as 
fan- or umbrella-shaped with the nitrogen-substituents adjacent to the carbene carbon oriented more towards 
the metal (Figure 1.5a). In an attempt to quantify the steric demand of NHC ligands Nolan et al.10 have 
introduced the %Vbur, (volume buried parameter) by overlap between a sphere with a radius of 3Å centered 
around the metal with the atoms of the ligand within this sphere. As a result, NHCs are generally considered 
to be sterically demanding ligands with variations in the nitrogen substituents and class of heterocycle having 
a large effect on the steric environment at the metal centre. In contrast to phosphines, where changing the 
phosphorus substituents invariably affects both the steric and electronic properties in that the substituents are 
directly attached to the donor atom itself, the NHC provide the possibility to separately modify the nitrogen 
substituents, the backbone functionality and the class of heterocycle, allowing independent variation of each 
parameter. With these attractive features, NHCs nowadays rival phosphines and cyclopentadienyls as ligands 
across organometallic chemistry and the extensive range of accessible complexes continues to grow at 
amazing rate.9b 
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1.1.2 Synthesis of NHC precursors and NHC-Transition Metal Complexes 
An additional advantges associated to NHCs is the relative ease with which libraries of structurally diverse 
analogues can be prepared and studied. 
Various methods of synthesizing complexes may be employed, and the main synthetic routes leading to the 
formation of NHC complexes are depicted in Scheme 1.1. The methodologies given are shown with 
imidazolydene ligands, however, they are applicable to other NHCs.  
Scheme 1.1. Main synthetic strategies for the formation of NHC-complexes. 
Route A consists of generating the free carbene (by deprotonation of the corresponding salt) followed by 
coordination to a metal centre (often with concomitant ligand displacement). Method B consists of using a 
metal precursor containing a base as ligand. The base deprotonates the imidazolium salt, leading to the 
coordination of the NHC and of the counter anion of the salt (if X is a coordinating anion). Method C employs 
a carbene transfer reagent (often a Ag-complex) that, by transmetallation reaction, delivers the NHC to a 
second metal centre.5 
Arguably, imidazolium-based carbenes synthesis have proven to be especially versatile and useful, in fact the 
synthesis of imidazolium salts has been developed over many decades and numerous powerful methods exist. 
Two main different routes can be distinguished:6 
1) imidazoles obtained by deprotonation of the corresponding cationic heterocyclic azolium salt with the
help of suitable bases (pKa = 21-24), can be alkylated using appropiate electrophiles (eg. alkyl halide)
resulting in the formation of N-alkyl-substituted imidazolium salts (Scheme 1.2).
Scheme 1.2. Synthesis of imidazolium salts by alkylation reactions. 
2) the imidazolium ring can be built up by condensation reaction. For example, glyoxal is reacted with
formaldehyde and a primary amine in the presence of a strong acid, resulting in the formation of
imidazolium salts (Scheme 1.3). Symmetric imidazolium salts can be easily obtained by similar
synthetic procedures when two equivalents of primary amine are employed (R1=R2). This latter route
has become the method of choice for many sterically demanding imidazolium salts.
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Scheme 1.3. Synthesis of imidaziolium salts by cyclization reaction followed by alkylation. 
The general applicability of these synthetic routes allow to modulate the steric and electronic properties of the 
NHC ligand by changing the R substituents. The insertion of appropriate functional groups on the R 
substituents can: 
 increase the complex stability through the formation of chelating system;
 promote hemilability;
 adjust the steric and electronic factor around the metal centre;
 induce chirality;
 increase the solubility in polar solvent.
Furthermore, the insertion of a donor substituent in the side chain of the NHC can: 
 be used for the immobilization of organic imidazolium salts or organometallic complexes by means of
NHC linker;
 act as a further coordination site.
1.2 Catalytic applications of NHC-Transition Metal Complexes 
The attractive features of NHC-metal coordination previously described have led to a wide range of different 
applications in many field of chemistry. As mentioned above, the largest application is in homogeneous 
catalysis; in particular the most important transformations mediated by NHC-transition metal complexes 
includes Ir- and Ru- catalysed hydrogenation and hydrogen transfer, gold-catalysed activation of π -bonds and 
Rh- and Pt-catalysed hydrosilylation11. The two most extensively studied classes of catalytic reactions, 
however, are cross-coupling (catalysed by Pd or other metals) and Ru-catalysed olefin metathesis. Much of 
the success of NHC spectator ligands in these transformations can be attributed to the increased catalyst 
stability, and consequent lower rates of catalyst decomposition resulting from strong metal–ligand binding.  
Figure 1.6. Comparison of Grubbs’ first- and second- generation catalyst in olefin metathesis. 
Arguably, the best example is provided by the excellent efficiency of the Grubbs’ second-generation olefin 
metathesis catalyst in comparison to the first-generation (Figure 1.6), which displays two PCy3 ligands bound 
to ruthenium(II).12 The substitution of one of the two phosphines with the SIMes carbene ligand in the second 
Grubbs generation displays significantly higher reactivity than its predecessor and has dramatically expanded 
the range of suitable substrates for metathesis reactions. Numerous related NHC–ruthenium complexes, 
including the widely used Hoveyda–Grubbs second-generation catalyst (Figure 1.6), have been developed for 
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applications in metathesis and the importance of these reactions was recognized with the award of the Nobel 
Prize for chemistry in 2005.7 
The major role of Ruthenium on the NHC chemistry of group 8 is the direct consequence of the immense 
interest raised by the Grubbs [(NHC)Ru] complexes in oleﬁn metathesis. A downside of this success is that 
the other catalytic applications of [(NHC)Ru] compounds have long been overshadowed.13  
1.2.1 Ru(NHC) complexes as homogeneous catalysts 
In the last decade the ruthenium-based NHC complexes have found applications in a wide homogeneous 
catalytic reaction, some examples are listed below: 
 Transfer Hydrogenation:14 
The reduction of carbonyl compounds using a hydrogen donor, typically isopropanol that is oxidized into 
acetone, has emerged as an attractive alternative to protocols based on dihydrogen and metal hydrides 
protocols. In this context, Ru(NHC) complexes have proven to be excellent catalysts, and have become the 
benchmark for newly developed catalytic transformation. 
The presence of a NHC ligands in the design of new catalysts enhanced the stability of the complex resulting 
in good catalytic performances, furthermore the ligand choice is a key issue toward both selectivity and activity 
of the metal center.  
Beller and co-workers evaluated the potential of a wide range of common N-heterocyclic carbenes in the 
transfer hydrogenation of acetophenone. Among differently substituent aryl and alkyl NHCs, IPr (isopropyl 
group) proved to be the most active, resulting in very high TON.15 Another example, (Figure 1.7) shows two 
type of transfer hydrogenation catalysts that contain an abnormal N-Heterocycle Carbene (aNHC) as ligand.  
Figura 1.7 Transfer hydrogenation of ketones by [Ru(aNHC)] catalysts. 
In this kind of carbene the imidazolylidenes bind the metal centers via the C4 or C5 position of the heterocycle. 
This peculiar coordination is considerably more electron-donating due to the reduced σ-withdrawal from the 
carbene center leading to a different electron properties and enhances reactivity. 
 Synthesis of amide from alcohol and nitrile:16
 Figure 1.8. Catalytic amide synthesis from an alcohol and a nitrile by an NHC-based Ru hydride catalyst. 
The synthesis of amide according to the principles of “atom-economic” is one of the top challenges in green 
organic synthesis and industrial processes in particular for pharmaceutical industries. The ﬁrst catalytic, single-
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step, and redox-neutral transformation of alcohols and nitriles into amide with 100% atom economy was 
performed by a Ru hydride complexes (eg. RuH2(CO)(PPh3)3) as pre-catalyst in the presence of an N-
heterocyclic carbene precursor such as 1,3-diisopropylimidazolium bromide and a base (Figure 1.8). The 
amide C−N bond is efficiently formed between the nitrogen atom of nitrile and the α-carbon of alcohol, with the 
help of an N-heterocyclic carbene-based ruthenium catalyst, without a single by-product. 
 H2-Mediated Hydrogenation:
Whittlesey and co-workers combined the potential of NHCs with that of metal borohydrides in molecular 
hydrogen-based reduction leading to the synthesis of a series of η2-BH4 ruthenium catalysts (Scheme 1.4) that 
displayed good activities in the reduction of acetophenone derivatives under 10 atm of H2.17 Similarly to Beller’s 
ﬁndings, the IPr-containing complex was found to be the most active. 
Scheme 1.4. Synthesis of η2-BH4 ruthenium carbene complexes. 
Recently, Albrecht et al.18 have proven that Ru(arene) complexes (Figure 1.9) containing a bidentate chelating 
NHC ligand, are effective catalyst precursors for the direct hydrogenation of olefin using H2. The chelating 
groups have a pronounced effect on the catalytic activity and the stability of the complexes. Whereas the olefin 
donor group in Ru1 was rapidly hydrogenated, thus inducing complex decomposition and predominantly 
heterogeneous hydrogenation, the carboxylate group in Ru2 markedly increased the stability of the complex. 
Figure 1.9. Chelate (Ru1-4) and monodentate (Ru5) ruthenium carbene complexes. 
 Water Oxidation:19 
The discovery of eﬃcient catalysts for water splitting is currently a major challenge due to need of technologies 
for fuel production in order to address the growing global energy demand. 
Mononuclear and dinuclear ruthenium complexes containing a pyridine-functionalized NHC (Figure 1.10) result 
active in this reaction. Tailoring the catalytic activity, still rare in water oxidation catalysis, is readily achieved 
by appropriate modiﬁcation of the substituents at the imidazolylidene nitrogens. 
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Figure 1.10. Ru(NHC) water oxidation catalyst synthetized by Albrecht group. 
 Antitumor metallodrugs:20 
Recently, NHCs came into the focus as carrier ligands for cytotoxic metal complexes because they perfectly 
fit prerequisites for an eﬃcient drug design and fast optimization. NHCs are readily accessible in few steps 
and their substituents can be widely varied allowing an easy fine-tuning of both the physicochemical properties 
and the reactivity in biological medium of the final metal–NHC complexes. Additionally, their high stability and 
ease of derivatization make them suitable candidates for drug development. Figure 1.11 shows two examples 
Ru(NHC) complexes synthetized as potential chemotherapeutic agents. 
Figura 1.11. Ru(NHC) as potential chemotherapeutic agents. 
Until recently, only two classes of ligands, both sterically and electronically tuneable, can be considered of 
very broad use in organometallic catalysis: phosphines (PR3) and cyclopentadienyls (C5R5). Comparison 
between NHCs and phosphines properties, being both monodentate 2 electron ligands, has discussed 
previously in the paragraph 1.1.1 Cyclopentadienyls, as 5 electron ligands (6e- on the ionic model), are less 
closely related to NHCs than phosphines, nevertheless both type of ligand can adopt the role of spectator or 
actor ligands in the activation steps of a catalytic cycle.21 Indeed, beside modulation of the electronic and steric 
properties of the ligand to affect the catalytic activity, bifunctional catalyst are emerging as powerful tools, 
provided that the ligands contain non-innocent functional groups, which are directly involved in the catalytic 
cycle.22 
2. Cyclopentadienone as non-innocent ligand in bifunctional catalysts
The development of new metal-ligand bifunctional hydrogenation catalysts has dramatically changed the face 
of catalytic reduction. These catalysts provide attractive “green” alternatives to stoichiometric LiAlH4 and 
NaBH4 reductions and utilize environmentally friendly terminal reductants, such as hydrogen and 2-propanol. 
The first metal-ligand bifunctional catalyst, the hydroxycyclopentadienyl diruthenium bridging hydride (Figure 
1.12, A), was reported by Shvo in the mid-1980s; it showed an efficient catalytic activity in a large variety of 
reactions and notably in hydrogenation and oxidation transformations. Fundamental contributions in this area 
have delivered by Noyori with a number of ruthenium catalysts, including the ruthenium(diamine)(BINAP) 
(Figure 1.12, B), which has displayed an extraordinary activity in the asymmetric reduction of ketones.23 
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Figure 1.12. Shvo,s and Noyori’s metal-ligand bifunctional catalysts. 
2.1 Outer Sphere mechanism in hydrogenation catalysis 
Shvo and of Noyori bifunctional catalysts, which contain a proton donor site (AH) on the ligand and a hydride 
donor sites (BH) on the metal center, suggest an outer sphere (OS) transfer mechanism, in contrast to the 
traditional inner sphere (IS) mechanism operated by the majority of homogeneous hydrogenation catalysts. In 
the OS mechanism the substrate does not bind to the metal but H+ and H- are instead transferred, either 
together or stepwise, from the catalyst to the unbound substrate. The proton donor site is typically an ancillary 
ligand such as cyclopentadienyl containing an OH or NH unit adjacent to the metal, and the hydride donor is 
a metal hydride, typically Ru–H. The two sites being adjacent and coupled electronically facilitates concerted 
(H+ + H-) transfer (Figure 1.13.).24 
Figure 1.13. A general scheme for the catalytic H2 hydrogenation of polar bonds where the hydride addition to the 
substrate in the outer coordination sphere is assisted by an ancillary ligand. 
An example of non-classical outer sphere mechanism for the hydrogenation of polar multiple bonds is shown 
in Scheme 1.5. In step I substrate 1 coordinates in step I by forming an outer sphere interaction between the 
atoms of its polar double bond and the proton and hydride of the complex B. This interaction allows for the 
simultaneous transfer of the hydride and the proton (step II) producing the hydrogenated substrate 2 and a 
ruthenium complex with a vacant coordination site, C. This 16-electron ruthenium center is usually stabilized 
by π-donation from the deprotonated ligand into the empty d-orbital. Hydrogen gas can then coordinate at this 
open site (III) producing a dihydrogen complex intermediate or transition state D. The dihydrogen ligand 
heterolytically cleaves in step IV to re- form the original hydride complex A.25 
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Scheme 1.5.  A general scheme for the H2 hydrogenation of polar bonds catalyzed by ruthenium catalysts where the 
hydride addition to the substrate in the outer coordination sphere is assisted by an ancillary ligand. 
2.2 Nature of Shvo’s catalyst and the role of the cyclopentadienone ligand 
Catalytic cycles of the type described in the Scheme 1.5 involves a NH or OH group on the ancillary ligand. 
As far as it concerns the OH group as proton donor, the most famous example is the Shvo catalyst. Shvo’s 
catalyst (Scheme 1.6, structure I)26 is an air- and water-stable crystalline solid that is commercially available 
from several sources. Its discoverer, Youval Shvo, and co-workers discovered and introduced this versatile 
ruthenium catalyst that utilizes non innocent cyclopentadienone ligands to stabilize the metal in low oxidation 
states. This complex and its analogues have been extensively applied as catalyst for reactions such as 
hydrogenation of aldehydes, ketones, alkynes, and alkenes, transfer hydrogenation, disproportionation of 
aldehydes to esters, isomerization of allylic alcohols, dynamic kinetic resolution (DKR), amine–amine coupling, 
and hydroboration reactions. 
2.2.1 Reactivity 
Complex I is a dimeric pre-catalyst that forms monomeric oxidizing (II) and reducing (III) forms upon 
dissociation in solution. The concentrations of these active forms are governed by equilibrium effects; mutual 
conversion of II and III take place through the gain or loss of “H2” from donors (AH2) and acceptors (A) as 
shown in Scheme 1.6.  
Scheme 1.6. Shvo’s Catalyst (I): Heterodimer of oxidizing (II) and reducing (III) species.27 
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2.2.2 Catalytic mechanism in hydrogenation reaction 
The dissociated monomeric forms of I are: a ruthenium hydride (III) and a coordinatively unsaturated dicarbonyl 
species (II). Upon dissociation both bridging hydrogen atoms are associated with the same monomer (III), this 
ruthenium is in the 2+ oxidation state while the other (II) is formally in the zero oxidation state. Curiosly, the 
species with higher formal oxidation state (Ru2+) is the reducing agent, and the formal ruthenium(0) species is 
the oxidizing complement. This interesting situation can be explained by the conversion of a formally neutral 
cyclopentadienone ligand (coordination η4) to a formally anionic hydroxycyclopentadienyl ligand (coordination 
η5).28 
Mechanistic studies by Casey, Backvall, and others have established that the catalyst transfers dihydrogen 
through a hydride on the transition metal (Ru-H) and a proton on the hydroxyl cyclopentadienyl ligand (O-H), 
as depicted in Scheme 1.7, thus it acts as a metal-ligand bifunctional catalyst. 
Scheme 1.7. Concerted delivery of H+/H-, and regeneration of the catalyst. 
As mentioned above, the catalyst precursor I has the two metals joined by a bridging hydride, and an O-H-O 
hydrogen bond connects the two cyclopentadienone ligands. The cleavage of the bimetallic starting material 
occurs by heating producing a formally 16-electron Ru fragment (II) and the 18-electron Ru-hydride containing 
the substituted hydroxycyclopentadienyl ligand (III). In fact, the catalytic hydrogenation of ketones requires a 
temperature over 90°C to generate the mononuclear species that are catalytically active in 
hydrogenation, according to the sequence shown in Scheme 1.7. The catalytic cycle is an example of metal 
ligand cooperation in a non-classical outer sphere mechanism thereby allowing to operate in mild 
conditions leading to high selectivity and conversions of the substrate with a low hydrogen consumption.29 
3. Catalytic Redox Processes
Redox transformations of coordination compounds have since long drawn considerable attention in 
consideration of the fact that catalytic reduction and oxidation reactions can be effectively mediated by 
transition metal complexes. The most common (“classical”) behaviour of a transition complex in a redox 
process involves oxidation or reduction of the metal, leaving the ligand unaffected. In other cases, as the 
example of the Shvo catalyst reported above, ligands can also participate in the redox process. In such cases, 
the ligand is referred to as being “redox non-innocent” or “redox active”. Such species have attracted 
substantial attention over the past decade, since they offer a unique opportunity to modify the reactivity of 
transition metal complexes.1 Among the variety of transition-metal mediated redox reactions, hydrogenation 
and dehydrogenation have gained a special role due to the wide application of these reactions in many 
laboratory and industrial processes, and in consideration of the increasing demand for “green” and suitable 
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transformations. In particular, this latter point has strongly motivated the development of a large number of 
new catalyst for hydrogenation – dehydrogenation reactions.30 
3.1 Transfer Hydrogenation 
Hydrogenation is one of the most fundamental transformations in organic synthesis, and its industrial 
applications span from ﬁne chemicals to pharmaceuticals synthesis. Direct hydrogenation, under H2 gas 
pressure, and transfer hydrogenation (TH) are the two most common strategies for hydrogenation.31 
TH reaction, referring to the addition of hydrogen to a molecule from a non-H2 hydrogen source, is a convenient 
and powerful method to access various hydrogenated compounds. It is an attractive alternative to 
direct hydrogenation, and it has recently become the subject of an interest research activity. The 
advantages of transfer hydrogenation are: 
(i) it does not require hazardous pressurized H2 gas nor elaborate experimental setup,
(ii) the hydrogen donors are readily available, inexpensive, and easy to handle,
(iii) the major side product deriving from the oxidation of the hydrogen donors can be recycled,
(iv) the catalysts involved are usually readily accessible and not sensitive. 
3.1.1 Main historical milestones of Transfer Hydrogenation reaction 
The hydrogen transfer reaction dates back more than a century. TH, is by far the most important and widely 
used subﬁeld. TH reactions are divided according to the catalyst type in Meerwein−Ponndorf−Verley (MPV) 
reductions, late transition metal-catalyzed reactions, organocatalytic, enzyme-catalyzed, thermal, base-
catalyzed, and uncatalytic processes. 
The illustrious MPV reduction32 was ﬁrst published independently by Meerwein and Verley in 1925, and it was 
the ﬁrst TH reaction of carbonyl compounds. In the MPV process, an aluminum alkoxide acts as a promoter 
for the reduction of a ketone to the corresponding alcohol in the presence of a secondary alcohol as a hydrogen 
donor. The transition state is a six-membered cycle in which both the reducing alcohol and the carbonyl are 
coordinated to the same metal center (Scheme 1.8). 
Scheme 1.8. Hydrogen Transfer in the MPV Reduction via a cyclic transition state. 
The MPV reduction has been extensively applied in both academic and industrial syntheses, particularly in the 
chemical manufacture of ﬂavor agents, due to its chemoselectivity toward the keto functionality and the mild 
reaction conditions. However, the well-known drawbacks of this method are the requirements of a large amount 
of reagents, side reactions that led to the formation of undesired products and moisture sensitivity (especially 
for Al catalysts). 
The next milestone of TH was the discovery of late transition-metal catalysts involving the metals of groups 8, 
9, 10, and 11. In the 1960s Mitchell and co-workers33 reported that an iridium hydride complex catalyzed the 
hydrogenation of cyclohexanones and α,β-unsaturated ketones to alcohols with isopropanol. 
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Subsequently, Sasson and Blum34 demonstrated that the complex [RuCl2(PPh3)3] is active in the biphasic TH 
of acetophenone in the presence of isopropanol at high temperature. Two decades later, Chowdhury and 
Backvall35 found that the catalytic activity of [RuCl2(PPh3)3] is strongly enhanced by adding NaOH as co-
catalyst.  
In the early 1980s, the ﬁrst reports of the Ru- catalyzed asymmetric TH emerged. Since then, asymmetric TH 
(ATH) has received signiﬁcant and increasing attention, culminating with the Nobel Prize award to Noyori and 
Knowles in 2001.36 ATH based on late transition-metal catalysts has proven to be among the most powerful 
methods for asymmetric reduction of various unsaturated substrates to produce chiral compounds. This is due 
to the excellent stereo-selectivity, the availability of various hydrogen sources, operational simplicity, and the 
use of readily accessible and little sensitive catalysts. 
Figure 1.14. Noyori catalysts. 
The chiral ruthenium complexes shown in Figure 1.14 are two examples of catalyst precursors synthetized by 
Noyori and used in the stereoselective hydrogenation of various ketone, aldehydes, and imines. 
Ir, Ru, and Rh complexes bearing N, P, O, S, C element-based ligands are perhaps the most classic and 
popular catalysts for TH. In the last decades, the family of N-heterocyclic carbene (NHC) ligands has arrived 
at the forefront of coordination chemistry and organometallic catalysis as ubiquitous ancillary ligands due to 
their attractive features such as strong coordination ability and the tuneable character of their steric and 
electronic properties which have been thoroughly described in the paragraph 1.1. The use of NHC as ligands 
in transition-metal complexes for catalytic TH was pioneered by Nolan et al.37 who designed and synthesized 
the complexes [Ir(cod)(py)(NHC)]PF6 (Ir1) (Figure 1.15). 
Figure 1.15. [Ir(NHC)] catalysts synthetized by Nolan (Ir1), Crabtree (Ir2) and Royo (Ir3).30 
These complexes were used as TH catalysts for the reduction of several unsaturated substrates including 
ketones, oleﬁns, and nitroarenes using isopropanol as hydrogen source. In the light of these results, many 
other Ir(NHC) complexes have been investigated. Crabtree and his group38 reported the new air-stable and 
moisture-insensitive Ir catalyst (Ir2, Figure 1.15) bearing a chelating bis(N-heterocyclic carbene) ligand for 
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eﬃcient TH of ketones. Royo and co-workers39 prepared the ﬁrst Cp*-functionalized NHC (Cp* = η5-C5Me5)
(Figure 1.15, Ir3).  
3.1.2 Ru(NHC) complexes as transfer hydrogenation catalysts 
Recent years have witnessed great improvements in the field of ruthenium-catalyzed Tranfer Hydrogenation, 
in particular due to the development of the diversity of ligands. Ligand choice is a key issue toward both 
selectivity and activity of the metal center. In consideration of the peculiar properties of NHCs mentioned above 
(paragraph 1.2), it is not surprising that a variety of ruthenium NHC complexes with different oxidation states, 
coordination geometries of ruthenium, and structural motifs have recently disclosed good activity and 
selectivity in catalytic TH.30 In particular, NHC ligands functionalized with an additional donor group have been 
extensively investigated, due to the potential hemilability of the additional donor group involving reversible 
dissociation from the ruthenium center. These donor groups include pyridine, pyrimidine, phosphine, 
carboxylate, indenyl, oxazoline, thioether, and ether. 
Early pioneering work on TH using Ru(NHC) catalysts was reported by Peris and Danopoulos;40 these authors 
used 2,6-bis(1-alkylimidazo-lium-3-yl)pyridine salts as a new source of tridentate CNC bis(carbenes) 
to coordinate Ru and readily assemble the Ru “pincer” NHCs complexes Ru6 and Ru7 (Figure 1.16). Both
the complexes exhibited high catalytic activity in the TH reduction of carbonyl compounds.  
Figure 1.16. [Ru(NHC)] catalysts reported by Peris and Danopoulos.30 
Ruthenium complexes with NHCs containing a pyridine moiety (e.g. complexes Ru8 and Ru9 Figure 1.17) 
have been established as effective catalysts in TH. Remarkably, only 0.1 mol% catalyst loading of Ru9 
appeared to be suﬃcient for the TH of a wide range of ketones and imines (Figure 1.17).41 
Figure 1.17. [Ru(NHC)] complexes bearing a pyridine group. 
Albrecht’ s group readily prepared a series of ruthenium complexes containing diﬀerent donor substituent-
functionalized NHCs (Figure 1.18).42 Among them, the oleﬁn-tethered NHC ruthenium complex Ru10 was a 
very eﬃcient and versatile catalyst toward reduction of oleﬁns, alkynes, ketones, nitrobenzene and benzonitrile 
under various conditions. Furthermore, the study on the double TH of α,β-unsaturated ketones catalyzed by a 
revealed fast isomerization of the enol intermediate to its saturated ketone tautomer prior to the second 
hydrogenation. 
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Figure 1.18. [Ru(NHC)] complexes synthetized by Albrecht. 
Most NHC ligands that are used in TH catalysis coordinate to the ruthenium center in a monodentate fashion. 
Chelating bis- or tetra-NHCs in general are of great interest, because they extend the range of possible NHC 
ligands, and their properties have been tuned. The complex Ru14 shown in Figure 1.19 displays an excellent 
activity in the reduction of ketones under TH conditions with 0.1 mol % of catalyst loading.43 
Figure 1.19. Ru catalysts with chelating NHC ligand.30
Peris and co-workers reported that the complexes [Ru(η6-arene)(bis-NHC)] (Figure 1.19, Ru15),44 gave good 
results in TH of carbon dioxide to formate using 2-PrOH as hydrogen source. The reaction was conducted at 
110°C under 50atm of carbon dioxide. These severe reaction conditions require a high stable catalyst; the 
presence of a bis-NHC ligand enhanced the stability of catalyst resulting in good catalytic performances. 
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3.2 Dehydrogenation reaction 
Reverse process of hydrogenation is called dehydrogenation (Scheme 1.9). Dehydrogenation involves loss of 
hydrogen from a molecule and converts a saturated substrate to an unsaturated one. 
Scheme 1.9. Hydrogenation is the same reaction of dehydrogenation but on the other way around. 
Carbonyls such as ketones and aldehydes are synthetically prevalent functional groups because of their 
outstanding versatility for derivatization. Amongst the various procedures to prepare carbonyl compounds, 
selective oxidation from alcohol is a mostly valuable approach in that precursors are abundant and readily 
available.45 
Hydrogen transfer in the context of alcohol oxidation in organic chemistry has been studied and developed 
since the 1930s. An early milestone in the chemistry of catalyzed hydrogen transfer from an alcohol is 
Oppenauer’s report of aluminum tert-butoxide oxidation of secondary alcohols in the presence of acetone.46 
Though aluminum alkoxides had been previously utilized in the reduction of aldehydes and ketones by 
Meerwein, Ponndorf, and Verley, Oppenauer was the ﬁrst to use the method for oxidizing an alcohol to ketone. 
Generally, the ‘catalysts’ used in classical Oppenauer oxidations are simple bases added in stoichiometric 
quantities.  
Subsequently, several groups have developed transition-metal catalyzed systems showing Oppenauer-type 
alcohol oxidation reactivity. Many of the ﬁrst catalysts discovered for hydrogen transfer from alcohols to 
carbonyls incorporated iridium, rhodium, or ruthenium. These catalysts tend to require harsh conditions for 
good conversion. Among the ﬁrst Oppenauer oxidation catalysts were [RhCl(PPh3)3] (Wilkinson’s catalyst) and 
[IrCl3(dmso)3].47 
The base often serves as an activator of hydrogen transfer catalysts and as a promoter for hydrogen transfer 
reactions. Therefore, the majority of alcohol activation reactions require at least catalytic amounts of base. The 
high use of oxidant in these systems is the main drawback due to the fact that provides significant quantities 
of (sometimes toxic) side-products and a low atom-economy of the overall reaction. In the recent years, the 
attention has been focused on more benign oxidants such as H2O2 and O2 as terminal oxidants, leading to 
substantial progresses, in particular in ruthenium- palladium-, and copper-catalyzed alcohol oxidation.48 
Furthermore, the recent quest for hydrogen as an alternative that does not impact the global carbon cycle has 
strongly stimulated research into acceptorless alcohol (and amine) dehydrogenation processes. Ruthenium-
catalyzed protocols for the dehydrogenation of primary and secondary alcohols have been developed for 
example by the groups of Beller, Milstein, and Williams.49 
Homogeneous dehydrogenative catalytic activation of alcohols can be considered as a development of 
hydrogen transfer catalysis. This reaction leads to transfer of 2H from a sacriﬁcial secondary alcohol to a 
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ketone facilitated by a transition-metal catalyst. One H is removed from a CH bond, hence is relevance to CH 
activation, and the other comes from the hydroxyl group. The classic early examples employed secondary 
alcohols such as isopropanol, in part because they are greater reducing alcohols.46  
As for hydrogenation, also dehydrogenation mechanism can be divided into two: 
 Inner-sphere or “classical” mechanism;
 Outer-sphere or bifunctional mechanism.
In inner-sphere mechanism, catalysts usually need a base for activation and heating for displacement of a 
labile ligand. The substrate is coordinated to the metal and a labile ligand is displaced in order to have a vacant 
site at metal center. By this way, a β-hydride elimination occurs and the product can be released from the 
metal complex. An example of this mechanism is reported in Scheme 1.10. After dehydrogenation, the catalyst 
is regenerated via H2 acceptorless release, or by hydrogen transfer to another molecule, which can be a 
sacrificial acceptor or substrate itself. 
Scheme 1.10. A schematic example of a traditional dehydrogenation mechanism. 
Outer-sphere catalysts are characterized by a basic site, usually a nitrogen in one ligand, and acidic site, on 
metal center. Also in this case dehydrogenation is typically performed using a base to obtain the active catalyst, 
but it is also possible to work without any base. This reaction is usually described as a concerted transfer, 
where the transition state with H2 transfer is shown as one single step. An example is described in Scheme 
1.11, where the active catalyst is a 16 electron complex. After dehydrogenation the catalyst becomes an 18 
electron complex. Catalyst needs to be recycled in the same way of inner-sphere catalyst, so by H2 release or 
by hydrogen transfer to another molecule.  
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Scheme 1.11. Example of outer-sphere mechanism. 
Many catalysts, which are believed to operate via outer-sphere or metal–ligand bifunctional mechanisms, 
have been utilized in hydrogen transfer, including Noyori and Shvo’s diruthenium complexes previously 
described in the paragraph 2.2.2. 
3.2.1 Ru(NHC) complexes as catalysts for dehydrogenation reaction 
In the last decade several ruthenium catalysts for the dehydrogenation of primary and secondary alcohols 
have been developed. Among them the Shvo’s catalyst is one of the most representative examples in terms 
of both efficiency and versatility. 
As mentioned above (see paragraph 3.1.2), N-heterocyclic carbene (NHC) ruthenium based catalysts have 
recently played an important role in the hydrogen transfer catalysis and thus include the catalytic 
dehydrogenation of alcohol. Notably, simple well-defined (η6-arene)Ru-(NHC) complexes are among the best 
catalysts for this transformation, which can be performed using a wide variety of substrates.50 
The use of NHC-based ligands seems to bring a series of advantages, in that the NHCs combine a number of 
attractive features (see paragraph 1.1 for more details). First, the azolium ligand precursor is stable toward 
oxidation. Second, the number of possible coordination modes of the carbene to the metal, paired with the 
large library of NHC-type ligands, may allow the electronic properties of the metal to be fine-tuned, with obvious 
implications for catalytic outcomes. Third, the carbene ligand displays a pronounced mesoionic character, thus 
accommodating positive and negative partial charges in the same heterocycle that allow to coordinate the 
metal centers in different oxidation states.51 
Albrecht’s group recently reported a series of Ru(II)(η6-arene) complexes containing 1,2,3-triazolylidene 
ligands with diﬀerent aryl and alkyl wingtip groups (Figure 1.20) that are active catalyst precursors for the base- 
and oxidant-free dehydrogenation of alcohols to the corresponding carbonyl compounds with concomitant 
release of H2. The absence of base and oxidant is appealing in terms of atom economy and experimental 
setup and should allow for wide functional group tolerance.47  
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Figure 1.20. Example of a triazolylidene Ruthenium(II) complex synthetized by Albrecht’s group. 
4. Scope of the thesis
Starting from the above reported state-of-the-art the main scope of this thesis concerned the synthesis, 
characterization and catalytic application of new ruthenium-based transition metal complexes that combine 
cyclopentadienones and N-heterocyclic carbenes ligands with ruthenium carbonyl fragments. 
The main goal was to design a new class of carbonylic ruthenium complexes bearing 
tetraarylcyclopentadienone ligands and N-heterocyclic carbenes in order to develop a novel bifunctional 
catalyst with the aim to exploit this new metal-ligand combination for applications in homogeneous catalysis. 
As already mentioned the tetraarylcyclopentadienones ligands behave as non-innocent ligands in reactions 
promoted by the well-known ruthenium based Shvo catalyst and the NHC are ancillary ligands due to their 
strong coordination ability and the possibility to modulate their steric and electronic properties by changing the 
R substituents. 
Figure 1.21. A schematic illustration of the two classes of ligands concerned: in blue the cyclopentadienone ligand on the 
Shvo catalyst (I); in yellow a general representation of a free N-heterocyclic carbene. 
On this bases the first scope of the thesis has been to synthetized a series of cyclopentadienone Ru 
carbene complexes by transmetallation reaction thought a dimeric ruthenium precursor and silver carbene 
complexes intermediates. The same synthetic route has been employed with imidazolylidene and 
triazolylidene leading to the formation of, respectively, normal and abnormal Ru(0) carbene complexes. 
The second object has been the evaluation of the catalytic activity of this new kind of mononuclear 
ruthenium complexes in redox reactions such as transfer hydrogenation of ketones and alcohol oxidation. 
A particular attention was focused on the activation of this catalyst precursors testing different routes (e.g. 
oxidizing additives, protonation reactions, photolysis) and on the investigation of the catalytic mechanism. 
In order to expand the scope of these kind of complexes to a more “green” chemistry with the aim of high 
atom-efficiency and more environment friendly, the third goal of the research has been focused on the 
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developing and characterization of a new iron-based complex, inspired by the ruthenium one. The iron would 
be a good choice due to his low toxicity, low price and high availability. 
Finally, the fourth aim has been addressed around the immobilization of these complexes on a dendritic 
support in order to allow the separation of the supported complexes from the reaction mixture combining 
advantages from both homogeneous and heterogeneous catalysis. 
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CHAPTER II 
Sterically driven synthesis of ruthenium and ruthenium-silver N-heterocyclic 
carbene complexes 
Abstract 
A straightforward and efficient synthetic route to novel Ru N-heterocyclic carbenes (NHC) complexes by 
transmetallation of non-bulky silver NHC to ruthenium dicarbonyl tetraarylcyclopentadienone is described. The 
same procedure with sterically demanding NHC leads to unprecedent heterobimetallic Ru-Ag(NHC) 
complexes. 
Introduction 
As reported in the introduction, ruthenium based N-heterocyclic carbene complexes are among the most 
versatile homogeneous catalysts. In addition to the well-known second generation Grubb’s metathesis 
catalysts,1 Ru(NHC) catalysts have found application in a broad variety of reactions,2 including: transfer 
hydrogenation,3 hydrogenation of olefins4 and esters,5 asymmetric hydrogenation,6 amide synthesis 
from alcohols and nitriles,7 dehydrogenation of esters and imines from alcohols,8 racemization of chiral 
alcohols,9 alcohol10 and water oxidation.11 Moreover, Ru(NHC) are also employed in medical and material 
science as potential antitumoral drugs,12 and in the development of sensitizers.13 From a more general 
perspective N-heterocyclic carbenes (NHCs) are widely documented as ubiquitous ancillary ligands due 
to their strong coordination ability and the tuneable character of their steric and  electronic properties.14 
Another class of versatile ligands is represented by tetraarylcyclopentadienones, which behave as non-
innocent ligands in reactions promoted by the well-known ruthenium based Shvo catalyst.15 
Since our research interests recently focused on both N-heterocyclic carbenes16 and cyclopentadienone 
ligands,17 we wondered about the possibility to exploit both ligands in the preparation of novel Ru(0) 
complexes. Indeed, most of the literature on Ru(NHC) complexes, is based on Ru(II), whereas the chemistry 
of Ru(0)(NHC) is essentially limited to the combination of NHCs (or their precursors) with Ru3(CO)12 and 
Ru(CO)2(PPh3)3.18 
In this chapter we report the sterically driven synthesis of ruthenium(0) and ruthenium-silver dicarbonyl 
tetraarylcyclopentadienone N-heterocyclic carbene complexes. 
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Results and discussion 
2.1 Synthesis of imidazolium salts 
As a first step, we prepared a small library of variously encumbered imidazolium salts, NHC precursors, by 
following procedures reported in the literature (Figure 2.1). As described in the introduction (paragraph 1.1.2) 
the two main synthetic routes leading to the formation of NHC precursors are by bis-alkylation or cyclization 
reactions. All the imidazolium salts 1a-l depicted in Figure 2.1 have been prepared following these 
two methodologies.  
Figure 2.1. Imidazolium salts precursors of NHC ligands. 
2.2 Synthesis of tetraarylcyclopentadienone Ru(0)-NHC complexes 
At a later stage, imidazolium salts 1a-e have been reacted with Ag2O, and the corresponding silver complexes 
(2, Experimental section) directly treated in situ with the dimeric precursor dicarbonyl(η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) (3). A quantitative and instant transmetallation reaction 
leads to the formation of the neutral Ru(0) complexes 4a-e (Scheme 2.1). The reaction is general with non-
bulky N-heterocyclic carbenes and tolerant to functional groups, in fact it occurs in the presence of a primary 
alcohol in the lateral chain (1d to 4d) without the need of protection.  
Scheme 2.1. Synthesis of dicarbonyl-cyclopentadienone-N-heterocyclic carbene ruthenium complexes (4a-e). 
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The synthesis of 4a-e has been followed by IR spectroscopy observing in all the cases a lowering in the CO 
stretching frequencies (e.g. 4a: ν(CO) = 2004, 1945 cm-1 vs. 3: 2018, 1967 cm-1) due to the strong  donor 
properties of N-heterocyclic carbenes. IR spectra are very similar for complexes 4a-c, whereas, in the case 
of the hydroxyl-functionalized complex 4d, increased frequency for terminal CO and lowering of 
cyclopentadienone ν C=O are observed [ν(CO) = 2011, 1952 cm-1; ν(C=O) = 1558 cm-1 vs. 1586 cm-1 for 4a] 
which is ascribable to the formation of hydrogen bond between –OH and the carbonyl group, as 
demonstrated by X-Ray diffraction. 13C-NMRs show a diagnostic signal for the Ru-Ccarbene within the range 
172-173 ppm (Figure 2.2) and molecular ions of complexes 4a-e are detectable by ESI-MS (see 
Experimental section). 
Figure 2.2. 13C-NMR spectrum of 4a in CDCl3. 
Complexes 4a, 4b and 4d have been also characterized by X-Ray diffraction studies. The molecular structure 
of 4a is reported in Figure 2.3, whereas those of 4b and 4d as well a list of their main bonding parameters are 
given in the Experimental section (Figs. 2.15 and 2.16, Table 2.1). The three complexes display almost 
identical structures, apart from the different substituents on the N-heterocyclic carbene ligand. The Ru(1)-C(3) 
distance [2.470(4) Å in 4a] is significantly longer than Ru(1)-C(4-7) [2.206(4)-2.270(3) Å, average 2.237(7) Å 
in 4a] and C(3)-O(3) [1.245(4) Å] is essentially a double bond.19 The Ru(1)-C(34) contact [2.117(3) Å] is in the 
typical range for the interaction between Ru(0) and a N-heterocyclic carbene.18a 
Figure 2.3. ORTEP drawing of 4a. Displacement ellipsoids are at the 30% probability level. H-atoms have been omitted 
for clarity. Selected bond lengths (Å): Ru(1)-C(1) 1.893(5), Ru(1)-C(2) 1.874(5), Ru(1)-C(3) 2.470(4), Ru(1)-C(4) 
2.263(4), Ru(1)-C(5) 2.206(4), Ru(1)-C(6) 2.208(3), Ru(1)-C(7) 2.270(3), Ru(1)-C(34) 2.117(4), C(3)-O(3) 1.245(4). 
Chapter II 
27 
2.3 Synthesis of dimetallic Ru-Ag-NHC complexes 
The use of the more sterically hindered imidazolium salts 1f-l led to the unexpected hitherto unreported 
heterodimetallic ruthenium-silver complexes of type 5 (Scheme 2.2). As reviewed by Kuhl,20 implications of the 
wingtip groups in N-heterocyclic carbene complexes are normally ascribable to steric factors, and this is also 
our case, in that encumbrance arise by both the tetraarylcyclopentadienone and the N-heterocyclic carbene 
moiety. On the other hand, a possible role of the donor properties of NHCs, in addition to their steric effects 
should not be excluded. Indeed, NHCs with bulky substituents generally display better donor properties, as 
evaluated by TEP values (Tolman Electronic Parameters).21 For example, 1g containing t-butyl groups is a 
better donor compared to 1a, containing methyls.21a A combination of these steric and electronic effects might 
increase both stability and inertness of the silver complexes intermediates (in case of 2f-l) and consequently 
disfavor carbene transmetallation compared with halide coordination.  If this hypothesis is realistic the 
observed formation of bimetallic products, in the case of bulky NHCs, should be the consequence of both steric 
congestion at the ruthenium products and lower tendency to transmetallation of the silver intermediates. 
This remarkable reactivity is likely to be favoured by the formation of a Ru-Cl-Ag bridge and by the concomitant 
interaction between the silver metal and the carbonyl of the cyclopentadienone. 
Scheme 2.2 Synthesis of heterodimetallic Ru-Ag(NHC) complexes (5f-l). 
The dinuclear complexes 5f-l have been characterized by IR, 1H and 13C-NMR and ESI-MS (see Experimental 
section). Suitable crystals for X-Ray diffraction have been obtained for 5f[Cl]. FT-IR CO stretching frequencies 
are in the range 2013-2014 cm-1 and 1953-1955 cm-1 (Figure 2.4), while at the 13C-NMR spectra the Ag-Ccarbene 
resonates as a doublet of doublet (e.g. 5f[Cl]: 188.6 ppm; dd, J (109Ag-13C) = 271 Hz; J (108Ag-13C) = 235 Hz). 
Figure 2.4. IR spectra of 5g, 5h, 5i, 5l: range of terminal CO stretching frequencies. 
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The structure of 5f[Cl] has been crystallographically determined (Figure 2.5 and Table 2.2). This is composed 
by a RuCl(CO)2(tetraarylcyclopentadienone) moiety chelating on the Ag(N-heterocyclic carbene) via O(3) and 
Cl(1). The C(3)-O(3) distance [1.246(7) Å] is almost identical to the one found in 4a [1.245(4) Å] retaining its 
double bond character and suggesting a dative bond between O(3) and Ag(1).  
Figure 2.5. ORTEP drawing of 5f[Cl]. Displacement ellipsoids are at the 30% probability level. H-atoms have been 
omitted for clarity. Selected bond lengths (Å): Ru(1)-C(1) 1.873(8), Ru(1)-C(2) 1.865(8), Ru(1)-C(3) 2.424(6), Ru(1)-C(4) 
2.248(6), Ru(1)-C(5) 2.194(6), Ru(1)-C(6) 2.190(6), Ru(1)-C(7) 2.245(6), Ru(1)-Cl(1) 2.4370(17), C(3)-O(3) 1.246(7), 
Ag(1)-O(3) 2.223(4), Ag(1)-Cl(1) 2.6282(18), Ag(1)-C(34) 2.086(6). 
2.4 Synthesis of dimetallic Ru-Cu(NHC) complex 
Once investigated the substrate scope, we have extended our studies to copper. The reaction between 1,3-
di-(2,6-diisopropylphenyl)imidazole-2-ylidene copper chloride and 3 confirmed the same reactivity as 
demonstrated by X-Ray crystal structure of the Ru-Cl-Cu-O complex 6 (Figure 2.17 and Table 2.2). 
Scheme 2.3. Synthesis of heterodimetallic Ru-Cu(NHC) complex (6). 
The heterodimetallic complexes 5 and 6 are stable in the solid state, while in solution they decompose in more 
than 24h. 
2.5 Synthesis of bis-trimethylsilyl-cyclopentadienone Ru(NHC) complexes 
In order to further extend the ligand scope, with the principal aim to change the solubility of the complex in 
polar solvents such as water the ruthenium triscarbonyl bis(TMS)-substituted cyclopentadienone complex 7, 
has been prepared with a novel method that exploit microwave irradiation (see Experimental section); our way 
of synthesis is indeed by far faster than that reported in the literature.22 By treating 7 with Me3NO in CH3CN, 
intermediate 8 has been obtained and employed as a precursor for the synthesis of NHC complexes 9 by 
transmetallation with silver carbene complexes prepared in situ (Scheme 2.4).  
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Scheme 2.4. Synthesis of dicarbonyl-bis(TMS)-substituted cyclopentadienone Ru(NHC) complexes (9a,d). 
Complexes 9a,d have been completely characterized by IR, 1H and 13C-NMR and ESI-MS (see Experimental 
section). It is important to underline that complex 9d can be protonated leading to a complex partially soluble 
in water. The latter complex for the sake of clarity will be discussed in Chapter V. 
Conclusions 
In summary, a very efficient and rapid synthetic route for obtaining novel Ru(0) complexes, which  combine N-
heterocyclic carbenes and tetraarylcyclopentadienone ligands, has been found. The reaction scope is general 
and transmetallation proved to be tolerant to primary alcohol. A role of the steric hindrance of the ligands has 
been observed leading to the remarkable formation of heterobimetallic complexes containing both Ru and Ag 
or Cu. The novel synthetic methods for the preparation of complexes of type 4, 5 and 6 pave the way for future 
developments in both homogeneous catalysis and medical applications. Finally, preliminary results showed 
that the solubility of the ruthenium complexes in polar solvents such as water can be increased by employing 
a bis-(TMS)-substituted cyclopentadienone ligand instead of the very lipophilic tetraarylcyclopentadienone. 
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Experimental Section 
Materials and procedures. Solvents: dichloromethane (CH2Cl2), tetrahydrofuran (THF), diethyl ether (Et2O), 
petroleum ether referring to a fraction of bp 60-80 °C, acetonitrile (CH3CN) were dried and distilled prior to use. 
Acetone has been degassed and stored under inert atmosphere on molecular sieves. Other solvents such as 
ethylacetate (EtOAc), chloroform, ethanol (EtOH), methanol (MeOH), heptane, toluene, CDCl3, D2O, CD3CN 
(Sigma Aldrich) have been employed without further purification. Reagents: triruthenium-dodecacarbonil 
(Ru3(CO)12) (Strem), methyl iodide, methyl bromide, bromidric and chloridric acid, silver oxide, 1-
methylimidazole, 1,3 diphenylacetone, benzyl bromide, benzyl chloride, paraformaldehyde, tert-butylamine, 
2,6-dimethylaniline, 2,6-diisopropylaniline, glyoxal, acetic acid, 2,4,6-trimethylaniline (Sigma Aldrich), 
4,4’dimethoxybenzil (Alfa Aesar), 1,7-octadiyne have been employed as purchased. 
1,3-dimethylimidazolium iodide (1a[I]),23 1,3-dimethylimidazolium trifluoromethanesulfonate (1a[OTf]), 1,3-
dimethylimidazolium hexafluorophosphate (1a[PF6]), 1,3-dibenzylimidazolium bromide (1b[Br]), 1,3-
dibenzylimidazolium chloride (1b[Cl]),24 1-methyl-3-butyl-imidazolium chloride (1c), 1-methyl-3-(2-
hydroxyethyl)imidazolium chloride (1d),25 1-methyl-3-tert-butylimidazolium iodide (1e), N,N′-bis(2,6-
diisopropylphenyl)-1,4-diaza-1,3-butadiene, 1,3-bis(2,6-diisopropylphenyl)imidazolium chloride (1f[Cl]), 1,3-
bis(2,6-diisopropylphenyl)imidazolium bromide (1f[Br]),26 1,3-di-tert-butylimidazolium chloride (1g),27 1-
methyl-3-(2,6-diisopropylphenyl)imidazolium iodide (1h),28 1-isopropyl-3-tert-butylimidazolium iodide (1i),23 2 
1,4-bis(2,4,6-trimethylphenyl)-1,4-diaza-1,3-butadiene, 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride 
(1l), 1,3-dimethylimidazol-2-ylidene silver iodide (2a[I]),29 1,3-dimethylimidazol-2-ylidene silver 
trifluoromethanesulfonate (2a[OTf]), 1,3-dimethylimidazol-2-ylidene silver hexafluorophosphate (2a[PF6]), 
1,3-dibenzylimidazol-2-ylidene silver chloride (2b[Cl]),30 1,3-dibenzylimidazol-2-ylidene silver bromide 
(2b[Br]),31 1-methyl-3-butylimidazol-2-ylidene silver chloride (2c), 1-methyl-3-(2-hydroxyethyl)imidazol-2-
ylidene silver chloride (2d),32 1-methyl-3-tert-butylimidazol-2-ylidene silver iodide (2e), 1,3-bis(2,6-
diisopropylphenyl)imidazol-2-ylidene silver chloride (2f[Cl]),33 1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene 
silver bromide (2f[Br]),34 1,3-di-tert-butylimidazol-2-ylidene silver chloride (2g), 1-methyl-3-(2,6-
diisopropylphenyl)imidazol-2-ylidene silver chloride (2h), 1-isopropyl-3-tert-butylimidazol-2-ylidene silver 
iodide (2i), 1,3-bis(2,4,6-trimethylphenyl)imidazole-2-ylidene silver chloride (2l), 1,3-di-(2,6-
diisopropylphenyl)imidazol-2-ylidene copper chloride,35 3,4-Bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-
2,4-dienone,36 have been prepared following procedures reported in the literature. 
The prepared derivatives were characterized by spectroscopic methods. The NMR spectra were recorded 
using Varian Inova 300 (1H, 300.1; 13C, 75.5 MHz), Varian Mercury Plus VX 400 (1H, 399.9; 13C, 100.6 MHz), 
Varian Inova 600 (1H, 599.7; 13C, 150.8 MHz) spectrometers at 298 K; chemical shifts were referenced 
internally to residual solvent peaks. Full 1H- and 13C-NMR assignments were done, when necessary, by 
gHSQC and gHMBC NMR experiments using standard Varian pulse sequences. Infrared spectra were 
recorded at 298 K on a Perkin-Elmer Spectrum 2000 FT-IR spectrophotometer. ESI-MS spectra were recorded 
on Waters Micromass ZQ 4000 with samples dissolved in MeOH or CH3CN. Elemental analyses were 
performed on a Thermo-Quest Flash 1112 Series EA instrument. 
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Synthesis of Ag-NHC complexes (2) 
Imidazolium salts (1), were reacted with Ag2O (1.2 eq.) in the appropriate solvent under inert atmosphere and 
with protection from light. After stirring the reaction for the time and at the temperature required in order to 
reach complete conversion to silver complexes (2), the solvent was then removed under vacuum and the silver 
complexes characterized by NMR spectroscopy observing the disappearance of the NC(H)N signal of 
imidazolium salts 1a-l (around 8-9 ppm: 1H-NMR)1-6 and the concomitant arising of the NMR signals of the 
silver complexes 2a-l which are consistent with literature data.7-12 
Figure 2.6. Mono and bis-carbene silver complexes (2) 
1,3-dimethylimidazol-2-ylidene silver iodide (2a[I]): 1,3-dimethylimidazolium iodide 0.149 g (0.665 mmol), 
Ag2O 0.185 g (0.798 mmol), room temperature, CH2Cl2, 3h. 1H-NMR (399.9 MHz, CDCl3): δ 6.97 (s, 2H, 
CHNHC), 3.84 (s, 6H, NCH3). 
1,3-dimethylimidazol-2-ylidene silver trifluoromethanesulfonate (2a[OTf]): 1,3-dimethylimidazolium 
trifluoromethanesulfonate 0.075 g (0.35 mmol), Ag2O 0.093 g (0.40 mmol) room temperature, CH2Cl2, 3h.  1H-
NMR (399.9 MHz, CDCl3): δ 6.96 (s, 2H, CHNHC), 3.90 (s, 6H, NCH3). 19F-NMR (282.4 MHz, CDCl3): δ -78.38 
(s, 3F). 
1,3-dimethylimidazol-2-ylidene silver hexafluorophosphate (2a[PF6]): 1,3-dimethylimidazolium 
hexafluorophosphate 0.075 g (0.35 mmol), Ag2O 0.093 g (0.40 mmol), 40 °C, CH2Cl2, 16h. 1H-NMR (399.9 
MHz, CDCl3): δ 7.00 (s, 2H, CHNHC), 3.84 (s, 6H, NCH3). 19F-NMR (282.4 MHz, CDCl3): δ -72.91 (d, 6F, JP-F = 
757 Hz). 
1,3-dibenzylimidazol-2-ylidene silver chloride (2b[Cl]): 1,3-dibenzylimidazolium chloride 0.024 g (0.083 
mmol), Ag2O 0.023 g (0.099 mmol), 80 °C reflux, CH3CN, 3h. 1H-NMR (399.9 MHz, CDCl3): δ 7.34-7.24 (m, 
10H, CHPh), 7.05 (s, 2H, CHNHC), 5.23 (s, 4H, CH2). Suitable crystals of 2b[Cl] has been obtained by 
CH2Cl2/petroleum ether double layer. 
1,3-dibenzylimidazol-2-ylidene silver bromide (2b[Br]): 1,3-dibenzylimidazolium bromide 0.027 g (0.083 
mmol), Ag2O 0.023 g (0.099 mmol), 80 °C reflux, CH3CN, 3h. 1H-NMR (399.9 MHz, CDCl3): δ 7.29-7.18 (m, 
10H, CHPh), 6.99 (s, 2H, CHNHC), 5.21 (s, 4H, CH2).  
1-methyl-3-butylimidazol-2-ylidene silver chloride (2c): 1-methyl-3-butyl-imidazolium bromide 0.018 g
(0.083 mmol), Ag2O 0.023 g (0.099 mmol), 80 °C reflux, CH3CN, 3h. 1H-NMR (399.9 MHz, CDCl3): δ 6.96 (m, 
1H, CHNHC), 6.93 (m, 1H, CHNHC), 4.46 (t, 2H, J = 7.5 Hz, NCH2), 4.06 (s, 3H, NCH3), 1.92 (m, 2H, CH2), 1.37 
(m, 2H, CH2), 1.07 (t, 3H, J = 7.2 Hz, CH3). 
1-methyl-3-(2-hydroxyethyl)imidazol-2-ylidene silver chloride (2d): 1-methyl-3-(2-
hydroxyethyl)imidazolium chloride 0.014 g (0.083 mmol), Ag2O 0.023 g (0.099 mmol), room temperature, 
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CH3CN, 3h. 1H-NMR (399.9 MHz, CDCl3): δ 7.17 (s, 1H, CHNHC), 6.99 (s, 1H, CHNHC), 4.24 (t, J = 5,2 Hz, 2H, 
CH2), 3.86 (t, J = 5,2 Hz, 2H, CH2), 3.68 (s, 3H, CH3). 
1-methyl-3-tert-butylimidazol-2-ylidene silver iodide (2e): 1-methyl-3-tert-butylimidazolium iodide 0.026 g
(0.098 mmol), Ag2O 0.027 g (0.117 mmol), room temperature, CH2Cl2, 4h.  1H-NMR (399.9 MHz, CDCl3): δ 
7.14 (s, 1H, CHNHC), 6.93 (s, 1H, CHNHC), 3.77 (s, 3H, NCH3), 1.72 (s, 9H, CH3tBu).  
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene silver chloride (2f[Cl]): 1,3-bis(2,6-
diisopropylphenyl)imidazolium chloride 0.070 g (0.17 mmol), Ag2O 0.047 g (0.20 mmol), 40 °C, CH2Cl2, 3h. 
1H-NMR (399.9 MHz, CDCl3): δ 7.49 (d, J = 7.8 Hz, 2H, CHPh), 7.29 (d, J = 7.8 Hz, 4H, CHPh), 7.21 (s, 2H, 
CHNHC), 2.54 (sept, J = 6.8 Hz, 4H, CHiPr), 1.23 (d, J = 6.8 Hz, 12 H, CH3iPr), 1.18 (d, J = 6.8 Hz, 12 H, CH3iPr). 
1,3-bis(2,6-diisopropylphenyl)imidazol-2-ylidene silver bromide (2f[Br]): 1,3-bis(2,6-
diisopropylphenyl)imidazolium bromide 0.038 g (0.083 mmol), Ag2O 0.023 g (0.099 mmol), 40 °C, CH2Cl2, 3h. 
1H-NMR (399.9 MHz, CDCl3): δ 7.49 (m, 2H, CHPh), 7.30 (m, 4H, CHPh), 7.21 (s, 2H, CHNHC), 2.54 (sept, J = 
6.8 Hz, 2H, CHiPr), 1.28 (d, J = 6.8 Hz, 12 H, CH3iPr), 1.20 (d, J = 6.8 Hz, 12 H, CH3iPr). 
1,3-di-tert-butylimidazol-2-ylidene silver chloride (2g): 1,3-di-tert-butylimidazolium chloride 0.018 g (0.083 
mmol), Ag2O 0.023 g (0.099 mmol), room temperature, CH2Cl2, 3h. 1H-NMR (399.9 MHz, CDCl3): δ 7.11 (s, 
2H, CHNHC), 1.76 (s, 18H, CH3tBu). 
1-methyl-3-(2,6-diisopropylphenyl)imidazol-2-ylidene silver chloride (2h):  1-methyl-3-(2,6-
diisopropylphenyl)imidazolium iodide 0.038 g (0.10 mmol), Ag2O 0.028 g (0.12 mmol) room temperature, 
CH2Cl2, 3h. 1H-NMR (399.9 MHz, CDCl3): δ 7.46 (t, J = 7.8 Hz, 1H, CHPh), 7.23 (m, 2H, CHPh), 7.17 (m, 1H, 
CHNHC), 6.98 (m, 1H, CHNHC), 3.98 (s, 3H, NCH3), 2.35 (sept, J = 6.8 Hz, 2H, CHiPr), 1.22 (d, J = 6.8 Hz, 6 H, 
CH3iPr), 1.10 (d, J = 6.8 Hz, 6 H, CH3iPr). 
1-isopropyl-3-tert-butylimidazol-2-ylidene silver iodide (2i): 1-isopropyl-3-tert-butylimidazolium iodide
0.031 g (0.11 mmol), Ag2O 0.029 g (0.13 mmol), room temperature, CH2Cl2, 24h.  1H-NMR (399.9 MHz, CDCl3): 
δ 7.16 (s, 1H, CHNHC), 6.97 (s, 1H, CHNHC), 4.83 (sept, J = 6.8 Hz, 1H, CHiPr), 1.72 (s, 9H, CH3tBu), 1.46 (d, J = 
6.8 Hz, 6H, CH3iPr). 
1,3-bis(2,4,6-trimethylphenyl)imidazole-2-ylidene silver chloride (2l): 1,3-bis(2,4,6-
trimethylphenyl)imidazolium chloride 0.028 g (0,083 mmol), Ag2O 0.023 g (0,099 mmol), 40 °C, CH2Cl2, 4h. 
1H-NMR (399.9 MHz, CDCl3): 7.13 (s, 2H, CHNHC), 6.99 (s,  4H, CHPh), 2.35 (s, 6H, p-CH3Ph), 2.07 (s, 12H, o-
CH3Ph). 
Synthesis of dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) 
ruthenium dimer (3). 
Figure 2.7. Structure of the dimeric ruthenium precursor (3). 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) ruthenium dimer (3) has been 
prepared following a procedure reported in the literature for a similar complex,37 by reacting 3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone 1.04 g (2.35 mmol) and Ru3(CO)12 0.50 g (0.78 mmol) in 
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heptane (130°C for 5 days, inert atmosphere). 3 was purified by filtration as a yellow solid and obtained with a 
yield of 80%. 1H-NMR (399.9 MHz, CDCl3): δ 7.10-6.40 (m, 36H, CHaryl), 3.60 (s, 12H, -OCH3); 13C-NMR (100.6 
MHz, CDCl3): δ 206.91 (CO), 169.65 (C=O), 158.53 (-COCH3), 132.70 (CHaryl), 130.96 (Cqaryl), 130.58 (CHaryl), 
126.27 (CHaryl), 122.67 (Cqaryl), 113.32 (-CHaryl), 112.54 (CHaryl), 97.78 (C2,5 Cp), 87.76 (C3,4 Cp), 54.90 (-
OCH3). IR (CH2Cl2, cm-1): 2018, 1967 (νCO); 1610, 1519 (νC=C).
Synthesis of Ru(NHC) complexes (4) 
I step: imidazolium salts (1), were reacted with Ag2O (1.2 eq.) in the appropriate solvent under inert atmosphere 
and with protection from light. After stirring the reaction for the time and at the temperature required in order 
to reach complete conversion to silver complexes (2), the solvent, if different from CH2Cl2, was removed under 
vacuo and the solid obtained dissolved in CH2Cl2. II step: then dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone) ruthenium dimer (3) (0.5 eq. vs. imidazolium salts) was straightforwardly 
added to the in situ prepared silver complexes solution. The reaction mixture was stirred until the end of the 
reaction at room temperature. Upon filtration on a celite pad and removal of the solvent the quantitative 
formation of the dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)(NHC)ruthenium complexes (4) was verified by 1H-NMR, 13C-NMR, ESI-MS and X-Ray crystal 
structure when suitable crystals were available. 
Figure 2.8. Structure of the mononuclear Ru carbene complexes (4). 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dimethylimidazol-2-
ylidene)ruthenium (4a): I step: 1,3-dimethylimidazolium iodide 0.149 g (0.665 mmol), Ag2O 0.185 g (0.798 
mmol), room temperature, CH2Cl2, 3h. II step: 3 0.400 g (0.332 mmol), 10 min. The beige solid obtained was 
identified as 4a (0.208 g, 90% yield). Suitable crystals of 4a for X-Ray diffraction were obtained by slow 
diffusion (CH2Cl2/Et2O). 
The same reaction performed in a J-Young valve equipped NMR tube in CDCl3 (0.7 mL) led to the in situ 
formation of the silver complex 2a by sonication of the sample containing 1,3-dimethylimidazolium iodide 0.011 
g (0.050 mmol) and Ag2O 0.014 g (0.060 mmol) for 2h. Afterwards 3 0.030 g (0.025 mmol) was added and 1H-
NMR analysis showed the quantitative and immediate formation of the complex 4a. Complex 4a is stable to 
air, moisture, in solution of organic solvents and in the presence of water. 4a has been analyzed by IR, 1H-
NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (599.7 MHz, CDCl3): δ 7.79 (m, 4H, CHaryl), 7.17-7.04 
(m, 10H, CHaryl), 6.76 (s, 2H, CHNHC), 6.65 (m, 4H, CHaryl), 3.71 (s, 6H, -OCH3), 3.09 (s, 6H, -NCH3). 13C-NMR 
(150.8 MHz, CDCl3, g-HSQC, g-HMBC): δ 202.47 (CO), 172.72 (Ccarbene), 169.33 (C=O, Cp), 158.54 (-COCH3), 
135.43 (Cqaryl), 133.62 (CHaryl), 129.16 (CHaryl), 127.43 (CHaryl), 125.27 (Cqaryl), 124.90 (CHaryl), 123.62 
(CHNHC), 112.93 (CHaryl), 103.85 (C2,5, Cp), 78.46 (C3,4, Cp), 55.00 (-OCH3), 38.23 (-NCH3). IR (CH2Cl2, cm-1): 
2004, 1945 (νCO); 1586 cm-1 (νC=O); 1601, 1518 (νC=C). ESI-MS (m/z) (+): 699 [M+H]+; 721 [M + Na]+. Anal. 
Calcd (%) for C38H32N2O5Ru: C, 65.41; H, 4.62. Found: C, 65.33; H, 4.58. 
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By using imidazolium salts with non-coordinating anions such as 1,3-dimethylimidazolium 
trifluoromethanesulfonate or 1,3-dimethylimidazolium hexafluorophosphate the formation of the corresponding 
silver complexes 2a[OTf] and 2a[PF6] occurs. The latter undergo a transmetallation reaction with 3 leading to 
the formation of complex 4a. 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dibenzylimidazol-
ylidene)ruthenium (4b): I step: 1,3-dibenzylimidazolium bromide 0.027 g (0,083 mmol), Ag2O 0.023 g (0.099 
mmol), 80 °C reflux, CH3CN, 3h. II step: 3 0.050 g (0.042 mmol), 2h. The beige solid obtained was identified 
as 4b (0.081 g, 97% yield). Suitable crystals of 4b for X-Ray diffraction were obtained by slow diffusion 
(toluene/hexane). The same result is obtained employing 1,3-dibenzylimidazolium chloride as imidazolium salt. 
4b has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (300.1 MHz, CDCl3): 
δ 7.85-6.60 (m, 28H, CHaryl), 6.57 (s, 2H, CHNHC), 4.67 (s, 4H, -CH2Ph), 3.69 (s, 6H, -OCH3). 13C-NMR (150.8 
MHz, CDCl3): δ 201.69 (CO), 174.73 (Ccarbene), 169.90 (C=O, Cp), 158.54 (-COCH3), 136.13-112.90 (Caryl), 
122.71 (CHNHC), 104.03 (C2,5, Cp), 78.87 (C3,4, Cp), 54.99, 54.27 (CH2Ph, -OCH3). IR (CH2Cl2, cm-1): 2006, 
1947 (νCO); 1586 (νC=O); 1603, 1518 (νC=C). ESI-MS (m/z) (+): 851 [M+H]+. Anal. Calcd (%) for C50H40N2O5Ru: 
C, 70.66; H, 4.74. Found: C, 70.58; H, 4.71. 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-3-butyl-
imidazol-ylidene)ruthenium (4c): I step: 1-methyl-3-butyl-imidazolium bromide 0.018 g (0.083 mmol), Ag2O 
0.023 g (0.099 mmol), 80 °C reflux, CH3CN, 3h. II step: 3 0.050 g (0.042 mmol), 1h. The beige solid obtained 
was identified as 4c (0.059 g, 96% yield). 4c has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR 
(300.1 MHz, CDCl3): δ 7.67-6.63 (m, 18H, CHaryl), 7.82 (s, 1H, CHNHC), 6.77 (s, 1H, CHNHC), 3.69 (s, 6H, -
OCH3), 3.31 (m, 2H, -NCH2), 3.05 (s, 3H, -NCH3), 1.39, 0.89 (m, 2H, -CH2CH2), 0.72 (-CH3). 13C-NMR (150.8 
MHz, CDCl3): δ 202.44 (CO), 172.23 (Ccarbene), 169.50 (C=O, Cp), 158.50 (-COCH3), 135.41-112.90 (Caryl), 
124.04 (CHNHC), 121.41 (CHNHC), 103.88 (C2,5, Cp), 78.35 (C3,4, Cp), 54.97 (-OCH3), 50.22 (-NCH2), 38.12 (-
NCH3), 33.24, 19.38 (-CH2CH2-), 13.72 (-CH3). IR (CH2Cl2, cm-1): 2003, 1943 (νCO); 1586 (νC=O); 1600, 1517 
(νC=C). ESI-MS (m/z) (+): 741 [M+H]+. Anal. Calcd (%) for C41H38N2O5Ru: C, 66.56; H, 5.18. Found: C, 66.51; 
H, 5.17. 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-3-(2-
hydroxyethyl)imidazol-ylidene)ruthenium (4d): I step: 1-methyl-3-(2-hydroxyethyl)imidazolium chloride 
0.014 g (0.083 mmol), Ag2O 0.023 g (0.099 mmol), room temperature, CH3CN, 3h. II step: 3 0.050g (0.042 
mmol), 1h. The beige solid obtained, was identified as 4d, (0.060 g, 98% yield). Suitable crystals of 4d for X-
Ray diffraction were obtained by slow diffusion (CH2Cl2/petroleum ether). 4d has been analyzed by IR, 1H-
NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (300.1 MHz, CDCl3): δ 7.67-6.65 (m, 18H, CHaryl), 
7.01 (s, 1H, CHNHC), 6.86 (s, 1H, CHNHC), 3.86 (m, 2H, -NCH2), 3.72 (s, 6H, -OCH3), 3.22 (s, 3H, -NCH3), 3.15 
(m, 2H, -CH2OH). 13C-NMR (150.8 MHz, CDCl3): δ 201.82 (CO), 172.88 (Ccarbene), 166.15 (C=O, Cp), 158.67 
(-COCH3), 134.07-112.95 (Caryl), 124.23 (CHNHC), 121.03 (CHNHC), 104.98 (C2,5, Cp), 80.68 (C3,4, Cp), 58.94 (-
NCH2), 55.04 (-OCH3), 52.47 (-CH2OH), 38.29 (-NCH3). IR (CH2Cl2, cm-1): 2011, 1952 (νCO); 1558 (νC=O); 1609, 
1518 (νC=C). ESI-MS (m/z) (+): 729 [M+H]+, 751 [M+Na]+. Anal. Calcd (%) for C39H34N2O6Ru: C, 64.36; H, 4.71. 
Found: C, 64.29; H, 4.69. 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-3-tert-butyl-
imidazol-ylidene)ruthenium (4e): I step: 1-methyl-3-(tert-butyl)imidazolium iodide 0.026 g (0.097 mmol), 
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Ag2O 0.027 g (0.17 mmol), room temperature, CH2Cl2, 4h. II step: 3 0.059 g (0.049 mmol), 2h. The beige 
solid obtained, was identified as 4e, (0.070 g, 98% yield). 4e has been analyzed by IR, 1H-NMR, 13C-NMR, 
ESI-MS. 1H-NMR (300.1 MHz, CDCl3): δ 7.73 (s, 1H, CHNHC), 7.71-6.62 (m, 18H, CHaryl), 6.08 (s, 1H, 
CHNHC), 3.71 (s, 6H, -OCH3), 3.24 (s, 3H, -NCH3), 1.31 (s, 9H, CH3tBu). 13C-NMR (150.8 MHz, CDCl3): 203.75 
(CO), 182.15 (Ccarbene), 168.31 (C=O, Cp), 158.29 (-COCH3), 149.03 (CHNHC), 135.86-112.73 (Caryl, CHNHC), 
103.18 (C2,5, Cp), 79.42 (C3,4, Cp), 56.62 (CqtBu), 55.00 (-OCH3), 37.63 (-NCH3), 29.69 (CH3tBu). IR (CH2Cl2, 
cm-1): 1996, 1933 (νCO); 1590 (νC=O); 1604, 1518 (νC=C). ESI-MS (m/z) (+): 741 [M+H]+. Anal. Calcd (%) for
C41H38N2O5Ru: C, 66.56; H, 5.18. Found: C, 66.53; H, 5.19. 
Synthesis of Ru-Ag(NHC) complexes (5) 
I step: imidazolium salts (1), were reacted with Ag2O in the appropriate solvent under inert atmosphere and 
with protection from light. After stirring the reaction for the time and at the temperature requested in order to 
reach complete conversion, the solvent, if different from CH2Cl2, was removed and the solid obtained dissolved 
in CH2Cl2. II step: successively dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) 
ruthenium dimer (3) (0.5 eq. vs. imidazolium salts) was straightforwardly added to the in situ prepared silver 
complexes solution. The reaction mixture was stirred until the end of the reaction at room temperature. Upon 
filtration on a celite pad and removal of the solvent the quantitative formation of the dicarbonyl-η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(NHC)silver halidee)ruthenium complexes (5) was 
verified by 1H-NMR, 13C-NMR, ESI-MS and X-Ray crystal structure when suitable crystals were available. 
Figure 2.9. Structure of the dimetallic Ru-Ag carbene complexes (5). 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-di-(2,6-
diisopropylphenyl)imidazol-2-ylidene silver chloride)ruthenium (5f[Cl]): I step: 1,3-bis(2,6-
diisopropylphenyl)imidazolium chloride 0.070 g (0.17 mmol), Ag2O 0.047 g (0.20 mmol), 40 °C, CH2Cl2, 3h. II 
step: 3 0.100 g (0.083 mmol), 1h. The beige solid obtained, was identified as 5f[Cl], (0.187 g, 96% yield). 
Suitable crystals of 5f[Cl] for X-Ray diffraction were obtained by slow diffusion (CH2Cl2/petroleum ether). 5f[Cl] 
has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 5f[Cl] is stable in the solid state; 
it decomposes in solution of CH2Cl2, CDCl3, Tol-d8 in more than 24h. 1H-NMR (399.9 MHz, CDCl3): δ 7.57-
6.51 (m, 24H, CHaryl), 7.24 (s, 2H, CHNHC), 3.68 (s, 6H, -OCH3), 2.53 (sept, J = 6.8 Hz, 4H, CHiPr), 1.16 (d, J = 
6.8 Hz, 12H, CH3iPr), 1.13 (d, J = 6.8 Hz, 12H, CH3iPr). 13C-NMR (150.8 MHz, CDCl3): δ 200.54 (CO), 188.6 
(dd, J (109Ag-13C) = 271 Hz; J (108Ag-13C) = 235 Hz), 165.38 (C=O, Cp), 158.47 (-COCH3), 145.53-112.55 
(Caryl), 123.04, 122.96 (CHNHC), 99.61 (C2,5, Cp), 83.12 (C3,4, Cp), 55.03 (-OCH3), 28.60 (CHiPr), 24.34, 24.05 
(CH3iPr). IR (CH2Cl2, cm-1): 2013, 1953 (νCO); 1608, 1518 (νC=C). ESI-MS (m/z) (-): 1169 [M+Cl]-. Anal. Calcd 
(%) for C60H60AgClN2O5Ru: C, 63.58; H, 5.34. Found: C, 63.49; H, 5.29. 
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The same reaction was performed on 1,3-bis(2,6-diisopropylphenyl)imidazolium bromide as starting material 
leading to the formation of the equivalent dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)(1,3-di-(2,6-diisopropylphenyl)imidazol-2-ylidene silver bromide)]ruthenium (5f[Br]) which show a 1H-
NMR and IR characterization superimposable to the one of 5f[Cl]. 1H-NMR (399.9 MHz, CDCl3): δ 7.57-6.51 
(m, 24H, CHaryl), 7.24 (s,2H, CHNHC), 3.68 (s, 6H, -OCH3), 2.53 (sept, J = 6.8 Hz, 4H, CHiPr), 1.16 (d, J = 6.8 
Hz, 12H,CH3iPr), 1.14 (d, J = 6.8 Hz, 12H, CH3iPr). IR (CH2Cl2, cm-1): 2013, 1953 (νCO); 1608, 1518 (νC=C). 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-di-tert-
butylimidazol-2-ylidene silver chloride)ruthenium (5g): I step: 1,3-di-tert-butylimidazolium chloride 0.018 g 
(0.083 mmol), Ag2O 0.023 g (0.10 mmol), room temperature, CH2Cl2, 3h. II step: 3 0.050 g (0.042 mmol), 2h. 
The beige solid obtained was identified as 5g (0.088 g, 95% yield). 5g has been analyzed by IR, 1H-NMR, 13C-
NMR, ESI-MS. 5g is stable in the solid state; it decomposes in solution in more than 24h. 1H-NMR (300.1 MHz, 
CDCl3): δ 7.50-6.55 (m, 18H, CHaryl), 7.01 (s, 2H, CHNHC), 3.70 (s, 6H, -OCH3), 1.60 (s, 18H, CH3tBu). 13C-NMR 
(150.8 MHz, CDCl3): δ 200.46 (CO), 177.51(s, Ccarbene), 165.20 (C=O, Cp), 158.60 (-COCH3), 133.14-112.75 
(CHaryl), 116.16  (CHNHC), 99.71 (C2,5, Cp), 84.00 (C3,4, Cp), 55.00 (-OCH3), 57.45 (CqtBu), 31.60 (CH3tBu). IR 
(CH2Cl2, cm-1): 2014, 1955 (νCO); 1608, 1518 (νC=C). ESI-MS (m/z) (-): 961 [M+Cl]-. Anal. Calcd (%) for 
C44H44AgClN2O5Ru: C, 57.12; H, 4.79. Found: C, 57.02; H, 4.75. 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-3-(2,6-
diisopropylphenyl)imidazol-2-ylidene silver chloride)ruthenium (5h): I step: 1-methyl-3-(2,6-
diisopropylphenyl)imidazolium iodide 0.038 g (0.10 mmol), Ag2O 0.028 g (0.12 mmol), room temperature, 
CH2Cl2, 3h. II step: 3 0.061 g (0.051 mmol), 2h. The beige solid obtained was identified as 5h (0.096 g, 97% 
yield). 5h has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 5h is stable in the solid state; it decomposes 
in solution in more than 24h. 1H-NMR (300.1 MHz, CDCl3): δ 7.53-6.54 (m, 21H, CHaryl), 7.07, 7.09 (m, 2H, 
CHNHC) 3.73 (3H, -NCH3), 3.72 (s, 6H, -OCH3), 2.33 (sept, J = 6.8 Hz, 2H, CHiPr), 1.20 (d, J = 6.8 Hz, 6H, 
CH3iPr), 1.09 (d, J = 6.8 Hz, 6H, CH3iPr). 13C-NMR (150.8 MHz, CDCl3): δ 200.27 (CO), 176.85 (Ccarbene), 168.36 
(C=O, Cp), 158.59 (-COCH3), 145.68-112.71 (Caryl), 123.33, 121.23 (CHNHC),100.39 (C2,5, Cp), 83.60 (C3,4, 
Cp), 55.00 (-OCH3), 38.55 (-NCH3), 28.06 (CHiPr), 24.40, 24.35 (CH3iPr). IR (CH2Cl2, cm-1): 2014, 1955 (νCO); 
1609, 1518 (νC=C). ESI-MS (m/z) (-): 1023 [M+Cl]-. Anal. Calcd (%) for C49H46AgClN2O5Ru: C, 59.61; H, 4.70. 
Found: C, 59.54; H, 4.67. 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-isopropyl-3-tert-
butyl)imidazol-2-ylidene silver iodide)ruthenium (5i): I step: 1-isopropyl-3-tert-butylimidazolium iodide 
0.062 g (0.22 mmol), Ag2O 0.058 g (0.26 mmol), room temperature, CH2Cl2, 24h. II step: 3 0.128 g (0.106
mmol), 2h. The beige solid obtained, was identified as 5i by IR and 1H-NMR. 5i decomposed in solution 
preventing 13C-NMR analysis. 1H-NMR (399.9 MHz, CDCl3): δ 7.54-6.56 (m, 20H, CHaryl, CHNHC), 3.71 (s, 6H, 
-OCH3), 4.52 (m, 1H, CHiPr), 1.56 (s, 9H, CH3tBu), 1.31 (d, 6H, J = 6.8 Hz, CH3iPr). IR (CH2Cl2, cm-1): 2016, 1958
(νCO); 1609, 1518 (νC=C). 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-bis-(2,4,6-
trimethylphenyl)imidazol-2-ylidene silver chloride)ruthenium (5l): I step: 1,3-bis-(2,4,6-
trimethylphenyl)imidazolium chloride 0.056 g  (0.17 mmol), Ag2O 0.046 g (0.20 mmol), room temperature, 
CH2Cl2, 2h. II step: 3 0.100 g (0.083 mmol), 1h. The beige solid obtained, was identified as 5l by IR and 1H-
NMR. 5l decomposed in solution preventing 13C-NMR analysis. 1H-NMR (399.9 MHz, CDCl3): δ 7.25-6.41 (m, 
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22H, CHaryl, CHNHC), 3.59 (s, 6H, -OCH3), 2.35 (s, 6H, p-CH3Ph), 1.91 (s, 12H, o-CH3Ph). IR (CH2Cl2, cm-1): 
2013, 1954 (νCO); 1608, 1517 (νC=C). 
Synthesis of Ru-Cu(NHC) complex (6) 
Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-di-(2,6-
diisopropylphenyl)imidazol-2-ylidene copper chloride)ruthenium (6) 
Figure 2.10. Structure of the dimetallic Ru-Cu carbene complex (6). 
To a CH2Cl2 solution of 1,3-di-(2,6-diisopropylphenyl)imidazol-2-ylidene copper chloride 0.081 g (0.16 mmol), 
3 0.100 g (0.083 mmol) was added. The reaction mixture was stirred for 1h at room temperature. Upon filtration 
on a celite pad and removal of the solvent the quantitative formation of 6 as a beige solid (0.164 g, 94% yield) 
was verified by 1H-NMR, 13C-NMR, ESI-MS. Suitable crystals of 6 for X-Ray diffraction were obtained by slow 
diffusion (toluene/hexane). 6 is stable in the solid state. It decomposes in solution in more than 24h. 1H-NMR 
(399.9 MHz, CDCl3): δ 7.57-6.52 (m, 24H, CHaryl), 7.05 (s, 2H, CHNHC), 3.69 (s, 6H, -OCH3), 2.68 (sept, J = 6.6 
Hz, 4H, CHiPr), 1.17 (d, J = 6.6 Hz, 12H, CH3iPr).13C-NMR (150.8 MHz, CDCl3): δ 200.43 (CO), 183.45 (Ccarbene), 
165.56 (C=O, Cp), 158.47 (-COCH3), 145.66-112.70 (Caryl), 130.76 (CHNHC), 99.17 (C2,5, Cp), 84.94 (C3,4, Cp), 
54.91 (-OCH3), 28.44 (CHiPr), 24.23, 23.84 (CH3iPr). IR (CH2Cl2, cm-1): 2014, 1956 (νCO); 1609, 1520 (νC=C). 
ESI-MS (m/z) (-): 1125 [M+Cl]-. Anal. Calcd (%) for C60H60CuClN2O5Ru: C, 66.16; H, 5.55. Found: C, 66.10; 
H, 5.51. 
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Synthesis of bis-trimethylsilyl-cyclopentadienone Ru complexes  
Triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)ruthenium (7) 
Figure 2.11. Structure of ruthenium triscarbonyl bis(TMS)-substituted cyclopentadienone complex (7). 
In a 75 mL Teflon tube equipped with magnetic stirrer, 1,7-octadiyne 0.150 g (0.6 mmol) and Ru3(CO)12 0.191 
g (0.3 mmol) were dissolved in 40 mL of toluene. The container is closed with a cap, equipped with a 
temperature sensor, and placed into microwave. The reaction is heated to 140 °C for 4h. Upon removal of the 
solvent, the crude was purified by neutral alumina column chromatography eluting, at first, with hexane, then 
with dichloromethane and finally with ethyl acetate to afford the yellow triscarbonyl-(2,4-
bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron complex (7) with a yield of 52%. 1H-NMR (399.9 MHz, 
CDCl3): δ (ppm) 2.65 (m, 4H, CH2), 1.80 (m, 4H, CH2), 0.26 (s, 18H, CH3, TMS). 13C-NMR (150.8 MHz, CDCl3, 
g-HSQC, g-HMBC): δ (ppm) 195.06 (CO), 184.54 (C=O), 112.62 (C2,5, Cp), 68.69 (C3,4, Cp), 24.96 (CH2, 2C),
22.59 (CH2, 2C), 0.14 (CH3, TMS, 6C).vIR (CH2Cl2, cm-1): 2076, 2017, 2000 (νCO), 1614 (νC=O).ESI-MS (m/z) 
(+): 465 [M+H]+; 487 [M + Na]+; 503 [M+K]+. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[acetonitrile]ruthenium (8) 
Figure 2.12. Structure of dicarbonyl-(2,4-bis(TMS)bicyclo[3.3.0]nona-1,4-dien-3-one)[acetonitrile]Ru precursor (8). 
In a dried 10 mL Schlenk flask, triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)ruthenium  
(7) 0.065 g (0.140  mmol)  and  trimethylamine-N-oxide 0.016 g (0.210  mmol) were dissolved in 3 mL of
anhydrous acetonitrile. Reaction mixture was stirred at room temperature and protected from light for 3 hours. 
A pale-yellow precipitate appeared. The solid was filtered and washed with cold hexane to afford the complex 
dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[acetonitrile]ruthenium (8) with a yield of 
75%.1H-NMR (399.9 MHz, CDCl3): δ (ppm) 2.42 (m, 4H, CH2), 2.25 (s, 3H, CH3), 1.60 (m, 4H, CH2), 0.26 (s, 
18H, CH3, TMS). 13C-NMR (150.8 MHz, CDCl3, g-HSQC, g-HMBC): δ (ppm) 199.10 (CO), 182.47 (C=O), 
124.51 (Cq, -CH3CN), 107.27 (C2,5, Cp), 67.99 (C3,4, Cp), 25.17 (CH2, 2C), 22.44 (CH2, 2C), 4.09 (-CH3CN), 
0.14 (CH3, TMS, 6C). IR (CH2Cl2, cm-1): 2010, 1948 (νCO), 1591 (νC=O). ESI-MS (m/z) (+): 478 [M+H]+; 500 [M 
+ Na]+.
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Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1,3-dimethyl-ilidene]ruthenium 
(9a)  
Figure 2.13. Structure of bis(TMS)-substituted cyclopentadienone Ru carbene complex (9a) 
A mixture of 1,3-dimethylimidazolium iodide (1a) (0.013g, 0.056mmol), Ag2O (1.2eq, 0.016g, 0.067mmol) and 
dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[acetonitrile]ruthenium precursor (8) 
(0.027g, 0.056mmol) were reacted in dry CH2Cl2 under inert atmosphere and with protection from light stirring 
for 1h at room temperature. Upon filtration on a celite pad and removal of the solvent the quantitative formation 
of the dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1,3-dimethyl-ilidene]ruthenium (9a) 
was verified  by 1H-NMR, 13 C-NMR and ESI-MS. 1H-NMR (399.9 MHz, CDCl3): δ (ppm) 6.98 (s, 2H, CHNHC), 
3.88 (s, 6H, CH3), 2.54 (m, 4H, CH2), 1.77 (m, 4H, CH2), 0.19 (s, 18H, CH3, TMS). 13C-NMR (150.8 MHz, 
CDCl3, g-HSQC, g-HMBC): δ (ppm) 202.60 (CO), 181.75 (Ccarbene), 177.12 (C=O), 122.98 (CHNHC), 105.88 
(C2,5, Cp), 68.03 (C3,4, Cp), 40.38 (-NCH3), 24.82 (CH2, 2C), 22.87 (CH2, 2C), 0.98 (CH3, TMS, 6C). 
IR (CH2Cl2, cm-1): 1997, 1935 (νCO), 1563 (νC=O). ESI-MS (m/z) (+): 533 [M+H]+; 555 [M + Na]+. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-hydroxyethyl))-3-
methylilidene]ruthenium (9d) 
Figure 2.14. Structure of bis(TMS)-substituted cyclopentadienone Ru carbene complex (9d). 
1-methyl-3-(2-hydroxyethyl) imidazolium chloride (1d) (0.014g, 0.096mmol), was reacted with Ag2O (1.2eq.,
0.027g, 0.115mmol) in dry CH3CN under inert atmosphere and with protection from light. The reaction mixture 
was stirred for 3h at room temperature in order to reach complete conversion to the corresponding silver 
carbene complex. Then, the solvent was removed under vacuum, the solid obtained dissolved in CH2Cl2 and 
0.046g (0.096mmol) of dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-
one)[acetonitrile]ruthenium precursor (2) was straightforwardly added to the in situ prepared silver complex 
solution. After stirring for 1h at room temperature, the reaction mixture was filtered on a celite pad and the 
solvent removed under vacuum leading to the quantitative formation of the dicarbonyl-(2,4-
bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(butyl-3-(2-pyridinyl)-imidazol-2-ylidene]ruthenium 
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complex (9d). 1H-NMR (399.9 MHz, CDCl3): δ (ppm) 7.24 (s, 1H, CHNHC), 7.06 (s, 1H, CHNHC), 4.23 (t, 2H, -
NCH2), 3.92 (t, 2H, CH2OH), 3.87 (s, 3H, -NCH3), 2.59 (m, 4H, CH2), 1.77 (m, 4H, CH2), 0.19 (s, 18H, CH3, 
TMS). 13C-NMR (150.8 MHz, CDCl3, g-HSQC, g-HMBC): δ (ppm) 202.94 (CO), 176.47 (Ccarbene), 175.68 
(C=O), 124.22 (CHNHC), 120.17 (CHNHC), 105.64 (C2,5, Cp), 70.04 (C3,4, Cp), 59.16 (-NCH2), 53.91 (-CH2OH), 
40.65 (-NCH3), 25.12 (CH2, 2C), 22.87 (CH2, 2C), 1.00 (CH3, TMS, 6C). IR (CH2Cl2, cm-1): 2003, 1939 (νCO), 
1525 (νC=O). ESI-MS (m/z) (+): 563 [M+H]+; 585 [M + Na]+. 
Chapter II 
41 
X-Ray diffraction studies
Figure 2.15. ORTEP drawing of 4b. Displacement ellipsoids are at the 30% probability level. H-atoms have been omitted 
for clarity. 
Figure 2.16. ORTEP drawing of 4d. Displacement ellipsoids are at the 30% probability level. H-atoms, except H(6), have 
been omitted for clarity. The H-bond between O(6)H(6) and O(3) is represented as a dashed line. 
Figure 2.17. ORTEP drawing of 6. Displacement ellipsoids are at the 30% probability level. H-atoms have been omitted 
for clarity. 
Figure 2.18. ORTEP drawing of 2b[Cl]. Displacement ellipsoids are at the 30% probability level. H-atoms have been 
omitted for clarity. 
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Table 2.1. Main bond lengths (Å) and angles (deg) of 4a, 4b and 4d. 
4a 4b 4d 
Ru(1)-C(1) 1.893(5) 1.868(10) 1.884(3) 
Ru(1)-C(2) 1.874(5) 1.840(11) 1.879(4) 
Ru(1)-C(3) 2.470(4) 2.503(10) 2.474(3) 
Ru(1)-C(4) 2.263(4) 2.242(8) 2.269(3) 
Ru(1)-C(5) 2.206(4) 2.203(8) 2.217(3) 
Ru(1)-C(6) 2.208(3) 2.181(8) 2.197(3) 
Ru(1)-C(7) 2.270(3) 2.269(8) 2.291(3) 
Ru(1)-C(34) 2.117(4) 2.103(10) 2.128(3) 
C(1)-O(1) 1.128(5) 1.144(9) 1.139(4) 
C(2)-O(2) 1.151(5) 1.170(10) 1.145(4) 
C(3)-O(3) 1.245(4) 1.235(9) 1.259(3) 
C(3)-C(4) 1.464(5) 1.510(11) 1.472(4) 
C(4)-C(5) 1.454(5) 1.418(11) 1.445(4) 
C(5)-C(6) 1.426(5) 1.412(11) 1.426(4) 
C(6)-C(7) 1.445(5) 1.439(11) 1.453(4) 
C(7)-C(3) 1.475(5) 1.481(11) 1.463(4) 
C(34)-N(1) 1.352(6) 1.361(11) 1.357(4) 
C(34)-N(2) 1.355(5) 1.369(11) 1.357(4) 
N(1)-C(35) 1.370(6) 1.392(12) 1.384(4) 
N(1)-C(37) 1.456(7) 1.409(11) 1.454(5) 
N(2)-C(36) 1.379(6) 1.378(12) 1.387(4) 
N(2)-C(38) 1.427(7) 1.439(12) 1.460(5) 
C(35)-C(36) 1.310(7) 1.284(13) 1.322(6) 
C(3)-C(4)-C(5) 108.5(3) 108.0(7) 107.9(2) 
C(4)-C(5)-C(6) 108.2(3) 109.3(7) 108.7(2) 
C(5)-C(6)-C(7) 108.1(3) 108.7(8) 108.0(2) 
C(6)-C(7)-C(3) 108.7(3) 108.5(8) 108.4(2) 
C(7)-C(3)-C(4) 105.0(3) 103.2(8) 105.7(2) 
C(7)-C(3)-O(3) 127.1(3) 128.7(8) 126.5(2) 
C(4)-C(3)-O(3) 127.6(3) 127.7(8) 127.6(3) 
Ru(1)-C(34)-N(1) 127.6(3) 130.2(8) 128.2(2) 
Ru(1)-C(34)-N(2) 128.4(3) 127.6(8) 127.2(2) 
N(1)-C(34)-N(2) 103.9(3) 102.2(9) 104.5(3) 
C(34)-N(1)-C(35) 111.2(4) 111.7(9) 110.6(3) 
N(1)-C(35)-C(36) 107.0(5) 106.5(11) 107.1(3) 
C(35)-C(36)-N(2) 107.8(4) 108.8(11) 107.5(3) 
C(36)-N(2)-C(34) 110.2(4) 110.7(9) 110.3(3) 
Ru(1)-C(1)-O(1) 178.7(4) 174.1(9) 178.3(3) 
Ru(1)-C(2)-O(2) 177.9(4) 177.0(9) 174.8(3) 
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Table 2.2. Main bond lengths (Å) and angles (deg) of 5f[Cl] and 6. 
5f[Cl] 6 
Ru(1)-C(1) 1.873(8) 1.885(12) 
Ru(1)-C(2) 1.865(8) 1.895(13) 
Ru(1)-C(3) 2.424(6) 2.386(10) 
Ru(1)-C(4) 2.248(6) 2.263(10) 
Ru(1)-C(5) 2.194(6) 2.205(9) 
Ru(1)-C(6) 2.190(6) 2.205(9) 
Ru(1)-C(7) 2.245(6) 2.247(9) 
Ru(1)-Cl(1) 2.4370(17) 2.411(3) 
C(1)-O(1) 1.149(8) 1.123(13) 
C(2)-O(2) 1.142(9) 1.130(14) 
C(3)-O(3) 1.246(7) 1.263(11) 
C(3)-C(4) 1.452(9) 1.448(13) 
C(4)-C(5) 1.451(9) 1.465(14) 
C(5)-C(6) 1.450(9) 1.462(13) 
C(6)-C(7) 1.437(8) 1.429(13) 
C(7)-C(3) 1.471(9) 1.460(14) 
O(3)-M(1) 2.223(4) 1.922(6) 
Cl(1)-M(1) 2.6282(18) 2.449(3) 
M(1)-C(34) 2.086(6) 1.869(10) 
N(1)-C(34) 1.351(8) 1.360(12) 
N(2)-C(34) 1.351(7) 1.343(13) 
N(1)-C(35) 1.389(8) 1.373(12) 
N(2)-C(36) 1.389(8) 1.389(15) 
C(35)-C(36) 1.329(9) 1.309(15) 
C(3)-C(4)-C(5) 108.6(5) 107.2(9) 
C(4)-C(5)-C(6) 107.4(5) 107.8(8) 
C(5)-C(6)-C(7) 108.4(5) 107.9(8) 
C(6)-C(7)-C(3) 108.1(5) 108.5(8) 
C(7)-C(3)-C(4) 106.2(5) 107.8(8) 
C(7)-C(3)-O(3) 125.8(6) 127.8(8) 
C(4)-C(3)-O(3) 127.7(6) 124.3(9) 
Ru(1)-Cl(1)-M(1) 112.36(6) 110.08(10) 
C(3)-O(3)-M(1) 127.9(4) 129.0(6) 
M(1)-C(34)-N(1) 124.2(4) 131.3(7) 
M(1)-C(34)-N(2) 132.0(4) 125.5(8) 
N(1)-C(34)-N(2) 103.8(5) 103.2(9) 
C(34)-N(1)-C(35) 111.8(5) 111.3(8) 
N(1)-C(35)-C(36) 106.0(6) 107.3(9) 
C(35)-C(36)-N(2) 107.4(6) 106.7(10) 
C(36)-N(2)-C(34) 111.0(5) 111.4(10) 
Ru(1)-C(1)-O(1) 175.5(7) 177.4(16) 
Ru(1)-C(2)-O(2) 179.7(9) 174.4(10) 
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X-ray Crystallography
Crystal data and collection details for 4a·0.5CH2Cl2·0.5H2O, 4b, 4d·0.5CH2Cl2, 
5f[Cl]·0.5CH2Cl2·0.5C5H12·0.25H2O, 6·0.5CHCl3·0.5C5H12·0.5H2O and 2b[Cl] (CCDC 1016378-1016383) are 
reported in Table 3. The diffraction experiments were carried out on a Bruker APEX II diffractometer equipped 
with a CCD detector using Mo–K radiation. Data were corrected for Lorentz polarization and absorption 
effects (empirical absorption correction SADABS).38 Structures were solved by direct methods and refined by 
full-matrix least-squares based on all data using F2.39 All non-hydrogen atoms were refined with anisotropic 
displacement parameters unless otherwise stated. All hydrogen atoms were fixed at calculated positions and 
refined by a riding model.  
4a·0.5CH2Cl2·0.5H2O: The asymmetric unit of the unit cell contains one Ru-complex (located on a general 
position), one CH2Cl2 molecule disordered over two symmetry related (by 2) positions (occupancy factor 0.5) 
and half of a H2O molecule (located on 2). The CH2Cl2 and H2O molecules have been refined isotropically. 
Similar U restraints [SIMU line in SHELXL, s.u. 0.01] were applied to the CH2Cl2 molecule and its C-Cl 
distances restrained to 1.75 Å [s.u. 0.01]. The independent H-atom bonded to O(50) in the H2O molecule has 
been located in the Fourier Map and refined isotropically using the 1.5 fold Uiso value of the parent O(50); the 
O(50)-H(50) distance was restrained to 0.87 Å [s.u. 0.01]. 
4b: The asymmetric unit of the unit cell contains one Ru-complex located on a general position. 4b crystallizes 
in very small and low-quality plate-like crystals. Therefore, the data have been cut at 2 = 47.06° and several 
restraints have been applied during the refinement. Similar U restraints [SIMU line in SHELXL, s.u. 0.01] have 
applied to all the C-atoms. Some of the C and O atoms have been restrained to as isotropic like behavior 
[ISOR line in SHELXL, s.u. 0.01]. The aromatic rings have been constrained to fit regular hexagons [AFIX 66 
line in SHELXL].  
4d·0.5CH2Cl2: The asymmetric unit of the unit cell contains one Ru-complex (located on a general position) 
and half of a CH2Cl2 molecule located on a 2-fold axis. Similar U restraints [SIMU line in SHELXL, s.u. 0.01] 
have applied to all the C-atoms. H(6) bonded to O(6) has been located in the Fourier Map and refined 
isotropically using the 1.5 fold Uiso value of the parent O(6); the O(6)-H(6) distance was restrained to 0.89 Å 
[s.u. 0.02]. 
5e[Cl]·0.5CH2Cl2·0.5C5H12·0.25H2O: The asymmetric unit of the unit cell contains two Ru-complexes (located 
on general positions), one CH2Cl2 molecule (on a general position), one C5H12 molecule (on a general position) 
and half of a H2O molecule disordered over two symmetry related (by an inversion center) positions. It has not 
been possible to locate the H-atoms of the H2O molecule. Similar U restraints [SIMU line in SHELXL, s.u. 
0.005] have applied to all the C, O and N-atoms. Some of the C and O atoms have been restrained to as 
isotropic like behavior [ISOR line in SHELXL, s.u. 0.005]. The aromatic rings have been constrained to fit 
regular hexagons [AFIX 66 line in SHELXL]. Restraints to bond distances have been applied as follows [s.u. 
0.01]: 1.75 Å to C-Cl in CH2Cl2; 1.53 Å to C-C in C5H12. 
6·0.5CHCl3·0.5C5H12·0.5H2O: The asymmetric unit of the unit cell contains two Ru-complexes, one CHCl3 
molecule, one C5H12 molecule and one H2O molecule (all located on general positions). The H2O molecule is 
disordered over two independent positions and has been refined isotropically with one occupancy parameter. 
It has not been possible to located the H-atoms of the H2O molecule. The crystals appear to be pseudo-
merohedrally twinned with twin matrix 1 0 0 0 -1 0 0 0 -1 and refined batch factor 0.2580(13). Similar U 
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restraints [SIMU line in SHELXL, s.u. 0.005] have applied to all the C-atoms. Some of the C and O atoms have 
been restrained to as isotropic like behavior [ISOR line in SHELXL, s.u. 0.01]. The aromatic rings have been 
constrained to fit regular hexagons [AFIX 66 line in SHELXL]. Restraints to bond distances have been applied 
as follows [s.u. 0.01]: 1.75 Å to C-Cl in CH2Cl2; 1.53 Å to C-C in C5H12. 
2b[Cl]: The asymmetric unit of the unit cell contains one Ag complex located on a general position. 
Table 2.3. Crystal data and experimental details for 4a·0.5CH2Cl2·0.5H2O, 4b, 4d·0.5CH2Cl2, 
5f[Cl]·0.5CH2Cl2·0.5C5H12·0.25H2O, 6·0.5CHCl3·0.5C5H12·0.5H2O and 2b[Cl]. 
4a·0.5CH2Cl2·0.5H2O 4b 4d·0.5CH2Cl2 
Formula C38.5H34ClN2O5.5Ru C50H40N2O5Ru C39.5H35ClN2O6Ru 
Fw 749.2 849.91 770.22 
T, K 295(2) 293(2) 294(2) 
, Å 0.71073 0.71073 0.71073 
Crystal system Monoclinic Monoclinic Monoclinic 
Space group P2/c P21/n C2/c 
a, Å 16.2736(16) 14.602(4) 24.188(4) 
b, Å 13.5024(13) 15.790(4) 14.213(3) 
c, Å 17.6132(17) 17.850(5) 24.171(4) 
,  113.2960(10) 101.118(3) 117.822(2) 
Cell Volume, Å3 3554.7(6) 4038.4(19) 7349(2) 
Z 4 4 8 
Dc, g cm-3 1.400 1.398 1.392 
, mm-1 0.563 0.440 0.547 
F(000) 1536 1752 3160 
Crystal size, mm 0.180.160.12 0.150.130.10 0.240.210.18 
limits,  1.66–25.66 1.65–23.53 1.72–25.02 
Reflections collected 34990 31532 30056 
Independent reflections 6728 [Rint= 0.0387] 6003 [Rint= 0.1717] 6287 [Rint= 0.0324] 
Data / restraints /parameters 6728 / 8 / 732 6003 / 378 / 451 6287 / 211 / 450 
Goodness on fit on F2 1.048 0.966 1.051 
R1 (I> 2(I)) 0.0427 0.0675 0.0327 
wR2 (all data) 0.1348 0.1946 0.1060 
Largest diff. peak and hole, e 
Å-3 
0.732 / –0.658 0.638 / –0.600 0.496 / –0.490 
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5f[Cl]·0.5CH2Cl2·0.5C5H12·0.25H2O 
6·0.5CHCl3· 
0.5C5H12·0.5H2O 
2b[Cl] 
Formula C63H67AgCl2N2O5.25Ru C63H66.5Cl2.5CuN2O5.5Ru C17H16AgClN2 
Fw 1216.03 1192.92 391.64 
T, K 295(2) 291(2) 293(2) 
, Å 0.71073 0.71073 0.71073 
Crystal system Monoclinic Monoclinic Triclinic 
Space group P21/c P21/c P1̅ 
a, Å 15.6360(14) 15.469(3) 8.1352(9) 
b, Å 20.8474(19) 20.983(5) 10.0028(11) 
c, Å 38.030(4) 37.639(8) 10.5175(11) 
, ° 90 90 88.1710(10) 
,  90.6730(10) 90.260(3) 68.1080(10) 
, ° 90 90 85.0180(10) 
Cell Volume, Å3 12396(2) 12217(5) 791.14(15) 
Z 8 8 2 
Dc, g cm-3 1.303 1.297 1.644 
, mm-1 0.693 0.753 1.437 
F(000) 5008 4944 392 
Crystal size, mm 0.190.160.13 0.190.160.14 0.210.190.12 
limits,  1.07–25.03 0.97–25.03 2.04–26.00 
Reflections collected 116087 114878 8194 
Independent reflections 21858 [Rint= 0.0524] 21522 [Rint= 0.0838] 3092 [Rint= 0.0176] 
Data / restraints 
/parameters 
21858 / 1014 / 1153 21522 / 909 / 1163 3092 / 0 / 190 
Goodness on fit on F2 1.022 1.014 1.064 
R1 (I> 2(I)) 0.0613 0.0812 0.0270 
wR2 (all data) 0.1956 0.2550 0.0667 
Largest diff. peak and hole, 
e Å-3 
1.313 / –0.759 0.939 / –1.064 0.643 / –0.268 
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CHAPTER III 
Ruthenium(0) complexes with triazolylidene spectator ligands: oxidative activation 
for (de)hydrogenation catalysis 
Abstract 
Transmetallation of silver triazolylidene intermediates with the ruthenium(0) precursor [Ru(Cp=O)(CO)2]2 
afforded low-valent ruthenium(0) complexes containing a triazole-derived NHC ligand (Cp=O = 3,4-di(4-
methoxyphenyl)-2,5-diphenyl-cyclopentadienone). Protonation of the carbonyl group of the Cp=O ligand 
significantly reduces the π character of the Ru–CO bond as deduced from νCO analysis. The new triazolylidene 
ruthenium(0) complexes were evaluated as catalyst precursors in transfer hydrogenation of 4-fluoro-
acetophenone and in the acceptorless dehydrogenation of benzyl alcohol. Low activities were noted, though 
in both reactions, catalytic performance is markedly increased when cerium(IV) was added. Electrochemical 
analysis indicates that activation of the catalyst precursor proceeds via cerium-mediated oxidation of the 
ruthenium center, which facilitates dissociation of a CO ligand to enter the catalytic cycle. Such oxidative 
activation of catalyst precursors may be of more general scope.  
Introduction 
N-Heterocyclic carbenes (NHCs), as pointed out in the Chapter I, have become some of the most popular 
ligands in transition metal chemistry due to their efficiency as ancillary ligands to improve catalytic activity.1 
Their success is due to a combination of unique properties, such as their easily tuneable electronic and steric 
properties that influence the metal center and which allow catalytic activity to be rationally optimized. The 
exploitation of such concepts is particularly appealing because the synthesis of NHC ligand precursors as well 
as NHC metal complexes is fairly simple and highly versatile.2 
Accordingly, a variety of catalytic reactions have strongly benefited from introduction of NHC ligands, such as 
ruthenium-catalyzed olefin metathesis,3 palladium-catalyzed cross-coupling reaction,4 iridium-catalyzed 
reductions and oxidations,5 and gold-catalyzed activation of π-bonds, to name but a few.6 Apart from olefin 
metathesis, NHC ruthenium complexes have shown catalytic activity in various redox transformations,7 
including: transfer hydrogenation,8 hydrogenation of olefins9  and esters,10 asymmetric hydrogenation,11 amide 
synthesis from alcohols and nitriles,12 dehydrogenation of esters and imines from alcohols,13 racemization of 
chiral alcohols,14 oxidation of alcohols15 and water oxidation16 (for more details see chapter I, paragraph 1.2.1). 
Most of the literature on NHC ruthenium chemistry features ruthenium(II) complexes, while low-valent NHC 
ruthenium(0) systems are restricted to a few examples based on either [Ru3(CO)12] or [Ru(CO)2(PPh3)3] as 
precursors.17 In the chapter II a straightforward approach towards NHC ruthenium(0) complexes has been 
presented,18 which is based on a dimeric ruthenium(0) cyclopentadienone dicarbonyl dimer (3).19 Cleavage of 
the dimer in the presence of a free carbene or a silver carbene precursor provided access to a new class of 
ruthenium complexes (4). 
Here we have expanded this synthetic methodology to 1,2,3-triazolylidenes as strong donor NHC-type 
ligands.20 The present work has been carried out in collaboration with Prof. Martin Albrecht, a pioneer of this 
research area, in the UCD School of Chemistry and Chemical Biology, University College of Dublin. 
The triazolylidenes are so-called abnormal carbenes (aNHC) because the binding to the metal center occurs 
via the C4 or C5 position, often the substitution pattern is chosen to block the C2 position. The triazolylidenes 
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are thus stabilized by only one nitrogen moiety, as the π-donating and σ-accepting properties of the second 
nitrogen atom are greatly reduced, in fact the donor properties can be significantly influenced by the number 
and position of heteroatoms within the heterocycle (Figure 3.1).  
 
Figure 3.1 Schematic and simplified donor ability scale illustrating the donor ability of different abnormal NHC ligands.20 
Such aNHC provide great scope for achieving different properties from so-called normal carbenes. They are 
considerably more electron-donating due to the reduced σ-withdrawal from the carbene center, in addition, 
they have been shown to be more π -accepting (due to reduced pπ – pπ delocalization). The different properties 
of these ligands will naturally confer different properties and reactivity to the metal centers to which they are 
coordinated directly affecting the catalytic activity of the complexes. 
Triazolylidenes offer a vast synthetic flexibility due to their convenient accessibility through [2+3] dipolar 
cycloaddition of alkynes and azides.21 In addition, their enhanced donor properties as compared to more 
commonly utilized imidazolylidenes may further destabilize the ruthenium(0) oxidation state and hence 
facilitate substrate activation by metal/ligand cooperation in analogy to the reduced portion of Shvo’s catalyst.22 
Thus, it will be of particular interest to evaluate the propensity of the new triazolylidene ruthenium(0) complexes 
to dehydrogenate substrates via formal H2 transfer, as this process may lead to efficient catalysts for 
acceptorless oxidation (alcohol dehydrogenation) or transfer hydrogenation.  
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Results and Discussion 
3.1 Synthesis of triazolylidene Ru complexes 
The triazolium salts 10a-d, readily accessible by “click” cycloaddition of the corresponding alkynes and azides 
and subsequent alkylation,21 were successfully transformed into the silver triazolylidene intermediates as 
reported previously.23 Transmetallation with the low-valent ruthenium precursor afforded complexes 11a–d in 
very high yields (Scheme 3.1). Complexes 11 constitute a class of ruthenium(0) complexes which contain 
exclusively carbon-donor ligands. 
 
Scheme 3.1. Synthesis of cyclopentadienone triazolylidene ruthenium(0) complexes 11a-d. 
Formation of complexes 11a–d was established by 1H NMR, 13C{1H} NMR, and IR spectroscopy as well as 
ESI-MS and for representative examples, by single crystal X-ray diffraction analysis (see Experimental 
section). IR spectroscopy provided a particularly convenient methodology for monitoring the progress of the 
transmetallation reaction, as the Ru–CO stretch vibrations of the precursor complex shifted distinctly by 20 
cm–1 to lower energy upon triazolylidene coordination (νCO = 2018, 1967 cm–1 in 3, and 1999, 1938 cm–1 in 
11b, Table 3.1). The bathochromic shift is slightly but consistently more pronounced when the triazolylidene 
ligand contained only alkyl substituents, and less strong when a phenyl substituent is present, irrespective of 
the connectivity pattern. The carbene ligand in 11a with the phenyl group attached to the carbon induced the 
same shift as the analogous carbene with the phenyl group attached to nitrogen (11d). These data suggest 
that the CO stretch vibration may be used as a probe for the qualitative assessment of the carbene donor 
properties.23,24 In line with this notion, coordination of 2-imidazolylidenes induces a slightly smaller 
bathochromic shift (Δν= 4 cm–1), which reflects their weaker donor properties when compared to 
triazolylidenes.20a,b Potentially, backbonding from the electron-rich ruthenium(0) center to the carbene ligand 
may affect the CO stretch vibration and may thus complicate a simple linear correlation between IR frequencies 
and donor properties. 
Table 3.1. Relevant carbonyl stretch vibrations (cm–1) of the complexes. 
complex Ru–CO Cp=O 
3 2018, 1967 --- 
11a 2004, 1945 1577 
11b 1999, 1938 1583 
11c 1998, 1937 1584 
11d 2003, 1944 1578 
11a + HBF4 2036, 1979 --- 
Further evidence of the formation of complexes 11a–d was obtained from NMR data, in particular the 
disappearance of the low field signal of the triazolium precursor in the 1H NMR spectrum and the downfield 
shift of the carbenic resonance in the 13C NMR spectra. This nucleus resonates in the 154–158 ppm range 
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and hence some 20 ppm higher field than in ruthenium(II) complexes, indicative for a low valent and electron-
rich metal center (Figure 3.2). 
Figure 3.2 13C NMR spectrum of triazolylidene Ru complex 11a in CD2Cl2. 
Unambiguous structural evidence was obtained by X-ray diffraction analysis of single crystals of complexes 
11a and 11d. The molecular structure reveals the expected piano-stool geometry with the cyclopentadienone 
ligand occupying one face and the two CO ligands and the triazolylidene forming the three legs (Figure 3.3). 
Bond lengths and angles (Table 3.2) are very similar in both complexes, suggesting only marginal steric 
consequences upon swapping the methyl and phenyl wingtip groups in the triazolylidene ligand. As expected, 
the Ru–Ctrz bond is longer in complexes 11 than in analogues featuring a higher-valent ruthenium(II) metal 
center (Δd = 0.06 Å).15 
Table 3.2. Selected bond lengths (Å) and angles (deg) for complexes 11a and 11d. 
11a 11d 
Ru–C1 2.1196(12) 2.120(2) 
Ru–C42 1.8965(13) 1.878(2) 
Ru–C43 1.8825(13) 1.898(2) 
Ru–Cg a) 1.930(<1) 1.932(<1) 
C1–Ru–C42 95.18(5) 91.08(8) 
C1–Ru–C43 91.66(6) 95.90(8) 
C1–Ru–Cg a) 116.44(3) 115.02(5) 
C42–Ru–Cg a) 125.76(4) 125.60(7) 
C43–Ru–Cg a) 127.83(4) 127.44(6) 
C42–Ru–C43 90.99(6) 92.96(9) 
C11–O1 1.2464(14) 1.239(2) 
a) Cg = centroid of cyclopentadienone ligand
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Figure 3.3. ORTEP representations (50% probability level, hydrogen atoms omitted for clarity) of complexes 11a (a) and 
11d (b). 
3.2 Catalytic alcohol oxidation 
The triazolylidene Ru(0) complex 11a was evaluated as catalyst precursor for the oxidation of alcohols using 
benzyl alcohol (BnOH) as model substrate. While ruthenium(II) systems with a cymene spectator ligand gave 
attractive conversions even in the absence of oxidants or base,15 runs performed with 11a in the absence of 
such additives were essentially non-productive with <5% conversion (Table 3.3, entry 1). Better results were 
obtained upon adding [Ce(NO3)6](NH4)2 (CAN) as oxidizing agent to activate the catalyst precursor 11a.  
Table 3.3. Ruthenium/cerium-catalyzed BnOH oxidation a) 
Entry Ru0 complex mol% CeIV Yield 2h (%) Yield 24h (%) 
1 11a --- <5 <5 
2 --- 10 25 80 
3 --- 5 12 42 
4 --- 2.5 12 31 
5 11a 10 57 97b) 
6 11a 5 24 85 
7 11a 2.5 20 84 
8 3 10 19 81 
a) General conditions: 0.19 mmol BnOH, 5 mol% Ru0 complex, 3 mL 1,2-C6H4Cl2, mol% CeIV and Ru relative to BnOH;
150 °C, yield of PhCHO determined by 1H NMR spectroscopy by using anisole as internal standard; b) reaction complete 
after 8 h. 
Initial background measurements indicated that in the absence of a ruthenium complex, CAN catalyzes the 
oxidation of BnOH to benzaldehyde on its own under the applied reaction conditions. Background conversions 
reached 80% when 10 mol% CAN were used, and dropped to 40% and 30% approximately, if the CAN loading 
was reduced to 5 and 2.5 mol%, respectively (entries 2–4, Figures 3.9-3.11). Addition of complex 3, i.e. the 
carbene-free ruthenium(0) precursor, had no notable effect and conversions mirrored those of CAN only (entry 
8). Possibly, the lack of a stabilizing ligand for ruthenium(II) induces rapid decomposition, supported also by 
the brown color that rapidly developed upon heating the mixture. In contrast, complex 11a induced a 
considerable accelaration (entries 5–7). For example, with 5 mol% 11a and 2.5 mol% CAN, 84% conversion 
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were accomplished within 24 h (cf. 31% conversion in the background reaction). At higher CAN loading (10 
mol%), the catalytic competence of 11a is evident in particular at early stages of the oxidation. After 2 h, 57% 
conversion were observed with the Ru0/CeIV couple (25% with CeIV only, 0% with Ru0 only), and oxidation was 
essentially complete after less than 8 h. Further improvement of the catalytic performance of 11a may need to 
focus on an oxidant for ruthenium that is less catalytically active than CAN. 
3.3 Catalytic transfer hydrogenation 
In addition to alcohol dehydrogenation, we were also interested to see whether complexes 11 are active in 
transfer hydrogenation. A model reaction employed complex 11a as catalyst precursor and 4-
fluoroacetophenone as substrate under standard transfer hydrogenation conditions,25 i.e. refluxing iPrOH as 
hydrogen source (Table 3.4). 
Table 3.4. Catalytic transfer hydrogenation of 4-fluoroacetophenone.a 
entry Ru0 complex additive b) Yield 8h (%) Yield 24h (%) 
1 11a --- 0 <6 
2 3 --- 96 n.d.c)
3 11a KOH 0 <6
4 3 KOH 94 n.d.c)
5 11a HBF4 <6 31
6 3 HBF4 55 58
7 11a CAN 58 88
8 3 CAN 0 6.5
9 11a CAN + HBF4 41 43
10 11a CAN + KOH <6 17
a) General conditions: Ruthenium complex (5 mol% Ru), iPrOH (5 mL), reflux; yield of alcohol determined
by 1H NMR spectroscopy, n.d. = not determined; b) quantities of additives as follows: HBF4 1 molequiv., 
KOH 2 molequiv., CAN 1 molequiv. per ruthenium center. c) n.d. = not determined due to complete 
conversion after 8h. 
Catalytic runs were performed in particular for comparing the catalytic activity of the triazolylidene ruthenium(0) 
complex 11a and the triazolylidene-free dimeric precursor 3 under various conditions. In the absence of any 
additives (entries 1,2), complex 11a is inactive and essentially no conversion was observed, while precursor 3 
reaches almost complete conversion within 8 h in pure iPrOH. Addition of KOH did not change the relative 
performance and conversions were indifferent to those in iPrOH only (entries 3,4). These results suggest that 
KOH is not a suitable additive for the activation of the ruthenium center in complex 11a, probably because the 
electron-rich ruthenium(0) center has no affinity for binding a hard alkoxide ligand, nor for dissociation of a CO 
ligand due to the high donor properties of the triazolylidene ligand, which are assumed to enhance Ru-CO 
backbonding. Conversely, the activity observed for complex 3 probably arises from splitting of the dimeric 
precursor into two monomeric forms which, in the presence of a hydrogen source lead to a derivative of Shvo’s 
catalyst (A, Figure 3.4).22 Such complexes are well-known to catalyze the transfer hydrogenation of a broad 
range of ketones. 
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Figure 3.4. Shvo-type catalyst A resulting from cleavage of dimer 3 in iPrOH, and cationic complexes B and C from 
protonation of complex 11a, featuring a ruthenium(0) and a ruthenium(II) center, respectively. 
In an attempt to labilize the CO ligands, a proton source was introduced. Protonation at the dienone system 
has been reported and may provide a cationic structure with a positive charge either at the oxygen (complex 
B, Figure 3.4) or at the ruthenium center (C), thus inducing formal oxidation of the metal center to 
ruthenium(II) and depletion of electron density, which in turn is expected to substantially reduce the π 
character of the Ru–CO bond. Stoichiometric experiments using HCl (10 molequiv.) or HBF4 (5 molequiv.) in 
CH2Cl2 with complex 11a indeed gave cationic complexes in which the carbonyl stretch vibration was 
significantly shifted to higher frequency (νCO = 2036 and 1979 cm–1, cf. 2004 cm–1, 1945 cm–1 in 11a), and 
the ketone C=O vibration observed in 11a for the Cp=O ligand disappeared in the cationic complexes. These 
data strongly suggesting formation of a cyclopentadienyl-type ligand as in complex C. Transfer 
hydrogenation in the presence of HBF4 (1 equiv) did indeed increase the catalytic activity of complex 11 
(entry 5), however the 30% conversion after 24 h are unremarkable when compared with other ruthenium 
carbene systems.26 The dimeric complex 3 performs significantly less in the presence of acid (entry 6), in 
agreement with the formation of a Shvo-type active system from formal dihydrogen transfer rather than 
protonation. Best result for complex 11a were obtained when using CAN as an oxidizing agent. Under these 
conditions, oxidation of the metal center from ruthenium(0) to ruthenium(II) takes place (see Electrochemical 
measurement), which weakens the bonding of CO and hence produces a methodology to activate the 
complex. In the presence of CAN, conversion of 4-fluoroacetophenone reaches 58% after 8 h and 89% after 
24 h (entry 7). In contrast, CAN efficiently quenches the activity of complex 3 (entry 8). Hence, conditions 
have been developed that favor catalytic transfer hydrogenation using the dimer 3 but not 11a (entries 1,2), 
and inversely, conditions that favor activity of complex 11a but not 3 (entries 7,8). These results demonstrate 
the orthogonality induced upon bonding of a triazolylidene ligand. Addition of either base or acid to the CAN-
activated complex 11a are not advantageous and conversions were consistently lower (entries 9,10). 
Variation of the amount of CAN did not result in further enhancement of activity. Both lowering the amount to 
0.25 or 0.5 equivalents relative to 11a as well as increasing the amount to 2, 4 or 6 equivalents resulted in 
slower and generally incomplete conversion (Figure 3.12). In particular using excess CAN lead to substantial 
catalyst deactivation after around 5 h. 
3.4 Electrochemical measurement 
Electrochemical analysis of the triazolylidene ruthenium(0) complex 11a by cyclic voltammetry 
measurements reveal a quasi-reversible oxidation of 11a in CH2Cl2 solution with E1/2 = +0.952(±3) vs SCE 
(Figure 3.5, Figure 3.14-Experimental). The redox process likely involves a Ru0/RuI oxidation which is 
according to the peak-current ratio reversible at higher scan rates (ipc/ipa = 0.96 at 200 mV s–1) and less 
reversible at slower scan rates (ipc/ipa = 0.56 at 20 mV s–1), suggesting a slow chemical transformation of 
the oxidized species (EC mechanism).27 The ipc/ipa ratio at different scan rates fits excellently with an 
irreversible first-order reaction after the oxidation process, with a rate constant k = 0.58 s–1 for the 
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homogeneous follow-up reaction (correlation > 0.99, Table 3.6, Figure 3.16-Experimental). 
These data are in agreement with a metal-centered oxidation process and subsequent slow dissociation 
of CO from the coordination sphere due to the lower electron-density upon ruthenium oxidation 
(cf. CAN-mediated activity of 11a in transfer hydrogenation). Consistent with this 
model, electrochemical analysis of 11a measured in MeCN shows a largely irreversible oxidation 
process (Epa = +0.96 V, (ipc/ipa = 0.64) even at high scan rates (500 mV s–1; Figure 3.16). The 
coordinating properties of MeCN may thus accelerate the substitution of CO and thus the EC mechanism.  
Figure 3.5. Cyclic voltammograms for 11a in CH2Cl2 at different scan rates (potential vs SCE, Fc as internal standard). 
Since the catalytic activity of the ruthenium complex 11a was considerably enhanced when pre-activated with 
CAN, both for transfer hydrogenation and alcohol dehydrogenation, a series of electrochemical measurements 
was performed on 11a in the presence of CAN. When 0.5 molequiv CAN were added to a solution of 11a in 
MeCN, differential pulse voltammetry revealed three oxidation processes (Figure 3.6). The first process at E 
= +0.90 V pertains to the Ru0/RuI oxidation of complex 11a and was also observed in measurements without 
CAN,28 and the second process with E = +1.06 V corresponds to a cerium-centered oxidation.29 A third 
oxidation process at E = +1.22 V with equal ratio to the first process is assumed to belong to a new species 
resulting from oxidation of complex 11a and has thus tentatively been attributed to a RuI/RuII oxidation. The 
equal relative intensity of the first and last oxidation process remains constant over several hours, suggesting 
an equilibrium. The 1:1 ratio indicates equal quantities of two ruthenium species, which agrees well with the 
provision of 0.5 molequiv CAN at the onset of the experiment and suggests a complete one-electron transfer 
from ruthenium(0) to cerium(IV), thus resulting in 50% [11a]+ and 50% of the parent complex 11a. In support 
of such a model, no oxidation process at +0.9 V was detected after addition of 1 molequiv CAN, thus indicating 
absence of significant amounts of the original complex 11a. Instead, only an oxidation process at E = +1.22 V 
was detected, together with the cerium-centered oxidation. These measurements are thus consistent with a 
CAN-mediated oxidation of the ruthenium-center in 11a to ruthenium(II) by consumption of two equivalents of 
cerium(IV), and concomitant release of CO (EC mechanism) as a process for entering the catalytic cycle. Such 
processes require the presence of a stabilizing donor ligand such as the triazolylidene used in this study. 
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Figure 3.6. Relevant section of differential pulse voltammetry analysis of complex 11a in presence of different equivalent 
of CAN: 0 equiv (orange dashed line), 0.5 equiv (blue bold line) and 1.0 equiv (red thin line; all measurements in MeCN 
at 50 mV s–1, potential vs SCE, Fc as internal standard). 
Conclusions 
A set of ruthenium(0) complexes 11 has been prepared which contain differently substituted triazolylidene 
ligands, thus demonstrating the suitability of such strongly donating NHC ligands to stabilize low-valent metal 
centers. Catalytic activity in hydrogen transfer reactions has been evidenced, though oxidative activation with 
CAN as a potent auxiliary is required. For alcohol dehydrogenation, both CAN and the ruthenium complex are 
pre-catalysts and the relative quantities of the two components can be used to increase the relevance of either 
the Ce- or the Ru-catalyzed transformation. Detailed electrochemical analyses lend support to a fast two-step 
oxidation of the ruthenium center of 11 in order to enter the catalytic cycle, an activation process that is 
complementary to that of the dimeric ruthenium carbonyl complex 3. Upon insertion of a triazolylidene ligand, 
loss of CO appears to be essential for the generation of an open coordination site for substrate coordination 
and catalytic turnover. Triazolylidene ligands with their strongly mesoionic character may be particularly useful 
for facilitating the metal oxidation and for entailing such catalyst activation. This concept may become 
particularly useful when employing other low-valent complexes as catalyst precursors and may provide an 
interesting opportunity for exploiting base metals in catalysis.  
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Experimental Section 
Materials and procedures. The syntheses of the ruthenium complexes were carried out under an inert 
atmosphere of N2 using Schlenk techniques and dry solvents. Purifications were performed in air using 
commercial solvents. 1H and 13C{1H} NMR spectra were recorded at room temperature on Varian 
spectrometers operating at 400 or 500 MHz unless stated otherwise. Chemical shifts (δ in ppm, J in Hz) were 
referenced to SiMe4. Signal assignments are based on homo- and heteronuclear (multiple-bond) correlation 
spectroscopy. Elemental analyses were performed by the Microanalytical Laboratory at the University College 
Dublin, Ireland. Infra-red spectra were recorded on a Perkin Elmer FTIR at 1 cm–1 resolution. Electrochemical 
studies were carried out on a Metrohm Autolab PGSTAT101 potentiostat using a gas-tight three electrode cell 
under an argon atmosphere. A platinum disk with 3.8 mm2 surface area was used as the working electrode 
and was polished before each measurement. The reference electrode was Ag/AgCl, the counter electrode was 
a Pt wire. In all experiments, [Bu4N]PF6 (100 mM in dry CH2Cl2 or MeCN) was used as supporting electrolyte 
with analyte concentrations of approximately 1 mM. The redox potentials were referenced to 
ferrocenium/ferrocene (Fc+/Fc; E1/2 = 0.46 V vs. SCE in CH2Cl2; E1/2 = 0.40 V vs. SCE in MeCN).30 The 
ruthenium precursors 328 and the triazolium salts 10a–d were prepared according to literature procedures.11 
All other reagents were purchased from commercial sources and were used as received, unless otherwise 
stated.  
 
Synthesis of the triazolylidene ruthenium complexes (11)  
The triazolium salts 10a-d were reacted at room temperature with Ag2O (0.5 eq.) in CH2Cl2 solution under inert 
atmosphere and protected from light. After 2 h, the dimeric ruthenium precursor 3 (0.5 eq.) was added to the 
mixture and stirring continued for 2 h. The mixture was then filtered through a short pad of celite and filtrate 
was evaporated to yield the triazolylidene Ru(0) complexes 11a-d in typically quantitative yield. Suitable 
crystals for X-Ray diffraction were obtained by slow diffusion of pentane into a CH2Cl2 solution of the complex. 
 
Figure 3.7 Structure of triazolylidene ruthenium complexes (11). 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dimethyl-4-phenyl-
1,2,3-triazol-ylidene)ruthenium (11a): 1H NMR (300 MHz, CD2Cl2): δ = 7.59–7.51 (m, 4H, CHaryl), 7.32-7.01 
(m, 15H, CHaryl + CHPh), 6.58–6.50 (m, 4H, CHaryl), 3.63 (s, 6H, OCH3), 3.61, 3.56 (2  s, 3H, NCH3); 13C{1H} 
NMR (400 MHz, CD2Cl2): δ = 203.11 (Ru–CO), 169.08 (CCp=O), 159.31 (COMe), 157.57 (Ru–Ctrz), 150.38 
(Ctrz–Ph), 136.51 (Caryl–Cp), 134.45 (CHaryl), 131.83, 130.48, 129.33 (3  CPh), 128.46 (CHaryl), 128.19 (CHaryl), 
125.93 (Caryl), 124.90 (CHaryl), 113.34 (CHaryl), 103.91 (C2,5 Cp), 80.59 (C3,4 Cp), 55.77 (OCH3), 42.11, 37.48 (2  
NCH3). IR (CH2Cl2) νCO: 2004 cm–1, 1945 cm–1, 1577 cm–1. ESI-MS (m/z) = 776 [M+H]+; 798 [M+Na]+. Anal. 
Calcd (%) for C43H35N3O5Ru (774.82): C, 66.66; H, 4.55; N 5.42. Found: C, 65.95; H, 4.64; N 5.34. 
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Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,4-dibutyl-3-methyl-
1,2,3-triazolylidene)ruthenium (11b): 1H NMR (300 MHz, CDCl3): δ = 7.79–7.20 (m, 4H, CHaryl), 7.37–6.63 
(m, 10H, CHaryl), 6.62–6.50 (m, 4H, CHaryl), 3.81 (s, 3H, NCH3), 3.63 (s, 6H, OCH3), 3.61 (m, 2H, NCH2), 1.87-
1.03 (m, 10H, -–CH2–), 0.73 (m, 6H, CH2CH3). 13C{1H} NMR (400 MHz, CDCl3): δ = 202.90 (CO), 158.44 
(COMe), 154.01 (Ru–Ctrz), 148.55 (Ctrz–Bu), 135.59 (Caryl), 133.71 (CHaryl), 129.11 (CHaryl), 127.37 (CH), 
125.25 (Caryl), 125.06 (CHaryl), 112.87 (CHaryl), 103.85 (C2,5 Cp), 78.43 (C3,4 Cp), 55.02 (OCH3), 53.31 (NCH2), 
36.05 (NCH3), 32.08 (NCH2CH2), 31.24 (Ctrz-CH2), 23.55 (Ctrz-CH2CH2), 22.38, 19.39 (2  CH2CH3), 14.05, 
13.60 (2  CH2CH3). IR (CH2Cl2) νCO: 1999 cm–1, 1938 cm–1, 1583 cm–1. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3,4-tributyl-1,2,3-
triazolylidene)ruthenium (11c): 1H NMR (300 MHz, CD2Cl2): δ = 7.70 (m, 4H, CHaryl), 7.21-7.03 (m, 10H, 
CHaryl), 6.66 (m, 4H, CHaryl), 4.03 (m, 2H, NCH2), 3.70 (s, 6H, -OCH3), 3.64 (m, 2H, NCH2), 1.79-1.04 (m, 14H, 
-CH2, nBu), 0.95-0.67 (m, 9H, -CH2CH3, nBu); 13C{1H} NMR (400 MHz, CD2Cl2): δ = 204.09 (CO), 169.47 
(CCp=O), 159.45 (COMe), 157.58 (Ru–Ctrz), 148.96 (Ctrz–Bu), 136.81 (Caryl), 134.60 (CHaryl), 129.90 (CHaryl), 
128.10 (CH), 126.36 (Caryl), 125.80 (CHaryl), 113.56 (CHaryl), 104.48 (C2,5 Cp), 79.07 (C3,4 Cp), 55.82 (OCH3), 
50.13 (NCH2), 34.96 (NCH3), 32.77, 32.67 (2 x NCH2CH2), 32.19 (Ctrz-CH2), 24.28 (Ctrz-CH2CH2), 23.18, 20.36, 
20.17 (3  CH2CH3), 14.63, 14.14, 14.09 (3  CH2CH3). IR (CH2Cl2) νCO: 1998 cm–1, 1937 cm–1, 1584 cm–1. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-phenyl-3,4-dimethyl-
1,2,3-triazol-ylidene)ruthenium (11d): 1H NMR (300 MHz, CDCl3) δ (ppm): 7.59–7.49 (m, 4H, CHaryl), 7.28–
6.92 (m, 15H, CHaryl + CHPh), 6.64–6.55 (m, 4H, CHaryl), 3.87 (s, 3H, NCH3), 3.66 (s, 6H, OCH3), 1.79 (s, 3H, 
Ctrz–CH3); 13C{1H} NMR (400 MHz, CDCl3): δ = 202.41 (CO), 167.75 (CCp=O), 159.84 (Ru–Ctrz), 158.27 
(COMe), 145.38 (Ctrz–Me), 139.18 (Caryl), 135.45–112.64 (Caryl), 133.57, 129.54, 127.31 (3  CPh), 103.34 (C2,5 
Cp), 79.72 (C3,4 Cp), 54.95 (OCH3), 35.99 (NCH3), 10.53 (Ctrz–CH3). ESI-MS (m/z): 798 [M+Na]+. IR (CH2Cl2) 
νCO: 2003 cm–1, 1944 cm–1, 1578 cm–1. 
General condition for alcohol oxidation 
 
Figure 3.8 Oxidation of BnOH catalyzed by Ruthenium/CAN. 
Complex 11a (7.4 mg, 9.5 μmol, 5 mol%), 1,2-dichlorobenzene (3 mL), and the appropriate amount of 
[Ce(NH3)6](NO3)2 dissolved in MeCN (0.5 mL) were stirred at reflux for 15 min. Benzyl alcohol (20 μL, 190 
μmol) was then added. Aliquotes (0.05 mL) were taken from the mixture at selected intervals, diluted with 
CDCl3 (0.5 mL) and conversions were determined by 1H NMR spectroscopy.  
General conditions for transfer hydrogenation 
 
Figure 3.9 Catalytic transfer hydrogenation of 4-fluoroacetophenone. 
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Complex 11a (12 mg, 15 μmol, 5 mol%), CAN (8 mg, 15 μmol, 5 mol%) and iPrOH (5 mL) were stirred at reflux 
for 15 min. Then 4-fluoroacetophenone (36 μL, 300 μmol) was added and samples were taken at regular 
intervals. Aliquots (ca. 0.05mL) were diluted with CDCl3 (0.5 mL) and conversions were determined by 1H NMR 
spectroscopy. 
 
Crystallographic details 
Crystal data for complexes 11a and 11d were collected by using an Agilent Technologies SuperNova A 
diffractometer fitted with an Atlas detector using Mo-Kα radiation (0.71073 Å; 11a) or Cu-Kα radiation (1.54184 
Å; 11d). A complete dataset was collected, assuming that the Friedel pairs are not equivalent. An analytical 
numeric absorption correction was performed.31 The structure was solved by direct methods using SHELXS-
9732 and refined by full-matrix least-squares fitting on F2 for all data using SHELXL-97.32 Hydrogen atoms were 
added at calculated positions and refined by using a riding model. Their isotropic temperature factors were 
fixed to 1.2 times (1.5 times for methyl groups) the equivalent isotropic displacement parameters of the carbon 
atom the H-atom is attached to. Anisotropic thermal displacement parameters were used for all nonhydrogen 
atoms.  
Table 3.5 Crystallographic details for complexes 11a and 11d 
CCDC No.  1043258 1043259 
Empirical formula  C43H35N3O5Ru C43H35N3O5Ru 
Formula weight  774.81 774.81 
Temperature  100(2) K 100(2) K 
Wavelength  0.71073 Å 1.54184 Å 
Crystal system  Monoclinic Triclinic 
Space group  P21/n (#14) P–1 (#2) 
Unit cell dimensions a = 14.2501(1) Å a = 11.59996(7) Å    = 96.3043(6)° 
 b = 12.8432(1) Å     = 91.0445(6)° b = 12.4497(1) Å = 107.6103(6)° 
 c = 19.6923(2) Å c = 13.3559(1) Å  = 105.4593(6)° 
Volume 3603.42(5) Å3 1733.40(2) Å3 
Z 4 2 
Density (calculated) 1.428 Mg m–3 1.484 Mg m–3 
Absorption coefficient 0.486 mm–1 4.088 mm–1 
F(000) 1592 796 
Crystal size 0.3520 x 0.2699 x 0.1758 mm3 0.2053 x 0.1485 x 0.0444 mm3 
 range for data collection 2.86 to 32.88° 3.55 to 76.91° 
Reflections collected 112232 69936 
Independent reflections 12821 [R(int) = 0.0412] 7272 [R(int) = 0.0366] 
Completeness to  = 32.00° 98.9 %  99.4 %  
Absorption correction Analytical Analytical 
Max. and min. transmission 0.932 and 0.882 0.867 and 0.588 
Refinement method Full–matrix least–squares on F2 Full–matrix least–squares on F2 
Data / restraints / parameters 12821 / 0 / 609 7272 / 0 / 473 
Goodness–of–fit on F2 1.062 1.063 
Final R indices [I>2 (I)] R1 = 0.0276, wR2 = 0.0633 R1 = 0.0262, wR2 = 0.0657 
R indices (all data) R1 = 0.0361, wR2 = 0.0680 R1 = 0.0280, wR2 = 0.0667 
Largest diff. peak and hole 0.651 and –0.562 e Å–3 0.842 and –0.659 eÅ–3 
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Time-conversion profiles 
Selected profiles of the conversion in the function of time are summarized in the following.  
 
Figure 3.10 Comparison of conversion for the alcohol oxidation of BnOH with 2 equivalents of CAN using as pre-catalyst 
the ruthenium dimer (), the carbene complex 11a (), and the blank without any precursor () 
 
 
Figure 3.11 Comparison of conversions for the alcohol oxidation of BnOH with complex 11a as pre-catalyst (), and the 
blank without any precursor () with 0.5 molequiv CAN (left) and 1 molequiv CAN (right) relative to 11a. 
 
Figure 3.12 Comparison of conversions for the alcohol oxidation of BnOH with 5 mol% complex 11a as pre-catalyst with 
2 equivalents (),1 equivalent () and 0.5 equivalent () of CAN as activator. 
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Figure 3.13 Comparison of the catalytic results for the transfer hydrogenation of 4-fluoroacetophenone with 11a in the 
presence of different amounts of CAN. Best results were obtained with stoichiometric quantities of the oxidazing agent; 
lower amounts of CAN give a lower conversion, probably due to a higher induction time. Higher CAN concentrations 
induced catalyst deactivation after 4–8 h and gave incomplete conversions. A blank experiment using 10 mol% CAN 
showed no conversion. 
Electrochemical analysis 
Further details on the electrochemical analysis performed on 11a are depicted in Figure 3.13 and 3.16 and in 
Table 3.6. 
Figure 3.14 Cyclic Voltammetry of 11a in CH2Cl2 at 200 mV s–1 (left) and in the presence of ferrocene (right): Epc = 1.013 
V and Epa = 0.894 V, hence E1/2 = 0.953 V (∆E = 120 mV); ipa = 17.0 A and ipc = 16.3 A, thus ipc/ipa = 0.96. 
Table 3.6 Scan rate dependence of the +0.95 V oxidation of complex 11a. 
Scan rate E1/2 (V) ∆E (mV) ipc/ipa 
20 mV s–1 0.946 90.3 0.56 
50 mV s–1 0.953 95.2 0.80 
75 mV s–1 0.954 111 0.84 
100 mV s–1 0.956 110 0.91 
200 mV s–1 0.953 120 0.96 
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Figure 3.15 Analysis of ipc/ipa ratios at different scan rates provides a linear fit for a coupled first-order irreversible follow-
up reaction to the oxidation (EC mechanism) with a first-order rate constant k = 0.58 s–1 (t = time between passing the 
E1/2 potential and reaching the switching potential Emax, here 0.95 V and 1.15 V, respectively). 
 
 
Figure 3.16 Cyclic Voltammetry diagrams of 11a in MeCN with different scan rates. 
 
 
 
Figure 3.17 Cyclic voltammogram of CAN measured in MeCN at 100 mV s–1. 
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CHAPTER IV 
Ruthenium hydroxycyclopentadienyl N-heterocyclic carbene complexes as transfer 
hydrogenation catalysts 
Abstract 
A series of novel cationic hydroxycyclopentadienyl and methoxycyclopentadienyl N-heterocyclic carbene 
ruthenium(II) complexes have been synthesized from the corresponding neutral ruthenium(0) complexes 
containing both the non-innocent cyclopentadienone ligand and variously functionalized N-heterocyclic 
carbenes (NHCs). In particular, an NHC derivative containing a pyridine group in the side chain has been 
designed and developed in order to evaluate the influence of a basic, potentially cooperative substituent in the 
catalytic activity of these complexes. All the prepared complexes were employed as selective catalysts for 
transfer hydrogenation reactions employing refluxing iPrOH as hydrogen source and several ketones and 
aldehydes as substrates. We found that while the presence of oxidizing additives such as CAN and 
benzoquinone is mandatory to activate the neutral ruthenium(0) complexes, no activation is needed for the 
cationic Ru(II) catalysts. The catalytic activity of the latter is also influenced by the coordinating ability of the 
counterion, and indeed the cationic complexes having a pyridine-functionalized NHC ligand and CF3SO3- as 
counterion, present the best conversion (> 99%) thus demonstrating the fundamental role played by the basic 
pyridine in the catalytic activity. With regard to the hydrogenation reaction mechanism, the release of the CO 
ligand was demonstrated to be the key step and the presence of hydride species has been detected at the 
end of the reaction. 
Introduction 
As emphasised many times in the previous chapters the attention of the research group was particularly focus 
on two popular classes of ligands: N-Heterocyclic carbenes, that are among the most popular ancillary ligands 
due to a combination of unique electronic and steric features1 allowing to the rational design of transition metal 
catalysts and the improvement of catalytic activity,2 and the cyclopentadienones which behave as non-innocent 
ligands exploiting the cyclopentadienone/hydroxycyclopentadienyl reversible transformation. The most famous 
example of its cooperativity with ruthenium in bifunctional catalysis is the Shvo catalyst, a well-known system 
employed in a plethora of catalytic applications.3 In principle by combining NHC and cyclopentadienone ligands 
on ruthenium complexes the properties of both ligands should be exploited allowing the design of novel 
catalysts finely tuning steric and electronic properties, solubility and the insertion of substituents suitable for 
heterogenization. Furthermore, by choosing a proper substituent, NHC ligand itself could cooperate with the 
metal as a non-innocent species.4 
With this aim in mind, a straightforward approach towards Ru(0)-NHC complexes has been developed as 
described in Chapter II,5 based on a dimeric Ru(0) cyclopentadienone dicarbonyl dimer (3). Cleavage of 3 in 
the presence of a silver carbene precursor provided access to a new class of ruthenium complexes in 
quantitative yields (for the sake of clarity some examples are recalled in Scheme 4.1). 
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Scheme 4.1. Synthesis of cyclopentadienone imidazolylidene ruthenium(0) complexes 4a,c,d. 
In this chapter we first describe an extension of this synthetic methodology to a complex containing a basic 
nitrogen on the side chain of the NHC ligand (4m: R1 = butyl; R2 = 2-pyridine; 4n: R1 = methyl; R2 = 2-BocNH-
ethyl; 4o: R1 = methyl; R2 = aminoethyl) then the main body of this work concerns the transformation of the 
cyclopentadienone imidazolylidene ruthenium(0) complexes (4a,c,d,m,o) into their corresponding cationic 
hydroxyl- and methoxy-cyclopentadienyl ruthenium(II) derivatives [12a,c,d,m,o[X] (X = Cl, BF4, NO3, CF3SO3) 
and 13a,m[CF3SO3]], and the use of both Ru(0) and Ru(II) complexes as catalysts for transfer hydrogenation 
of ketones and aldehydes in refluxing isopropanol. Comparison between monodentate and pyridine-
functionalized NHC ligands, has provided some insights into the reaction mechanism. 
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Results and discussion 
4.1 Synthesis of imidazolylidene Ru complexes 
The novel complexes 4m (R1 = butyl; R2 = 2-pyridine) and 4n (R1 = methyl; R2 = 2-BocNH-ethyl) were prepared 
in one pot following the same procedure described in Scheme 4.1 and fully characterized by spectroscopic 
methods and elemental analysis. In particular, the 13C NMR spectra show the downfield shifted resonance of 
the carbene (δ = 173.20 ppm (4m), 173.16 ppm (4n)), whereas in the IR spectrum the CO stretching bands 
are consistent with those of similar complexes (νCO = 2008 cm-1, 1949 cm-1 (4m); 2008 cm-1, 1948 cm-1 (4n) 
vs νCO = 2004 cm-1, 1945 cm-1 (4a)). Further evidences were produced by ESI-MS and X-Ray diffraction 
analyses. 
The molecular structure of 4m has been determined by single crystal X-ray crystallography as its 
4m·0.5CH2Cl2 solvate (Figure 4.1). 
Figure 4.1. ORTEP drawing of 4m. Displacement ellipsoids are at the 30% probability level. H-atoms have been omitted 
for clarity. Selected bond lengths (Å): Ru(1)-C(1) 1.845(16), Ru(1)-C(2) 1.883(12), Ru(1)-C(3) 2.511(11), Ru(1)-C(4) 
2.279(11), Ru(1)-C(5) 2.199(11), Ru(1)-C(6) 2.212(10), Ru(1)-C(7) 2.280(11), Ru(1)-C(34) 2.139(12), C(3)-O(3) 
1.246(13). 
Its structure is similar to those previously reported for the analogous complexes 4a,c,d.5 In particular, the 
Ru(1)-C(3) distance [2.511(11) Å] is significantly longer than Ru(1)-C(4-7) [2.199(11)-2.280(11) Å, average 
2.242(2) Å] and C(3)-O(3) [1.246(13) Å] is essentially a double bond.6 The Ru(1)-C(34) contact [2.117(3) Å] is 
in the typical range for the interaction between Ru(0) and a N-heterocyclic carbene.7 
The reaction of 4a,c,d,m with strong acids or a methylating agent such as MeCF3SO3, leads to the quantitative 
formation of the hydroxycyclopentadienyl and methoxycyclopentadienyl cationic complexes 12a,c,d,m[X] (X 
= Cl, BF4, NO3, CF3SO3) and 13a,m [CF3SO3] (Scheme 4.2), in which Ru(0) is formally oxidized to Ru(II). 
Scheme 4.2. Synthesis of hydroxycyclopentadienyl imidazolylidene ruthenium complexes 12a,c,d,m[X] and 
methoxycyclopentadienyl imidazolylidene ruthenium complexes 13a,m[CF3SO3]. 
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Infrared spectroscopy provides a convenient technique for monitoring the progress of the protonation as, in 
agreement with the reduced back-donation from the metal center to the carbonyl ligands, ν-CO stretch 
vibrations undergo a significant high-energy shift upon formation of the cationic complex (Figure 4.2) [e.g. νCO 
= 2008 cm-1, 1949 cm-1 (4m), and 2041 cm-1, 1991 cm–1 (12m[CF3SO3])].  
Figure 4.2 Comparison of CO stretching frequencies of the neutral (4m) and the cationic (12m[CF3SO3]) pyridine-
functionalized NHC complexes. 
The change in the coordination from η4 (cyclopentadienone ligand) to η5 (hydroxycyclopentadienyl ligand) is 
further evidenced by 13C-NMR shift of the resonance due to the endocyclic carbon involved in the ketone-
alcohol transformation [δ 169.33 ppm (C=O, Cp, in 4a) vs δ 142.77 ppm (C-OH, Cp, in 12a[CF3SO3])]. Ru-
carbene signals are also shifted to higher fields; from δ 172.72 ppm (4a) to δ 161.35 ppm (12a[CF3SO3]) 
(Figure 4.3). 
Figure 4.3. 13C-NMR spectrum of 12a[CF3SO3] in CDCl3. 
With regard to the methylated complexes 13a[CF3SO3] and 13m[CF3SO3] IR spectra show a shift of 40 cm-1 
from the neutral to the cationic species (e.g. νCO = 2004 cm-1, 1945 cm-1 (4a), and 2045 cm-1, 1995 cm-1 
(13a[CF3SO3]) and both IR and NMR data are similar to those obtained for the hydroxycyclopentadienyl 
complexes 12a[CF3SO3] and 12m[CF3SO3] with the methyl group arising at δ 3.19 (1H NMR) and δ 61.93 (13C 
NMR) ppm. 
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Moreover, structural evidences were obtained by X-ray diffraction analysis of single crystals of the 
cationic complexes [12a]+ and [12d]+ as their [12a][CF3SO3]·0.5toluene and [12d][CF3SO3]·CHCl3 
solvate salts (Figure 4.4). X-ray crystallography confirms that protonation has occurred on the 
O-atom of the cyclopentadienone ligand. As a consequence, the C(3)-O(3) interaction [1.335(6) and 
1.339(9) Å for [12a]+  and [12d]+, respectively] is considerably elongated compared to the parent neutral 
complexes [e.g., 1.246(13) Å for 4m] and displays the character of a C(sp2)-O single bond. In addition the 
Ru(1)-C(3) distance [2.323(5) and 2.319(7) Å for [12a]+  and [12d]+, respectively] is shortened in respect 
to the parent complexes [e.g., 2.511(11) Å for 4m] and comparable to the other Ru(1)-C(4-7) distances 
[2.227(5)- 2.290(5) Å, average 2.253(10) Å for [12a]+; 2.271(8)- 2.221(7) Å, average 2.248(12) Å for [12d]+]. 
Thus, the protonated ligand of [12a]+ and [12d]+ is better described as a η5-cyclopentadienyl ligand, as 
previously reported for analogous complexes.18d, 23 The O(3)-H(3) group of [12a]+ is involved in an inter-
molecular H-bond with the [CF3SO3]– anion [O(3)-H(3) 0.885(10) Å, H(3)···O(301) 1.80(3) Å, O(3)···O(301) 
2.626(5) Å, <O(3)H(3)O(301) 155(5)°]. Conversely, the O(3)-H(3) group of [12d]+ forms an intra-molecular 
H-bond with the O(6) atom of the side chain of the NHC ligand [O(3)-H(3) 0.84 Å, H(3)···O(6) 1.83 Å, 
O(3)···O(6) 2.646(7) Å, <O(3)H(3)O(6) 163.7°]. In addition, there is in [12d]+ also an inter-molecular H-bond 
between the O(6)-H(6) group of the complex and the [CF3SO3]– [O(6)-H(6) 0.84 Å, H(6)···O(301)#1 1.91 Å, 
O(6)···O(301)#1 2.739(9) Å, <O(6)H(6)O(301)#1 167.7°; symmetry transformations used to generate 
equivalent atoms: #1 x+1,y,z    #2 -x+1,-y+1,-z+1]. The carbene interaction Ru(1)-C(34) [2.101(5) and 
2.109(7) Å for [12a]+ and [12d]+, respectively] is almost unchanged compared to the parent neutral 
complexes [e.g., 2.117(3) Å for 4m]. 
Figure 4.4. Left: ORTEP drawing of [12a]+ Displacement ellipsoids are at the 30% probability level. H-atoms have been 
omitted for clarity, except H(3). Selected bond lengths (Å): Ru(1)-C(1) 1.882(7), Ru(1)-C(2) 1.881(7), Ru(1)-C(3) 
2.323(5), Ru(1)-C(4) 2.290(5), Ru(1)-C(5) 2.238(5), Ru(1)-C(6) 2.227(5), Ru(1)-C(7) 2.256(5), Ru(1)-C(34) 2.101(5), 
C(3)-O(3) 1.335(6). Right: ORTEP drawing of [12d]+. Displacement ellipsoids are at the 30% probability level. H-atoms 
have been omitted for clarity, except H(3) and H(6). Selected bond lengths (Å): Ru(1)-C(1) 1.876(8), Ru(1)-C(2) 1.901(9), 
Ru(1)-C(3) 2.319(7), Ru(1)-C(4) 2.262(7), Ru(1)-C(5) 2.240(7), Ru(1)-C(6) 2.221(7), Ru(1)-C(7) 2.271(8), Ru(1)-C(34) 
2.109(7), C(3)-O(3) 1.339(9). 
In order to obtain a basic nitrogen on the side chain of the carbene, the complex 4n, containing an amide-
functionalized NHC ligand, has been treated with tetrafluoroboric acid diethyl ether complex allowing the 
cleaving of the NHBoc group and leading to the formation of the cationic complex 12o[BF4] with an amine 
group on the side chain of the carbene (Scheme 4.3). Infrared characterization evidences the presence of two 
species in equilibrium demonstrated by two set of CO stretching frequencies [ν(CO): 2042 cm-1, 1992 cm-1 
(12o’[BF4]) and 2021 cm-1, 1966 cm-1(12o’’[BF4])]. Conversely, the 1H-NMR spectrum shows only one set of 
averaged signal resulting from a fast exchange between the two species (12o’[BF4] and 12o’’[BF4]). Indeed, 
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a VT-NMR experiment performed at T = -50°C in (in CDCl3) reveals the presence of two set of signals 
belonging to the two cationic forms. Conversely, the 1H-NMR spectrum shows only one set of averaged signal 
resulting from a fast exchange between the two species (12o’[BF4] and 12o’’[BF4]) at room temperature. 
The protonation, in fact, can occurs on the cyclopentadienone ligand leading to the formation of the 
hydroxycyclopentadienyl cationic complex 12o’[BF4] or on the -NH2 obtaining the complex 12o’’[BF4] that 
contain a terminal ammonium cation on the side chain of the carbene (Scheme 4.3). Quite surprisingly the bis-
cationic complex, which would arise from the bis-protonation, has never been observed even though an excess 
of HBF4 is employed. 
Scheme 4.3 Deprotection reaction of NHBoc group. 
Furthermore, the treatment of 12o[BF4], formally containing a protected amine, with bases such as K2CO3 and 
KOH led to the formation of the corresponding neutral complex 4o that has been subsequently protonate with 
trifluoromethanesulfonic acid in order to achieve the cationic complex 12o[CF3SO3] with the triflate as 
conterion (Scheme 4.4) thus demonstrating the reversibility of the protonation. It is important to underline 
that while employing triflic acid as protonating agent only one isomer is observed by IR spectroscopy [ν(CO): 
2042 cm-1, 1993 cm-1].
Scheme 4.4 Synthesis of dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-(2-aminoethyl)-
3-methylimidazol-2-ylidene)ruthenium (4o).
Due to the peculiar acid/base chemistry of amino-functionalized complexes, with the aim of allowing the 
coordination of a basic nitrogen to the metal centre, the pyridine containing complex 12m[CF3SO3] has been 
irradiated with a UV lamp. The photolytic removal of one terminal CO led to the formation of the chelated 
complex 14m[CF3SO3] in good yield (Scheme 4.5). 
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Scheme 4.5. Photolytic removal of terminal CO. 
The IR spectrum shows the disappearance of the two absorptions due to the CO stretching of 12m[CF3SO3], 
and the appearance of a unique band at 1967 cm-1 (14m[CF3SO3]). Carbene resonance, in 13C NMR spectrum, 
is shifted to lower fields (δ 185.63 ppm (14m[CF3SO3]) vs δ 166.07 ppm (12m[CF3SO3]). 
The X-Ray molecular structure of 14m[CF3SO3] further supports the characterization performed in solution 
(Figure 4.5) and consists of a Ru center coordinated to a ƞ5-cyclopentadienyl ligand, a terminal CO and a 
chelating NHC ligand bonded to Ru via the carbene and the N-atom of the pyridine side group. The Ru(1)-Cp 
distances [2.216(7)- 2.302(8) Å, average 2.248(16) Å] are comparable to those reported above for [12a]+ 
and [12d]+ and analogous Ru-complexes containing protonated cyclopentadienone ligands.3d, 8 As in the 
case of [12a]+ and [12d]+, the C(3)-O(3) interaction [1.338(9) Å] is a single bond, in view of the presence of a 
H atom on the oxygen, which is involved in H-bond with the triflate anion. 
Figure 4.5. ORTEP drawing of 14m[CF3SO3]. Displacement ellipsoids are at the 30% probability level. H-atoms have 
been omitted for clarity, except H(3). Selected bond lengths (Å): Ru(1)-C(1) 1.860(9), Ru(1)-C(3) 2.302(8), Ru(1)-C(4) 
2.237(7), Ru(1)-C(5) 2.216(7), Ru(1)-C(6) 2.236(7), Ru(1)-C(7) 2.251(7), Ru(1)-C(34) 2.030(7), Ru(1)-N(3) 2.127(10), 
C(3)-O(3) 1.338(9). 
It is worth mentioning that UV irradiation (3 h) of the neutral complexes 4a and 4m leaves the reactant unaltered 
indicating that the formal oxidation of Ru complex, upon protonation, favor the CO removal. The same result 
was surprisingly obtained with the cationic complexes 12a[CF3SO3] and 13a[CF3SO3], for which CO release 
was expected (16 h of irradiation in iPrOH). Nonetheless irradiating 12a[CF3SO3] and 13a[CF3SO3], in the 
presence of a trapping agent such as pyridine, the formation of the complexes 15[CF3SO3] and 16[CF3SO3] 
was finally observed (Figure 4.6) actually demonstrating that the CO release occurs in the cationic complexes. 
Indeed, neutral complex 4a did not lose CO under UV irradiation even in the presence of pyridine. It is thus 
likely that, in the case of cationic complexes, without the help of pyridine the removal of CO is an equilibrium 
in which ruthenium-CO bond is reformed at the end of the reaction leading to the recovery of the precursors 
12a[CF3SO3] and 13a[CF3SO3]. 
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Figure 4.6. Molecular structure of 15CF3SO3] and 16[CF3SO3]. 
Formation of 15[CF3SO3] and 16[CF3SO3] is evidenced by the disappearance of the two carbonyl stretching 
bands associated to 12a[CF3SO3] (2037, 1985 cm-1) and 13a[CF3SO3] (2045, 1995 cm-1), with the concomitant 
appearance of a single band associated with the new complex 15[CF3SO3] (1943 cm-1) and 16[CF3SO3] (1948 
cm-1) (Figure 4.6). Complexes 15[CF3SO3] and 16[CF3SO3] have been found in mixture with other species 
and their characterization was not complete. However, the bathochromic shift observed in IR spectra is in 
agreement with the replacement of a strong π ligand with a σ N-donor ligand such as pyridine. Furthermore, 
ESI-MS analyses performed on complexes 15[CF3SO3] and 16[CF3SO3] showed the presence of the 
molecular ions. 
4.2 Catalytic transfer hydrogenation 
The Ru complexes 4a,c,d,m,o, 12a,c,d,m,o[X] [(X = Cl, BF4, NO3, CF3SO3)] and 13a,m[CF3SO3] were 
evaluated as catalyst precursors under transfer hydrogenation conditions i.e. refluxing iPrOH as hydrogen 
source employing 4-fluoroacetophenone as model substrate. Catalytic runs were performed to investigate the 
role of different additives in the activation of 4a,c,d,m,o to compare the catalytic activity of the ruthenium(0) 
complexes 4a,c,d,m,o with the corresponding ruthenium(II) cationic complexes 12a,c,d,m,o[X] and 
13a,m[CF3SO3] and finally to evaluate the influence of a pyridine substituent on the NHC side chain. Results 
are reported in Table 4.1: in all cases selectivity is complete and conversion corresponds to yield unless 
otherwise stated. 
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Table 4.1. Catalytic transfer hydrogenation of 4-fluoroacetophenone.a 
 
entry [Ru] additive conversion 8h (%)  conversion 24h (%)  
1 4a --- 0 0 
2 4c --- 0 0 
3 4d --- 0 0 
4 4m --- 0 0 
5 4o --- 0 0 
6 4a CANb 25 61 
7 4ac CANb 0 27 
8 4c CANb 10 87 
9 4d CANb 10 25 
10 4m CANb 0 9 
11 4o CAN <5 40 
12 4a NaIO4d 0 0 
13 4a BQd 25 55 
14 12a[CF3SO3] --- 58 93 
15 12a[CF3SO3]c --- 5 29 
16 12a[CF3SO3]e --- 64 87 
17 12a[CF3SO3] KOtBud 14 35 
18 12a[BF4] --- 41 71 
19 12a[Cl] --- 16 24 
20 4a CF3SO3Hd 32 >99f 
21 4a H2SO4d 45 92 
22 4a HNO3d 60 65 
23 12c[CF3SO3] --- 9 60 
24 12d[CF3SO3] --- 35 46g 
25 12m[CF3SO3] --- 84 >99 
26 12m[Cl] --- 0 5 
27 12m[BF4] --- 37 40 
28 12o[BF4] --- 6 38 
29 12o[CF3SO3] --- 81 88 
30 4m CF3SO3Hd 84 >99f 
31 4m H2SO4d 76 86 
32 4m HNO3d 0 36 
33 13a[CF3SO3] --- 28 64 
34 13m[CF3SO3] --- 10 13 
35 14d[CF3SO3] --- 0 5 
36 HCF3SO3 --- 0 0 
aGeneral conditions: Ruthenium complex (5 mol% Ru), iPrOH (3 mL), reflux; conversions determined by 19F NMR 
spectroscopy; bCAN 1 mol equiv. per ruthenium center; ccatalyst loading reduced to 1 mol% Ru; dNaIO4, BQ 
(benzoquinone), KOtBu and acids: 1 mol equiv. per ruthenium center; erecycling test; fyield ~70% the co-product arising 
from the acid catalyzed etherification of 4-fluoroacetophenol with the solvent 2-propanol; g yield ~ 35% the coproduct was 
not identified. 
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The neutral complexes 4a,c,d,m,o did not present any catalytic activity in the absence of additives (entry 1-
5), as well as by adding NaIO4 (entry 12). However, we found that the addition of one equivalent of CAN (entry 
6-11) results in the formation of active intermediates, likely deriving from the release of one CO ligand, favoured 
by oxidation as discussed in the previous section. In fact, the use of benzoquinone as oxidant additive under 
the same conditions (entry 13), activates the catalyst even though leading to a slightly lower conversion if 
compared with CAN. 
Reduction of the catalyst loading to 1 mol% (4a) increases the induction time halving the conversion in 24 h 
(entry 6 vs 7). In general pre-catalysts 4a,c,d,m,o resemble the behaviour of the triazolylidene ruthenium(0) 
congener, namely the dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-
dimethyl-4-phenyl-1,2,3-triazol-ylidene)ruthenium (11), previously tested as hydrogen transfer catalyst (see 
Chapter III).9 
The oxidation state of the metal center appears to be the key point in order to activate the catalyst and indeed, 
better conversions are reached with the pre-catalysts 12a,c,d,m,o[X] [(X = Cl, BF4, NO3, CF3SO3) (entries 14, 
18, 19, 23-29)]. A recycling test has been performed with 12a[CF3SO3], the catalyst can be reused although a 
slight decrease in conversion from 93 to 87% was observed after 24 h (entry 16). Noteworthy also the 
counterion shows to influence the catalytic activity, and CF3SO3- provides the best results: for example, we 
observed almost complete conversion within 24 h in the case of 12a[CF3SO3], 12m[CF3SO3] and 12o[CF3SO3] 
(entries 14, 25, 29). Furthermore, the latter pyridine- and amine-functionalized catalyst 12m[CF3SO3] and 
12o[CF3SO3] shows a faster activation if compared with 12a[CF3SO3] (conversion of 84%, 81% and 58% 
respectively in 8 h). On the other hand, catalytic activity is suppressed in the case of 12a[Cl] and 12m[Cl] 
(entry 19, 26), possibly due to the coordinating ability of Cl- counterion; on the contrary 12a[BF4], 12m[BF4] 
and 12o[BF4] give intermediate results (entry 18, 27, 28). In particular in the case of 12o[BF4] the quite low 
conversion could be attributed also to the presence of two species in solution, it is assumed that the specie 
12o’’[BF4] (see Scheme 4.4) is less active compared to the other cationic complexes 12a,c,d,m,o’[X]. The 
latter hypothesis is supported by IR spectrum of 12o’’[BF4] for which a lowering in the CO stretching 
frequencies is observed reasonably due to the ƞ4 coordination of cyclopentadienonic ligand [ν(CO): 2042 cm-
1, 1992 cm-1 (12o’[BF4]) and 2021 cm-1, 1966 cm-1(12o’’[BF4])]. Further investigations on the catalytic activity 
of this complex are being carried out. 
The in situ addition of various acids such as HCF3SO3, H2SO4 and HNO3 to 4a and 4m (entries 20-22, 30-32) 
produces, in the case of triflic acid, similar conversions as for the corresponding preformed catalysts (e.g. entry 
25, 12m[CF3SO3] vs entry 30, 4m + CF3SO3H in situ). However, a lower selectivity is observed due to the acid 
catalyzed etherification of 4-fluorobenzylalcohol and isopropanol. Best in situ performances are accomplished 
by sulfuric acid (entries 21, 31), which gives much better results than HNO3 (entry 22, 32), confirming the 
detrimental effect of the coordination ability of counterions. A base, such as KOtBu, has a negative effect on 
the reaction (entry 17), likely due to deactivation of the pre-catalyst by deprotonation. Finally, a blank 
experiment performed with HCF3SO3 in refluxing isopropanol rule out an exclusive role of the acid itself in the 
catalytic activity (entry 36). 
With the aim of evaluating the role of the hydroxyl group in the catalytic reaction methylated complexes 
13a[CF3SO3] and 13m[CF3SO3] have been also tested as catalysts (entry 33 and 34). Quite surprisingly, the 
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methylated complex 13a[CF3SO3] shows a remarkable catalytic activity although in the absence of the acidic 
OH. Worst performances came from the pyridine-functionalized methylated complex 13m[CF3SO3], probably 
due to a deactivation pathway associated with the formation of stable species in the chelated form. Indeed, no 
conversion is observed when the chelated cationic complex 14m[CF3SO3] is employed as pre-catalyst (entry 
35). 
The substrate scope has been also evaluated extending the reactivity of 4a, 12a[CF3SO3] and 12m[CF3SO3] 
as hydrogen transfer catalysts to acetophenone, benzophenone and benzaldehyde. Data are reported in Table 
4.2. All the substrates are converted to the corresponding alcohol by activated 4a and by the cationic complex 
12a[CF3SO3]. As expected the catalysts are much more active in the case of benzaldehyde (entry 7 and 9), 
since aldehydes are substrates more prone to reduction than ketones. Additionally, the scale of activity is 
consistent with the electron withdrawing properties of the ketones examined. Again, 12m[CF3SO3] (entry 3, 6, 
9) shows a faster activation. As an example, benzaldehyde reaches complete conversion within 4 h, that 
becomes 8 h in the case of 12a[CF3SO3] (entry 9c vs 8). 
Table 4.2. Catalytic transfer hydrogenation.a 
entry substrate [Ru] Additiveb Conversion 8h (%) Conversion 24h (%) 
1  4a CAN 10 77 
2 
 
12a[CF3SO3] --- 15 68 
3  12m[CF3SO3] --- 45 48 
4  4a CAN 0 42 
5 
 
12a[CF3SO3] --- 0 36 
6  12m[CF3SO3] --- 42 43 
7  4a CAN 31 39 
8 
 
12a[CF3SO3] --- >99  
9  12m[CF3SO3] --- >99%c  
aReaction conditions: [Ru] = 5 mol%, iPrOH (3mL), reflux. Conversions determined by GC; bCAN 1 mol equiv. per 
ruthenium center; c) Complete conversion is reached within 4 h. 
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4.3 Mechanistic insight 
On the basis of the results described above, we can draw some considerations regarding the active catalytic 
species. First of all, the trapping experiments with pyridine (see cyclization of 12m[CF3SO3] to 14m[CF3SO3], 
Scheme 4.3 and complexes 15[CF3SO3] and 16[CF3SO3], Figure 4.6) demonstrates that CO release is 
involved in the activation, leaving unaltered the Ru-carbene bond. Indeed, all the crude products of catalytic 
reactions have been analyzed by IR and NMR spectroscopy and only in a couple of cases traces of Shvo 
catalyst, which would results from NHC ligand release, were visible in NMR spectra, accompanied by a very 
bright yellow color of the solution typical of Shvo complex.3 Furthermore, an outer sphere mechanism is likely 
to be followed, in that the complex [CpRu(CO)2][CF3SO3], obtained by reaction between [Cp2Ru2(CO)4] with 
AgOTf, did not present any catalytic activity, supporting the role of hydroxycyclopentadienyl complex as a 
bifunctional catalyst. Noteworthy, in the case of 12m[CF3SO3] the pyridine itself can be involved in the catalytic 
cycle as a cooperative ligand through the formation of the active catalyst A in which a hydride and two different 
acid hydrogens should be available for the hydrogen transfer. (Figure 4.7). 
 
Figure 4.7. Proposed activation of the pre-catalyst 12m[CF3SO3]. 
Indeed, 12m[CF3SO3] results to be the best pre-catalyst. Furthermore, from the crude reaction mixture at the 
end of the reaction some resonances in the 1H-NMR spectrum are detected in the hydride region: a singlet at 
δ -10.18 ppm is presumably associated with monomeric Ru-H species, while the signal at δ -14.95 ppm falls 
in the region of bridging hydrides (Ru-H-Ru). Even though we were not able to isolate these hydride species, 
in analogy with what observed in the synthesis of Shvo catalyst (δ RuHRu -18.80 ppm for the dimeric specie 
and δ -9.37 ppm for the monomeric one),3d, 8 the formation of active hydride complexes containing the NHC 
ligand in place of a terminal CO reasonably occurs. 
Labeling experiments on the reduction of 4-fluoroacetophenone with 12a[CF3SO3] and 12m[CF3SO3] in 
isopropanol-d8 (see Experimental section for reaction conditions and spectra) lead to the formation of the 
corresponding deuterated alcohol further confirming the role of isopropanol as hydrogen source as well as the 
action of the catalysts in its activation. 
With regard to 12d[CF3SO3], which in our experiments leads to the worst conversion after 24h and lower 
selectivity (Table 4.1, entry 22), its molecular structure (Figure 4.4, right side) evidences a hydrogen bond 
between the hydroxycyclopentadienyl ligand and the –OH group in the NHC side chain. Furthermore, 
12d[CF3SO3], upon CO release, would be prone to an intramolecular dehydrogenation, probably leading to 
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the formation of an inactive catalyst. By comparing the behavior of 12d[CF3SO3] with that of an iridium complex 
containing the NHC hydroxymethyl ligand which  
 
lead to the formation of an [Ir(Cp*)(I)(NHC-CH2C=O)] complex upon oxidation and cyclometallation10 we can 
propose a similar reactivity for our ruthenium complex in agreement with the ν(CO) and ν(C=O) bands found 
at 1950 cm-1 and 1723 cm-1. 
Concerning monodentate NHC complexes 12a,c,d[X] (X = Cl, BF4, NO3, CF3SO3) due to the absence of a N-
containing side group able to be protonated, the active catalytic species has to be different from the proposed 
intermediate A. Once a vacant coordination site is formed by CO removal, proton abstraction from iPrOH 
should be performed by the counteranion CF3SO3- as external base, or by the oxygen of the -OH group (or -
OMe group) on the catalyst itself, but at present we do not have any evidence to support such hypothesis. 
Conclusions 
A series of cationic hydroxy- or methoxy-cyclopentadienyl ruthenium(II) N-heterocyclic carbene complexes 
have been prepared in quantitative yield upon protonation with strong acids or methylation with MeCF3SO3 of 
neutral ruthenium(0) complexes containing both the non-innocent cyclopentadienone ligand and variously 
functionalized NHCs. These novel complexes have been successfully employed as selective catalysts in 
transfer hydrogenation. The reaction is general and several substrates such as various ketones and aldehydes 
can be selectively reduced to the corresponding alcohol. The catalytic activity can thus be tuned by the proper 
choice of both substituents on NHC ligand and counterions. Neutral Ru(0) complexes 4a,c,d,m,n,o need an 
oxidizing agent such as CAN or benzoquinone in order to be activated, while the corresponding cationic 
complexes 12a,c,d,m,n,o[X] (X = Cl, BF4, NO3, CF3SO3) and 13a,m[CF3SO3], formally containing a Ru(II) 
center are more prone to release a CO ligand and do not need any additives to be activated. In the cationic 
complexes the counterion plays a non-innocent role and CF3SO3- showed the best outcome due to its 
coordinating ability. 
Noteworthy the insertion of a pyridine substituent on the NHC side chain further improves the catalytic activity 
due to the presence of a second cooperative ligand containing a basic nitrogen. 
With regard to the reaction mechanism CO release and its key role in the catalyst activation was demonstrated 
by trapping experiment with pyridine as well as by the UV-mediated formation of the chelated complex 
14m[CF3SO3]. Hydride species has been identified in the reaction mixture of the pyridine functionalized 
complex 12m[CF3SO3] and the cooperative function of nitrogen- (pyridine in 12m[X] and 13m[CF3SO3]) and 
oxygen-containing (CF3SO3- or -OH and -OMe in 12a,c,d[X] and 13a[CF3SO3]) moieties with the vacancy on 
ruthenium prone to accept an hydride species has been drawn as consideration in order to explain iPrOH 
activation and subsequent active catalyst formation. 
The versatility of NHC ligands which can be variously functionalized, together with the presence of the non-
innocent cyclopentadienone open the way to the rational design of novel metal-ligand bifunctional catalysts 
liable to heterogenization and tunable solubility. 
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Experimental section 
Material and procedures. Solvents: dichloromethane (CH2Cl2), tetrahydrofuran (THF), diethyl ether (Et2O), 
petroleum ether referring to a fraction of bp 60-80 °C, acetonitrile (CH3CN) were dried and distilled prior to use. 
Acetone has been degassed and stored under inert atmosphere on molecular sieves. Other solvents such as 
ethylacetate (EtOAc), chloroform, ethanol (EtOH), methanol (MeOH), heptane, hexane, 2-propanol, CDCl3, 
D2O, CD3CN (Sigma Aldrich) have been employed without further purification. Reagents: triruthenium-
dodecacarbonil (Ru3(CO)12) (Strem), methyl iodide, silver oxide, 1-methylimidazole, 1-chlorobutane, 1-
butylimidazole, 1-chloroethanol, 1,3 diphenylacetone, 4,4’dimethoxybenzil (Alfa Aesar), 2-bromopyridine, 4-
fluoroacetophenone, acetophenone, benzophenone, benzaldehyde, dodecane, trifluoromethanesulfonic acid, 
tetrafluoroboric acid diethyl ether complex (Sigma Aldrich), chloridric, nitric and sulfuric acid, methyl 
trifluoromethanesulfonate, pyridine, cerium ammonium nitrate (CAN), benzoquinone, sodium periodate have 
been employed as purchased. 1,3-dimethylimidazolium iodide (1a),11 1-methyl-3-butyl-imidazolium chloride 
(1c), 1-methyl-3-(2-hydroxyethyl)imidazolium chloride (1d),12 1-butyl-3-(2-pyridinyl)-imidazolium bromide 
(1m)13, 3,4-Bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone,14 dicarbonyl(η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) ruthenium dimer (3),15 dicarbonyl-η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)-1,3(dimethyl)-imidazol-2-ylidene)ruthenium (4a), 
dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)-1-methyl-3-butyl-imidazol-2-
ylidene)ruthenium (4c), dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4- dienone)-1-
methyl-3-butyl-imidazol-2-ylidene)ruthenium (4d),5 have been prepared as previously reported. The prepared 
derivatives were characterized by spectroscopic methods. The NMR spectra were recorded using Varian Inova 
300 (1H, 300.1; 13C, 75.5 MHz), Varian Mercury Plus VX 400 (1H, 399.9; 13C, 100.6 MHz), Varian Inova 600 
(1H, 599.7; 13C, 150.8 MHz) spectrometers at 298 K; chemical shifts were referenced internally to residual 
solvent peaks. Full 1H- and 13C-NMR assignments were done, when necessary, by gHSQC and gHMBC NMR 
experiments using standard Varian pulse sequences. Infrared spectra were recorded at 298 K on a Perkin-
Elmer Spectrum 2000 FT-IR spectrophotometer. ESI-MS spectra were recorded on Waters Micromass ZQ 
4000 with samples dissolved in MeOH or CH3CN. Elemental analyses were performed on a Thermo-Quest 
Flash 1112 Series EA instrument. The conversions were monitored by GC analysis (Agilent Technologies 
7890A GC system) and 19F-NMR. UV irradiation was performed by using a commercial Hg lamp (365 nm, 125 
W). 
Synthesis of neutral imidazolylidene Ru(0) complex (4) 
 
Figure 4.8 Structure of imidazolylidene Ru(0) complexes 4. 
Synthesis of dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) 1-(butyl-3-
(2-pyridinyl)-imidazol-2-ylidene)ruthenium (4m): A mixture of 1-butyl-3-(2-pyridinyl)-1H-imidazolium 
bromide (1m) 0.094g (0.33mmol), Ag2O 0.092g (0.40mmol) and dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone) ruthenium dimer (3) 0.200g (0.16mmol) in dry CH2Cl2 were stirred in the dark 
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under inert atmosphere at room temperature for 1h. Upon filtration on a celite pad and removal of the solvent 
the quantitative formation of the dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) 
1-(butyl-3-(2-pyridinyl)-imidazol-2-ylidene)ruthenium (4m) was verified by 1H-NMR, 13C-NMR, ESI-MS and X-
Ray crystal structure. Suitable crystals were obtained by slow diffusion from toluene/hexane double layer 1H-
NMR (599.7 MHz, CDCl3) δ (ppm): 8.36 (dd, 1H, CHpy), 7.60 (m, 4H, CHaryl), 7.04-6.97 (m, 10H, CHaryl + 1H, 
CHpy + 2H, CHNHC), , 6.60-6.55 (m, 4H, CHaryl + 1H, CHpy), 3.67 (s, 6H, -OCH3), 3.54 (t, 2H, NCH2), 1.46 (m, 
2H, -CH2CH2-), 1.04 (m, 2H, -CH2CH3), 0.75 (t, 3H, -CH3); 13C{1H} NMR (150.8 MHz, CDCl3) δ (ppm): 201.77 
(CO), 173.20 (Ccarbene), 168.22 (C1=O, Cp), 158.41 (-COCH3), 152.16 (Cipso), 148.11 (CHpy), 138.40 (CHpy),  
135.17 (Cqaryl), 133.45 (CHaryl), 129.49 (CHaryl), 127.43 (CHaryl), 125.28 (Cqaryl), 124.85 (CHaryl), 124.54 
(CHNHC), 123.89 (CHpy), 122.43(CHNHC), 121.82 (CHpy), 112.76 (CHaryl), 103.10 (C2,5, Cp), 79.69 (C3,4, Cp), 
54.98 (-OCH3), 50.72 (NCH2), 33.08, 19.41 (-CH2CH2), 14.11 (-CH3); IR (CH2Cl2) ν(CO): 2008 cm-1, 1949 cm-
1, ν(C=O) 1583 cm-1, ν(C=C) 1609 cm-1, 1518 cm-1. ESI-MS (m/z) (+) = 804 [M+H]+; 826 [M + Na] +. Anal. Calcd 
(%) for C45H39N3O5Ru: C, 67.23; H, 4.89; N, 5.23. Found: C, 67.21; H, 4.87; N, 5.24. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)[1-(2-Boc-NH-ethyl)-3-
methyl)-imidazol-2-ylidene]ruthenium (4n): A mixture of 1-1-(2-BocNH-ethyl-)-3-methylimidazolium iodide 
(1n) 0.062g (0.17mmol), Ag2O 0.047g (0.20mmol) and dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone) ruthenium dimer (3) 0.100g (0.08mmol) in dry CH2Cl2 were stirred in the dark 
under inert atmosphere at room temperature for 1h. Upon filtration on a celite pad and removal of the solvent 
the quantitative formation of the Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)[1-(2-Boc-NH-ethyl)-3-methylilidene]ruthenium (4n) was verified by 1H-NMR and 13C-NMR. 1H-NMR 
(599.7 MHz, CDCl3) δ (ppm): 7.76 (m, 4H, CHaryl), 7.17-7.08 (m, 10H, CHaryl), 6.99 (d, 1H, CHNHC), 6.79 (d, 1H, 
CHNHC), 6.64 (m, 4H, CHaryl), 4.85 (t, 2H, -NCH2), 3.72 (s, 6H, -OCH3), 3.11 (s, 3H, -NCH3), 2.96 (m, 2H, -
CH2NHBoc), 1.40 (s, 9H, -CH3). 13C{1H} NMR (150.8 MHz, CDCl3) δ (ppm): 202.13 (CO), 173.16 (Ccarbene), 
168.80 (C1=O, Cp), 158.61 (-COCH3), 156.27 (C=O, Boc), 135.00 (Cqaryl), 133.60 (CHaryl), 129.49 (CHaryl), 
127.60 (CHaryl), 125.64 (Cqaryl), 124.54 (CHaryl), 124.11 (CHNHC), 121.46 (CHNHC), 112.95 (CHaryl), 103.90 (C2,5, 
Cp), 79.18 (C3,4, Cp), 78.90 (Cq, tBu), 55.04 (-OCH3), 49.47 (NCH2), 39.81 (-CH2NHBoc), 38.18 (-NCH3), 28.40 
(CH3, tBu). IR (CH2Cl2) ν(CO): 2008 cm-1, 1948 cm-1, ν(C=O, Boc) 1707 cm-1, ν(C=O) 1577 cm-1, ν(C=C) 1602 
cm-1,1518 cm-1. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)[1-(aminoethyl)-3-
methyl)-imidazol-2-ylidene]ruthenium (4o): A solution of [Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-
diphenylhydroxycyclopentadienyl)(1-(2-aminoethyl)-3-dimethylimidazol-2-ylidene)ruthenium]tetrafluoroborato 
(12o[BF4]) in CH2Cl2 was neutralized by a saturated solution of sodium bicarbonate (pH = 7–8). The aqueous 
layer was extracted with CH2Cl2 and washed with a potassium hydroxide solution (2 M ) (3x30 mL), After 1h 
under mixing the organic phase was extracted with CH2Cl2 then concentrated under vacuum. The slightly 
brown solid obtained was identified as 4o by IR, 1H-NMR and 13C-NMR. 1H-NMR (599.7 MHz, CDCl3) δ (ppm): 
7.78 (m, 4H, CHaryl), 7.15-7.07 (m, 10H, CHaryl), 6.97 (s, 1H, CHNHC), 6.82 (s, 1H, CHNHC), 6.64 (m, 4H, CHaryl), 
NH non si vede, 3.71 (s, 6H, -OCH3), 3.58 (m, 2H, -NCH2), 3.11 (s, 3H, -NCH3), 2.56 (m, 2H, -CH2-). 13C{1H} 
NMR (150.8 MHz, CDCl3) δ (ppm): 202.33 (CO), 173.14 (Ccarbene), 169.43 (C1=O, Cp), 158.56 (-COCH3), 
135.26 (Cqaryl), 133.60 (CHaryl), 129.40 (CHaryl), 127.54 (CHaryl), 125.45 (Cqaryl), 124.69 (CHaryl), 112.92 (CHaryl), 
124.13 (CHNHC), 121.19 (CHNHC), 103.92 (C2,5, Cp), 78.76 (C3,4, Cp), 55.02 (-OCH3), 53.06 (-NCH2), 41.95 (-
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CH2CH2-), 38.23 (-NCH3). IR (CH2Cl2) ν(CO): 2008 cm-1, 1946 cm-1, ν(C=O) 1578 cm-1, ν(C=C) 1602 cm-1,1515 
cm-1. 
Synthesis of hydroxycyclopentadienyl imidazolylideneRu(II) complexes (12) 
 
Figure 4.9 Structure of hydroxycyclopentadienyl imidazolylidene ruthenium complexes. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1,3-
dimethylimidazol-2-ylidene)ruthenium]trifluoromethanesulfonate (12a[CF3SO3]): Dicarbonyl-η4-3,4-
bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dimethylimidazol-2- ylidene)ruthenium 
complex (4a) 0.100g (0.143mmol) was dissolved in 10 mL of CH2Cl2 under inert atmosphere. 1.2 equivalent 
of HCF3SO3 (solution at 0.98% in CH2Cl2) 1.55mL (0.172mmol) were subsequently added. The reaction 
mixture was stirred for 10 minutes at room temperature, then the solvent was removed under vacuum and the 
crude washed twice with 10 ml of Et2O. The slightly brown solid obtained was identified as 12a[CF3SO3] by 
IR, 1H-NMR, 13C-NMR, 19F-NMR, ESI-MS. The yield was quantitative and suitable crystals for X-Ray diffraction 
analysis were prepared by toluene/hexane double layer. 1H-NMR (599.7 MHz, CDCl3) δ (ppm): 7.43 (m, 4H, 
CHaryl), 7.27-7.01 (m, 10H, CHaryl), 6.97 (s, 2H, CHNHC), 6.65 (m, 4H, CHaryl), 3.71 (s, 6H, -OCH3), 3.27 (s, 6H, 
NCH3,NHC); 13C{1H} NMR (150.8 MHz, CDCl3) δ (ppm): 199.64 (CO), 161.35 (Ccarbene), 159.88 (-COCH3), 142.77 
(C-OH, Cp), 133.86 (CHaryl), 130.93 (CHaryl), 129.07 (CHaryl), 125.27 (Cqaryl), 128.38 (Cqaryl), 125.97 (CHaryl), 
121.40 (CHNHC), 113.81 (CHaryl), 104.85 (C2,5, Cp), 87.90 (C3,4, Cp), 55.55 (-OCH3), 39.23 (CH3,NHC). 19F-NMR 
(282.4 MHz, CDCl3) δ (ppm): -78.34 (CF3SO3). IR (CH2Cl2) ν(CO): 2037 cm-1, 1985 cm-1, ν(C=C) 1611 cm-1, 
1520 cm-1. ESI-MS (m/z) (+) = 699 [M]+; 149 [M]-. Anal. Calcd (%) for C39H33F3N2O8RuS: C, 55.18; H, 3.92; N, 
3.30. Found: C, 55.14; H, 3.90; N, 3.32. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1,3-
dimethylimidazol-2-ylidene)ruthenium]chloride (12a[Cl]): Dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone)(1,3-dimethylimidazol-2-ylidene)ruthenium complex (4a) 0.023g (0.0330 
mmol) was dissolved in 5 mL of CH2Cl2 under inert atmosphere. Two equivalent of HCl (aqueous solution at 
37%, 0.005 mL, 0.0660 mmol) were subsequently added. The reaction mixture was stirred for 2h at room 
temperature, then the solvent was removed under vacuum and the crude washed twice with 10 ml of Et2O . 
The slightly brown solid identified as 12a[Cl] by IR, 1H-NMR, 13C-NMR, ESI-MS obtained in quantitative yield. 
1H-NMR (599.7 MHz, CDCl3) δ (ppm): 7.57 (m, 4H, CHaryl), 7.23-7.03 (m, 10H, CHaryl), 6.93 (s, 2H, CHNHC), 
6.65 (m, 4H, CHaryl), 3.71 (s, 6H, -OCH3), 3.03 (s, 6H, NCH3,NHC); 13C{1H} NMR (150.8 MHz, CDCl3) δ (ppm): 
199.79 (CO), 162.42 (Ccarbene), 159.24 (-COCH3), 144.52 (C-OH, Cp), 133.47 (CHaryl), 130.95 (CHaryl), 128.60 
(CHaryl), 128.18 (Cqaryl), 125.35 (CHaryl), 121.60 (CHNHC), 113.24 (CHaryl), 104.55 (C2,5, Cp), 86.61 (C3,4, Cp), 
55.09 (-OCH3), 39.22 (CH3,NHC).  IR (CH2Cl2) ν(CO): 2033 cm-1, 1981 cm-1, ν(C=C) 1611 cm-1, 1520 cm-1. ESI-
MS (m/z) (+) = 699 [M]+. Anal. Calcd (%) for C38H33ClN2O5Ru: C, 62.11; H, 4.53; N, 3.81. Found: C, 62.13; H, 
4.55; N, 3.79. 
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[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1,3-
dimethylimidazol-2-ylidene)ruthenium]tetrafluoroborato (12a[BF4]): Dicarbonyl-η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dimethylimidazol-2-ylidene)ruthenium complex (4a) 
0.050g (0.072mmol) was dissolved in 10mL of CH2Cl2 under inert atmosphere. 1.2 equivalent of 
tetrafluoroboric acid diethyl ether complex (0.012mL, 0.086mmol) were subsequently added. The reaction 
mixture was stirred for 1h at room temperature, then the solvent was removed under vacuum and the crude 
washed twice with 10 ml of Et2O. The slightly brown solid identified as 12a[BF4] by IR, 1H-NMR, 13C-NMR, 19F-
NMR was obtained in quantitative yield. 1H-NMR (599.7 MHz, CDCl3) δ (ppm): 7.42 (m, 4H, CHaryl), 7.31-7.03 
(m, 10H, CHaryl), 7.05 (s, 2H, CHNHC), 6.68 (m, 4H, CHaryl), 3.74 (s, 6H, -OCH3), 3.29 (s, 6H, NCH3,NHC); 13C{1H} 
NMR (150.8 MHz, CDCl3) δ (ppm): 199.06 (CO), 160.82 (Ccarbene), 159.57 (-COCH3), 141.82 (C-OH, Cp), 
133.43 (CHaryl), 130.40 (CHaryl), 128.80 (CHaryl), 128.78 (Caryl), 127.89 (Caryl), 125.74 (CHaryl), 120.80 (CHNHC), 
113.47 (CHaryl), 104.31 (C2,5, Cp), 87.51 (C3,4, Cp), 55.15 (-OCH3), 38.75 (CH3,NHC); 19F-NMR (282.4 MHz, 
CDCl3) δ (ppm): -152.01 (BF4). IR (CH2Cl2) ν(CO): 2038 cm-1, 1987 cm-1, ν(C=C) 1611 cm-1, 1520 cm-1. Anal. 
Calcd (%) for C38H33BF4N2O5Ru: C, 58.09; H, 4.20; N, 3.57. Found: C, 58.11; H, 4.17; N, 3.58. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1-methyl-3-butyl-
imidazol-2-ylidene)ruthenium]trifluoromethanesulfonate (12c[CF3SO3]): Dicarbonyl-η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-3-butyl-imidazol-2-ylidene)ruthenium complex 
(4c) 0.100g (0.135mmol) was dissolved in 10mL of CH2Cl2 under inert atmosphere. 1.2 equivalent of HCF3SO3 
(solution at 0.98% in CH2Cl2 1.39 mL, 0.157mmol) were subsequently added. The reaction mixture was stirred 
for 1h at room temperature, then the solvent was removed under vacuum and the crude washed twice with 10 
ml of Et2O. The slightly brown solid identified as 12c[CF3SO3] by IR, 1H-NMR, 13C-NMR and 19F-NMR was 
obtained in quantitative yield. 1H-NMR (599.7 MHz, CDCl3) δ (ppm): 7.44 (m, 4H, CHaryl), 7.28-7.02 (m, 10H, 
CHaryl), 7.05 (2H, CHNHC), 6.66 (m, 4H, CHaryl), 3.72 (s, 6H, -OCH3), 3.70(m, 2H, -NCH2), 3.32 (s, 3H, NCH3, 
NHC), 1.49 (m, 2H, -CH2CH2-), 0.97 (m, 2H, -CH2CH3), 0.77 (m, 3H, -CH3); 13C{1H} NMR (150.8 MHz, CDCl3) δ 
(ppm): 199.27 (CO), 160.57 (Ccarbene), 159.47 (-COCH3), 142.83 (C-OH, Cp), 133.43 (CHaryl), 130.55 (CHaryl), 
128.60 (CHaryl), 128.09 (Caryl), 126.24 (Caryl), 123.02 (CHaryl), 121.01 (CHNHC), 113.39 (CHaryl), 104.42 (C2,5, 
Cp), 87.45 (C3,4, Cp), 55.13(-OCH3), 50.81 (-NCH2), 38.91 (-NCH3), 32.97 (-CH2CH2-), 19.48 (-CH2CH3), 
13.65(-CH3); 19F-NMR (282.4 MHz, CDCl3) δ (ppm): -78.37. IR (CH2Cl2) ν(CO): 2035 cm-1, 1984 cm-1, ν(C=C) 
1610 cm-1, 1520 cm-1. ESI-MS (m/z) (+) = 741[M]+, 149 [M]-. Anal. Calcd (%) for C42H39F3N2O8RuS: C, 56.62; 
H, 4.38; N, 3.15. Found: C, 56.59; H, 4.37; N, 3.16. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1-methyl-3-(2-
hydroxyethyl-imidazol-2-ylidene)ruthenium]trifluoromethanesulfonate (12d[CF3SO3]): Dicarbonyl-η4-
3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-3-(2-hydroxyethyl-imidazol-2-
ylidene)ruthenium complex (4d) 0.050g (0.069mmol) was dissolved in 10 mL of CH2Cl2 under inert 
atmosphere. 1.2 equivalent of HCF3SO3 (solution at 0.98% in CH2Cl2 0.73 mL, 0.082mmol) were subsequently 
added. The reaction mixture was stirred for 1h at room temperature, then the solvent was removed under 
vacuum and the crude washed twice with 10 ml of Et2O. The slightly brown solid identified as 12d[CF3SO3] by 
IR, 1H-NMR, 13C-NMR, 19F-NMR, ESI-MS was obtained in quantitative yield. Suitable crystals for X-Ray 
diffraction analysis were prepared by slow diffusion from CH2Cl2/Et2O double layer. 1H-NMR (399.9 MHz, 
CDCl3) δ (ppm): 7.46 (m, 4H, CHaryl), 7.30-7.03 (m, 10H, CHaryl), 7.40 (s, 1H, CHNHC), 7.01 (s, 1H, CHNHC), 6.68 
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(m, 4H, CHaryl), CH2 not detected, (m, 2H,-NCH2), 3.73 (s, 6H, -OCH3), 3.24 (s, 3H, -NCH3); 13C-NMR (100.6 
MHz, CDCl3) δ (ppm): 206.97 (CO), 162.98 (Ccarbene), 159.58 (-COCH3), 142.23 (C-OH, Cp), 133.41 (CHaryl), 
130.49 (CHaryl), 128.84 (CHaryl) 128.62 (Caryl), 126.08 (Caryl), 123.02 (CHaryl), 120.75 (CHNHC), 113.48 (CHaryl), 
Caryl, Cp not detected,, 58.43 (-NCH2) , 55.14 (-OCH3), 51.82 (-CH2OH), 38.45 (-NCH3); 19F-NMR (282.4 MHz, 
CDCl3) δ (ppm): -78.37. IR (CH2Cl2) ν(CO): 2038 cm-1, 1988 cm-1, ν(C=C) 1610 cm-1, 1520 cm-1.. ESI-MS (m/z) 
(+) = 729 [M]+, 149 [M]- Anal. Calcd (%) for C40H35F3N2O9RuS: C, 54.67; H, 3.85; N, 3.19. Found: C, 54.68; H, 
3.83; N, 3.22. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1-butyl-3-(2-
pyridinyl)-imidazol-2-ylidene)ruthenium]trifluoromethanesulfonate (12m[CF3SO3]): Dicarbonyl-η4-3,4-
bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-butyl-3-(2-pyridinyl)-imidazol-2-
ylidene)ruthenium complex (4m) 0.100g (0.124mmol) was dissolved in 10mL of CH2Cl2 under inert 
atmosphere. 1.2equivalent of HCF3SO3 (solution at 0.98% in CH2Cl2 1.35mL, 0.149mmol) were subsequently 
added. The reaction mixture was stirred for 15 minutes at room temperature, then the solvent was removed 
under vacuum and the crude washed twice with 10 ml of Et2O. The slightly orange solid identified as 
12m[CF3SO3] by IR, 1H-NMR, 13C-NMR, 19F-NMR, ESI-MS was obtained in quantitative yield. 1H-NMR (599.7 
MHz, CD3CN) δ (ppm): 7.88 (m, 1H, CHpy), 7.38 (m, 1H, CHpy), 7.34 (m, 1H, CHpy), 7.28 (d, 1H, CHNHC), 7.25 
(d, 1H, CHNHC), 7.23 (m, 1H, CHpy), 7.17-6.99 (m, 10H, CHaryl), 6.78 (m, 4H, CHaryl), 6.48 (m, 4H, CHaryl), 3.70 
(t, 2H, NCH2), 3.68 (s, 6H, -OCH3), 1.72 (m, 2H, -CH2CH2-), 1.19 (m, 2H, -CH2CH3), 0.88 (t, 3H, -CH3); 13C{1H} 
NMR (150.8 MHz, CD3CN) δ (ppm): 199.59 (CO), 166.73 (Ccarbene), 160.80 (-COCH3), 149.27 (Cipso), 147.43 
(CHpy), 144.94 (CHpy), 136.56 (C1-OH, Cp), 134.52-114.29 (Caryl), 127.93 (CHNHC), 125.71 (CHpy), 
125.13(CHpy), 121.95 (CHNHC), 104.10(C2,5, Cp), 94.05 (C3,4, Cp), 55.98 (-OCH3), 52.87 (-NCH2), 33.72 (-
CH2CH2), 20.42 (-CH2CH3), 13.93 (-CH3); 19F-NMR (282.4 MHz, CD3CN ) δ (ppm): -79.33  (CF3SO3). IR 
(CH2Cl2) ν(CO): 2041 cm-1, 1991 cm-1, ν(C=C) 1610 cm-1, 1520 cm-1. ESI-MS (m/z) (+) = 804 [M]+, 149 [M]-. 
Anal. Calcd (%) for C46H40F3N3O8RuS: C, 57.91; H, 4.23; N, 4.41. Found: C, 57.89; H, 4.22; N, 4.38. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1-butyl-3-(2-
pyridinyl)-imidazol-2-ylidene)ruthenium]chloride (12m[Cl]): Dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone)(1-butyl-3-(2-pyridinyl)- imidazol-2-ylidene)ruthenium complex (4m) 0.025g 
(0.031mmol) was dissolved in 5 mL of CH2Cl2 under inert atmosphere. Two equivalent of HCl (aqueous 
solution at 37%, 0.005mL, 0.061mmol) were subsequently added. The reaction mixture was stirred for 1h at 
room temperature, then the solvent was removed under vacuum and the crude washed twice with 10 ml of 
Et2O. The slightly brown solid identified as 12m[Cl] by IR, 1H-NMR, 13C-NMR obtained in quantitative yield. 
1H-NMR (599.7 MHz, CD3CN) δ (ppm): 8.10 (m, 1H, CHpy), 7.69 (m, 1H, CHpy), 7.48 (d, 2H, CHNHC), 7.45 (d, 
2H, CHNHC), 7.41-7.19 (m, 10H, CHaryl + 2H, CHpy), 6.98 (m, 4H, CHaryl), 6.65 (m, 4H, CHaryl), 3.68 (t, 2H, -
NCH2), 3.69 (s, 6H, -OCH3), 1.70 (m, 2H, -CH2CH2-), 1.14 (m, 2H, -CH2CH3), 0.84 (t, 3H, -CH3); 13C{1H} NMR 
(150.8 MHz, CD3CN) δ (ppm): 199.73 (CO), 166.09 (Ccarbene), 160.67 (-COCH3), 150.34 (Cipso), 147.87 (CHpy), 
143.52 (CHpy), 136.47 (C1-OH, Cp), 134.62-114.23 (Caryl + CHpy), 124.71 (CHNHC), 122.13 (CHNHC), 102.43 
(C2,5, Cp), 87.44 (C3,4, Cp), 55.95 (-OCH3), 52.65 (-NCH2), 33.24 (-CH2CH2), 20.40 (-CH2CH3), 13.93 (-CH3);  
IR (CH2Cl2) ν(CO): 2041cm-1, 1992 cm-1, ν(C=C) 1609 cm-1, 1521 cm-1. Anal. Calcd (%) for C45H39ClN3O5Ru: 
C, 64.43; H, 4.69; N, 5.01. Found: C, 64.40; H, 4.66; N, 5.02. 
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[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)( 1-butyl-3-(2-
pyridinyl)-imidazol-2-ylidene)ruthenium]tetrafluoroborate (12m[BF4]): Dicarbonyl-η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-butyl-3-(2-pyridinyl)-imidazol-2-ylidene)ruthenium 
complex (4m) 0.050 g (0.062 mmol) was dissolved in 5 mL of CH2Cl2 under inert atmosphere. 1.2 equivalent 
of tetrafluoroboric acid diethyl ether complex (0.012mL, 0.086mmol) were subsequently added. The reaction 
mixture was stirred for 1h at room temperature, then the solvent was removed under vacuum and the crude 
washed twice with 10 ml of Et2O. The slightly brown solid identified as 12m[BF4] by IR, 1H-NMR, 19F-NMR, 
13C-NMR, ESI-MS was obtained in quantitative yield. 1H-NMR (599.7 MHz, CD3CN) δ (ppm): 7.95 (m, 1H, 
CHpy), 7.49-7.16 (m, 10H, CHaryl + 3H, CHpy + 2H, CHNHC), 6.98 (m, 4H, CHaryl), 6.69 (m, 4H, CHaryl), 3.69 (s, 
6H, -OCH3), 3.67 (t, 2H, NCH2), 1.75 (m, 2H, -CH2CH2-), 1.25 (m, 2H, -CH2CH3), 0.79 (t, 3H, -CH3); 13C{1H} 
NMR (150.8 MHz, CD3CN) δ (ppm): 199.65 (CO), 166.30 (Ccarbene), 160.78 (-COCH3), 151.52 (Cipso), 149.07 
(CHpy), 142.05 (CHpy), 134.63 (C1-OH, Cp), 134.06-114.30 (Caryl), 126.82 (CHNHC), 124.74 (CHpy), 124.25 
(CHpy), 122.20 (CHNHC), 104.16(C2,5, Cp), 87.35 (C3,4, Cp), 56.00 (-OCH3), 52.84 (NCH2), 33.21 (-CH2CH2-), 
20.55 (-CH2CH3), 13.91 (-CH3); 19F-NMR (282.4 MHz, CD3CN ) δ (ppm): -151.63 (BF4).  IR (CH2Cl2) ν(CO): 
2041 cm-1, 1992 cm-1, ν(C=C) 1609 cm-1, 1521 cm-1. Anal. Calcd (%) for C45H39BF4N3O5Ru: C, 60.66; H, 4.41; 
N, 4.71. Found: C, 60.63; H, 4.40; N, 4.69. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1-(2-aminoethyl)-3-
dimethylimidazol-2-ylidene)ruthenium]tetrafluoroborato (12o[BF4]): Dicarbonyl-(η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)[1-(2-Boc-NH-ethyl)-3-methyl)-imidazol-2-
ylidene]ruthenium (4n) 0.084g (0.10mmol) was dissolved in 10 mL of Et2O under inert atmosphere. 10 
equivalents of tetrafluoroboric acid diethyl ether complex (0.14mL, 1.04mmol)  were subsequently added. . 
The reaction mixture was stirred for 1h at room temperature, then the precipitation of a slightly brown solid 
was observed. The crude was filtered under inert atmosphere and the solid washed twice with 10 ml of Et2O. 
The slightly brown solid identified as 12o[BF4] by IR, 1H-NMR and 13C-NMR. 1H-NMR (599.7 MHz, CD3CN) δ 
(ppm): 7.46-7.36 (m, 10H, CHaryl), 7.23 (d, 1H, CHNHC), 7.21 (d, 1H, CHNHC), 7.12 (m, 4H, CHaryl), 6.71 (m, 4H, 
CHaryl), 6.40 (br, s, 1H, NH), 3.94 (m, 2H, -NCH2), 3.70 (s, 6H, -OCH3), 3.32 (s, 3H, -NCH3), 3.15 (m, 2H, -CH2-
). 13C{1H} NMR (150.8 MHz, CD3CN) δ (ppm): (CO) not detected, 164.72 (Ccarbene), 160.11 (-COCH3), ),142.03 
(C1-OH, Cp), 134.15 – 113.58 (Caryl, CHNHC), 105.52 (C2,5, Cp), 84.21 (C3,4, Cp), 55.49 (-OCH3), 47.35 (-NCH2), 
40.02 (-NCH3), 39.35 (-CH2CH2-). IR (CH2Cl2) ν(CO): 2042 cm-1, 2021 cm-1, 1992 cm-1, 1966 cm-1, ν(C=C) 
1610 cm-1, 1520 cm-1. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1-(2-aminoethyl)-3-
dimethylimidazol-2-ylidene)ruthenium]tetrafluoroborato (12o[CF3SO3]): Dicarbonyl-(η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)[1-(aminoethyl)-3-methyl)-imidazol-2-ylidene]ruthenium 
complex (4o) 0.039g (0.005mmol) was dissolved in 5mL of CH2Cl2 under inert atmosphere. 1.5equivalents of 
HCF3SO3 (solution at 0.98% in CH2Cl2 0.71mL, 0.008mmol) were subsequently added. The reaction mixture 
was stirred for 15 minutes at room temperature, then the solvent was removed under vacuum and the crude 
washed twice with 10 ml of Et2O. The slightly orange solid identified as 12o[CF3SO3] by IR, 1H-NMR, 13C-NMR 
and 19F-NMR. 1H-NMR (599.7 MHz, CDCl3) δ (ppm): 7.42-7.34 (m, 10H, CHaryl), 7.24 (s, 1H, CHNHC), 7.10 (s, 
1H, CHNHC), 7.00 (m, 4H, CHaryl), 6.78 (br, s, 1H, NH), 6.66 (m, 4H, CHaryl), 4.07 (m, 2H, -NCH2), 3.73 (s, 6H, 
-OCH3), 3.41 (s, 3H, -NCH3), 2.67 (m, 2H, -CH2-). 19F-NMR (282.4 MHz, CDCl3 ) δ (ppm): -78.52.  13C{1H} 
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NMR (150.8 MHz, CDCl3) δ (ppm): 198.28 (CO), 162.39 (Ccarbene), 159.66 (-COCH3), 140.38 (C1-OH, Cp), 
133.37-113.52 (Caryl + CHNHC), 103.92 (C2,5, Cp), 88.67 (C3,4, Cp), 55.16 (-OCH3), 48.02 (-NCH2), 39.68 (-
CH2CH2-), 39.37 (-NCH3). IR (CH2Cl2) ν(CO): 2042 cm-1, 1993 cm-1, ν(C=C) 1612 cm-1,1520 cm-1. 
Synthesis of cationic methoxycyclopentadienyl imidazolylidene Ru(II) complexes (13)  
 
Figure 4.10. Structure of methoxycyclopentadienyl imidazolylidene ruthenium complexes (13). 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylmethoxycyclopentadienyl)(1,3-dimethyl-
imidazol-2-ylidene)ruthenium]trifluoromethanesulfonate (13a[CF3SO3]): Dicarbonyl-η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dimethylimidazol-2-ylidene)ruthenium complex (4a) 
0.100g (0.143mmol) was dissolved in 10 mL of CH2Cl2 under inert atmosphere. Three equivalent of MeCF3SO3 
(0.048mL, 0.429 mmol) were subsequently added. The reaction mixture was stirred for 1h at room 
temperature, then the solvent was removed under vacuum and the crude washed twice with 10 ml of Et2O. 
The slightly brown solid identified as 13a[CF3SO3] by IR, 1H-NMR, 13C-NMR, 19F-NMR, ESI-MS was obtained 
in quantitative yield. 1H-NMR (599.7 MHz, CD3CN) δ (ppm): 7.40-7.31 (m, 10H, CHaryl), 7.13 (s, 2H, CHNHC), 
7.04 (m, 4H, CHaryl), 6.66 (m, 4H, CHaryl), 3.68 (s, 6H, -OCH3), 3.43 (s, 6H, NCH3), 2.99 (s, 3H, -OCH3); 13C{1H} 
NMR (150.8 MHz, CD3CN) δ (ppm): 199.52 (CO), 161.90 (Ccarbene), 160.59 (-COCH3), 141.45 (C-OCH3, Cp), 
134.53 (CHaryl), 132.34 (CHaryl), 129.66 (CHaryl), 129.28 (Caryl), 128.24 (Caryl), 126.22 (CHaryl), 121.71 (CHNHC), 
114.04 (CHaryl), 104.86 (C2,5, Cp), 93.24 (C3,4, Cp), 62.47 (-OCH3, Cp), 55.87 (-OCH3), 39.71 (-NCH3); 19F-
NMR (282.4 MHz, CD3CN) δ (ppm): -78.23. IR (CH2Cl2) ν(CO): 2045 cm-1, 1995 cm-1; ν(C=C) 1610 cm-1, 1521 
cm-1. ESI-MS (m/z) (+) = 713 [M]+; 149 [M]-. Anal. Calcd (%) for C40H35F3N2O8RuS: C, 55.68; H, 4.09; N 3.25. 
Found: C, 55.65; H, 4.07; N 3.27. 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylmethoxycyclopentadienyl1-butyl-3-(2-pyridinyl)-
imidazol-2-ylidene)ruthenium]trifluoromethanesulfonate (13m[CF3SO3]): Dicarbonyl-η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-butyl-3-(2-pyridinyl)-imidazol-2-ylidene)ruthenium 
complex (4m) 0.050g (0.072mmol) was dissolved in 10 mL of CH2Cl2 under inert atmosphere. Three equivalent 
of MeCF3SO3 (0.023mL, 0.216mmol) were subsequently added. The reaction mixture was stirred for 1h at 
room temperature, then the solvent was removed under vacuum and the crude washed twice with 10 ml of 
Et2O. The slightly brown solid identified as 13m[CF3SO3] by IR and ESI-MS was obtained in quantitative yield. 
. 1H-NMR (599.7 MHz, CD3CN) δ (ppm): 8.47 (m, 1H, CHpy), 7.87 (m, 1H, CHpy), 7.71 (m, 1H, CHpy), 7.65 (d, 
1H, CHNHC), 7.56 (d, 1H, CHNHC), 7.46-6.59 (m, 18H, CHaryl + 1H, CHpy), 3.69 (s, 6H, -OCH3), 3.63 (t, 2H, 
NCH2), 3.15 (s, 6H, -OCH3, Cp), 1.52 (m, 2H, -CH2CH2-), 1.11 (m, 2H, -CH2CH3), 0.77 (t, 3H, -CH3); 13C{1H} 
NMR (150.8 MHz, CD3CN) δ (ppm): 199.85 (CO), 167.40 (Ccarbene), 160.61 (-COCH3), 150.52 (Cipso), 149.56 
(CHpy), 145.70 (CHpy), 140.66 (C1-OCH3, Cp), 134.60-114.14 (Caryl), 127.56 (CHNHC), 124.19 (CHpy), 121.64 
(CHpy), 120.73 (CHNHC), Caryl, Cp not detected, 63.36 (-OCH3, Cp),  55.93 (-OCH3), 52.14 (-NCH2), 33.04 (-
CH2CH2), 20.15 (-CH2CH3), 14.01 (-CH3);  19F-NMR (282.4 MHz, CD3CN ) δ (ppm): -79.32  (CF3SO3). IR 
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(CH2Cl2) ν(CO): 2045 cm-1, 1996 cm-1, ν(C=C) 1611 cm-1, 1520 cm-1. ESI-MS (m/z) (+) = 818 [M]+; 149 [M]-. 
Anal. Calcd (%) for C47H42F3N3O8RuS: C, 58.32; H, 4.34; N, 4.34. Found: C, 58.30; H, 4.32; N, 4.35. 
Synthesis of monocarbonylic Ru carbene complexes  
[Carbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylmethoxycyclopentadienyl)(1-butyl-3-(2-pyridinyl)-
imidazol-2-ylidene)ruthenium]trifluoromethanesulfonate (14m[CF3SO3]) 
 
Figure 4.11. Structure of chelated ruthenium complex (14m[CF3SO3])). 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1-butyl-3-(2-pyridinyl)-
imidazol-2-ylidene)ruthenium]trifluoromethanesulfonate(12m[CF3SO3]) was dissolved in 25 mL of  iPrOH. The 
reaction mixture was irradiated under stirring for 3h, then the solvent was removed under vacuum and the 
crude washed twice with 20 mL of hexane. The brown solid was identified as 6 and obtained with a yield of 78 
%. 14m[CF3SO3] has been completely characterized by IR, 1H-NMR, 13C-NMR, 19F-NMR, ESI-MS. Suitable 
crystals for X-Ray diffraction analysis were prepared by slow diffusion from CH2Cl2/hexane double layer. 1H-
NMR (599.7 MHz, CDCl3) δ (ppm): 8.33 (d, 1H, CHpy), 8.27 (m, 1H, CHpy), 8.09 (m, 1H, CHpy), 7.04 (m, 4H, 
CHaryl), 7.30-6.66 (m, 2H, CHNHC+ 10H, CHaryl), 3.86 (m, 2H, NCH2), 3.79 (s, 3H, -OCH3), 3.74 (s, 3H, -OCH3), 
1.47 (m, 2H, -CH2CH2), 0.97 (m, 2H, -CH2CH3), 0.72 (t, 3H, -CH3); 13C{1H} NMR (150.8 MHz, CDCl3) δ (ppm): 
199.57 (CO), 185.63 (Ccarbene), 159.30, 159.08 (-COCH3), 154.60 (Cipso), 153.34 (CHpy), 141.53 (C1-OH, Cp), 
138.08 (CHpy), 133.31-112.74 (Caryl + CHNHC), 97.38 (C2,5, Cp), 84.34 (C3,4, Cp), 55.21 (-OCH3), 50.67 (NCH2), 
32.66, 19.35 (-CH2CH2), 13.56 (-CH3); 19F-NMR (282.4 MHz, CD3CN ) δ (ppm):  -78.19 (CF3SO3); IR (CH2Cl2) 
ν(CO): 1967 cm-1, ν(C=C) 1609 cm-1, 1521 cm-1; ESI-MS (m/z) (+) = 776 [M]+, 149 [M]-. Anal. Calcd (%) for 
C45H40F3N3O7RuS: C, 58.37; H, 4.36; N, 4.54. Found: C, 58.35; H, 4.35; N, 4.51. 
[Carbonyl-pyridin-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1,3-
dimethylimidazol-2-ylidene)ruthenium] trifluoromethanesulfonate (15[CF3SO3]) 
 
Figure 4.12. Structure of monocarbonylic ruthenium carbene complex (15[CF3SO3]). 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylhydroxycyclopentadienyl)(1,3-dimethylimidazol-2-
ylidene)ruthenium]trifluoromethanesulfonate (12a[CF3SO3]) 0.060g (0.071mmol) and pyridine 0.023mL 
(0.283mmol) were dissolved in iPrOH (25 mL). The reaction mixture was irradiated under stirring for 6h and 
15[CF3SO3] identified from the reaction mixture by IR and ESI-MS. IR (CH2Cl2) ν(CO): 1943 cm-1, ν(C=C) 1610 
cm-1,1520 cm-1. ESI-MS (m/z) (+) (CH3CN) = 671 [M-py]+, 643 [M-py-CO]+ 
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[Carbonyl-pyridin-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylmethoxycyclopentadienyl)(1,3-
dimethylimidazol-2-ylidene)ruthenium] trifluoromethanesulfonate (16[CF3SO3]) 
 
Figure 4.13. Structure of monocarbonylic ruthenium complex (16[CF3SO3]). 
[Dicarbonyl-η5-3,4-bis(4-methoxyphenyl)-2,5-diphenylmethoxycyclopentadienyl)(1,3-dimethyl-imidazol-2-
ylidene)ruthenium]trifluoromethanesulfonato (13a[CF3SO3]) 0.050g (0.058mmol) and pyridine 0.023mL 
(0.232mmol) were dissolved in toluene (25 mL). The reaction mixture was irradiated under stirring for 18h and 
16[CF3SO3] identified from the reaction mixture by IR and ESI-MS. IR (CH2Cl2) ν(CO): 1948 cm-1, ν(C=C) 1610 
cm-1,1520 cm-1. ESI-MS (m/z) (+) (MeOH) = 764 [M]+; 149 [M]- 
General procedure for transfer hydrogenation 
Complex (15 μmol, 5% mol), additive (1 eq. when needed) and iPrOH (3 mL) were stirred at reflux for 15 min. 
Then 4-fluoroacetophenone (36 μL, 300 μmol) was added and samples were taken at regular intervals. 
Aliquots (ca. 0.05mL) were diluted with CDCl3 (0.5 mL) and conversions were determined by 19F-NMR 
spectroscopy and GC analysis. 
X-ray Crystallography 
Crystal data and collection details for 4m·0.5CH2Cl2, [12a][CF3SO3]·0.5toluene, [12d][CF3SO3]·CHCl3 and 
[14m][CF3SO3] are reported in Table 4.3. The diffraction experiments were carried out on a Bruker APEX II 
diffractometer equipped with a CCD detector using Mo–K radiation. Data were corrected for Lorentz 
polarization and absorption effects (empirical absorption correction SADABS).16 Structures were solved by 
direct methods and refined by full-matrix least-squares based on all data using F2.17 All hydrogen atoms were 
fixed at calculated positions and refined by a riding model, unless otherwise stated. All non-hydrogen atoms 
were refined with anisotropic displacement parameters. 
4m·0.5CH2Cl2: The asymmetric unit of the unit cell contains one 4m complex (on a general position) and half 
of a CH2Cl2 molecule disordered over two symmetry related (by 2) positions. The disordered solvent molecule 
has been refined isotropically. The crystals are non-merohedrally twinned. The TwinRotMat routine of 
PLATON18 was used to determine the twinning matrix and to write the reflection data file (.hkl) containing the 
two twin components. Refinement was performed using the instruction HKLF 5 in SHELXL and one BASF 
parameter (0.291(8) after refinement). The Bu-group of the 4m complex is disordered over two positions and 
has been refined isotropically using one occupancy factor per disordered group. Similar U restraints (SIMU 
line in SHELXL; s.u. 0.01) have been applied to C, N and O atoms. Restraints to bond distances were applied 
as follow (s.u. 0.02): 1.53 Å for C–C in the disordered Bu-group of 4m; 1.75 Å for C–Cl in CH2Cl2. The Ph-rings 
have been constrained to fit regular hexagons (AFIX 66 line in SHELXL). 
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[12a][CF3SO3]·0.5toluene: The asymmetric unit of the unit cell contains two cations, two anions and one 
toluene molecule (all located in general positions). The H-atoms bonded to the O-atoms have been located in 
the Fourier map and refined using the 1.5 fold Uiso value of the parent atoms. The O-H distances have been 
restrained to 0.89 Å (s.u. 0.01). Similar U restraints (SIMU line in SHELXL; s.u. 0.01) have been applied to C 
and F atoms. The F-atoms have been restrained to isotropic behaviour (ISOR line in SHELXL, s.u. 0.01).  
[12d][CF3SO3]·CHCl3: The asymmetric unit of the unit cell contains two cations, two anions and two CHCl3 
molecules (all located in general positions). One CHCl3 molecule is disordered over two positions and has 
been refined using one occupancy parameter per disordered group. The H-atoms bonded to the O-atoms have 
been initially located in the Fourier map and, then, refined by a riding model. The F-atoms have been restrained 
to isotropic behaviour (ISOR line in SHELXL, s.u. 0.01). 
[14m][CF3SO3]: The asymmetric unit of the unit cell contains one cation and one anion (all located in general 
positions). The F and O atoms of the CF3SO3– anion are disordered and, thus, have been split and refined 
using one occupancy parameter per disordered group. The chelating NHC ligand in the cation is disordered 
and, thus, it has been split into two postions and refined using one occupancy parameter per disordered group. 
The H-atoms bonded to the O-atoms have been initially located in the Fourier map and, then, refined by a 
riding model. Similar U restraints (SIMU line in SHELXL; s.u. 0.01) have been applied to C, N, F and O atoms. 
The C, N, O and F atoms of the disordered groups have been restrained to isotropic behaviour (ISOR line in 
SHELXL, s.u. 0.01). The Ph-rings have been constrained to fit regular hexagons (AFIX 66 line in SHELXL). 
Restraints to bond distances were applied as follow (s.u. 0.02): 1.53 Å for C–C in the Bu-group; 1.43 Å for 
C(sp3)–O; 1.34 Å for C(sp2)–O. 
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X-Ray diffraction studies
Table 4.3. Crystal data and experimental details for 4m·0.5CH2Cl2, [12a]
[CF3SO3]·0.5toluene, [12d][CF3SO3]·CHCl3 and [14m][CF3SO3]. 
4m·0.5CH2Cl2 [12a][CF3SO3]·0.5toluene 
Formula C45.5H40ClN3O5Ru C42.5H37F3N2O8RuS 
Fw 845.33 893.87 
T, K 293(2) 294(2) 
, Å 0.71073 0.71073 
Crystal system Monoclinic Monoclinic 
Space group C2/c P21/n 
a, Å 34.655(3) 24.1374(17) 
b, Å 10.7672(8) 14.9455(10) 
c, Å 23.2262(18) 24.6819(17) 
,  90 90 
,  100.455(8) 114.6170(10) 
,  90 90 
Cell Volume, Å3 8522.6(12) 8094.6(10) 
Z 8 8 
Dc, g cm-3 1.318 1.467 
, mm-1 0.478 0.508 
F(000) 3480 3656 
Crystal size, mm 0.180.160.13 0.190.160.12 
 limits,  1.78–25.03 1.54–25.03 
Reflections collected 53344 76067 
Independent reflections 7457 [Rint= 0.1264] 14300 [Rint= 0.1315] 
Data / restraints /parameters 7457 / 363 / 435 14300/ 513 / 1042 
Goodness on fit on F2 1.049 1.004 
R1 (I> 2(I)) 0.1302 0.0621 
wR2 (all data) 0.3601 0.1331 
Largest diff. peak and hole, e Å-3 3.643 / –2.129 1.007 / –0.721 
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 [12d][CF3SO3]·CHCl3 [14m][CF3SO3] 
Formula C41H36Cl3F3N2O9RuS C45H40F3N3O7RuS 
Fw 997.20 924.93 
T, K 100(2) 100(2) 
, Å 0.71073 0.71073 
Crystal system Monoclinic Monoclinic 
Space group P21/n P21/c 
a, Å 12.0563(6) 12.0040(4) 
b, Å 20.5906(11) 35.1188(12) 
c, Å 35.1658(19) 10.2256(4) 
,  90 90 
,  95.724(3) 95.344(2) 
,  90 90 
Cell Volume, Å3 8686.3(8) 4292.0(3) 
Z 8 4 
Dc, g cm-3 1.525 1.431 
, mm-1 0.662 0.480 
F(000) 4048 1896 
Crystal size, mm 0.190.160.12 0.190.160.12 
 limits,  1.53–26.00 1.16–28.27 
Reflections collected 126772 76597 
Independent reflections 17081 [Rint= 0.0741] 10513 [Rint= 0.0719] 
Data / restraints /parameters 17081 / 144 / 1095 10513/ 967 / 644 
Goodness on fit on F2 1.139 1.129 
R1 (I> 2(I)) 0.0883 0.1087 
wR2 (all data) 0.2451 0.2626 
Largest diff. peak and hole, e Å-3 2.741 / –1.475 0.862 / –1.227 
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Time-conversion profiles 
Selected profiles of the conversion in the function of time are summarized in the following: 
 
 
Graphic 4.1. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the neutral 
complexes 4a,c,d,m as pre-catalyst with 1 equivalent (per Ru center) of CAN as additive. 
 
Graphic 4.2. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the neutral 
complexes 4a as pre-catalyst in the presence of 1 equivalent of different oxidant additives. 
 
Graphic 4.3. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the cationic 
complexes 12a[CF3SO3], 12a[Cl] and 12a[BF4] as pre-catalysts. 
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Graphic 4.4. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the cationic 
complexes 12m[CF3SO3], 12m[Cl] and 12m[BF4] as pre-catalysts. 
 
Graphic 4.5. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the cationic 
complexes 12a,c,d,m[CF3SO3] as pre-catalysts. 
 
Graphic 4.6. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the neutral 
complex 4a as pre-catalyst with in situ addition of various acids. 
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Graphic 4.7. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the neutral 
complex 4m as pre-catalyst with in situ addition of various acids.  
 
Graphic 4.8. Comparison of conversion for transfer hydrogenation of 4-fluoroacetophenone with 5mol% of the 
methylated complexes 13a[CF3SO3] and 13m[CF3SO3] as pre-catalyst.  
 
Graphic 4.9. Comparison of conversion for transfer hydrogenation of different substrates such as acetophenone 
benzophenone and benzaldehyde with 5mol% of the cationic complex 12a[CF3SO3] as pre-catalyst. 
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Labeling experiments in isopropanol-d8 
Scheme 4.6. Catalytic Transfer Hydrogention of 4-fluoroacetophenone in iPrOD-d8 as solvent. 
Complex 12m[CF3SO3] (0.007 g, 7.5 μmol, 5 mol%) was dissolved in 2-propanol d8 (0.5 mL) in a NMR tube 
and heated at 60°C for 10 minutes, then the substrate 4-fluoroacetophenone (18 μL, 150 μmol) and the internal 
standard anisole (10 μL, 150 μmol) were added. The reaction mixture were heated at 60°C for 24h and followed 
by 1H-NMR spectroscopy at regular intervals (Figures 4.14 and 4.15). The mixture at the end of the catalysis 
was further characterized by GC-MS analysis (Figures from 4.16 to 4.19). 
Figure 4.14. 1H-NMR spectrum in 2-propanol-d8 after 24h of reaction. 
Figure 4.15. Enlargement of the range 1.25-2.65 ppm of the 1H-NMR spectrum in 2-propanol-d8 after 24h of reaction. 
GC-MS analysis were performed on the instrument Focus-DSQ Thermo. 
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Figure 4.16. GC-MS spectrum in 2-propanol-d8 after 24h of reaction. 
 
Figure 4.17. GC-MS spectrum in 2-propanol-d8 after 24h of reaction. Retention time = 4.15 min. 
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Figure 4.18. GC-MS spectrum in 2-propanol-d8 after 24h of reaction. Retention time = 4.35 min. 
 
Figure 4.19. GC-MS spectrum in 2-propanol-d8 after 24h of reaction. Retention time = 4.54 min. 
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CHAPTER V 
Synthesis and catalytic performance of poly(propylene imine) (PPIs) dendrimers 
modified with ruthenium cyclopentadienone N-heterocyclic carbene complexes 
Abstract 
The organometallic functionalization of the five generations of polypropylene imine dendrimers with up to 64 
N-heterocyclic carbene cyclopentadienone ruthenium(0) complexes is obtained by the formation of carbamate 
linkers between NH2 peripheral group of the dendrimers and OH functionality in the lateral chain of the NHC 
employing carbonyldiimidazole as coupling agent. Synthesis, purification and characterization of the five 
generations and an example of complete and reversible protonation of peripheral ruthenium complexes is 
described. To the best of our knowledge, this is one of the rare examples in which an NHC is employed as 
peripheral organometallic ligand in dendritic systems for homogeneous catalysis, in the place of more usual 
phosphines or nitrogen chelating ligands, based on pyridine or triazoles. Preliminary results on the use of the 
first generation dendrimers (n=4), in the protonated form, as hydrogen transfer (TH) catalyst in iPrOH showed 
higher catalytic activity if compared with the corresponding monomeric species. However, a more detailed 
study indicated that the higher activity is not ascribable to a true dendritic effect. More likely, the observed 
activity is due to decomposition of the cationic dendrimer, which led to the release of a peripheral ruthenium 
monomeric active species recognized as the active form of the famous Shvo catalyst. Preliminary results 
indicate that cationic and neutral ruthenium NHC functionalized dendrimers do not decompose under oxidizing 
conditions. 
Introduction 
Dendritic catalysts are functional macromolecules which exhibit well defined structures and possess a 
monodisperse nature. Therefore, dendritic catalysts retain some advantages of homogeneous catalysts: fast 
kinetic behavior, easy tenability and rationalization. Furthermore, they can be easily removed from the reaction 
mixture by precipitation, membrane or nanofiltration techniques because of their larger size compared to 
products, which an advantage typical of heterogeneous catalysts. Moreover, it is possible to finely tune the 
catalytic properties of dendritic catalysts through adjustment of their structure, size, shape, chemical 
functionality, and solubility. In a few words, dendrimers have been proposed to bridge the gap between 
homogeneous and heterogeneous catalysis. Grafting catalytic sites on the periphery of dendrimers is the most 
straightforward approach to construct dendritic catalysts, with potential high loading capacity and high ligand 
concentrations. Obviously, high catalytic site concentration might result in high reaction rates. At the same 
time the proximal interactions between catalytic groups and steric crowding at the periphery of dendritic 
catalysts might lead to cooperative effects and selective reaction profiles, respectively.  Many reviews concern 
the use of dendrimers in homogeneous catalysis,1 but few are specifically focused on the dendrimer effect in 
catalysis.2 Several consequences of dendritic effects have been identified, such as the influence on the rates 
of reaction, substrate activation, or selectivity. The main reason proposed for such effects in periphery-
functionalized dendritic catalysts is cooperativity between proximal catalytic sites in the dendrimer structure. 
As a general trend, the bulk provided at the periphery upon increasing the dendrimer generation, restricts 
access of the substrate to the catalytic metal center. This brings about a large number of catalytically active 
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species in a small nano-object but, on the other hand, restriction of substrate access can sometime lead to a 
negative dendritic effect resulting from bulk limiting reaction rates.  
Dendritic catalysts provided excellent performances in rhodium mediated hydrogenation. Most dendritic 
catalysts for hydrogenation contain diphosphine or monophosphine since these units demonstrated to be ideal 
bridge between dendritic support and metals for grafting metal complexes, due to their outstanding capability 
of coordination, stability, and catalytic performance.3 Dendritic systems with chiral phosphine ligands applied 
for Rh and Ir promoted asymmetric hydrogenation, providing positive dendritic effects such as high 
enantioselectivities (up to 99% ee) and catalytic activities (up to 4850 h−1 TOF).4 
A lower number of examples concern the field of transfer hydrogenation. A “green” example of dendritic 
catalysis involves the fluorinated dendritic chiral mono-N-tosylated 1,2-diphenylethylenediamine (FTsDPEN), 
which was synthesized and applied in the ruthenium(II) complex-catalyzed asymmetric transfer hydrogenation 
of prochiral ketones in aqueous media.5 
A tetrabranched phosphoranyl-terminated carbosilane derivative coordinated to four [Ru(p-cymene)Cl 
bipyRu(p-cymene)Cl2] units catalyzed hydrogen-transfer of cyclohexanone, with cyclohexadiene or formic acid 
as stoichiometric hydrogen donor. This G1 dendrimer was very active but less than mononuclear species, 
and the dendritic effect was also negative up to G3, which was less active than G1.6 
As reported in the previous chapters, the scope of the thesis is the development of novel ruthenium complexes 
for bifunctional catalysis7 containg both cyclopentadienones, which cooperate with the metal center in catalytic 
redox reactions,8 and  N-heterocyclic carbenes (NHC)9 (Scheme 5.1), that are valuable ligands due to their 
easy preparation, the tunability of electronic and steric properties,10 the rational design of transition metal 
catalysts11 and the possibility to decorate the structure with substituents suitable for heterogenization (e.g. –
OH functionalization in 4d and 12d[X], Scheme 5.1). In the Chapter IV has been reported the study on the 
cationic Ru complexes of type 12 which showed good catalytic activity in the transfer hydrogenation of the 
model substrate 4-fluoroacetophenone. Furthermore, the best catalyst among these complexes contained a 
pyridine in the lateral chain (12d[CF3SO3]), which in principle might be involved in the catalytic reaction as a 
non-innocent ligand. On the other hand, the neutral complexes of type 4 needed to be activated by CAN in 
order to favor the release of CO and also act as catalys in the same type of reactions.8b 
Scheme 5.1. Hydrogen transfer of 4-fluoroacetophenone catalyzed by [Ru] = 4a,c,d,m,o and 12a,c,d,m,o[X] complexes 
at 80°C in iPrOH as solvent and hydrogen source, [Ru] = 5 mol%. 
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Since NHCs are outstanding ancillary ligands, comparable to phosphine, it is quite surprising the lack of 
examples in the literature concerning NHC functionalized dendrimers.  Indeed,  we found only one example of 
a core functionalized NHC-Rh dendrimer showing a positive dendrimer effect in hydrosililation of ketones 
communicated in 2005 by Tsuji et al..12 Hoveida also successfully supported a ruthenium NHC complex for 
olefin metathesis, but in this case the catalyst was bonded to the dendrimer by the aromatic moiety 
functionalized with C=Ru double bond without exploiting the ancillary NHC for the immobilization of the 
catalyst.13 As stated above, phosphine and diphosphine represented preferential ligands even though nitrogen 
based chelating ligands containing pyridine or triazole are also frequently employed.1,2 In order to fill this gap 
and to evaluate a possible dendrimer effect on the behavior of our catalysts we developed a method, inspired 
to our previous work on dendrimers,14 for the straightforward synthesis of the [Ru(NHC)] functionalized five 
generations of polypropylene imine dendrimers (PPI) with up to 64 organometallic moieties DAB-dendr-
[NH(O)CO(NHC)Cp=ORu(CO)2]n {n=4, 8, 16, 32, 64}. Preliminary results on the use of the first 
generation (n=4), in both neutral and protonated forms, as hydrogen transfer catalysts in iPrOH are herein 
described. 
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Results and discussion 
5.1 Synthesis and characterization of the ruthenium tetraarylcyclopentadienone NHC-
decorate dendrimers 
The straightforward preparation of the new CO2-imidazole functionalized cyclopentadienone NHC 
ruthenium(0) complex 4p in 84% yield was achieved by reacting 4d with a slight excess of CDI (CDI : 4d = 
1.1) in CH2Cl2 at room temperature for 2 h as described in Scheme 5.2. The product 4p is easily purified by 
extracting the imidazolium co-product in water (see Experimental section). 
Scheme 5.2 Synthesis of CO2Im functionalized cyclopentadienone NHC ruthenium complex (4p). 
The air-stable white-brown solid 4p has been fully characterized by analytical and spectroscopic 
measurements. The NMR spectra in CDCl3 show a pattern similar to that of complex 4d.8b In particular, the 
13C NMR spectrum shows the downfield shifted resonance of the carbene (δ = 174.80 ppm). Moreover, the 
imidazole moiety (1H-NMR δ = 8.03, 7.33, 7.08 13C-NMR δ = 136.95, 130.88, 116.97) displays, as expected, 
chemical shifts comparable to those of the starting material CDI, whereas at 147.89 ppm resonates the C=O 
group typical of the carbamate (-OC(O)N-). The IR spectrum shows CO stretching bands (νCO = 2007cm-1, 
1948 cm-1) consistent with those of 4d, and an absorption, ν(C=O,-O2CIm): 1768cm-1, ascribable to the 
carbamate group. Further evidences were produced by ESI-MS. 
The reaction of a 4.8 fold excess of the complex 4p in CH2Cl2 at room temperature with the commercially 
available poly(propylenimine) dendrimer DAB-dendr-(NH2)4 leads, after 2 h, to the quantitative formation of 
DAB-dendr-[NH(O)CO(NHC)Cp=ORu(CO)2]n (17G1) (Scheme 5.3). 
Scheme 5.3. Synthesis of DAB-dendr-[NH(O)CO(NHC)Cp=ORu(CO)2]4 (17G1) 
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Under the same experimental conditions the CO2-imidazole group of the ruthenium derivative 4p reacts with 
the DAB-dendr- (NH2)n {n = 8, 16, 32, 64}, up to the fifth generation, to form the completely functionalized new 
dendritic organometallic macromolecules DAB-dendr-[NH(O)CO(NHC)Cp=ORu(CO)2]n (17Gn) in quantitative 
yields (Figure 5.1). 
 
Figure 5.1. Structure of functionalized dendrimers from second to fifth generation: DAB-dendr-
[NH(O)CO(NHC)Cp=ORu(CO)2]n n=8 (17G2), n=16 (17G3), n=32 (17G4) n=64 (17G5). 
The excess of 4p and the side products can be removed easily from the crude reaction mixture by water 
extraction, followed by washing with Et2O. All five organometallic dendrimers 17Gn were isolated as brown 
solids and are air and moisture stable They are soluble in dichloromethane and THF, slightly soluble in Et2O, 
insoluble in hexane and toluene and aqueous solvents. 
The dendritic compounds were characterized by 1H, 13C NMR and IR spectroscopy and mass spectrometry 
when possible. The NMR spectra in CDCl3 combine the signals due to the diaminobutane-based 
poly(propylenimine) framework (1H: four broad multiplets in the range of 3.8–1.3 ppm; 13C: four broad 
resonances in the range of 63–25 ppm) with those derived from the newly introduced peripheral NHC 
ruthenium moieties (see Figures 5.2 - 5.3 and Experimental section).  
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Figura 5.2: 1H-NMR spectrum(CDCl3) of 17G1. 
Figura 5.3: 13C-NMR spectrum(CDCl3) of 17G1. 
In addition, evaluation of the signal intensities also provided evidence of the complete polyamines 
functionalization. Even though all the signals of the proton spectra presented the typical peak broadness of a 
polymer-like structure, they clearly show that the proton resonances of the two methylene groups in the –
NHCCH2CH2O2CNH– unit of the organometallic moieties (at 3.77 and 3.59 ppm) are more shielded than those 
of complex 4p (4.05 and 3.99 –NHCCH2CH2O2CIm). 
In the 1H NMR, the signal of the –NH– belonging to the carbamate linkers residing on the surface of the 
poly(propylenimine) dendrimer is not easily recognizable due to the fact that the resonance is expected  in 
the same region of aromatic signals and that hydrogen bonds –NH…(O)CO– or –NH…cyclopentadienone 
become more relevant when the interacting groups get in closer contact, namely with increasing generation.  
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The IR spectra in CH2Cl2 of all five dendritic species show a strong absorption at 1718 cm−1 (s) due to both 
(C=O, –O2CNH–) stretching bands. 
The structures of the first- (n = 4) (17G1) generation dendrimers (Scheme 5.3) was confirmed by ESI mass 
spectroscopy, which showed molecular ions at m/z 3355 [M + Na] + . The higher molecular weight of the upper 
generations 17G2-5 prevented their mass detection. 
The straightforward and quantitative reaction between –CO2-imidazole functionalized cyclopentadienone-
NHC-ruthenium complexes and DAB-dendr-(NH2)n {n = 4, 8, 16, 32, 64} here described (Figure 5.1) provides 
a valuable route towards the immobilization of –OH functionalized NHC complexes on organic and inorganic 
amino functionalized supports.15 
The reaction of 17G1 with a strong acid such as HCF3SO3, leads to the quantitative formation of the 
hydroxycyclopentadienyl tetra-cationic dendrimer 17G1-H (Figure 5.4), in which Ru(0) is formally oxidized to 
Ru(II). 
Figure 5.4. Structure of the tetra-cationic DAB-dendr-[NH(O)CO(NHC)Cp-OHRu(CO)2]4 (17G1-H). 
Infrared spectroscopy provides a convenient technique for monitoring the progress of the protonation in that, 
in agreement with the reduced back-donation from the metal centre to the carbonyl ligands, -CO stretch 
vibrations undergo a significant high-energy shift upon formation of the cationic complex [e.g. νCO = 2006 cm-
1, 1947 cm-1 (17G1), and 2039 cm-1, 1988 cm–1 (17G1-H)]. It is important to underline that during the 
protonation stretching bands with intermediate frequency between the neutral and the tetra-cation form (νCO = 
2017 cm-1, 1958 cm-1) appear in the CO region of the IR spectrum. These latter bands are probably associated 
to the formation of hydrogen bonds between the cationic and the adjacent neutral forms of the ruthenium 
complex.  The change in the coordination from η4 (cyclopentadienone ligand) to η5 (hydroxycyclopentadienyl 
ligand) due to protonation, is further evidenced by 13C-NMR shift of the resonance attributable  to the endocyclic 
carbon involved in the ketone-alcohol transformation [δ 169.56 ppm (C=O, Cp, in 17G1) vs δ 141.63 ppm (C-
OH, Cp, in 17G1-H)]. Ru-carbene signals are also shifted to higher fields; from δ 172.67 ppm (17G1) to δ 
160.81 ppm (17G1-H) (see Experimental section for more details). 
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5.2 Synthesis and characterization of the ruthenium 2,5-bis-tetrimethylsilane-3,4 
cyclohexane-cyclopentadienone NHC-decorate first generation of PPI dendrimer 
Once obtained the five generations of polypropilenimine NHC-Ru functionalized dendrimers (17G1-5) we 
wondered about the possibility to control the solubility by varying the cyclopentadienone ligand, as mentioned 
in Chapter II (paragraph 2.5). The interest toward this point arose from the synthesis of the new mononuclear 
complexes 9d and 18d[Cl] (Scheme 5.4) which are very similar to 4d and 14d[X] except for the substituents 
of the cyclopentadienone ligands. Indeed, in this case we found a partial solubility of 18d[Cl] in water (5 
mmol/L) that should be potentially transferable to the corresponding functionalized dendrimers. 
 
Scheme 5.4 Synthesis of Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-hydroxyethyl))-3-
methylilidene]ruthenium (9d) and the corresponding cationic complex Dicarbonyl-(2,4-
bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dienyl)[1-(2-hydroxyethyl))-3-methylilidene]ruthenium chloride (18d[Cl]). 
Spectroscopic data of complexes 9d and 18d[Cl] are in perfect agreement with those previously reported for 
similar complexes (synthesis and characterizations of complexes 7, 8 and 9d have been reported in the 
Experimental section of Chapter II).8, 10, 16 The same is true for the corresponding first generation 19G1 (Figure 
5.5) prepared following the same procedure as for the tetraarylcyclopentadienone complex 4d by a coupling 
reaction of 9d and the NH2 functionality of [DAB-dendr-NH2]4 favoured by carbonyldiimidazole. The latter 
derivative shows similar solubility as 17G1.  
 
Figure 5.5. Synthesis of DAB-dendr-[NH(O)CO(NHC)Cp(TMS)=ORu(CO)2]4 (19G1). 
Hereafter are described preliminary results obtained in redox catalysis with the neutral and cationic first 
generations 17G1 and 17G1-H and their comparison with what found in the case of mononuclear species 4 
and 12[X]. 
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5.3 Catalytic transfer hydrogenation 
The Ru(NHC) peripherally functionalized dendrimers 17G1 and 17G1-H were evaluated as catalyst precursors 
under transfer hydrogenation conditions i.e. refluxing iPrOH as hydrogen source employing 4-
fluoroacetophenone as model substrate. Catalytic runs were performed to investigate the stability of complexes 
on the polypropyleneimine dendrimers and eventual dendrimer effect due to close proximity of complexes in 
connection with the mononuclear species. The role of CAN in the activation of the 17G1 has been investigated, 
and the catalytic activity of the ruthenium(0) dendrimer 17G1 compared with the corresponding ruthenium(II) 
cationic complexes 17G1-H. Results are reported in Table 5.1: in all cases selectivity is complete and 
conversion corresponds to yield unless otherwise stated. 
The neutral dendrimer 17G1 has no catalytic activity in the absence of additives (entry 1), as already stated in 
the case of mononuclear complexes8b  reported in Table 5.1 for the sake of clarity (entry 2-5). In the monomeric 
neutral form, the addition of one equivalent of an oxidizing agent such as CAN (entry 7-10) promote the CO 
release giving rise to active intermediates. Under the same conditions a detrimental effect of the dendritic form 
is observed, in that only 4% conversion is reached after 24h. The degree of oxidation of the metal center 
remains the key point in order to activate the catalyst, and better conversions are reached employing the 
cationic monomeric pre-catalysts 12[CF3SO3] as reported in Chapter IV (Table 4.1).8b Higher conversions 
have been found in the case of the tetra-cationic dendrimer 17G1-H (entry 11 vs. entries 12-15). Forwarding 
evidence of a possible dendrimer effect. The crude reaction mixture has been analyzed by NMR and 
IR spectroscopy, after appropriate workup. The study has allowed to identify, in the organic fraction, a 
ruthenium complex corresponding to the Shvo catalyst.17 Conversely, in the water soluble fraction the NMR 
signals (in D2O) associated to the dendrimer skeleton and imidazolium salt have been found. This result 
suggests that the catalytic activity of 17G1-H, as transfer hydrogenation catalyst, is not ascribable to a 
dendritic effect but is better explained by the decomposition of the cationic dendrimer, leading to the 
release of a peripheral ruthenium monomeric active species without the NHC moiety. This behavior, not 
observed in the case of monomeric complexes, should arise from the structure of the dendrimer itself, 
which contains non innocent nitrogen atoms adjacent to methylenic groups susceptible of both acid-base 
chemistry and dehydrogenation. On the other hand, a role of the crowding around the mononuclear 
complexes, which favors their mutual contact should also be taken into consideration. In order to better 
understand the mechanism related to the detachment of the complex, the reactivity of 17G1-H is still under 
investigation. 
Table 5.1. Catalytic transfer hydrogenation of 4-fluoroacetophenone.a 
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entry [Ru] additive conversion 8h (%) conversion 24h (%) 
1 17G1 --- 0 0 
2 4a --- 0 0 
3 4c --- 0 0 
4 4d --- 0 0 
5 4m --- 0 0 
6 17G1 CANb 0 4 
7 4a CANb 25 61 
8 4c CANb 10 87 
9 4d CANb 10 25 
10 4m CANb 0 9 
11 17G1-H --- >99c >99 
12 12a[CF3SO3] --- 58 93 
13 12c[CF3SO3] --- 9 60 
14 12d[CF3SO3] --- 35 46g 
15 12m[CF3SO3] --- 84 >99 
aGeneral conditions: Ruthenium complex (5 mol% Ru), iPrOH (3 mL), reflux; conversions determined by 19F NMR 
spectroscopy; bCAN 1 mol equiv. per ruthenium center; cconversion is complete already after 6h. 
Furthermore, with the aim to understand the role of the solvent, 17G1-H has been refluxed in iPrOH for 5h, 
followed by cooling under inert atmosphere of argon and the solvent removal under vacuum. 1H-NMR 
performed in a J-young valve NMR tube under inert conditions allow to identify the formation of the hydride 
derivative [Ru(CO)2HCpOH] (A) which, in CDCl3 solution, evolve to the formation of [Ru(CO)2ClCpOH] (B) in 
24h, also identified by means of IR spectroscopy;18 Trace of the Shvo complex (in 1H-NMR the bridging hydride 
is revealed at -18.46 ppm) were also detected, whereas no signals ascribable to the methylene groups of the 
dendrimer have been observed in the fraction soluble in CDCl3.  Moreover, the water soluble fraction evidenced 
typical NMR signals (in D2O) of both the dendrimer skeleton and imidazolium salt associated to 20G1. On the 
light of these results, a proposed decomposition pathway has been formulated (Scheme 5.5). 
 
Scheme 5.5 Detachment of ruthenium hydride complex from the first generation 17G1-H. 
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Since the solvent iPrOH is supposed to have a crucial role as hydrogen donor in the detachment of the 
hydroxycyclopentadienyl complex reported in Scheme 5.5, we performed the same decomposition test under 
reflux in toluene for 16h. In this case the crude reaction product, after solvent removal, was completely 
insoluble in D2O but mostly soluble in CDCl3. 1H-NMR of this latter solution showed the pattern ascribable both 
to dendrimer skeleton and to ruthenium complexes. IR spectrum [v(CO) = 2009, 1951; v(C=O) = 1720 cm-1] 
revealed the formation of a neutral species in which both the ruthenium terminal carbonyl and carbamate linker 
are present. The IR frequencies are slightly higher than those found for 17G1, suggesting formation of 
a hydrogen bond between C=O of cyclopentadienone and protonated species.10 A possible explanation is 
that protons are transferred from the hydroxycyclopentadienyl moiety to the nitrogen atoms available 
in the dendrimer skeleton. The latter hydrogen maintaining a hydrogen bond with the C=O 
group of cyclopentadienone. The hypothesis is also in agreement with the small shift of the signals due to -
CH2- (broad signals around 3 ppm and 1.6 ppm) from dendrimer, if compared with 17G1. 
5.4 Catalytic oxidation of alcohols 
Since the ruthenium complexes look to remain linked to the dendrimer in refluxing toluene we moved to check 
the behavior of functionalized dendrimers versus mononuclear complexes under oxidative conditions in the 
dehydrogenation of benzyl alcohol to benzaldehyde. Preliminary tests were performed on mononuclear 
ruthenium complexes 4a and 12a[CF3SO3] in 1,2-dichlorobenzene (DCB) at 150°C (entry 1,2 and 5 in Table 
5.2). A fair conversion is obtained with the complex 4a which reaches a conversion of 71% within 8h (entry 1). 
Anyway, it seems that after a rapid activation, the catalyst is somehow off (75% after 24h). The presence of 
an oxidizing additive such as CAN play a detrimental role, giving only a 34% yield (the reaction is completely 
selective thus conversion correspond to the yield) in 24h. It is important to underline that under hydrogen 
transfer conditions (see Table 5.1) the same complex is not activated. On the other hand, the cationic complex 
12a[CF3SO3] (entry 5) gave good results also in the microscopy reverse transfer hydrogenation. In order to 
employ a greener solvent and to reduce the energy of the reaction with a lower temperature we checked 
toluene as solvent. The reaction works also at 110°C (entry 6) with similar results, even though the induction 
time is shorter in the case of DCB probably due to the higher temperature which can favor the CO release that 
is the key step of catalyst activation.8b 
Table 5.2. Catalytic oxidation of benzyl alcohol to benzaldehyde.a 
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entry [Ru] additive conversion 8h (%) conversion 24h (%) 
1 4ab CANc 21 34 
2 4ab --- 71 75 
3 4ad --- 16 67 
4 4ad CANc 0 18 
5 12a[CF3SO3]b --- 60 66 
6 12a[CF3SO3]d --- 72 80 
7 12a[CF3SO3]d Benzoquinonee >99f  
8 17G1-Hg  17 23h 
aGeneral conditions: Ruthenium complex (5 mol% Ru), solvent (3 mL), reflux; conversions determined by GC; bsolvent: 
DCB; cCAN 1 mol equiv. (dissolved in 1mL of CH3CN) per ruthenium center; dsolvent: toluene; e2 equivalents of 
benzoquinone per ruthenium center; econversion is complete already after 1 h; g Experiment performed in Tol-d8; h 
adding 2 eq. per ruthenium center of benzoquinone to the reaction mixture the conversion arose from 23 to 37% in 2h 
and 44% in 18h. Further addition of an excess of acetone allow the conversion to reach 68% in two further hours. 
In order to prevent the deactivation of the catalyst, a hydrogen acceptor such as benzoquinone has been 
added to the reaction mixture. This additive, as expected, is able to regenerate the catalyst in situ allowing to 
reach a complete conversion within 1h (entry 7). Performing the reaction with an equimolar quantity of 
ruthenium center immobilized on dendrimer 17G1-H a detrimental dendrimer effect is observed (entry 8). In 
the latter reaction Tol-d8 has been used as solvent in order to better follow the conversion and the destiny of 
ruthenium complexes. Indeed, by adding oxidizing additive such as benzoquinone or acetone the conversion 
is increased as expected. (see note h in Table 5.2) 
With the aim to shed light on the role of solubility in the negative dendrimer effect a sample of 17G1-H (9.8 mg 
in 0.6 mL of Tol-d8) has been heated at 110 °C under inert atmosphere (J-young NMR tube under Argon) for 
2h. The large majority of the dendrimer remains insoluble, anyway some signals ascribable to the ruthenium 
fragment are present in solution. 
Since the decomposition of the dendrimer under reducing condition looks to be connected to the non-innocent 
solvent iPrOH, we added a slight excess of benzyl alcohol in order to understand if there is an effective role of 
–CHxOH groups in the complex detachment above described. After 2h at 110°C, without stirring, only 2% 
conversion is observed. Anyway, the diagnostic signal of Shvo complex is observable at -17.87 ppm. Insoluble 
fraction has been analyzed in acetone-d6 revealing the presence of the pattern of signals arising from 20G1. 
Anyhow performing the same reaction in acetone-d6, where the dendrimer is completely soluble, neither 
conversion of benzyl alcohol nor decomposition of 17G1 is observed. Studies with different solvents in order 
to increase the reaction temperature will be investigated in the near future in order to activate the peripheral 
complexes avoiding functionalized dendrimer decomposition. 
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Conclusion 
The novel cyclopentadienone-NHC-ruthenium functionalized five generations of polypropylene imine 
dendrimers (PPI) with up to 64 organometallic moieties DAB-dendr-[NH(O)CO(NHC)Cp=ORu(CO)2]n {n=4, 8, 
16, 32, 64} have been obtained by the formation of carbamate linkers between NH2 peripheral group of the 
dendrimers and OH functionality in the lateral chain of the NHC employing carbonyldiimidazole as coupling 
agent. This straightforward and quantitative reaction provides a valuable route towards the immobilization of –
OH functionalized NHC complexes on organic and inorganic amino functionalized supports. The dendritic 
compounds 17G1-5 have been characterized by 1H, 13C NMR and IR spectroscopy and mass spectrometry 
when possible. The quantitative formation of the hydroxycyclopentadienyl tetra-cationic dendrimer 17G1-H has 
been observed by reacting 17G1 with a strong acid such as HCF3SO3. 
By varying the cyclopentadienone ligand on the mononuclear ruthenium complexes a partial solubility in water 
has been found for the trimethylsilyl-functionalized ruthenium cation complex 18d[Cl] even though the 
corresponding functionalized first generation dendrimer 19G1 shows similar solubility as 17G1. 
Preliminary results on the use of the first generation dendrimers in the protonated form (17G1-H), as hydrogen 
transfer (TH) catalyst in iPrOH showed higher catalytic activity if compared with the corresponding monomeric 
species. However, a more detailed study indicated that this is not ascribable to a true dendritic effect but is 
better explained by the decomposition of the cationic dendrimer, which led to the release of a peripheral 
ruthenium monomeric active species recognized as the active form of the famous Shvo catalyst. Preliminary 
results on dehydrogenation reaction indicate that cationic and neutral ruthenium NHC functionalized 
dendrimers 17G1 and 17G1-H do not decompose under oxidizing conditions but in the applied conditions any 
conversion of the substrate has been achieved. Further investigations will focus on the study of different 
solvents in order to increase the reaction temperature and to activate the peripheral complexes avoiding 
functionalized dendrimer decomposition.  
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Experimental Section 
Materials and procedures. Solvents: dichloromethane (CH2Cl2), diethyl ether (Et2O), acetonitrile (CH3CN), 
Toluene were dried and distilled prior to use. Acetone has been degassed and stored under inert atmosphere 
on molecular sieves. Other solvents such as 2-propanol (IPrOH), heptane, hexane, CDCl3, D2O, Toluene-d8 
(Sigma Aldrich) have been employed without further purification. Reagents: triruthenium-dodecacarbonil 
(Ru3(CO)12) (Strem), silver oxide, 1-methylimidazole, 1-chloroethanol, 1,3 diphenylacetone, 
4,4’dimethoxybenzil (Alfa Aesar), 4-fluoroacetophenone, trifluoromethanesulfonic acid, 1,1'-
carbonyldiimidazole (CDI) and DAB-dendr-(NH2)n {n = 4, 8, 16, 32, 64}, cerium ammonium nitrate (CAN) 
(Sigma Aldrich) have been employed as purchased. 1-methyl-3-(2-hydroxyethyl)imidazolium chloride,27 3,4-
Bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone,29 dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone) ruthenium dimer,30 dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone)-1-methyl-3-(2-hydroxyethyl-imidazol-2-ylidene)ruthenium,20 have been 
prepared as previously reported. The prepared derivatives were characterized by spectroscopic methods. The 
NMR spectra were recorded using Varian Inova 300 (1H, 300.1; 13C, 75.5 MHz), Varian Mercury Plus VX 400 
(1H, 399.9; 13C, 100.6 MHz), Varian Inova 600 (1H, 599.7; 13C, 150.8 MHz) spectrometers at 298 K; chemical 
shifts were referenced internally to residual solvent peaks. Full 1H- and 13C-NMR assignments were done, 
when necessary, by gHSQC and gHMBC NMR experiments using standard Varian pulse sequences. Infrared 
spectra were recorded at 298 K on a Perkin-Elmer Spectrum 2000 FT-IR spectrophotometer. ESI-MS spectra 
were recorded on Waters Micromass ZQ 4000 with samples dissolved in MeOH or CH3CN. GC analysis have 
been performed on an Agilent Technologies 7890A Gas Cromatograph provided with a capillary column Agilent 
19091J-433 HP-5 (5%phenyl)-methylpolysiloxane, 30 m x 0.320 mm x 0.25 μm. 
Elemental analyses were performed on a Thermo-Quest Flash 1112 Series EA instrument. The conversions 
were monitored by 1H-NMR 19F-NMR.  
 
Synthesis of Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-
3-(2-CO2Im-ethyl)imidazol-ylidene)ruthenium (4p). 
 
Figure 5.6. Structure of ruthenium carbene complex 4p. 
1.44 g (1.98 mmol) of 4d and 0.97 g (5.99 mmol) of 1,1’-carbonyldiimidazole were reacted under nitrogen 
atmosphere in 30 mL of anhydrous CH2Cl2. The reaction mixture was stirred at room temperature for 2h. The 
solution was then extracted with water (3x20 mL). Trace of water were removed from organic phase with 
Na2SO4, then the solvent was removed under vacuum and the white/brown product,identified as 4p, was 
obtained with an yield of 84%. 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 8.03 (s, 1H, Im); 7.78 (m, 4H, CHaryl), 
7.33 (m, 1H, Im), 7.16-7.12 (m, 8H, CHaryl), 7.08 (m, 1H, Im), 7.06 (m, 2H, CHaryl), 6.96 (d, J = 2.00 Hz, 1H, 
CHNHC), 6.85 (d, J = 2.00 Hz, 1H, CHNHC), 6.65 (m, 4H, CHaryl), 4.05 (m, 2H,-CH2-), 3.99 (m, 2H,-CH2-), 3.72 
(s, 6H, -OCH3), 3.14 (s, 3H, -NCH3). 13C-NMR (100.6MHz, CDCl3, DEPT): δ (ppm): 202.15 (CO), 174.80 
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(Ccarbene), 169.41 (C=O, Cp), 158.64 (-COCH3), 147.89 (-OC(O)N-), 136.95 (CH, Im), 134.91 (Cqaryl), 133.55 
(CHaryl), 130.88 (CH, Im), 129.36 (CHaryl), 127.63 (CHaryl), 125.63 (Cqaryl), 124.70 (CHNHC), 124.37 (CHaryl), 
121.76 (CHNHC), 116.97 (CH, Im), 112.96 (CHaryl), 104.09 (C2,5, Cp), 78.88 (C3,4, Cp), 67.02 (-CH2-), 55.00 (-
OCH3), 49.20 (-CH2-), 38.41 (CH3, NHC). IR (CH2Cl2): ν(CO): 2007cm-1, 1948 cm-1; ν(C=O,-O2CIm): 1768cm-
1. ESI-MS (m/z) (+): 823 [M+H]+; 845 [M + Na] +. 
Synthesis of DAB-dendr-[NH(O)CO(NHC)Cp=ORu(CO)2]n {n=4, 8, 16, 32, 64; NHC=[-CH2CH2-5-
CH3-imidazol-2-ylidene]; Cp=[3,4-(CH3O-C6H4)2-2,5-Ph2(η4-C4CO)]} (17G) 
17G1: DAB-dendr-(NH2)4 (0.02 g, 0.06 mmol) and 4p (0.26 g, 0.31 mmol) were dissolved in anhydrous CH2Cl2 
(10 mL) under inert atmosphere. Reaction mixture was stirred at room temperature for two days. The solution 
was then extracted with water (3x20 mL). Trace of water were removed from organic phase with MgSO4, then 
the solvent was removed under vacuum and the crude was washed with Et2O (3x15 mL). The yellow solid was 
identified as 17G1 (n=4) and obtained with 42% yield. 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 7.72-6.60 (CHaryl), 
6.81 (m, 4H, CHNHC), 6.62 (m, 4H, CHNHC), 3.77 (m, 8H, -CH2-), 3.68 (s, 24H, -OCH3), 3.59 (m, 8H, -CH2-), 
3.09 (s, 12H, -NCH3), 3.07, 2.97, 2.36, 1.57, 1.36 (br, 32H, CH2, DAB-dendr). 13C-NMR (100.6 MHz, CDCl3): 
δ (ppm): 202.06 (C=O), 172.67 (Ccarbene), 169.56 (C=O, Cp), 158.53 (-COCH3), 156.00 (-OC(O)N-), 135.04 
(Cqaryl), 133.55 (CHaryl), 129.40 (CHaryl), 127.45 (CHaryl), 125.50 (Cqaryl), 124.44 (CHaryl), 124.36 (CH, NHC), 
121.80 (CH, NHC), 112.85 (CHaryl), 103.73 (C2,5, Cp), 78.97 (C3,4, Cp), 63.29 (-CH2-), 54.96 (-OCH3), 49.75 (-
CH2-), 38.25 (CH3, NHC), 53.73, 51.65, 39.51, 26.99, 24.88 (CH2, DAB-dendr). IR (CH2Cl2): ν(C=O): 2006 cm-
1, 1947 cm-1; ν(C=O, -NHC(O)O-): 1718 cm-1; ν(C=C): 1601 cm-1, 1518 cm-1; ν(C=O, Cp): 1582 cm-1. ESI-MS 
(m/z) (+): 3355 [M + Na] + 
The upper generations of PPI dendrimers, functionalized with n ruthenium complexes, respectively n = 8 17G2, 
n = 16 17G3, n = 32 17G4 and n = 64 17G5 were prepared with the same procedure, but they required seven 
days of reaction time. 
17G2 (prepared from 0.02 g (0.03 mmol) of DAB-dendr-(NH2)8 and 0.26 g (0.31 mmol) of 4p with a yield of 
25%). 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 7.75-6.61 (CHaryl), 6.96 (m, 8H, CHNHC), 6.79 (m, 8H, CHNHC), 
3.77 (m, 16H, -CH2-), 3.70 (s, 48H, -OCH3), 3.59 (m, 16H, -CH2-), 3.10 (s, 24H, -NCH3), 3.20-2.80, 2.60-2.20, 
1.96-1.42 (br, 80H, CH2, DAB-dendr). 13C-NMR (100.6 MHz, CDCl3): δ (ppm): 202.18 (C=O), 173.96 (Ccarbene), 
169.52 (C=O, Cp), 158.61 (-COCH3), 156.14 (-OC(O)N-), 135.00 (Cqaryl), 133.58 (CHaryl), 129.49 (CHaryl), 
127.59 (CHaryl), 125.78 (Cqaryl), 124.55 (CHaryl), 124.30 (CH, NHC), 122.43 (CH, NHC), 112.95 (CHaryl), 103.65 
(C2,5, Cp), 78.68 (C3,4, Cp), 63.29 (-CH2-), 55.02 (-OCH3), 50.00 (-CH2-), 38.31 (CH3, NHC), 53.47, 51.54, 
39.51, 26.84, 23.63 (CH2, DAB-dendr). IR (CH2Cl2): ν(C=O): 2008cm-1, 1948 cm-1; ν(C=O, -NHC(O)O-): 
1719cm-1; ν(C=C): 1603 cm-1, 1518 cm-1; ν(C=O, Cp): 1577 cm-1. 
17G3: (prepared from 0.02 g (0.01 mmol) of DAB-dendr-(NH2)16 and 0.17 g (0.21 mmol) of 4p with a yield of 
32%). 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 7.76-6.61 (CHaryl), 6.96 (m, 16H, CHNHC), 6.78 (m, 16H, CHNHC), 
3.77 (m, 32H, -CH2-), 3.71 (s, 96H, -OCH3), 3.67 (m, 32H, -CH2-), 3.10 (s, 48H, -NCH3), 3.20-1.50 (br, 176H, 
CH2, DAB-dendr). 13C-NMR (100.6 MHz, CDCl3): δ (ppm): 202.17 (C=O), 173.94 (Ccarbene), 169.46 (C=O, Cp), 
158.60 (-COCH3), 153.57 (-OC(O)N-), 135.00 (Cqaryl), 133.57 (CHaryl), 129.29 (CHaryl), 127.59 (CHaryl), 125.52 
(Cqaryl), 124.54 (CHaryl), 124.29 (CH, NHC), 122.38 (CH, NHC), 112.95 (CHaryl), 103.98 (C2,5, Cp), 78.67 (C3,4, 
Cp), 63.69 (-CH2-), 55.01 (-OCH3), 50.01 (-CH2-), 38.30 (CH3, NHC), 53.39, 51.39, 38.41, 26.78, 24.02 (CH2, 
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DAB-dendr). IR (CH2Cl2): ν(C=O): 2008cm-1, 1949 cm-1; ν(C=O, -NHC(O)O-): 1718cm-1; ν(C=C): 1602 cm-1, 
1517 cm-1; ν(C=O, Cp): 1577 cm-1. 
17G4: (prepared from 0.02 g (6.00 µmol) of DAB-dendr-(NH2)32 and 0.20 g (0.25 mmol) of 4p with a yield of 
41%); 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 7.75-6.60 (CHaryl), 6.96 (m, 32H, CHNHC), 6.79 (m, 32H, CHNHC), 
3.77 (m, 64H, -CH2-), 3.71 (s, 192H, -OCH3), 3.67 (m, 64H, -CH2-), 3.10 (s, 96H, -NCH3), 3.20-1.50 (br, 368H, 
CH2, DAB-dendr). 13C-NMR (100.6 MHz, CDCl3): δ (ppm): 202.16 (C=O), 173.88 (Ccarbene), 169.38 (C=O, Cp), 
158.60 (-COCH3), 153.58 (-OC(O)N-), 134.97 (Cqaryl), 133.57 (CHaryl), 129.31 (CHaryl), 127.59 (CHaryl), 125.54 
(Cqaryl), 124.53 (CHaryl), 124.30 (CH, NHC), 122.38 (CH, NHC), 112.95 (CHaryl), 103.96 (C2,5, Cp), 78.75 (C3,4, 
Cp), 63.68 (-CH2-), 55.02 (-OCH3), 49.99 (-CH2-), 38.32 (CH3, NHC), 52.47, 51.22, 38.43, 24.10, 19.73 (CH2, 
DAB-dendr). IR (CH2Cl2): ν(C=O): 2009cm-1, 1947 cm-1; ν(C=O, -NHC(O)O-): 1718cm-1; ν(C=C): 1603 cm-1, 
1518 cm-1; ν(C=O, Cp): 1576 cm-1. 
17G5: (prepared from 0.02 g (3.00 µmol) of DAB-dendr-(NH2)64 and 0.20 g (0.25 mmol) of 4p with a yield of 
43%). 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 7.75-6.58 (CHaryl), 6.96 (m, 64H, CHNHC), 6.78 (m, 64H, CHNHC), 
3.77 (m, 128H, -CH2-), 3.71 (s, 384H, -OCH3), 3.66 (m, 128H, -CH2-), 3.10 (s, 192H, -NCH3), 3.20-1.50 (br, 
752H, CH2, DAB-dendr). 13C-NMR (100.6 MHz, CDCl3): δ (ppm): 202.16 (C=O), 173.91 (Ccarbene), 169.43 (C=O, 
Cp), 158.60 (-COCH3), 153.57 (-OC(O)N-), 134.98 (Cqaryl), 133.57 (CHaryl), 129.30 (CHaryl), 127.59 (CHaryl), 
125.53 (Cqaryl), 124.54 (CHaryl), 124.30 (CH, NHC), 122.38 (CH, NHC), 112.95 (CHaryl), 103.97 (C2,5, Cp), 78.70 
(C3,4, Cp), 63.80 (-CH2-), 55.02 (-OCH3), 49.92 (-CH2-), 38.31 (CH3, NHC), 52.46, 51.35, 38.39, 26.70, 24.09 
(CH2, DAB-dendr). IR (CH2Cl2): ν(C=O): 2006cm-1, 1950 cm-1; ν(C=O, -NHC(O)O-): 1717cm-1; ν(C=C): 1602 
cm-1, 1518 cm-1; ν(C=O, Cp): 1577 cm-1. 
Synthesis of DAB-dendr-[NH(O)CO(NHC)Cp-OHRu(CO)2]4 (17G1-H) 0.150 g (0.045 mmol) of DAB-dendr-
[NH(O)CO(NHC)Cp=ORu(CO)2]4 (17G1) was dissolved in 10 mL of CH2Cl2 under inert atmosphere. 4.8 
equivalent of HCF3SO3 (solution at 1% in CH2Cl2) 1.9mL (0.216 mmol) were subsequently added. The reaction 
mixture was stirred for 30 minutes at room temperature, then the solvent was removed under vacuum and the 
crude washed twice with 10 ml of Et2O. The slightly brown solid obtained was identified as 17G1-H by IR, 1H-
NMR, 13C-NMR, 19F-NMR, ESI-MS. The yield was quantitative. 1H-NMR (400 MHz, CDCl3): δ (ppm) 7.36-6.40 
(CHaryl), 7.02 (m, 4H, CHNHC), 6.65 (m, 4H, CHNHC), 3.87 (m, 8H, -CH2-), 3.70 (m, 24H, -OCH3), 3.56 (m, 8H, -
CH2-), 3.31 (s, 12H, -NCH3), 3.10, 1.84, 1.73, 0.85 (br, 32H, CH2-DAB-dendr). 13C-NMR (400 MHz, CDCl3): δ 
(ppm) 198.72 (CO), 160.81 (Ccarbene), 159.47 (COCH3), 141.63 (C-OH, Cq), 133.34 (CHaryl), 130.48 (CHaryl), 
128.66 (CHaryl), 127.81(Cqaryl), 126.21 (Cqaryl), 121.66 (CHNHC), 120.62 (CHaryl), 118.49 (CHNHC), 113.38 
(CHaryl), 104.14 (C2,5, Cp), 87.79 (C3,4, Cp), 62.71 (CH2), 55.06 (OCH3), 51.87 (CH2), 51.11 (CH2), 49.90 (CH2), 
38.93 (NCH3), 37.49 (CH2), 23.67 (CH2), 19.85 (CH2). 19F-NMR (282.4 MHz, CDCl3) δ (ppm):  -78.67 (CF3SO3). 
IR (CH2Cl2): ν(C=O): 2039cm-1, 1988 cm-1; ν(C=O, -NHC(O)O-): 1724, 1701 cm-1; ν(C=C): 1611 cm-1, 1520 
cm-1. ESI-MS (m/z) (+): [M/4]+ = 833; (-): [CF3SO3]- = 149. 
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Synthesis of DAB-dendr-[NH(O)CO(NHC)Cp=ORu(CO)2]4 {NHC=[-CH2CH2-5-CH3-imidazol-2-
ylidene]; Cp=[2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one]} (20G) 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dienyl)[1-(2-hydroxyethyl))-3-
methylilidene]ruthenium chloride (18d[Cl]). 
 
Figure 5.7 Structure of ruthenium cationic complex 18d[Cl]. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-hydroxyethyl))-3-
methylilidene]ruthenium (9d) (0.040g, 0.071mmol) was dissolved in 10 mL of CH2Cl2 under inert atmosphere. 
Two equivalent of HCl (aqueous solution at 37%) were subsequently added. The reaction mixture was stirred 
for 2 h at room temperature. At the end of the reaction the solvent was removed under vacuum and a slightly 
brown solid identified as 2cTMS[Cl] by IR, 1H-NMR, 13C-NMR and ESI-MS was obtained in quantitative yield. 
1H-NMR (399.9 MHz, CDCl3): δ (ppm) 7.67 (s, 2H, CHNHC), 4.36 (t, 2H, -NCH2), 4.04 (t, 2H, CH2OH), 3.91 (s, 
3H, -NCH3), 2.50 (m, 4H, CH2), 1.73 (m, 4H, CH2), 0.33 (s, 18H, CH3, TMS). 13C-NMR (150.8 MHz, CDCl3, g-
HSQC, g-HMBC): δ (ppm) 199.17 (CO), 164.85 (Ccarbene), 152.58 (C-OH), 125.95 (CHNHC), 124.62 (CHNHC), 
108.26 (C2,5, Cp), 81.10 (C3,4, Cp), 60.37 (-NCH2), 54.36 (-CH2OH), 41.18 (-NCH3), 24.29 (CH2, 2C), 22.41 
(CH2, 2C), 0.98 (CH3, TMS, 6C). IR (CH2Cl2, cm-1): (νCO) 2038cm-1, 1985 cm-1. ESI-MS (m/z) (+):563 [M+H]+; 
585 [M + Na]+.  
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-(imidazolcarbonyloxy)ethyl)-
3-methylilidene]ruthenium (9p). 
 
Figure 5.8. Structure of ruthenium cationic complex 9p. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-hydroxyethyl))-3-
methylilidene]ruthenium (9d) (0.029 g, 52 μmol) was dissolved in 5 ml of CH2Cl2 under inert atmosphere. Three 
equivalent of carbonyldiimidazole (CDI) (0.025 g, 156 μmol ) were added to the solution and the reaction 
mixture was stirred for 24h at room temperature. The solution was then extracted with water (3x20ml). Water 
traces were removed from the organic solution with MgSO4 and the solvent was removed under vacuum. The 
yellow solid was characterized by IR, 1H-NMR, 13C-NMR and ESI-MS and identified as Dicarbonyl-(2,4-
bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-(imidazolcarbonyloxy)ethyl)-3-
methylilidene]ruthenium (9p) obtained with 79% yield. 1H-NMR (599,7 MHz, CDCl3): δ (ppm) 8.12 (s, 1H, 
CHImid), 7.41 (s, 1H, CHImid), 7.12 (s, 1H, CHNHC), 7.09 (s, 1H, CHImid), 7.06 (s, 1H, CHNHC), 4.75 (s, 4H, CH2 
LINKER), 3.91 (s, 3H, -NCH3), 2.58 (m, 4H, CH2), 1.78 (m, 4H, CH2), 0.19 (s, 18H, TMS). 13C-NMR (150.8 MHz, 
CDCl3): δ (ppm) 202.74 (CO), 181.03 (Ccarbene), 179.01 (CO, Cp), 148.15 (-OC(O)N-), 137.00 (CH, Imid), 131.04 
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(CH, Imid), 124.19 (CH, NHC), 121.66 (CH, NHC), 117.02 (CH, Imid), 106.07 (C2,5, Cp), 68.83 (C3,4, Cp), 66.93 
(-NCH2-), 50.74 (-CH2O-), 40.77 (NCH3), 24.91 (CH2), 22.81 (CH2), 0.60 (CH3, TMS). ESI-MS (m/z) (+): 657 
[M+H]+; 679 [M + Na]+. 
20G1: DAB-dendr-(NH2)4 (2.91 mg, 9.2 μmol) and Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-
dien-3-one)[1-(2-(imidazolcarbonyloxy)ethyl)-3-methylilidene]ruthenium (9p) (0,027 g, 41.2 μmol) was 
dissolved in 5 ml of CH2Cl2 under inert atmosphere. The reaction mixture was stirred at room temperature for 
six days. At the end solvent was removed under vacuum and the brown solid was washed with water (3x20mL). 
The product, obtained in quantitative yield was identified as 20G1. 1H-NMR (399.9 MHz, CDCl3): δ (ppm) 7.15 
(m, 4H, CHNHC), 6.99 (m, 4H, CHNHC), 4.52 (s, 8H, CH2 linker), 4.33 (s, 8H, CH2 linker), 3.87 (s, 12H, -NCH3), 3.19, 
2.43, 238, 1.61, 1.41 (br, 32H, CH2, DAB-dendr), 2.53 (s, 16H, CH2), 1.76 (s, 16H, CH2), 0.18 (s, 72H, TMS). 
13C-NMR (150.8 MHz, CDCl3, g-HSQC, g-HMBC): δ (ppm) 202.51 (CO), 181.10 (Ccarbene), 177.28 (CO, Cp), 
155.96 (-OC(O)N-), 123.63 (CH, NHC), 122.22 (CH, NHC), 106.20 (C2,5, Cp), 68.41 (C3,4, Cp), 63.57 (-NCH2-), 
51.61 (-CH2O-), 40.52 (-NCH3), 24.74 (CH2), 22.79 (CH2), 0.63 (CH3, TMS). IR (CH2Cl2): ν(CO):1999 cm-1, 
1937 cm-1; ν(C=O,-O2CIm):1760 cm-1. ESI-MS (m/z) (+): 2669 [M+H]+; 679 [M + Na]+. 
Characterization of dendrimer DAB-dendr-[NH(O)COCH2CH2Im(CH3)]4 (19G1): 1H-NMR (400 MHz, D2O): 
δ (ppm) 8.81 (m, 4H, NCHN), 7.57 (m, 4H, CHIm), 7.46 (m, 4H, CHIm), 4.52 (m, 8H, -CH2-), 4.47 (m, 8H, -CH2-
), 3.92 (s, 12H, -NCH3), 3.15, 1.92, 1.78, 0.85 (br, 32H, CH2-DAB-dendr). 
1H-NMR (400 MHz, acetone-d6): δ (ppm) 9.06 (m, 4H, NCHN), 7.79  (m, 4H, CHIm), 7.70 (m, 4H, CHIm), 4.61 
(m, 8H, -CH2-), 4.42 (m, 8H, -CH2-), 4.05 (s, 12H, -NCH3), 3.38-0.85 (br, 32H, CH2-DAB-dendr). 
Characterization of Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
hydroxycyclopentadienyl)(H)ruthenium (A): 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 7.46-6.54 (m, 18H, 
CHaryl), 3.71 (s, 6H, -OCH3), -9.88 (s, 1H, hydride).  
Characterization of Dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
hydroxycyclopentadienyl)(Cl)ruthenium (B): 1H-NMR (399.9 MHz, CDCl3): δ (ppm): 7.44-6.61 (m, 18H, 
CHaryl), 3.74 (s, 6H, -OCH3). 13C-NMR (100.6MHz, CDCl3, DEPT): δ (ppm): 197.48 (CO), 159.49 (-COCH3), 
140.44 (-C-OH), 132.99-113.35 (CHaryl), 99.25 (C2,5, Cp), 88.52 (C3,4, Cp), 55.14 (-OCH3). IR (CH2Cl2): ν(CO): 
2038 cm-1, 2018 cm-1.  
General method for transfer hydrogenation 
Functionalized dendrimer (15 μmol [Ru] (3.75 μmol for 4g1 and 4g1-H , 5 mol% [Ru]), additive (1 eq. when 
needed) and iPrOH (3 mL) were stirred at reflux for 15 min. Then 4-fluoroacetophenone (36 μL, 300 μmol) was 
added and samples were taken at regular intervals. Aliquots (ca. 0.05mL) were diluted with CDCl3 (0.5 mL) 
and conversions were determined by 19F-NMR spectroscopy. 
General method for dehydrogenation 
Ruthenium complex (5%mol, 9.5 µmol) was dissolved in 3mL of the solvent (1,2-dichlorobenzene or toluene). 
Once reached the reaction temperature (150°C for 1,2-dichlorobenzene and 110 °C for toluene) 19.7 µL of 
benzyl alcohol (190 µmol) were added. Samples were taken at regular intervals and conversions were 
determined by GC. 
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CHAPTER VI 
Imidazolium salts of ruthenium anionic cyclopentadienone complexes: ion pair for 
bifunctional catalysts in ionic liquids 
Abstract 
A new class of ruthenium anionic complexes that form ion pair with imidazolium salts has been prepared by 
direct reaction between the dinuclear complex dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone and various imidazolium salts. The reaction is clean, general and quantitative 
and the complexes formed are stable to air and moisture both in the solid state and in solution. The novel 
complexes show affinity for ionic liquids and represent stable precursors of the catalytic active form of the Shvo 
catalyst, a well-established homogeneous catalyst for several bifunctional applications in common organic 
solvents. The novel ion pairs here developed allow the use of green ionic liquids (IL) as solvents and 
preliminary results demonstrate that they exhibit fair catalytic activity (up to 75% of conversion within 24h) in 
the transfer hydrogenation of 4-fluoroacetophenone and almost complete conversion in the dehydrogenation 
of benzyl alcohol. The IL-supported oxidative catalyst can be recycled with a relevant increasing in activity that 
should be ascribed to a stabilization of the active specie in a more available form by the IL itself. The synthetic 
method here discussed represents a novelty within the field of IL-supportation and is potentially useful for the 
heterogenization of the catalysts exploiting SILP technology.  
Introduction 
Over the past decade, ionic liquids (ILs) have gained recognition in the context of green organic synthesis 
in that they can be environmentally benign solvents and also behave as a liquid support in various 
chemical processes.1 Although ILs were recently introduced as alternative green reaction media in organic 
synthesis because of their unique chemical and physical properties such as no volatility, non-flammability, 
thermal and chemical stability, controlled miscibility and ionic conductivity, they have already made a 
revolutionary impact on a number of fields including: analytical chemistry, electrochemistry, polymer 
chemistry, nanotechnology and biotechnology, energy2 and catalysis.3 Reactions which are 
successfully performed in ILs include hydrogenation and oxidation.3 However, redox reactions 
mediated by bifunctional catalysts such as homogeneous transfer hydrogenation4 and dehydrogenation, 
which are reaction of great general interest and particularly within the field of bio-refinery,5 have been  
scarcely investigated.
In the previous chapters the new class of ruthenium complexes that combine cyclopentadienone and 
NHC ligands has been described6 together with their properties as redox bifunctional catalysts. 7 Their 
preparation is recalled in Scheme 6.1 in order to make clearer the comparison between the novel ionic pair 
complexes and the “classic” neutral organometallic compounds of type 4.  The easy functionalization of 
imidazolium salts, precursors of NHC ligands, allow to tune steric and electronic properties, solubility 
and the insertion of substituents suitable for heterogenization. Furthermore, by choosing a proper 
substituent, NHC ligand itself is potentially able to cooperate with the metal and behave as non-innocent 
species.7b,8 
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Scheme 6.1 Synthesis of cyclopentadienone imidazolylidene ruthenium(0) complexes 4a–d,m.  
During our study on the reactivity of imidazolium salts with the dinuclear ruthenium carbonyl cyclopentadienone 
3, aimed at obtaining to obtain NHC Ru complexes, we serendipitously observed the formation of a novel class 
of anionic ruthenium complexes behaving as ILs. Some of these complexes are soluble in ionic liquids such 
as [BMIM][PF6] and demonstrated to be active in hydrogen transfer employing 2-propanol as the hydrogen 
donor. Anionic complexes bearing an imidazolium salt as couterion are poorly reported in the literature even 
though they offer several interesting properties and have been exploited in catalysis,9 and medicinal 
chemistry.10 To the best of our knowledge they have never been employed in transfer hydrogenation. On the 
other hand, several ionic tagged complexes have been designed in order to obtain catalysts soluble in ionic 
liquids for ILs-supported catalysis, with the benefit of simplified product isolation and possible catalyst reuse.11 
Here, we report on the synthesis and characterization of a novel class of ruthenium complexes ion paired with 
imidazolium salts and on their application as hydrogen transfer catalysts. 
A comparison between NHC complexes and [Ru][ILs] ion pairs in [BMIM][PF6] is also described for TH and 
the reverse reaction: dehydrogenation. The easy and quantitative synthetic approach and the stability of the 
ion-pairs make this procedure available for the immobilization of ruthenium bifunctional catalysts on 
imidazolium functionalized insoluble supports, such as those employed in the emerging SILP technology.12 
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Results and discussion 
6.1 Synthesis and structures of ruthenium complexes 
The reactivity of the dinuclear complex 3 with imidazolium salts has been explored using a library of variously 
functionalized imidazolium salts, prepared according to literature procedures (Figure 6.1). 
 
Figure 6.1 Imidazolium salts employed in this work. 
Imidazolium salts 1a–m were reacted directly with the dimeric precursor dicarbonyl(η4-3,4-bis-(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone) (3). A quantitative and instant reaction leads to the 
formation of the ionic pairs 21a–m consisting of the imidazolium cation and Ru(0) anionic complexes (Scheme 
6.2). These latter are obtained upon the coordination of the imidazolium counterion to the 16 electron 
ruthenium mononuclear form, which is generated as soon as the dimer is dissolved in organic solvents such 
as dichloromethane.  
 
Scheme 6.2 Synthesis of cyclopentadienone ruthenium(0) complexes ion paired to imidazolium salts 21a–m. 
The reaction is general, involving both hindered and non-bulky N-heterocyclic carbenes, and tolerant to 
functional groups: in fact it occurs in the presence of a primary alcohol in the lateral chain (1d to 21d) and in 
the presence of pyridine (1m to 21m). It proceeds with the halide counterion of the starting imidazolium salt, 
as well as with trifluoromethanesulfonate. On the other hand, it does not occur with NTf2- 
(bis(trifluoromethylsulfonyl)imide) as counterion, probably due to its peculiar coordination properties.13 The 
synthesis of 21a–m is followed by IR spectroscopy, observing the lowering in vCO stretching frequencies (e.g. 
21a: ν(CO) = 2004, 1945 cm−1 vs. 3: 2018, 1967 cm−1). Lower stretching frequencies suggest that the negative 
charge is more localized on the metal than on the oxygen of the cyclopentadienone ligand (Figure 6.2). This 
observation is confirmed by the C=O distance in the X-Ray diffraction structure of 21a (1.225 Å – vide infra - 
vs 1.245 Å for 4a7 and 1.334 Å for the hydroxycyclopentadienyl analogue8b 12a[X] obtained by protonation of 
4a). An 4 coordination of the cyclopentadienone is thus reasonable and the negative charge on the metal 
together with the -donor nature of chloride and congeners allow more back-bonding toward the CO ligands. 
120 
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Figure 6.2. Localization of the negative charge in complexes of type 21. The ruthenium(0) form on the left is the one 
supported by experimental evidences. 
IR spectra of the other ion pairs of type 21 are very similar to that of complex 21a, except for the hydroxyl-
functionalized complex 21d, that shows increased frequency for terminal CO and lowering of 
cyclopentadienone ν C=O [21d: ν(CO) = 2009, 1948 cm−1; ν(C=O) = 1566 cm−1 vs. 21a: ν(CO) = 2004, 1945 
cm−1, 1580 cm−1]. This behavior is in agreement with what observed for NHC ruthenium complexes reported 
in Chapter II and described in the introduction,7 and is ascribable to the formation of a hydrogen bond between 
–OH of the imidazolium salt and the carbonyl group of cyclopentadienone. All the complexes of type 21 show 
in 1H-NMR and 13C-NMR spectra the typical pattern of the starting reagents moved to different chemical shift; 
in Figure 6.3 and 6.4 the spectra of 21a[I] are reported as examples.  
Figure 6.3. 1H-NMR spectrum of 21a[I] in CDCl3. 
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Figure 6.4. 13C-NMR spectrum of 21a[I] in CDCl3. 
More significant indication of the structure reported in Scheme 6.2 is given by ESI-MS analyses which show 
the molecular anion [Ru(CO)2{C5(C6H4OMe)2(Ph)2=O}(X)]- and the molecular cation [R1ImR2]+. Further 
confirmation of the structure proposed came from X-Ray diffraction of single crystals obtained for the 
complexes 21a[I] and 21f (Figure 6.5). 
The solid state structures of 21a[I] and 21f are composed of [{2,5-Ph2-3,4-(p-MeO-C6H4)2(4-
C4C=O)}Ru(CO)2X]– (X = I, Cl) complex anions and imidazolium [1,3-R2-C3N2H3]+ (R = Me, tBu) cations. The 
cations display structures similar to those previously reported with other anions.14 The molecular structures of 
the [{2,5-Ph2-3.4-(p-MeO-C6H4)2(4-C4C=O)}Ru(CO)2X]– anions are closely related to the neutral {2,5-Ph2-3.4-
(p-MeO-C6H4)2(4-C4C=O)}Ru(CO)2(L) (L = NHC carbene ligand) complexes, for what concerns the 
coordination of the cyclopentadienone ligand.6,7 In particular, the Ru(1)-C(3) distance [2.499(7) and 2.503(7) 
Å for 21a[I] and 21f, respectively] is significantly longer than Ru(1)-C(4-7) [2.201(7)-2.251(6) Å, average 
2.225(12) Å for 21a[I]; 2.149(7)-2.267(7) Å, average 2.213(12) Å for 21f] as previously found in other 
complexes where the cyclopentadienone ligand is essentially 4-coordinated to Ru.15 For comparison, the 
same Ru-C contact is shortened to 2.32-2.34 Å in the case of Ru-complexes containing 5-cyclopentadienone 
derived ligands.7,16 In agreement with the above 4-coordination, the C(3)-O(3) contact [1.242(7) and 1.226(8) 
Å] is essentially a double bond.  
It must be remarked that in both the solid state structures, a C-H···O inter-molecular contact is present involving 
the C(41)-H(41) group of the imidazolium cation and the O(3) atom of the cyclopentadienone ligand of the 
anion [C(41)-H(41) 0.93 Å, H(41)···O(3)#1 2.16 Å, C(41)···O(3)#1 2.957(10) Å, <C(41)H(41)O(3)#1 143.1° for 
21a[I], symmetry #1 x+1,y-1,z; C(41)-H(41) 0.93 Å, H(41)···O(3) 2.49 Å, C(41)···O(3) 3.380(9) Å, 
<C(41)H(41)O(3) 159.7° for 4a]. 
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Figure 6.5 ORTEP drawing of 21a[I]. Displacement ellipsoids are at the 30% probability level. 
  
Figure 6.6 ORTEP drawing of 21f. Displacement ellipsoids are at the 30% probability level. 
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Table 6.1. Selected bond lengths (Å) and angles (deg) for 21a[I] and 21f. 
 21a[I] 21f 
Ru(1)-C(1) 1.900(8) 1.866(8) 
Ru(1)-C(2) 1.880(8) 1.872(8) 
Ru(1)-X(1) 2.7604(8) 2.4464(18) 
Ru(1)-C(3) 2.499(7) 2.503(7) 
Ru(1)-C(4) 2.245(7) 2.252(7) 
Ru(1)-C(5) 2.201(7) 2.185(7) 
Ru(1)-C(6) 2.202(6) 2.149(7) 
Ru(1)-C(7) 2.251(6) 2.267(7) 
C(1)-O(1) 1.115(7) 1.156(8) 
C(2)-O(2) 1.152(8) 1.158(8) 
C(3)-O(3) 1.242(7) 1.226(8) 
C(3)-C(4) 1.476(8) 1.494(10) 
C(4)-C(5) 1.453(8) 1.439(10) 
C(5)-C(6) 1.434(8) 1.442(9) 
C(6)-C(7) 1.439(8) 1.451(10) 
C(7)-C(3) 1.484(8) 1.462(10) 
C(41)-N(1) 1.306(9) 1.324(9) 
C(41)-N(2) 1.311(9) 1.299(8) 
N(1)-C(43) 1.358(9) 1.353(10) 
N(2)-C(42) 1.336(9) 1.368(10) 
C(42)-C(43) 1.343(11) 1.302(12) 
O(3)-C(3)-C(4) 125.3(6) 128.1(7) 
O(3)-C(3)-C(7) 129.9(6) 127.2(7) 
C(7)-C(3)-C(4) 104.7(6) 104.3(6) 
C(3)-C(4)-C(5) 107.9(6) 108.5(6) 
C(4)-C(5)-C(6) 107.9(6) 108.0(6) 
C(5)-C(6)-C(7) 108.8(6) 107.9(6) 
C(6)-C(7)-C(3) 107.8(6) 109.3(6) 
N(1)-C(41)-N(2) 110.9(8) 110.1(6) 
C(41)-N(2)-C(42) 106.9(8) 107.4(7) 
C(41)-N(1)-C(43) 107.0(8) 106.2(7) 
N(2)-C(42)-C(43) 108.4(9) 107.2(8) 
N(1)-C(43)-C(42) 106.7(8) 109.1(8) 
It has to be underline that complex 21a, treated with Ag2O in CH2Cl2 solution converts to 4a by transmetallation, 
and that precipitation of AgI is observed, as expected. Thus, the present method represents another route to 
easily obtain complexes of type 4. 
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6.2 Catalytic transfer hydrogenation  
The ruthenium ionic complexes 21a[I] and 21a[CF3SO3] have been evaluated as catalyst precursors using 
ionic liquid as reaction solvent under transfer hydrogenation conditions (i.e. employing iPrOH as hydrogen 
source and 4-fluoroacetophenone as model substrate). The crude at the end of the reaction has been cooled 
and then the product extracted with diethyl ether and analyzed by GC. Preliminary catalytic runs were 
performed in order to investigate the catalytic activity of these kind of ionic complexes in non-conventional 
media, the results and the comparison between the ruthenium(0) complex 4a with the corresponding 
ruthenium(0) anionic complex 21a in ionic liquid [BMIM][PF6] are reported in Table 6.2.  
Table 6.2. Catalytic transfer hydrogenation of 4-fluoroacetophenone.a 
 
entry [Ru] solvent (ILs) conversion 8h (%) conversion 24h (%) 
1 21a[I] [BMIM][PF6] 69 75 
2 21a[CF3SO3] [BMIM][PF6] 63 72 
3 4a [BMIM][PF6] 0 0 
4 21a[I] [BMIM][BF4] 24 24 
5 21a[CF3SO3] [BMIM][BF4] 54 57 
aGeneral conditions: Ruthenium complex (5 mol% Ru),ionic liquid ( 2 mL), iPrOH (2 mL), T = 100°C; 
conversions determined by 19F NMR spectroscopy. 
The neutral complex 4a did not present any catalytic activity in the absence of additives even in ionic liquid 
media (entry 3) as already stated in the case of organic solvent. By contrast, the ionic complexes 21a show a 
good catalytic activity without any use of additive. This behavior can be easily explained by the fact that the 
neutral complexes (4) need the release of a CO ligand to be activated (more details in Chapter IV paragraph 
4.3); conversely, in the ionic complexes (21) the hypothetic de-coordination of iodide or CF3SO3- , as 
imidazolium counterion, would lead to the formation of the 16 electron counting active species ruthenium 
fragment able to perform the hydrogen transfer from iPrOH to the substrate 4-fluoroacethophenone.  
 
Schema 6.3 Proposed activation of ionic complexes 21. 
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Therefore, the catalytic mechanism is similar to that of the Shvo catalyst (see Chapter I paragraph 2.2.2) with 
the advantage of a possible recover and reuse of the catalyst immobilized in the ionic liquid phase. 
The catalytic activity of the ionic complexes 21a[I] and 21a[CF3SO3], containing different imidazolium 
counterions, have been found to be similar, (entries 1, 2), suggesting that there is no influence of the 
coordination ability of the counterion in the pre-catalyst activation. 
The study of the role of different imidazolium salts in the activation of 21, such as the influence of a pyridine or 
an -OH substituent on the side chain of the heterocycle, are still under investigation. Further studies will also 
affect the choice of the hydrogen donor in order to optimized the reaction conditions. In fact, an excess of 2-
propanol (2 mL) has been required in these tests due to the fact that the operational temperature is higher 
than its boiling point. With the aim to understand the role of the ionic liquid, some catalytic runs have been 
carried out employing [BMIM][BF4] as reaction solvent, under the same hydrogen transfer conditions. In these 
cases, a lower conversion is observed compared to the congener [BMIM][PF6] (24% vs. 69% in 8h; entries 5, 
4 respectively). This is probably due to the physical properties of the ILs that depend on the nature of both 
cation and anion;3 in this case the different anions can affect some physical properties such as viscosity, 
density, and solubility that, subsequently, influence the catalytic activity of the complexes. A screening of 
different ILs as reaction solvent is still under investigation. 
6.3 Catalytic dehydrogenation 
In addition to transfer hydrogenation, we were also interested to see whether complexes 21 are active in 
alcohol dehydrogenation in ionic liquid media. The ionic complexes 21 have been employed as catalyst 
precursors for the oxidation benzyl alcohol (BnOH), as model substrate. 
Table 6.3. Catalytic oxidation of benzyl alcohol to benzaldehyde.a 
 
entry [Ru] solvent  additive conversion 8h (%) conversion 24h (%) 
1 21a[I] [BMIM][PF6] --- 36 >99 
2 21a[CF3SO3] [BMIM][PF6] --- 35 >99b 
3 21d [BMIM][PF6] --- 57  60 
4 21m [BMIM][PF6] --- >99c --- 
5 21a[CF3SO3] toluene Benzoquinoned 56 >99 
aGeneral conditions: Ruthenium complex (5 mol% Ru), solvent (2 mL), T = 110°C; conversions determined by GC; 
brecycling test; cafter 8h the conversion was complete then at 24h of reaction only the presence of a not identified by-
product was detected; d2 equivalents of benzoquinone per ruthenium center 
As for the hydrogen transfer, the complexes 21a[I] and 21a[CF3SO3] show a similar catalytic activity leading 
to an almost complete conversion in 24h, while the complex 21d, having a OH group on the side chain of the 
imidazole, leads to lower conversion. This result is consistent with what found for the corresponding NHC 
complex 12d[CF3SO3] probably due to intramolecular dehydrogenation, causing the formation of inactive 
species. This hypothesis has been described in Chapter IV (paragraph 4.3). The pyridine-functionalized ionic 
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complex 21m exhibits the faster activation, in fact, a complete conversion was observed within 8h, however 
after 24h any traces of the benzaldehyde as detected but only the presence of a not identified by product was 
observed.  
Aimed at comparing the catalytic activity of the complexes 21 in non-conventional solvent (ILs) and in 
traditional organic solvent, a catalytic test has been performed with 21a[CF3SO3] using toluene as solvent and 
in the presence of a hydrogen acceptor such as benzoquinone (the same reaction conditions that have been 
employed for the ruthenium NHC complexes of type 12, see Chapter V paragraph 5.4). In the case of ion pair, 
the BQ additive do not accelerate the induction time of the catalytic reaction, leading to the same result as that 
obtained in ionic liquid without additive. Infact, also in this conditions a complete conversion of the substrate 
was reached within 24h. 
As mentioned in the Introduction, the major advantage of the use of the ionic liquids as reaction solvents is the 
efficient immobilization of the catalyst in the ionic liquid phase, which means that, after product extraction, the 
reaction medium and the catalyst can be reused several times. A recycling test has been performed with 
21a[CF3SO3], after the extraction with Et2O (3x5mL) the mixture (IL with the catalyst inside) was dried under 
vacuum in order to remove all the volatiles, then, the benzyl alcohol was added to the recycled system and 
heated at 110°C. After only 2h, complete conversion of the substrate was observed. 
Further investigations on the catalytic activity and mechanism of these complexes are being carried out. 
Conclusion 
The direct and straightforward reaction of the dinuclear ruthenium complex dicarbonyl(η4-3,4-bis(4-
methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone (3) with a series of variously functionalized imidazolium 
salts afforded a novel class of anionic ruthenium cyclopentadienone complexes ionic paired with imidazolium 
salts as counterions. The reaction is clean, general and quantitative and the complexes are stable to air and 
moisture both in the solid state and in solution. All the complexes obtained have been characterized by means 
of IR, NMR and ESI-MS techniques and, when possible, with X-ray diffraction studies. The peculiar structure 
of the novel complexes made them good candidates for redox catalysis in reaction such as hydrogen transfer 
and dehydrogenation. Indeed, preliminary results demonstrated their activity in such reactions. Moreover, 
exploiting their affinity for ionic liquids, bifunctional catalysis has been transferred in ILs, such as [BMIM][PF6], 
with very promising results. The catalysts are fairly active in hydrogen transfer, although the high temperature 
and the induction time required, make them still far from being competitive with best ruthenium catalysts 
available in the literature. Anyway, the use of ionic liquid gives a greener character to the reaction. On the 
contrary, good preliminary results have been obtained in oxidation reactions, such as the dehydrogenation of 
benzyl alcohol to aldehyde. Indeed, in this particular reaction the best results is provided by catalyst 
21a[CF3SO3] which gives complete conversion of the alcohol in 24h. Furthermore, initial results obtained by 
recycling this catalyst are very promising and demonstrate that, once activated, the catalyst remains active 
and protected by the ionic liquid environment until the introduction of a further portion of substrate. Studies on 
complexes of type 21, depicted in the present chapter are ongoing and will be further developed  in the near 
future in order to shed more light on both the catalytic activity and recyclability of the ionic pairs in ionic liquid 
and on the corresponding mechanism. The synthetic methods here discussed represent a novelty within the 
field of IL-supportation and might be exploited also for the heterogenization of the catalysts using, for example, 
SILP technology.   
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Experimental Section 
Materials and procedures. Solvents: dichloromethane (CH2Cl2), tetrahydrofuran (THF), diethyl ether (Et2O), 
petroleum ether referring to a fraction of bp 60-80 °C, acetonitrile (CH3CN) were dried and distilled prior to use. 
Acetone has been degassed and stored under inert atmosphere on molecular sieves. Other solvents such as 
ethylacetate (EtOAc), chloroform, ethanol (EtOH), methanol (MeOH), heptane, toluene, CDCl3, D2O, CD3CN 
(Sigma Aldrich) have been employed without further purification. Reagents: triruthenium-dodecacarbonil 
(Ru3(CO)12) (Strem), methyl iodide, methyl bromide, bromidric and chloridric acid, silver oxide, 1-
methylimidazole, 1,3 diphenylacetone, benzyl bromide, benzyl chloride, paraformaldehyde, tert-butylamine, 
2,6-dimethylaniline, 2,6-diisopropylaniline, glyoxal, acetic acid, 2,4,6-trimethylaniline, (Sigma Aldrich), 
4,4’dimethoxybenzil (Alfa Aesar) have been employed as purchased. 
1,3-dimethylimidazolium iodide (1a[I]),17 1,3-dimethylimidazolium trifluoromethanesulfonate (1a[OTf]), 1,3-
dimethylimidazolium hexafluorophosphate (1a[PF6]), 1,3-dibenzylimidazolium bromide (1b[Br]), 1,3-
dibenzylimidazolium chloride (1b[Cl]),18 1-methyl-3-butyl-imidazolium chloride (1c), 1-methyl-3-(2-
hydroxyethyl)imidazolium chloride (1d),19 N,N′-bis(2,6-diisopropylphenyl)-1,4-diaza-1,3-butadiene, 1,3-
bis(2,6-diisopropylphenyl)imidazolium chloride (1f[Cl]), 1,3-bis(2,6-diisopropylphenyl)imidazolium bromide 
(1f[Br]),20 1,3-di-tert-butylimidazolium chloride (1g),21 1-butyl-3-(2-pyridinyl)-imidazolium bromide (1m)22,3,4-
Bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone,23 dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone) ruthenium dimer (3),24 have been prepared as previously reported. 
The prepared derivatives were characterized by spectroscopic methods. The NMR spectra were recorded 
using Varian Inova 300 (1H, 300.1; 13C, 75.5 MHz), Varian Mercury Plus VX 400 (1H, 399.9; 13C, 100.6 MHz), 
Varian Inova 600 (1H, 599.7; 13C, 150.8 MHz) spectrometers at 298 K; chemical shifts were referenced 
internally to residual solvent peaks. Full 1H- and 13C-NMR assignments were done, when necessary, by 
gHSQC and gHMBC NMR experiments using standard Varian pulse sequences. Infrared spectra were 
recorded at 298 K on a Perkin-Elmer Spectrum 2000 FT-IR spectrophotometer. ESI-MS spectra were recorded 
on Waters Micromass ZQ 4000 with samples dissolved in MeOH or CH3CN. Elemental analyses were 
performed on a Thermo-Quest Flash 1112 Series EA instrument. 
Synthesis of [dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)halogenide][1R1-3R2 imidazolium] ruthenium complexes (21) 
 
Figure 6.7. Structure of the ionic pair 21a-m. 
Imidazolium salts (1), were reacted with dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone) ruthenium dimer (3) (0.5 eq. vs. imidazolium salts). The reaction mixture was stirred until the end of 
the reaction at room temperature. Upon removal of the solvent the quantitative formation of the [dicarbonyl-η4-
3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)halogenide][1R1-3R2 imidazolium] ruthenium 
complexes (21) were verified by 1H-NMR, 13C-NMR, ESI-MS and X-Ray crystal structure when suitable crystals 
were available. 
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[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(iodine)ruthenium][1,3-
dimethylimidazolium] (21a[I]): 1,3-dimethylimidazolium iodide (1a) 0.011 g (0.0499 mmol), 3 0.030 g (0.0249 
mmol), CH2Cl2, room temperature, 1h. The beige solid obtained was identified as 21a[I].  Complex 21a[I] is 
stable to air, moisture, in solution of organic solvents and in the presence of water. Suitable crystals for X-Ray 
diffraction has been obtained by toluene/hexane double layer. 21a[I] has been analyzed by IR, 1H-NMR, 13C-
NMR, ESI-MS and X-Ray diffraction. 1H-NMR (599.7 MHz, CDCl3): δ 9.91 (s, NCHN), 7.58-6.55 (m, 18H, 
CHaryl), 7.07 (s, 2H, CHim), 3.75 (s, 6H, NCH3), 3.70 (s, 6H, -OCH3). 13C-NMR (150.8 MHz, CDCl3, g-HSQC, g-
HMBC, DEPT): δ 201.00 (CO), 172.12 (C=O, Cp), 158.40 (-COCH3), 138.96 (NCHN), 135.21-112.66 (Caryl), 
122.55 (CHim), 100.09 (C2,5, Cp), 81.40 (C3,4, Cp), 55.01 (-OCH3), 36.55 (NCH3). IR (CH2Cl2, cm-1): 2004, 1944 
(νCO); 1580 (νC=O), 1604, 1518 (νC=C). ESI-MS (m/z) (+): 97 [M]+; (-): 729 [M]-. Anal. Calcd (%) for 
C38H33IN2O5Ru: C, 55.28; H, 4.03; N, 3.39. Found: C, 55.26; H, 4.00; N, 3.41. 
[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)(trifluoromethanesulfonate)ruthenium][1,3-dimethylimidazolium] (21a[OTf]): 1,3-
dimethylimidazolium trifluoromethanesulfonate (1a[OTf]) 0.012 g (0.0499 mmol), 2 0.030 g (0.0249 mmol), 
CH2Cl2, room temperature, 2h. The beige solid obtained was identified as 21a[OTf]. Complex 21a[OTf] is 
stable to air, moisture, in solution of organic solvents and in the presence of water. 21a[OTf] has been analyzed 
by IR, 1H-NMR, 13C-NMR, 19F-NMR, ESI-MS. 1H-NMR (599.7 MHz, CDCl3): δ 9.71 (s, NCHN), 7.85-6.55 (m, 
18H, CHaryl), 7.19 (s, 2H, CHim), 3.80 (s, 6H, NCH3), 3.70 (s, 6H, -OCH3). 13C-NMR (150.8 MHz, CDCl3): δ 
201.09 (CO), 172.13 (C=O, Cp), 158.38 (-COCH3), 138.24 (NCHN), 135.20-112.64 (Caryl), 122.85 (CHim), 
100.24 (C2,5, Cp), 81.34 (C3,4, Cp), 54.99 (-OCH3), 36.62 (NCH3). 19F-NMR (282.4 MHz, CDCl3): δ -78.61 (s, 
3F). IR (CH2Cl2, cm-1): 2004, 1944 (νCO); 1579 (νC=O), 1604, 1518 (νC=C). ESI-MS (m/z) (+): 97 [M]+; (-): 751 [M]-
. Anal. Calcd (%) for C39H33F3N2O8RuS: C, 55.25; H, 3.92; N, 3.30. Found: C, 55.21; H, 3.89; N, 3.31. 
[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)(bromine)ruthenium][1,3-dibenzylimidazolium] (21b): 1,3-dibenzylimidazolium bromide (1b) 
0.011 g (0.0332 mmol), 3 0.020 g (0.0166 mmol), CH2Cl2, room temperature, 30 min. The beige solid obtained 
was identified as 21b. Complex 21b is stable to air, moisture, in solution of organic solvents and in the presence 
of water. 21b has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (599.7 MHz, CDCl3): δ 10.66 (s, 
NCHN), 7.66-6.54 (m, 20H, CHaryl, CHim), 5.08 (s, 4H, CH2Ph), 3.70 (s, 6H, -OCH3). 13C-NMR (150.8 MHz, 
CDCl3): δ 200.85 (CO), 171.34 (C=O, Cp), 158.42 (-COCH3), 138.96 (NCHN), 136.13-112.67 (Caryl, CHim), 
99.47 (C2,5, Cp), 81.98 (C3,4, Cp), 55.01 (-OCH3), 53.26 (CH2Ph). IR (CH2Cl2, cm-1): 2006, 1945 (νCO); 1580 
(νC=O), 1605, 1517 (νC=C). ESI-MS (m/z) (+): 249 [M]+; (-): 683 [M]-. Anal. Calcd (%) for C50H41BrN2O5Ru: C, 
64.52; H, 4.44; N, 3.00. Found: C, 64.55; H, 4.42; N, 2.99. 
[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(bromine)ruthenium][1-
methyl-3-butyl-imidazolium] (21c): 1-methyl-3-butylimidazolium bromide (1c) 0.005 g (0.0332 mmol), 3 
0.020 g (0.0166 mmol), CH2Cl2, room temperature, 30 min. The beige solid obtained was identified as 21c. 
Complex 21c is stable to air, moisture, in solution of organic solvents and in the presence of water. 21c has 
been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (599.7 MHz, CDCl3): δ 8.46 (s, NCHN), 7.55-6.59 
(CHaryl, CHim), 4.10 (t, 2H, NCH2), 3.78 (s, 3H, -NCH3), 3.67 (s, 6H, -OCH3), 1.77, 1.32 (m, 2H, -CH2CH2-), 0.93 
(t, 3H, -CH3). 13C-NMR (150.8 MHz, CDCl3): δ 200.97 (CO), 171.55 (C=O, Cp), 158.38 (-COCH3), 135.21 
(NCHN), 133.19-112.64 (Caryl, CHim), 99.64 (C2,5, Cp), 81.66 (C3,4, Cp), 55.00 (-OCH3), 48.88 (-NCH2), 36.02 
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(-NCH3), 31.90, 19.42 (-CH2CH2-), 13.45 (-CH3). IR (CH2Cl2, cm-1): 2005, 1944 (νCO); 1581 (νC=O), 1605, 1517 
(νC=C). ESI-MS (m/z) (+): 139 [M]+; (-): 683 [M]-. Anal. Calcd (%) for C41H39BrN2O5Ru: C, 59.91; H, 4.77; N, 
3.40. Found: C, 59.94; H, 4.80; N, 3.40. 
[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(chloro)ruthenium][3-(2-
hydroxyethyl)-1-methyl-imidazolium] (21d): 3-(2-hydroxyethyl)-1-methyl-imidazolium (1d) 0,03 g (0,17 
mmol), 3 0,10 g (0,08 mmol), CH2Cl2, room temperature, 1h. The beige solid obtained was identified as 21d.  
Complex 21d is stable to air, moisture, in solution of organic solvents and in the presence of water. 21d has 
been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (599.7 MHz, CDCl3): δ 9.40 (s, NCHN), 7.57-6.54 
(Caryl), 6.97 (s, 2H, CHIm), 6.82 (s, 2H, CHIm), 4.06 (br, H, OH), 3.99 (m, 2H,-NCH2-), 3.69 (s, 6H, -OCH3), 3.47 
(m, 2H, -CH2OH), 3.44 (s, 3H, -NCH3). 13C-NMR (150.8 MHz, CDCl3): δ 200.97 (CO), 169.79 (C=O, Cp), 
158.44 (-COCH3), 138.48 (-NCHN-), 134.52-112.65 (Caryl), 125.97 (CHIm), 121.96 (CHIm), 99.64 (C2,5, Cp), 
82.47 (C3,4, Cp), 59.69 (-CH2-), 54.93 (-OCH3), 51.50 (-CH2-), 35.70 (NCH3). IR (CH2Cl2, cm-1): 2009, 1948 
(νCO), 1566 cm-1 (νC=O), 1605, 1518 (νC=C). ESI-MS (m/z) (+): 127 [M]+; (-): 638 [M]-. Anal. Calcd (%) for Anal. 
Calcd (%) for C39H35ClN2O6Ru: C, 61.23; H, 4.60; N, 3.66. Found: C, 61.24; H, 4.58; N, 3.67. 
[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(chloro)ruthenium][1,3-
bis(2,6-diisopropylphenyl)imidazolium] (21f): 1,3-bis(2,6-diisopropylphenyl)imidazolium chloride (1f) 0.013 
g (0.0332 mmol), 3 0.020 g (0.0166 mmol), CH2Cl2, room temperature, 1h. The beige solid obtained was 
identified as 21f. Complex 21f is stable to air, moisture, in solution of organic solvents and in the presence of 
water. 21f has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (599.7 MHz, CDCl3): δ 8.54 (s, 
NCHN), 7.98 (s, 2H, CHIm), 7.57-6.51 (CHaryl), 3.67 (s, 6H, -OCH3), 2.41 (sept., J = 6.8 Hz, 4H, CHiPr), 1.28 (d, 
J = 6.8 Hz, 12H, CH3iPr), 1.14 (d, J = 6.8 Hz, 12H, CH3iPr). 13C-NMR (150.8 MHz, CDCl3): δ 201.76 (CO), 170.80 
(C=O, Cp), 158.15 (-COCH3), 135.13 (NCHN), 145.15-112.49 (Caryl), 128.30 (CHim), 100.01 (C2,5, Cp), 88.56 
(C3,4, Cp), 54.94 (-OCH3), 28.84 (CHiPr), 24.72 (CH3iPr), 23.77 (CH3iPr). IR (CH2Cl2, cm-1): 2000, 1937 (νCO); 
1591 (νC=O), 1607, 1517 (νC=C). ESI-MS (m/z) (+): 389 [ImIPr]+; 602 {[Ru(CO)2CpO] + Na+}. Anal. Calcd (%) for 
C60H61ClN2O5Ru: C, 70.19; H, 5.99; N, 2.75. Found: C, 70.21; H, 6.01; N, 2.77. 
[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(chloro)ruthenium][1,3-
bis(2,6-diisopropylphenyl)imidazolium] (21g): 1,3-di-tert-butylimidazolium chloride (1g) 0.010 g (0.0499 
mmol), 3 0.030 g (0.0249 mmol), CH2Cl2, room temperature, 1h. The beige solid obtained was identified as 
21g. Complex 21g is stable to air, moisture, in solution of organic solvents and in the presence of water. 
Suitable crystals for X-Ray diffraction has been obtained by CDCl3/petroleum ether double layer. 21g has been 
analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (599.7 MHz, CDCl3): δ 9.81 (s, 
NCHN), 7.62-6.52 (Caryl), 7.36 (s, 2H, CHIm), 3.68 (s, 6H, -OCH3), 1.59 (s, 18H, CH3tBu). 13C-NMR (150.8 MHz, 
CDCl3): δ 201.76 (CO), 171.10 (C=O, Cp), 158.16 (-COCH3), 134.16 (NCHN), 135.32-112.45 (Caryl), 119.50 
(CHim), 100.20 (C2,5, Cp), 82.47 (C3,4, Cp), 60.50 (CqtBu), 54.91 (-OCH3), 30.01 (CH3tBu). IR (CH2Cl2, cm-1): 
2001, 1938 (νCO); 1578 (νC=O), 1607, 1518 (νC=C). ESI-MS (m/z) (+): 180 [M]+; (-): 638 [M]-. Anal. Calcd (%) for 
C44H45ClN2O5Ru: C, 70.19; H, 5.99; N, 3.42. Found: C, 70.21; H, 6.01; N, 3.44. 
[dicarbonyl(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(chloro)ruthenium][1-
(butyl-3-(2-pyridinyl)-imidazolium] (21m): 1-(butyl-3-(2-pyridinyl)-imidazolium (1m) 0,034 g (0,17 mmol), 3 
0,10 g (0,08 mmol), CH2Cl2, room temperature, 1h. The beige solid obtained was identified as 21m.  Complex 
21m is stable to air, moisture, in solution of organic solvents and in the presence of water. 21m has been 
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analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (599.7 MHz, CDCl3): δ 10.85 (s, NCHN), 8.36 (dd, 1H, 
CHpy), 8.19 (1H, CHpy), 8.01 (1H, CHpy), 7.60-6.55 (CHaryl, CHim), 3.77 (t, 2H, NCH2), 3.70 (s, 6H, -OCH3), 1.60, 
1.14 (m, 2H, -CH2CH2-), 0.86 (t, 3H, -CH3). 13C-NMR (150.8 MHz, CDCl3): δ 200.93 (CO), 171.01 (C=O, Cp), 
158.39 (-COCH3), 147.95-112.63 (Caryl,py), 137.76 (-NCHN-), 124.54 (CHim), 120.07 (CHim), 99.92 (C2,5, Cp), 
82.36 (C3,4, Cp), 55.00 (–OCH3), 49.54 (NCH2), 31.48, 19.36 (–CH2CH2), 13.56 (–CH3). IR (CH2Cl2, cm-1): 
2006, 1945 (νCO), 1577 cm-1 (νC=O), 1602, 1518 (νC=C). ESI-MS (m/z) (+): 202 [M]+; (-):683 [M]-. Anal. Calcd (%) 
for Anal. Calcd (%) for C45H40BrN3O5Ru: C, 50.85; H, 4.52; N, 4.75. Found: C, 50.92; H, 4.56; N, 4.73. 
General method for hydrogenation 
Ruthenium ionic complex (15 μmol, 5% mol) was dissolved in a mixture of ionic liquid (Bmim[PF6] or 
Bmim[BF4], 2 mL) and iPrOH (2 mL) in a10mL two neck-flask and stirred at 100°C for 10 min. Then 4-
fluoroacetophenone (36 μL, 300 μmol) was added and samples were taken at regular intervals. Aliquots (ca. 
0.05mL) were diluted with CDCl3 (0.5 mL) and conversions were determined by 19F-NMR spectroscopy and 
GC analysis. 
General method for dehydrogenation 
Ruthenium ionic complex (5%mol, 9.5 µmol) was dissolved in 2mL of the ionic liquid Bmim[PF6]. Once reached 
the reaction temperature (110°C) 19.7 µL of benzyl alcohol (190 µmol) were added. Samples were taken at 
regular intervals and conversions were determined by GC. 
X-Ray diffraction studies 
Crystal data and collection details for 21a[I] and 21f·0.5CH2Cl2 are reported in Table 6.4. The diffraction 
experiments were carried out on a Bruker APEX II diffractometer equipped with a CCD detector using Mo–K 
radiation. Data were corrected for Lorentz polarization and absorption effects (empirical absorption correction 
SADABS).25 Structures were solved by direct methods and refined by full-matrix least-squares based on all 
data using F2.26 All hydrogen atoms were fixed at calculated positions and refined by a riding model. All non-
hydrogen atoms were refined with anisotropic displacement parameters. 
21a[I]: The asymmetric unit of the unit cell contains one anion and one cation (located on general positions). 
Similar U restraints (SIMU command in SHELXL; s.u. 0.01) have been applied to the C atoms. 
21f·0.5CH2Cl2: The asymmetric unit of the unit cell contains one anion and one cation (located on general 
positions), as well as half of a CH2Cl2 molecule disordered over four positions two by two related by a 2-fold 
axis. The CH2Cl2 molecule has been refined isotropically. One Ph and one p-MeO-C6H4 group in the anion and 
one tBu substituent in the cation are disordered. Disordered groups have been split into two positions and 
refined using one occupancy factor per disordered group. Similar U restraints (SIMU command in SHELXL; 
s.u. 0.005) have been applied to C and O atoms. Some of the C and O atoms of the disordered groups have 
been restrained to isotropic behaviour (ISOR command in SHELXL, s.u. 0.005). The disordered aromatic rings 
have been constrained to fit regular hexagons (AFIX 66 command in SHELXL). Restraints to bond distances 
were applied as follow (s.u. 0.01): 1.75 Å for C–Cl in CH2Cl2. 
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Table 6.4 Crystal data and experimental details for 21a[I] and 21f·0.5CH2Cl2. 
 21a[I] 21f·0.5CH2Cl2 
Formula C38H33IN2O5Ru C44.5H46Cl2N2O5Ru 
Fw 825.63 860.80 
T, K 298(2) 293(2) 
, Å 0.71073 0.71073 
Crystal system Triclinic Monoclinic 
Space group P1̅ C2/c 
a, Å 10.0781(13) 40.674(11) 
b, Å 10.2434(13) 10.346(3) 
c, Å 17.587(2) 24.634(7) 
,  79.250(2) 90 
,  86.754(2) 122.090(3) 
,  74.504(2) 90 
Cell Volume, Å3 1718.8(4) 8782(4) 
Z 2 8 
Dc, g cm-3 1.595 1.302 
, mm-1 1.400 0.523 
F(000) 824 3560 
Crystal size, mm 0.160.130.11 0.180.160.14 
 limits,  2.10–25.02 1.66–26.00 
Reflections collected 16644 43695 
Independent reflections 6053 [Rint= 0.0954] 8633 [Rint= 0.1049] 
Data / restraints 
/parameters 
6053 / 210 / 424 8633/ 707 / 633 
Goodness on fit on F2 0.939 1.017 
R1 (I> 2(I)) 0.0519 0.0763 
wR2 (all data) 0.0943 0.2420 
Largest diff. peak and 
hole, e Å-3 
0.463 / –0.419 
1.266 / –0.641 
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CHAPTER VII 
Straightforward synthesis of iron cyclopentadienone N-heterocyclic carbene 
complexes 
Abstract 
Novel iron complexes bearing both cyclopentadienone and N-heterocyclic carbene ancillary ligands have been 
obtained by a straightforward synthesis from Fe2(CO)9. The preparation represents a rare example of silver 
transmetallation involving iron. The reaction is general and occurs in the presence of variously functionalized 
NHC and cyclopentadienones. 
Introduction 
Iron is the most abundant transition metal in Earth’s crust; it is cost effective and environmentally benign. 
Furthermore, its low toxicity is vouched for its involvement in several biological processes that make iron as 
one of the most important elements in nature.1 For a long time noble metals such as Pd, Rh, Ir, Ru have 
dominated the field of homogeneous catalysis and only in the last decade the use of iron complexes in catalysis 
has witnessed a strong acceleration.2 In particular iron cyclopentadienone complexes have recently received 
a special attention due to their easy preparation from simple and cheap materials, air–water stability and, most 
important, their unique catalytic features arising from the presence of a non-innocent ligand able to trigger 
powerful redox properties.3 Furthermore, in addition to the economic benefits, developing iron-based 
complexes produces an opportunity to access complementary chemoselectivities and discover new reactivity 
patterns. 
One important aspect in coordination chemistry is the control and fine-tuning of electronic and steric properties 
of the ligand sphere. Good candidates for this goal are N-heterocyclic carbenes (NHC), widespread used 
ligands for coordination and catalysis (for more details see Chapter I, paragraph 1.1).4 NHC ligands are easily 
prepared and, due to the robust bond formed with most metal centers, are highly resistant toward 
decomposition. A series of reports in the last few years have shown that iron-NHC complexes have 
considerable potential for unique and wide-ranging applications including: novel coordination chemistry, 
homogeneous catalysis, and bio-mimetic chemistry.5 Developments in homogeneous catalysis involving iron-
NHC complexes are represented by cross-coupling Kochi reactions, C-C bond formation reactions, 
hydrosilylation,6 allylic alkylation, C−X bond formation (X = B, N, Mg, S), reduction reactions, transfer 
hydrogenation7 and cyclization reactions.1 
In the previous chapters it has been evidenced that ruthenium carbonyls containing both NHC and 
cyclopentadienone ligands take advantage of the properties of both ligands affording novel metal-
cyclopentadienone bifunctional catalysts in which steric and electronic properties, solubility and the 
introduction of substituents suitable for heterogenization can be finely tuned through the NHC ancillary ligand. 
Furthermore, by choosing a proper substituent such as a pyridine (e.g. complex 12m[CF3SO3]), the NHC 
ligand itself could cooperate with the metal as non-innocent species. 
The access to the new class of Ru(0) carbene complexes of type 4 (see Chapter II) has been provided by the 
cleavage of the dimeric Ru(0) cyclopentadienone dicarbonyl precursor (3) in the presence of the silver carbene 
intermediate 2 as shown in Scheme 7.1.8 
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Scheme 7.1. Synthesis of dicarbonyl-cyclopentadienone-N-heterocyclic carbene ruthenium complexes (4). 
The reaction, clean and quantitative, can be also performed in one pot by generating the silver-NHC complex 
in situ. The same procedure has been successively extended to triazolylidene ligands (see Chapter III); the 
both imidazolylidene (4) and triazolylidene (11) complexes showed to be active in transfer hydrogenation and 
alcohol oxidation in the presence of additives such as cerium ammonium nitrate (see Chapter IV).9 
In order to expand the scope of this reaction to iron, a cyclopentadienone triscarbonyl iron complex has been 
chosen as precursor. This chapter concerns a novel synthesis of cyclopentadienone NHC iron complexes 
suitable for catalytic reactions such as those investigated for the ruthenium analogues. To the best of our 
knowledge this is the first report in which iron complexes containing both a cyclopentadienone and a NHC 
ligand are reported. 
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Results and Discussion 
7.1 Synthesis of Iron carbene complexes 
Inspired by our previous work on ruthenium (paragraph 2.5), we tried to take advantage of microwave 
irradiation10 for the synthesis of the triscarbonyl cyclopentadienone precursor (22) with significant reduction 
of the reaction time. Indeed, after screening different temperatures and times, best reaction conditions have 
been found at 140°C, with a reaction time of 70 minutes. Under these conditions a yield of 50% has been 
reached which is identical to that obtained with the classical protocol (heating under reflux for 18 h).11 
Scheme 7.2. Microwave assisted synthesis of triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron (22). 
Crystals of 22, suitable for X-ray diffraction, have been obtained with the double layer technique 
(dichloromethane/hexane). The structure of 22 is described in the Experimental Section. 
After having optimized the preparation of 22, one of the terminal carbonyls has been replaced upon reaction 
with Me3NO in acetonitrile, with the more labile acetonitrile ligand, leading to the formation of biscarbonyl-
acetonitrile(η4-3,4- bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)iron (23). Complex 23 has been 
treated with silver-NHC complexes (2), obtained in situ by reaction of imidazolium salts 1 and Ag2O.8 The latter 
reaction, performed in refluxing toluene, leads to the formation of the desired NHC complexes 24a-d,n,q 
generally in good or excellent yields (50-80%, Scheme 3). The low yield (18%) observed for 24d can be 
probably ascribed to the presence of an –OH group in the NHC side chain which might interact with the C=O 
group of cyclopentadienone and/or with the metal center, with detrimental influence on transmetallation. 
Indeed, indication of an intramolecular hydrogen bond between the cyclopentadienone and –OH group in 
complex 24d can be inferred from IR and 13C NMR spectra. In the IR spectra the low-energy shift of the 
carbonyl band of 24d [ν(CO) = 1576 cm-1] compared with those of 24a-c,n,q [ν(CO) = 1584-1587 cm-1] 
suggests a ƞ4 to an ƞ5 coordination change of cyclopentadienone. Furthermore the 13C-NMR shift of the C=O 
signal (24a-c,n,q: 166-167 ppm vs. 24d: 163 ppm) and the broadness of CH2 signals in 1H-NMR are in 
agreement with H-bond formation. 
The same behaviour was observed for a similar ruthenium complex (4d, Chapter II) for which the H-bond 
formation was also confirmed by X-Ray diffraction.8 To further confirm the influence of –OH group on 
transmetallation to iron complexes, the corresponding silver complex of the –OMe functionalized imidazolium 
salt 1q has been reacted with 23 affording 24q in 55% yield. 
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Scheme 7.3. Synthesis of dicarbonyl-cyclopentadienone-N-heterocyclic carbene iron complexes (24a-d,n,q) and 
28a,b,d,n). 
The reaction is general with non-bulky NHCs and tolerant of functional groups: in fact it occurs in the presence 
of a primary alcohol and amide in the lateral chain (1d,n to 24d,n). The synthesis of 24a-d,n,q has been 
followed by IR spectroscopy observing in all cases a lowering in the CO stretching frequencies (e.g. 24a: ν(CO) 
= 1988, 1930 cm-1 vs. 22: 2008, 1954 cm-1) due to the strong NHC  donor properties. 13C-NMRs show a 
diagnostic signal for the Fe-Ccarbene within the range 182-185 ppm (e.g. 13C-NMR spectrum of 24c in Figure 
7.1) and molecular ions of complexes 24a-d,n,q are detectable by ESI-MS. Complexes 24a-d,n,q are air- and 
moisture-stable both in solid state and in solution and are soluble in the most common organic solvents. 
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Figure 7.1 13C-NMR spectrum of 24c in C7D8. 
The neutral iron complex 24a treated with a strong acid such as HCF3SO3 (Scheme 7.4) displayed the same 
behaviour of the analogue ruthenium complex (4a) leading to the quantitative formation of the 
hydroxycyclopentadienyl cationic complexes 25a[CF3SO3]. 
IR spectroscopy revealed a significant high-energy shift of the CO stretching frequencies upon protonation 
[e.g. ν(CO) = 1988 cm-1, 1930 cm-1 (24a), and 2023 cm-1, 1977 cm–1 (25a[CF3SO3])], as observed for the 
related ruthenium cationic complex 12a[CF3SO3] (see Chapter IV). 
The change in the coordination from η4 (cyclopentadienone ligand) to η5 (hydroxycyclopentadienyl ligand) is 
further evidenced by 13C-NMR shift of the resonance due to the endocyclic carbon involved in the ketone-
alcohol transformation [δ 166.57 ppm (C=O, Cp, in 24a) vs δ 136.12 ppm (C-OH, Cp, in 25a[CF3SO3])]. Fe-
carbene signals are also shifted to higher fields; from δ 182.41 ppm (24a) to δ 169.62 ppm (25a[CF3SO3]). 
 
Scheme 7.4 Synthesis of hydroxycyclopentadienyl imidazolylidene iron complex 25a[CF3SO3]. 
In order to further extent the ligand scope, the Knölker’s cyclopentadienone triscarbonyl complex,12 has been 
obtained, exploiting microwave irradiation (see Experimental section, Scheme 7.5). As previously observed for 
22, the synthesis is by far faster than that reported in the literature affording 26 in good yield (83%) (Scheme 
7.3). By treating 26 with Me3NO in CH3CN, the intermediate 27 has been obtained and employed as precursor 
for the synthesis of NHC complexes by transmetallation with silver-NHC complexes prepared in situ (Scheme 
7.3). Complexes 28a,b,d, have been characterized by spectroscopy and mass spectra (see Experimental 
section). The protonation reaction of 28a with triflic acid leads to the quantitative formation of the 
hydroxycyclopentadienyl cationic complex 29a[CF3SO3]. 
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Noteworthy –OH functionalized complex 28d (y = 13 %) resembles the behavior of the congener 24d further 
confirming an influence of the hydroxyl group on the reactivity of these complexes.  
Complexes 24a, 24b, 24c and 28a have been also characterized by X-Ray diffraction studies. The molecular 
structure of 24a is reported in Figure 7.2, whereas those of 24b and 24c are given in the Experimental section 
(Figures 7.11 and 7.12). Their structures are similar to those previously reported for analogous Ru-complexes 
(see Chapter II).8 In particular, the Fe(1)-C(3) distance [2.348(3) Å in 24a] is significantly longer than Fe(1)-
C(4-7) [2.053(3)- 2.162(3) Å, average 2.118(6) Å in 24a] and C(3)-O(3) [1.246(4) Å in 24a] is essentially a 
double bond,13 in agreement with C=O bond, absorptions around 1585 cm-1 were found in the IR spectra of 
complexes 24. The Fe(1)-C(34) contact [1.980(3) Å in 24a] is in the typical range for the interaction between 
Fe(0) and a N-heterocyclic carbene.7a 
 
Figure 7.2. ORTEP drawing of 24a. Displacement ellipsoids are at the 30% probability level. H-atoms have been omitted 
for clarity. Selected bond lengths (Å): Fe(1)-C(1) 1.754(3), Fe(1)-C(2) 1.765(3), Fe(1)-C(3) 2.348(3), Fe(1)-C(4) 2.162(3), 
Fe(1)-C(5) 2.053(3), Fe(1)-C(6) 2.099(3), Fe(1)-C(7) 2.156(3), Fe(1)-C(34) 1.980(3), C(3)-O(3) 1.246(4). 
The structure of 28a is similar to 24a apart from the different substituents on the cyclopentadienone ring (Figure 
7.3). 
 
Figure 7.3. ORTEP drawing of 28a. Displacement ellipsoids are at the 30% probability level. H-atoms have been omitted 
for clarity. Selected bond lengths (Å): Fe(1)-C(1) 1.747(3), Fe(1)-C(2) 1.754(3), Fe(1)-C(3) 2.359(2), Fe(1)-C(4) 2.153(3), 
Fe(1)-C(5) 2.091(3), Fe(1)-C(6) 2.067(2), Fe(1)-C(7) 2.177(2), Fe(1)-C(34) 1.996(3), C(3)-O(3) 1.250(3). 
The reaction reported in Scheme 7.3 is one of the rare examples of transmetallation from silver complexes to 
first row transition metals, such as iron1,14 and the first example in which transmetallation is employed in the 
synthesis of piano stool complexes. Such complexes were initially obtained upon reaction of diamines with 
mononuclear [FeCp(SnPh3)(CO)(CS)] or dinuclear [Fe2Cp2(CO)2(µ-CO)(µ-C(SMe2)(CN))]+ thiocarbonyl 
complexes.15 Later on, the procedure consisting in the deprotonation of the imidazolium salts followed by 
reaction of the resulting carbene with an iron halide precursor (e.g. [FeCp(CO)2I]) was introduced.16 Finally, an 
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elegant synthetic approach, was described by Royo et al.17 based on the formation of bidentate 
cyclopentadienyl functionalized iron(II)-NHC by direct reaction of the imidazolium proligands with Fe3(CO)12. 
The disadvantage of the deprotonation method is that the generation of a free, often unstable, carbene 
intermediate requires special bases, rigorous air and moisture-free conditions and yields are generally scarcely 
reproducible. On the other hand, transmetallation with silver complexes does not require any particular reaction 
conditions and can be applied to a broad range of imidazolium salts bearing various N-substituents. 
In our case transmetallation might be favored by the presence of the non-innocent cyclopentadienone ligand,18 
which can interact with silver8 and labilize the silver-carbene bond. The oxidation state of iron might also have 
an influence on the reactivity, as suggested by the related complex [FeCp(CO)2(CH3CN)]BF4, obtained 
reacting [FeCp(CO)2]2 with AgBF4, that does not undergo transmetallation with silver-NHC complexes. 
Furthermore, a possible role of the NHCs donor properties, in addition to steric effects, should not be excluded 
(complex 23 is unreactive towards hindered silver-NHC such as 1,3-bis(2,6-diisopropylphenyl)imidazol-2-
ylidene silver chloride). Indeed, NHCs with bulky substituents generally display better donor properties, as 
evaluated by TEP values (Tolman Electronic Parameters). A combination of these steric and electronic effects 
might increase both stability and inertness of the silver complexes intermediates and consequently disfavor 
carbene transmetallation.19 
7.2 Catalytic transfer hydrogenation 
The Iron carbene complexes 24a and 25a[CF3SO3] were evaluated as catalyst precursors under transfer 
hydrogenation conditions i.e. refluxing iPrOH as hydrogen source employing 4-fluoroacetophenone as model 
substrate. Catalytic runs were performed in order to compare the catalytic activity of the iron carbene 
complexes 24a and 25a[CF3SO3] with the precursor biscarbonyl-acetonitrile(η4-3,4- bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone)iron (23), containing more labile acetonitrile ligand, and with the analogues 
ruthenium complexes 4a and 12[CF3SO3] previously tested in the same catalytic reaction (more details in 
Chapter IV, paragraph 4.2). The role of additives such as CAN (cerium ammonium nitrate) and Me3NO in the 
activation of 24a has been also investigated.  
Table 7.1. Catalytic transfer hydrogenation of 4-fluoroacetophenone.a 
 
entry [Fe] additive conversion 24h (%)  
1 24a --- 0 
2 24a CANb 0 
3 24a Me3NOc 0 
4 25a[CF3SO3] --- 0 
5 23 --- 96 
6 23d --- 58 
7 4a-[Ru] CAN 61 
8 12a[CF3SO3]-[Ru] --- 93 
aGeneral conditions: Iron complex (5 mol% Fe), iPrOH (3 mL), reflux; conversions determined by 19F NMR spectroscopy; 
bCAN 1 mol equiv. per iron center; cMe3NO 1.5 mol equiv. per iron center,  dcatalyst loading reduced to 2 mol% Fe. 
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The catalytic results shown in Table 7.1 reveal that the iron carbene complexes 24 and 25a[CF3SO3] are not 
active in the transfer hydrogenation of 4-fluoroacetophenone. In fact, no conversion of the substrate has been 
observed for the both, neutral (24a) and cationic complexes (25a[CF3SO3]) (entries 3,4), even by adding 
promoters such as CAN or Me3NO (entries 2,3). In particular, the use of CAN as additive lead to a complete 
oxidation and subsequently decomposition of the catalyst, while with Me3NO or in absence of additive the initial 
complex 24a or 25a[CF3SO3] has been recovered unaltered at the end of the reaction. The catalytic tests 
performed with biscarbonyl-acetonitrile(η4-3,4- bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)iron 
(23) as pre-catalyst lead to an almost complete conversion of the substrate in 24h. This is reasonably due to 
the presence of the labile ligand acetonitrile as the equivalent of a vacant coordination site. Conversely, in the 
carbonylic-NHC transition metal-carbene complexes, coordinative insaturation is obtained by CO removal 
(Chapter IV paragraph 4.3). Whereas CO release in ruthenium complexes can be reached through the 
oxidation of the metal center (upon protonation or treatment with CAN), this doesn’t occur for the congener 
iron complexes. The iron complexes of type 24 and 25[X] need a different way to be activated; therefore, a 
screening of several reaction conditions and parameters (temperature, solvent, additives), as well as higher 
catalytic loadings, are still under investigation. 
7.3 Catalytic alcohol oxidation 
Iron carbene complexes have been also tested as catalyst precursor under oxidative conditions in the 
dehydrogenation of benzyl alcohol to benzaldehyde. In particular, it has been investigated the catalytic activity 
of the bis-trimethylsilyl-cyclopentadienone substituted iron carbene complexes 28a and 29a[CF3SO3],which are 
more stable in solution compared to the analogues complexes with tetraaryl-cyclopentadienone substituent 
(type 24 and 25).  
A screening of different solvents and additives have been performed; the results are reported in Table 7.2. 
Table 7.2. Catalytic oxidation of benzyl alcohol. a 
entry [Fe] solvent additive conversion 24h (%) 
1 28a toluene --- 0 
2 28a toluene BQb 0 
3 28a 1,4-dioxane Me3NOc 4 
4 28a 1,4-dioxane Me3NOd 10 
5 28a 1,4-dioxane Me3NOe 15 
6 29a[CF3SO3] toluene --- 11 
7 29a[CF3SO3] toluene BQb 11 
8 29a[CF3SO3] 1,4-dioxane Me3NOc 11 
9 29a[CF3SO3] acetone --- 0 
10 26 toluene BQb 3 
aGeneral conditions: Iron complex (5 mol% Fe), solvent (3 mL), reflux; conversions determined by GC; bBQ 10 mol equiv. 
per iron center; cMe3NO 7 mol equiv. per iron center,  dMe3NO 25 mol equiv. per iron center; ecatalyst loading increased 
to 10 mol% Fe. 
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The neutral iron complex 24a did not present any catalytic activity in refluxing toluene, even in the presence 
of benzoquinone. This additive, with the analogues ruthenium complexes, is able to regenerate the catalyst in 
situ, (see Chapter V, paragraph 5.4), whereas, in the case of iron complexes, leads to their decomposition.. 
Moreover, catalytic tests performed with the well-known catalyst triscarbonyl-(2,4-
bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron (26) (entry 10) in the presence of BQ, show that the 
complex is not able to convert the substrate but, as reported in the literature,3 it needs an additive such 
as Me3NO in order to exhibit catalytic activity. 
On these basis, catalytic tests have been also performed in 1,4-dioxane as solvent with Me3NO as additive, in 
these conditions some conversion has been observed: 4% with 7 mol% of Me3NO, up to 10% with Me3NO 
loading raised to 25 mol% (entries 3, 4). Increasing the catalyst loading to 10mol% with 25mol% of Me3NO 
resulted in only 15% of conversion (entry 5). More catalytic runs have been carried out with the cationic 
complex 29a[CF3SO3] testing different solvents and additives: under all the applied reaction conditions a low 
conversion (11%) has been observed (entries 6, 7 ,8) and the presence of the carbene-free iron(0) precursor 
26 has been detected at the end of the reaction. Using acetone as solvent (entry 9) no conversion has been 
reached but the complex 29a[CF3SO3] has been recovered unaltered in the reaction crude, indicating that the 
complex is stable but not activated under these conditions.  
With the aim to test the complexes on more active substrates, the reactivity of 28a and 29a[CF3SO3] has been 
extended to 1-phenylethanol.  Indeed, secondary alcohols are more prone to oxidation.20 Furthermore, in these 
experiments, the concentration of the substrate in the reaction mixture has been increased to 0.25 M. The 
catalytic results are reported in Table 7.3 
Table 7.3. Catalytic oxidation of 1-phenylethanol.a 
entry [Fe] solvent conversion 24h (%) 
1 29a[CF3SO3] toluene 35 
2 29a[CF3SO3] acetone
b 27 
3 28a acetone
b 41c 
aGeneral conditions: Iron complex (5 mol% Fe), substrate concentration = 0.25 M, reflux; conversions determined by GC; 
b test performed in a sealed glass ampoules equipped with a Young valve heating at 90°C; cyield ~ 21% the byproduct is 
identidied as bis(alpha-methylbenzyl) ether. 
The cationic complex 29a[CF3SO3] under these conditions exhibits some catalytic activity in the oxidation of 
1-phenylethanol both in toluene and acetone, leading to a conversion of 35% and 27% respectively (entry 1, 
2). Furthermore, 41% of conversion has been observed employing the neutral complex 28a as catalyst 
precursor, even though the effective yield is lower (~ 21%) because of the formation of the bis(alpha-
methylbenzyl) ether as by-product.  
The observed catalytic activity of both neutral and cationic complexes 28a and 29a[CF3SO3] in these catalytic 
tests is encouraging and a screening of different substrates and NHCs (with different substituents) will be 
matter of further studies in this field in order find active iron NHC complexes. 
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7.4 Electrochemical measurement 
Electrochemical analysis of the carbene iron(0) complex 24a by cyclic voltammetry measurements reveal a 
reversible oxidation of 24a in CH2Cl2 solution with E1/2 = +0.581(±4) vs SCE (Figure 7.4). The redox process 
likely involves a Fe0/FeII oxidation which is reversible according to the peak-current ratio (ipc/ipa = 0.95 at 100 
mV s–1) that is maintained quite constant at different scan rates.  
Figure 7.4. Cyclic voltammograms for 24a in CH2Cl2 at at different scan rates (potential vs SCE, Fc as internal standard). 
The electrochemical data of the imidazolylidene iron(0) complex 24a evidences a similar behaviour of the 
triazolylidene ruthenium(0) complex 11a (see Chapter III, paragraph 3.4), but with a lower potential (11a: E1/2 
= +0.952(±3)) and a more reversible oxidation mechanism. This feature suggests that under electrochemical 
conditions the iron complexes undergo oxidation of the metal center that can be the key point of the activation 
in the catalytic reactions. Investigations on the catalytic activity of this complex in these conditions are being 
carried out. 
From an electrochemical point of view this complex show good electrochemical reversibility, regeneration at 
low potential, and generation of stable redox form. These features indicate that iron cyclopentadienone NHC 
complexes (24) are promising electrocatalysts and redox mediators,21 potentially useful for the development 
of novel sensors for amperometric detection of interesting molecules, such as dopamine (DA).22  
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Conclusions 
A very efficient and rapid synthetic route for obtaining a new class of Fe(0) complexes, which contain both N-
heterocyclic carbenes and cyclopentadienone ligands has been developed. The synthetic approach takes 
advantage of transmetallation from silver-NHC complexes, which is a method rarely exploited in the case of 
iron-NHC complexes. Transmetallation could be favored either by non-innocent cyclopentadienone ligand or 
by iron valence. Donor and steric properties of NHCs can also play a role. The novel synthetic method for the 
preparation of complexes of type 24 and 28 is general and pave the way for future developments in iron 
mediated redox homogeneous catalysis. The iron complexes didn’t show good catalytic activity as transfer 
hydrogenation catalysts, but under oxidative conditions some promising results have been obtained, even 
though the conversions observed are so far low. Moreover, the interesting electrochemical properties displayed 
by the iron complex 24a indicate possible development and applications in the field of electrocatalytic 
processes and amperometric sensor devices. 
  
Chapter VII 
 
144 
Experimental Section 
Materials and procedures. Solvents: dichloromethane (CH2Cl2), tetrahydrofuran (THF), diethyl ether (Et2O), 
petroleum ether referring to a fraction of bp 60-80 °C, acetonitrile (CH3CN) were dried and distilled prior to use. 
Acetone has been degassed and stored under inert atmosphere on molecular sieves. Other solvents such as 
ethylacetate (EtOAc), chloroform, ethanol (EtOH), methanol (MeOH), heptane, toluene, CDCl3, D2O, CD3CN 
(Sigma Aldrich) have been employed without further purification. Reagents: Fe2(CO)9 (Strem), methyl iodide, 
chloridric acid, silver oxide, 1-methylimidazole, 1,3 diphenylacetone, benzyl bromide, 4,4’dimethoxybenzil (Alfa 
Aesar) have been employed as purchased. 
1,3-dimethylimidazolium iodide (1a),23 1,3-dibenzylimidazolium bromide (1b),24 1-methyl-3-butyl-imidazolium 
chloride, 1-methyl-3-(2-hydroxyethyl)imidazolium chloride (1d),25 1-(2-BocNH-ethyl)-3-methylimidazolium 
iodide (1e)26 1-methyl-3-(2-methoxyethyl)imidazolium chloride (1f), 1,3-bis(2,6-diisopropylphenyl)imidazolium 
bromide,27 1,3-dimethylimidazol-2-ylidene silver iodide (2a),28 1,3-dibenzylimidazol-2-ylidene silver bromide 
(2b),29 1-methyl-3-(2-hydroxyethyl)imidazol-2-ylidene silver chloride (2d),30 1,3-bis(2,6-
diisopropylphenyl)imidazol-2-ylidene silver bromide,31 3,4-Bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone,32 have been prepared following procedures reported in the literature. 
The prepared derivatives were characterized by spectroscopic methods. The NMR spectra were recorded 
using Varian Inova 300 (1H, 300.1; 13C, 75.5 MHz), Varian Mercury Plus VX 400 (1H, 399.9; 13C, 100.6 MHz), 
Varian Inova 600 (1H, 599.7; 13C, 150.8 MHz) spectrometers at 298 K; chemical shifts were referenced 
internally to residual solvent peaks. Full 1H- and 13C-NMR assignments were done, when necessary, by 
gHSQC and gHMBC NMR experiments using standard Varian pulse sequences. Infrared spectra were 
recorded at 298 K on a Perkin-Elmer Spectrum 2000 FT-IR spectrophotometer. ESI-MS spectra were recorded 
on Waters Micromass ZQ 4000 with samples dissolved in MeOH or CH3CN. Elemental analyses were 
performed on a Thermo-Quest Flash 1112 Series EA instrument. 
Synthesis of Iron complexes  
Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylciclopenta-2,4-dienone)iron (22) 
 
 
Figure 7.5. Structure of triscarbonyl cyclopentadienone precursor (22). 
In a 75 mL Teflon tube equipped with magnetic stirrer, 3,4-Bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone 0.53 g (1.2 mmol) and Fe2(CO)9 0.728 g (2 mmol) were dissolved in 40 mL of toluene. The container 
is closed with a cap, equipped with a temperature sensor, and placed into microwave. The reaction is heated 
to 140 °C for 70 min. Upon removal of the solvent, the crude was purified to afford the yellow triscarbonyl-η4-
3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)iron complex (22) by neutral alumina column 
chromatography using dichloromethane/ethyl acetate (100/0 to 0/100). Yield = 50% 
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Suitable crystals of 5 for X-Ray diffraction were obtained by slow diffusion (CH2Cl2/Hexane). 22 has been 
analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (399.9 MHz, CDCl3): δ (ppm) 7.55-
6.69 (m, 18H, Caryl), 3.76 (s, 6H, -OCH3). 13C-NMR (150.8 MHz, CDCl3, g-HSQC, g-HMBC): δ (ppm) 208.58 
(CO), 169.75 (C=O, Cp), 159.58 (-COCH3), 133.05-121.56 (Caryl), 113.40 (CHaryl), 103.44 (C2,5, Cp), 82.75 
(C3,4, Cp), 55.12 (-OCH3). IR (CH2Cl2, cm-1): (νCO) 2067, 2013, 1997; (νC=O) 1636; (νC=C) 1609, 1518. ESI-MS 
(m/z) (+): 585 [M+H]+; 607 [M + Na] +; 623 [M+K]+. Anal. Calcd (%) for C34H24O6Fe: C, 69.88; H, 4.14. Found: 
C, 68.97; H, 3.93. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(acetronitrile)iron (23) 
 
Figure 7.6 Structure of Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(acetronitrile)iron 
precursor (23) 
In a dried 15 mL Schlenk flask, triscarbonyl-(η4-3,4-bis(4methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron (22) 0.145 g (0.249 mmol) and trimethylamine-N-oxide 0.028 g (0.374 mmol) were dissolved in 3 
mL of anhydrous acetonitrile. Reaction mixture was stirred at room temperature and protected from light for 3 
hours. A yellow precipitate appeared. The solid was filtered and washed with diethyl ether and hexane. Yield: 
54% 
23 has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (399.9 MHz, C7D8): δ (ppm) 8.24-6.433 (m, 
18H, CHaryl); 3.10 (s, 6H, -OCH3); 0.72 (s, 3H, -NCCH3). 13C-NMR (150.8 MHz, C7D8, g-HSQC, g-HMBC): δ 
(ppm) 214.21 (CO), 169.74 (C=O, Cp), 159.56 (-COCH3), 134.99-124.45 (Caryl), 113.44 (CHaryl), 101.41 (C2,5, 
Cp), 81.31 (C3,4, Cp), 54.32 (-OCH3), 2.48 (CH3, CH3CN). IR (CH2Cl2, cm-1): (νCO) 2008, 1954; (νC=O) 1636; 
(νC=C) 1608, 1515. ESI-MS (m/z) (+): 557 [M-CH3CN]+, 583 [M-CH3]+, 598 [M+H]+. Anal. Calcd (%) for 
C35H27NO5Fe: C, 70.36; H, 4.56. Found: C, 70.75; H, 4.35. 
Synthesis of dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)(NHC)iron complexes (24) 
 
Figure 7.7 Structure of imidazolylidene Fe(0) complexes 24. 
Imidazolium salts (1), silver oxide (1.2 eq.), triscarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-
2,4-dienone) iron precursor (22) and trimethylammine-N-oxide (1.5 eq.) were reacted in CH3CN under inert 
atmosphere and with protection from light. After stirring the reaction for the time and at the temperature 
required in order to reach complete conversion to silver complexes (2), the solvent was removed under 
vacuum, then the solid dissolved in toluene. The reaction mixture was stirred for 1 hour at 110 °C. Upon 
Chapter VII 
 
146 
removal of the solvent, the crude was purified to afford the dicarbonyl-η4-3,4-bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone)(NHC)iron complexes (24) by neutral alumina column chromatography using 
dichloromethane/ethyl acetate (100/0 to 0/100). Formation of the iron complexes (24) was verified by IR, 1H-
NMR, 13C-NMR, ESI-MS and X-Ray crystal structure, when suitable crystals were available. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dimethyl-
ilidene)iron (24a): Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)iron (22) 
0.150 g, (0.256 mmol), trimethylammine-N-oxide 0.029 g (0.384 mmol), 1,3-dimethylimidazolium iodide (1a) 
0.057 g (0.256 mmol) and silver oxide 0.071 g (0.307 mmol), room temperature, 3h. Yield: 60%. 
Suitable crystals of 24a for X-Ray diffraction were obtained by slow diffusion (THF/Hexane). 24a has been 
analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (399.9 MHz, C7D8): δ (ppm) 8.33-
6.50 (m, 18H, CHaryl), 5.88 (s, 2H, CHNHC) 3.10 (s, 6H, -OCH3), 2.93 (s. 6H, -NCH3NHC). 13C-NMR (150.8 MHz, 
C7D8, g-HSQC, g-HMBC): δ (ppm) 218.11 (CO), 182.41 (Ccarbene), 166.57 (C=O, Cp), 159.30 (-COCH3), 123.96 
(CHNHC), 136.44-125.66 (CHaryl), 113.39 (CHaryl), 100.73 (C2,5, Cp), 79.76 (C3,4, Cp), 54.28 (-OCH3) 38.18 (-
NCH3). IR (CH2Cl2, cm-1): (νCO) 1988, 1930; (νC=O) 1585; (νC=C) 1603, 1518. ESI-MS (m/z) (+): 653 [M+H]+; 675 
[M + Na]+; 691 [M+K]+. Anal. Calcd (%) for C38H32N2O5Fe: C, 69.95; H, 4.94. Found: C, 69.33; H, 4.63. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-
dibenzylimidazole)iron (24b): Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron (22) 0.030 g (0.005 mmol), trimethylammine-N-oxide 0.006 g (0.080 mmol), 1,3-
dibenzylimidazolium bromide (1b) 0.016 g (0.005 mmol), and silver oxide 0.014 g (0.016 mmol), 80 °C, 3h. 
Yield : 70 %. 
Suitable crystals of 24b for X-Ray diffraction were obtained by slow diffusion (Toluene/Hexane). 24b has been 
analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (399.9 MHz, C7D8) δ (ppm): 8.43-
6.46 (m, 28H, CHaryl), 6.06 (s, 2H, -CHNHC), 5.15 (m, -CH2), 4.50 (m, -CH2) 3.06 (s, 6H, -OCH3). 13C-NMR 
(150.8 MHz, C7D8, g-HSQC, g-HMBC) δ (ppm): 217.43 (CO), 184.99 (Ccarbene), 167.37 (C=O, Cp), 159.27 (-
COCH3), 137.34-123.15 (Caryl), 127.78 (CHNHC), 113.36 (CHaryl), 101.31 (C2,5, Cp), 80.08 (C3,4, Cp), 54.57 (-
CH2), 54.22 (-OCH3). IR (CH2Cl2, cm-1): (νCO) 1989, 1933; (νC=O) 1586; (νC=C) 1603, 1518. ESI-MS (m/z) (+): 
805 [M+H]+; 827 [M + Na]+; 843 [M+K]+. Anal. Calcd (%) for C50H40N2O5Fe: C, 74.63; H, 5.01. Found: C, 74.19; 
H, 4.65. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1-methyl-3-butyl-
imidazol-ylidene)iron (24c): Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron (5) 0.030 g (0.005 mmol), trimethylammine-N-oxide 0.006 g (0.075 mmol), 1-methyl-3-butyl-
imidazolium bromide (1c) 0.011 g (0.005mmol) and silver oxide 0.014 g (0.006 mmol), 80 °C, 3 hours. Yield: 
50 %. 
Suitable crystals of 24c for X-Ray diffraction were obtained by slow diffusion (Toluene/Hexane). 24c has been 
analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (399.9 C7D8) δ (ppm): 8.97-7.13 
(m, 18H, CHaryl), 6.85 (d, H, -CHNHC), 6.69 (d, H, -CHNHC), 4.19 (m, 2H, CH2 NHC), 3.73 (s, 6H, -OCH3), 3.60 (s. 
6H, -CH3 NHC), 2.73 (m, 2H, CH2 NHC), 1.53 (t, 2H, CH2 NHC), 1.36 (t, 3H, CH3 NHC). 13C-NMR (150.8 MHz, C7D8, 
g-HSQC, g-HMBC) δ (ppm): 216.04 (CO), 182.41 (Ccarbene), 166.83 (C=O, Cp), 159.29 (-COCH3), 129.18-
121.65 (Caryl), 124.54 (CHNHC), 113.40 (CHaryl), 100.87 (C2,5, Cp), 80.26 (C3,4, Cp), 54.27 (-OCH3), 50.39 (-
NCH2-), 38.22 (-NCH3), 33.63 (-CH2-), 25.83 (-CH2-), 13.99(-CH3). IR (CH2Cl2, cm-1): (νCO) 1987, 1931; (νC=O) 
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1587; (νC=C) 1607, 1518. ESI-MS (m/z) (+): 695 [M+H]+; 717 [M + Na]+; 733 [M+K]+. Anal. Calcd (%) for 
C41H38N2O5Fe: C, 70.90; H, 5.51. Found: C, 69.19; H, 5.13. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)[1-(2-hydroxyethyl)-3-
methylilidene]iron (24d): Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron 0.060 g (0.103 mmol), trimethylammine-N-oxide 0.012 g (0.155 mmol), 13-(2-hydroxyethyl)-1-
methylimidazole chloride (24d) 0.016 g (0.103 mmol) and silver oxide 0.029 g (0.124 mmol), room temperature, 
3 h. Chromatography eluent: dichloromethane/ethyl acetate/MeOH (100/0/0 to 0/0/100). Yield: 18 %. 
24d has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (399.9 MHz, C7D8) δ (ppm): 8.10 (m, 18H, 
CHaryl), 6.63 (s, 1H, CHNHC), 6.07 (s, 1H, CHNHC), (CH2 not visible), 3.10 (s, 6H, -OCH3), 2.90 (s, 3H, -NCH3). 
13C-NMR (150.8 MHz, C7D8, g-HSQC, g-HMBC) δ (ppm): 218.60 (CO), 181.69 (Ccarbene), 163.0 (C=O, Cp), 
159.46 (-COCH3) 134.80-125.37 (CHaryl), 124.48 (CHNHC), 121.99 (CHNHC), 113.47 (CHaryl), (not visible C3,4, 
Cp), (not visible C2,5, Cp), 59.24 (-CH2), 53.30 (-OCH3), 52.40 (-CH2), 37.92 (-NCH3). IR (CH2Cl2, cm-1) (νCO) 
1991, 1935; (νC=O) 1576 (broad); (νC=C) 1604, 1517. ESI-MS (m/z) (+): 683 [M+H]+, 705 [M+Na]+. Anal. Calcd 
(%) for C39H34N2O6Fe: C, 68.63; H, 5.02. Found: C, 68.35; H, 4.69. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)[1-(2-Boc-NH-ethyl)-3-
methylilidene]iron (24n): Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron (5) 0.150 g (0.257 mmol), trimethylammine-N-oxide 0.029 g (0.386 mmol), 1-(2-BocNH-ethyl-)-3-
methylimidazolium iodide (1n) 0.091 g (0.257 mmol) and silver oxide 0.071 g (0.308 mmol), room 
temperature,1 h. Yield : 53 %.  
7e has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (399.9 MHz, C7D8) δ (ppm): 8.10-6.48 (m, 
18H, CHaryl), 6.68 (s, H, CHNHC), 5.98 (s, H, CHNHC), 3.12 (s, 2H, -CH2), 3.11 (s, 6H, OCH3), 2.96 (s, 2H, CH2), 
2.79 (s, 3H, NCH3), 1.45 (s. 9H, -CH3 BOC). 13C-NMR (150.8 MHz, C7D8, g-HSQC, g-HMBC) δ (ppm): 217.63 
(CO), 182.44 (Ccarbene), 164.51 (C=O, Cp), 159.43(-COCH3), 156.86 (C=O, BOC), 137.68-121.84 (Caryl), 125.41 
(CHNHC), 121.84 (CHNHC), 113.46 (CHAryl), 98.92 (C2,5, Cp), 88.59 (C3,4, Cp), 77.94 (C, BOC), 58.32 (CH2), 
54.38 (-OCH3), 49.33 (NCH2), 37.82(NCH3), 28.66 (-CH3, BOC). IR (CH2Cl2, cm-1): (νCO) 1991, 1935; (νC=O) 
1576 (broad); (νC=C) 1604, 1517. ESI-MS (m/z) (+) = 782[M+H]+, 804 [M+Na]+. Anal. Calcd (%) for 
C44H43N3O7Fe: C, 67.61; H, 5.54. Found: C, 66.95; H, 5.06. 
Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)[1-(2-methoxyethyl)-3-
methylilidene]iron (24q): Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron (5) 0.060 g (0.100 mmol), trimethylammine-N-oxide 0.012 g (0.150 mmol), 3-(2-methoxyethyl)-1-
methylimidazole chloride (1q) 0.016 g (0.103 mmol) and silver oxide 0.028 g (0.120 mmol, room temperature,1 
h. Yield : 55 %. 
7f has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (399.9 MHz, C7D8) δ (ppm): 8.29-6.49 (m, 
18H, CHaryl), 6.95 (s, 1H, CHNHC), 6.00 (s, 1H, CHNHC), 3.86 (br, 2H, CH2), 3.09 (s, 6H, -OCH3), 2.92 (s, 3H, -
NCH3) 2.88 (s, 3H, -OCH3), 2.08 (br, 2H, CH2). 13C-NMR (150.8 MHz, C7D8, g-HSQC, g-HMBC) δ (ppm): 
218.05 (CO), 182.42 (Ccarbene), 166.72 (C=O, Cp), 159.34 (-COCH3), 136.23-125.61 (CHaryl), 124.24 (CHNHC), 
123.53 (CHNHC), 113.41 (CHaryl), 100.83 (C3,4, Cp), 79.97 (C2,5, Cp), 72.72 (-CH2), 58.17 (-OCH3), 54.30 (-
OCH3), 50.73 (CH2), 38.14 (-NCH3). IR (CH2Cl2, cm-1): (νCO) 1987, 1931; (νC=O) 1586 (broad); (νC=C) 1518. ESI-
MS (m/z) (+) = 697 [M+H]+, 719 [M+Na]+. Anal. Calcd (%) for C40H36N2O6Fe: C, 68.97; H, 5.21. Found: C, 
68.80; H, 4.99. 
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Dicarbonyliodo-(η4-3,4-bis(4-methoxyphenyl)- 2,5-diphenylhydroxycyclopentadienyl)(1,3-dimethyl-
ilidene)iron triflate (25a[CF3SO3]): Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)(1,3-dimethyl-ilidene)iron complex (24a) 0.020g (0.031mmol) was dissolved in 5 mL of CH2Cl2 under 
inert atmosphere. 1.2 equivalent of HCF3SO3 (solution at 0.98% in CH2Cl2) were subsequently added. The 
reaction mixture was stirred for 10 minutes at room temperature, then the solvent was removed under vacuum 
and the crude washed twice with 10 ml of hexane. The orange solid obtained was identified as 25a[CF3SO3] 
by IR, 1H-NMR, 13C-NMR, 19F-NMR, ESI-MS. 1H-NMR (399.9 MHz, CD3CN)  
δ (ppm): 7.45-6.71 (m, 18H, CHaryl), 7.14 (s, 2H, CHNHC), 3.71 (s, 6H, -OCH3), 3.39 (s. 6H, -NCH3). 13C-NMR 
(150.8 MHz, CD3CN) δ (ppm): 215.00 (CO), 169.62 (Ccarbene), 160.83 (-COCH3), 136.12 (C-OH), 131.97-127.56 
(Caryl), 121.62 (CHNHC), 114.21 (CHaryl), 98.92 (C2,5, Cp), 88.59 (C3,4, Cp), 55.98 (-OCH3), 39.55 (-NCH3). 19 F-
NMR (282.4 MHz, CD3CN) δ (ppm): -79.10 (CF3SO3). IR (CH2Cl2) ν(CO) 2023 cm-1, 1977 cm-1; ν(C=C) 1610 cm-
1, 1521 cm-1. ESI-MS (m/z) (+) = 653 [M]+; 149 [M]-. 
Triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron (26) 
 
Scheme 7.5 Microwave assisted synthesis of triscarbonyl-(η4-2,4-bis(trimethylsilil)biciclo[3.3.0]nona 1,4-dien-3-one)4-
methoxyphenyl)iron (26). 
In a 75 mL Teflon tube equipped with magnetic stirrer, 1,7-octadiyne 0.027 g (0.11 mmol) and Fe2(CO)9 0.039 
g (0.11 mmol) were dissolved in 40 mL of toluene. The container is closed with a cap, equipped with a 
temperature sensor, and placed into microwave reactor. The reaction is heated to 140 °C for 140 min. Upon 
removal of the solvent, the crude was purified to afford the yellow triscarbonyl-(2,4-
bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron (26) by neutral alumina column chromatography using 
dichloromethane/ethyl acetate (100/0 to 0/100). Yield = 83% 
26 has been analyzed by IR, 1H-NMR. 1H-NMR (399.9 MHz, CDCl3): δ (ppm) 2.56 (m, 4H, CH2), 1.82 (m, 4H, 
CH2), 0.27 (s, 18H, CH3, TMS). IR (CH2Cl2, cm-1): (νCO) 2063, 2004, 1987. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[acetonitrile]iron (27) 
  
Figure 7.8. Structure of iron triscarbonyl bis(TMS)-substituted cyclopentadienone complex (27). 
In a dried 15 mL Schlenk flask, triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron (26) 
0.039 g (0.094 mmol) and trimethylamine-N-oxide 0.011 g (0.14 mmol) were dissolved in 3 mL of anhydrous 
acetonitrile. Reaction mixture was stirred at room temperature and protected from light for 3 hours. A yellow 
precipitate appeared. The solid was filtered and washed with diethyl ether and hexane. Yield : 78%. 
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27 has been analyzed by IR, 1H-NMR. 1H-NMR (399.9 MHz, CDCl3): δ (ppm) 2.28 (m, 4H, CH2), 2.23 (s, 3H, 
CH3), 1.56 (m, 4H, CH2), 0.24 (s, 18H, CH3, TMS). IR (CH2Cl2, cm-1): (νCO) 1999, 1938. 
Synthesis of dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)(NHC)iron 
complexes (28) 
 
Figure 7.9 Structure of bis(TMS)-substituted cyclopentadienone Fe carbene complex (28) 
Same general procedure for complex 24. Precursor is triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-
1,4-dien-3-one)iron (26). 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1,3-dimethyl-ilidene]iron (28a): 
Triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron (26) 0.035 g (0.084 mmol), 
trimethylammine-N-oxide 0.009 g (0.12 mmol), 1,3-dimethylimidazolium iodide 0.019 g (0.084 mmol) and silver 
oxide 0.035 g (0.084 mmol), room temperature, 3 h. Yield : 86 % 
Suitable crystals of 28a for X-Ray diffraction were obtained by slow diffusion (Toluene/Hexane). 28a has been 
analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS and X-Ray diffraction. 1H-NMR (399.9 CDCl3) δ (ppm): 6.98 (s, 
2H, CHNHC), 3.91 (s, 6H, CH3), 2.45 (t, 4H, CH2), 1.85-1.87 (m, 4H, CH2), 0.174 (s, 18H, CH3, TMS). 13C-NMR 
(150.8 MHz, C7D8, g-HSQC, g-HMBC) δ (ppm): 217.00 (CO), 182.00 (Ccarbene), (C=O, Cp) (not visible), 123.79 
(CHNHC), 103.72 (C3,4q), 65.00 (C2,5q), 39.94 (CH3), 24.52 (CH2), 22.55 (CH2), 0.23 (CH3, TMS). IR (CH2Cl2, cm-
1): (νCO) 1983, 1922. ESI-MS (m/z): 487 [M+H]+, 509 [M+Na]+, 525 [M+K]+. Anal. Calcd (%) for 
C22H34N2O3Si2Fe: C, 54.31; H, 7.04. Found: C, 54.82; H, 6.72. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1,3-dibenzylimidazol-lilidene]iron 
(28b): Triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron (26) 0.077 g (0.018 mmol), 
trimethylammine-N-oxide 0.021 g (0.28 mmol), 1,3-dibenzylimidazolium bromide 0.060 g (0.018 mmol) and 
silver oxide 0.051 g (0.022 mmol), 80 °C 3 h. Yield : 61%. 
28b has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (399.9 CDCl3) δ (ppm): 7.42-7.18 (10H, 
CHaryl), 6.82 (s, 2H, CHNHC), 5.6 (br, 4H, NCH2), 2.49 (m, 4H, CH2), 1.78-1.72 (m, 4H, CH2), 0.19 (s, 18H, CH3, 
TMS). 13C-NMR (150.8 MHz, C7D8, g-HSQC, g-HMBC) δ (ppm): 216.14 (CO), 186.32 (Ccarbene), 177.02 (C=O, 
Cp), 136.30 (Caryl), 128.75 (CHaryl), 127.88 (CHaryl), 126.81(CHaryl), 123.30 (CHaryl), 103.91 (C3,4q), 70.12 (C2,5q), 
55.15 (-NCH2-), 23.94 (CH2), 22.04 (CH2), 0.98 (CH3, TMS). IR (CH2Cl2, cm-1): (νCO) 1986, 1924. ESI-MS (m/z): 
639 [M+H]+, 661 [M+Na]+, 677 [M+K]+. Anal. Calcd (%) for C34H42N2O3Si2Fe: C, 63.93; H, 6.63. Found: C, 
64.22; H, 6.21. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-hydroxyethyl))-3-
methylilidene]iron (28d): Triscarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)iron (26) 
0.048 g (0.103 mmol), trimethylammine-N-oxide 0.012 g (0.155 mmol), 3-(2-hydroxyethyl)-1-methylimidazole 
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chloride 0.020 g (0.103 mmol) and silver oxide 0.037 g (0.160 mmol), room temperature, 3 h. Chromatography 
eluent: dichloromethane/ethyl acetate/MeOH (100/0/0 to 0/0/100). Yield = 13 % 
28c has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (399.9 CDCl3) δ (ppm): 7.27 (d, 1H, -
CHNHC), 7.04 (d, 1H, -CHNHC), 4.33 (t, CH2, NHC), 4.00 (t. 2H, -CH2, NHC), 3.83 (s, 3H, -NCH3), 2.52-2.45 (m, 
4H, CH2), 1.85-1.75 (m, 4H, CH2), 0.18 (s, 18H, CH3, TMS). 13C-NMR (150.8 MHz, C7D8, g-HSQC, g-HMBC) 
δ (ppm): 217.68 (CO), 183.60 (Ccarbene), 171.22 (C=O, Cp), 126.63 (C3,4, Cp ), 124.28 (CHNHC), 120.91 (CHNHC), 
75.27 (C2,5, Cp), 59.06 (-CH2-), 52.66 (-CH2-), 40.24 (-NCH3), 25.01 (-CH2-, Cp), 22.43 (-CH2-, Cp), 0.21 (CH3, 
TMS). IR (CH2Cl2, cm-1): (νCO) 1986, 1926. ESI-MS (m/z): 517 [M+H]+, 539 [M+Na]+. Anal. Calcd (%) for 
C23H36N2O4Si2Fe: C, 53.48; H, 7.02. Found: C, 53.54; H, 6.67. 
Dicarbonyl-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dien-3-one)[1-(2-BocNH-ethyl)-3-
methylilidene]iron (28n): Triscarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-
dienone)iron (26) 0.082 g (0.197 mmol), trimethylammine-N-oxide 0.022 g (0.296 mmol), 1-(2-BocNH-ethyl-)-
3-methylimidazolium iodide 0.070 g (0.197 mmol) and silver oxide 0.055 g (0.236 mmol), room temperature, 1 
h. Yield = 52 %. 
28n has been analyzed by IR, 1H-NMR, 13C-NMR, ESI-MS. 1H-NMR (399.9 CDCl3) δ (ppm): 7.19 (s, 1H, -
CHNHC), 6.98 (s, 1H, -CHNHC), 6.41 (br, 1H, NH), 4.33 (t, CH2, NHC), 3.85 (s, 6H, -NCH3), 3.65 (t. 2H, -CH2, 
NHC), 2.47 (t, 4H, CH2), 1.83-1.77 (m, 4H, CH2), 1.35 (s, 9H, CH3, BOC), 0.17 (s, 18H, CH3, TMS). 13C-NMR 
(150.8 MHz, C7D8, g-HSQC, g-HMBC) δ (ppm): 217.61 (CO), 184.56 (Ccarbene), 174.08 (C=O, Cp), 156.66 
(C=O, BOC), 123.91 (CHNHC), 121.17 (CHNHC), 103.26 (C3,4, Cp), 78.80 (Cq, BOC), 73.31 (C2,5, Cp), 49.55 (-
NCH2-), 40.16 (-NCH3), 38.73 (-NCH2-), 28.32 (CH3, BOC), 24.87 (-CH2), 22.47 (-CH2), 0.29 (CH3, TMS) IR 
(CH2Cl2, cm-1 ): (νCO) 1982, 1922. ESI-MS (m/z): 638 [M+Na]+, 654 [M+K]+. Anal. Calcd (%) for 
C28H46N3O5Si2Fe: C, 54.53; H, 7.52. Found: C, 54.53; H, 7.10. 
Dicarbonyliodo-(2,4-bis(trimethylsilyl)bicyclo[3.3.0]nona-1,4-dienyl)(1,3-dimethyl-ilidene)iron triflate 
(29a[CF3SO3]): Dicarbonyl-(η4-3,4-bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone)(1,3-dimethyl-
ilidene)iron complex (28a) 0.020g (0.035mmol) was dissolved in 5 mL of diethyl ether under inert atmosphere. 
3.3 µL of HCF3SO3 (solution at 98% in CH2Cl2) were subsequently added. The reaction mixture was stirred for 
10 minutes at room temperature, then the precipitate obtained was filtered, washed with 10 ml of hexane and 
died under vacuum. The orange solid obtained was identified as 29a[CF3SO3] by IR, 1H-NMR, 13C-NMR, 19F-
NMR, ESI-MS. 1H-NMR (399.9 MHz, CDCl3) δ (ppm): 7.28(s, 2H, CHNHC), 3.39 (s. 6H, -NCH3). 2.41 (m, 4H, 
CH2), 1.79 (m, 4H, CH2), 0.29 (s, 18H, CH3, TMS). 13C-NMR (150.8 MHz, CDCl3, g-HSQC, g-HMBC): δ (ppm) 
214.16 (CO), 170.93 (Ccarbene), C-OH not visible, 126.26 (CHNHC), 104.00 (C2,5, Cp), 82.43 (C3,4, Cp), 39.87 (-
NCH3), 23.79 (CH2, 2C), 21.97 (CH2, 2C), 0.99 (CH3, TMS, 6C). 19F-NMR (282.4 MHz, CDCl3) δ (ppm): -78.18 
(CF3SO3).IR (CH2Cl2, cm-1): (νCO) 2018cm-1, 1969 cm-1. 
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X-Ray diffraction studies 
Crystal Structure of 22 
The crystal structure of 22 closely resembles those previously reported for other Fe(CO)3-cyclopentadienone 
complexes.33 The X-ray crystal structure clearly illustrates the 4 character of the bonding of the 
cyclopentadienone ligand. The average bonding distance from the iron to the tetracyclone ring carbons C(4)-
C(7) is 2.11 Å and is markedly shorter than the distance to the ketonic carbon Fe(1)-C(3) [2.4074(19) Å]. 
 
Figure 7.10. ORTEP drawing of 22. Displacement ellipsoids are at the 30% probability level. H-atoms have been omitted 
for clarity. Selected bond lengths (Å): Fe(1)-C(1) 1.807(2), Fe(1)-C(2) 1.800(2), Fe(1)-C(34) 1.809(2), Fe(1)-C(3) 
2.4074(19), Fe(1)-C(4) 2.1257(19), Fe(1)-C(5) 2.1065(19), Fe(1)-C(6) 2.1016(19), Fe(1)-C(7) 2.1027(19), C(3)-O(3) 
1.230(2). 
Crystal Structure of 24b and 24c 
 
Figure 7.11. ORTEP drawing of 24b. Displacement ellipsoids are at the 30% probability level. H-atoms have been 
omitted for clarity. Selected bond lengths (Å): Fe(1)-C(1) 1.7678(18), Fe(1)-C(2) 1.7671(17), Fe(1)-C(3) 2.3784(16), 
Fe(1)-C(4) 2.1442(15), Fe(1)-C(5) 2.0912(15), Fe(1)-C(6) 2.0766(15), Fe(1)-C(7) 2.1758(16), Fe(1)-C(34) 2.0138(17), 
C(3)-O(3) 1.2444(19). 
 
Figure 7.12 ORTEP drawing of 24c. Displacement ellipsoids are at the 30% probability level. H-atoms have been 
omitted for clarity. Selected bond lengths (Å): Fe(1)-C(1) 1.764(3), Fe(1)-C(2) 1.766(4), Fe(1)-C(3) 2.392(3), Fe(1)-C(4) 
2.161(3), Fe(1)-C(5) 2.079(3), Fe(1)-C(6) 2.082(3), Fe(1)-C(7) 2.168(3), Fe(1)-C(34) 2.000(3), C(3)-O(3) 1.240(4). 
Chapter VII 
 
152 
X-ray Crystallography 
Crystal data and collection details for 22·0.5C6H14, 24a·thf·C6H14, 24b, 24c and 28a are reported in Table 7.4. 
The diffraction experiments were carried out on a Bruker APEX II diffractometer equipped with a CCD detector 
using Mo–K radiation. Data were corrected for Lorentz polarization and absorption effects (empirical 
absorption correction SADABS).34 Structures were solved by direct methods and refined by full-matrix least-
squares based on all data using F2.35 All hydrogen atoms were fixed at calculated positions and refined by a 
riding model. All non-hydrogen atoms were refined with anisotropic displacement parameters. 
The C6H14 molecule of 22·0.5C6H14 is located on an inversion center.  
The C6H14 and THF molecules of 24a·thf·C6H14 are disordered and, therefore, they have been split into two 
positions each and refined isotropically using one occupancy parameter per disordered group. The disordered 
molecules have been restrained to have similar geometries (SAME line in SHELXTL; s.u. 0.02) and similar U 
parameters (SIMU line in SHELXTL; s.u. 0.01). Restraints to bond distances were applied as follow (s.u. 0.02): 
1.53 Å for C–C and 1.43 Å for C–O in THF and C6H14. 
Table 7.4 
Crystal data and experimental details for 22·0.5C6H14, 24a·thf·C6H14, 24b, 24c and 28a. 
 22·0.5C6H14 24a·thf·C6H14 
Formula C37H31FeO6 C48H54FeN2O6 
Fw 627.47 810.78 
T, K 100(2) 100(2) 
, Å 0.71073 0.71073 
Crystal system Monoclinic Monoclinic 
Space group P21/n P21/n 
a, Å 14.3553(2) 9.4831(7) 
b, Å 11.8026(2) 23.5286(19) 
c, Å 17.6616(3) 19.2990(16) 
,  90 90 
,  90.0710(10) 103.518(4) 
,  90 90 
Cell Volume, Å3 2992.40(8) 4186.8(6) 
Z 4 4 
Dc, g cm-3 1.393 1.286 
, mm-1 0.552 0.412 
F(000) 1308 1720 
Crystal size, mm 0.220.180.14 0.250.210.16 
 limits,  1.83–25.03 1.73–26.00 
Reflections collected 42504 64046 
Independent reflections 5268 [Rint= 0.0285] 8231 [Rint= 0.0740] 
Data / restraints /parameters 5268 / 0 / 397 8231/ 121 / 505 
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Goodness on fit on F2 1.024 1.023 
R1 (I> 2(I)) 0.0335 0.0641 
wR2 (all data) 0.0881 0.1870 
Largest diff. peak and hole, e Å-3 1.714 / –0.278 1.401 / –0.827 
 
 24b 24c 28a 
Formula C50H40FeN2O5 C41H38FeN2O5 C22H34FeN2O3Si2 
Fw 804.69 694.58 486.54 
T, K 100(2) 100(2) 100(2) 
, Å 0.71073 0.71073 0.71073 
Crystal system Monoclinic Monoclinic Triclinic 
Space group P21/n P21/n P1̅ 
a, Å 14.8500(8) 12.7360(4) 8.3374(2) 
b, Å 15.3813(8) 17.9148(5) 10.1477(3) 
c, Å 17.4682(10) 15.2500(4) 15.9325(4) 
,  90 90 75.869(2) 
,  101.570(3) 95.190(2) 77.444(2) 
,  90 90 76.216(2) 
Cell Volume, Å3 3908.9(4) 3465.22(17) 1251.27(6) 
Z 4 4 2 
Dc, g cm-3 1.367 1.331 1.291 
, mm-1 0.439 0.483 0.723 
F(000) 1680 1896 516 
Crystal size, mm 0.190.150.12 0.160.130.10 0.180.160.11 
 limits,  1.65–27.00 1.76–26.00 1.34–27.00 
Reflections collected 64623 39892 21430 
Independent reflections 8525 [Rint= 0.0444] 6797 [Rint= 0.0844] 5441 [Rint= 0.0497] 
Data / restraints 
/parameters 
8525 / 0 / 523 6797 / 18 / 442 5441 / 0 / 279 
Goodness on fit on F2 1.015 1.040 1.016 
R1 (I> 2(I)) 0.0336 0.0472 0.0399 
wR2 (all data) 0.0866 0.1309 0.0987 
Largest diff. peak and 
hole, e Å-3 
0.370 / –0.428 
0.584 / –0.488 0.281 / –0.232 
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CHAPTER VIII 
Microwave-assisted synthesis of functionalized Shvo’s type complexes 
Abstract 
A simple and expeditious microwave-assisted procedure for the synthesis of a variety of Shvo’s type ruthenium 
complexes has been developed by reacting Ru3(CO)12 with variously functionalized 
tetraarylcyclopentadienones under microwave irradiation in MeOH. Ligand precursors have been also 
prepared under microwave heating by a bis-aldol condensation of 1,3 diphenylacetone with variously 
functionalized aromatic diketones. All the reactions resulted to be very fast and clean, leading to good yields 
and selectivities. 
Introduction 
Hydroxycyclopentadienylruthenium hydride dimer complexes, well known as Shvo’s type complexes,1 have 
been inspired the work reported in this thesis, since the Shvo catalyst is the one of most relevant example of 
the bifunctional catalysis and cooperativity of a metal centre (ruthenium) with a non-innocent ligand 
(cyclopentadienone), based on the cyclopentadienone/hydroxycyclopentadienyl reversible transformation.  
As mentioned in Chapter I (paragraph 2.2), Shvo’s type complexes are precursors of useful and versatile 
catalysts, successfully applied in a broad variety of hydrogen-transfer processes, such as hydrogenation of 
carbonyls and imines, oxidation of alcohols and amines.2 More recently, applications have been extended to 
a broader number of reactions including: synthesis of primary amines by using ammonia,3 biomimetic aerobic 
oxidation,4 chemoenzymatic dynamic kinetic resolution of amines,5 N-acylation of heterocycles with 
aldehydes,6 ammonia−borane dehydrogenation,7 and α,β-deuteration of bioactive amines.8 Furthermore, the 
catalyst, supported on silica, has been used in the hydroformylation and hydrogenation of propene to butanol9 
and, combined with Rh complexes, it has been exploited in tandem reactions, resulting in the 
isomerization/hydroformylation/hydrogenation of internal alkenes to yield n-alcohols.10 Promising perspectives 
are also in the field of green chemistry, in the transformation of renewable feedstocks,11 including upgrading 
of bio-oil by hydrogenation11a and selective conversion of levulinic and formic acids into γ‑valerolactone.12 
Stimulated by the possibility to decorate the cyclopentadienyl of Shvo’s complexes with various functionalities, 
we investigated the synthesis of new hydroxypropargyl arylcyclopentadienone ligands. These functionalized 
tetraarylcyclopentadienones, besides providing a tool for controlling the properties of the catalyst, are 
themselves fascinating compounds, with interesting properties as organogels,13 and useful applications in 
material science.14 
The considerable potential of the Shvo catalyst, which might be further improved by use of functionalized 
tetraarylcyclopentadienones, is unfortunately affected by the lack of a simple and efficient synthetic method. 
Indeed, different synthetic approaches have been developed since its first synthesis,2a-c,15 but all the reported 
procedures still require high temperatures and long reaction times. 
In this chapter a new rapid, clean and general method for the synthesis of variously functionalized Shvo’s type 
complexes, which takes advantage of microwave heating, is described.  
Furthermore, microwave irradiation also provides easier access to the corresponding 
tetraarylcyclopentadienone ligands. 
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Results and Discussion 
8.1 Microwave assisted tetraarylcyclopentadienone ligands synthesis 
Most common synthetic routes to tetraarylcyclopentadienones involve reaction of diaryl--diketones 30 with 
the diphenylacetone 31, in the presence of KOH or NaOH, in refluxing EtOH for variable reaction times (2-
16h) (Scheme 1).13,16 
 
Scheme 8.1: Examples of conventional synthesis of tetraarylcyclopentadienones 32. 
In consideration of the fact that microwave irradiation has proved to be efficient in the acceleration of many 
organic reactions, becoming a standard tool in organic synthesis,17 we have applied this technique for the base 
catalyzed bis-aldol condensation of 1,3 diphenylacetone with -diketones. As initial approach, we investigated 
benzil (30A, Scheme 8.1) as model substrate to study its condensation with 1,3-diphenylacetone and NaOH, 
employing EtOH as solvent. The mixture was stirred and heated in a microwave teflon closed reaction vessel. 
Optimization studies led to identify the best reaction conditions in heating at 70°C for 25 min to obtain 
tetraphenylcyclopentadienone (32A) in 78% yields. No significant variation has been observed leaving the 
mixture under microwave irradiation for a longer time (e.g. 50 min). On the other hand, a shorter reaction time 
(15 min) did not give complete conversion of the starting material, leading to lower yields (55%). Similar results 
were observed by lowering the temperature: T = 30 °C, Yield = 27%; T = 50 °C, Yield = 40%. Finally, yields 
decrease performing the reaction at 120°C (Yield = 32%) due to partial decomposition of the product. 
Once established the optimized reaction conditions (T = 70°C and t = 25 min) for the un-functionalized benzil, 
we investigated the substrate scope with diketones 30B-H as reported in Table 8.1. We found that the 
procedure can be extended to several variously substituted diketones in that microwave irradiation affords 
yields comparable to the classic reflux methods, but with much shorter reaction times. Comparisons with 
reaction yields reported in the literature are shown in Table 8.1. The only exception is the synthesis of 32H 
(Table 8.1, entry 8), which better occurs at room temperature, in that typically suffers from thermal oxidative 
degradation.18 
Table 8.1: Scope of the microwave assisted condensation.a 
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Entry 
Starting 
material 
Ar’ Ar” Product Yield (%) 
1 30A Ph Ph 32A 78 (91)b,19 
2 30B 4-MeO-C6H4 4-MeO-C6H4 32B 75 (86)b,16f 
3 30C 4-Br-C6H4 4-Br-C6H4 32C 70 (85)b,16e 
4 30D 4-(HOMe2C-CC)-C6H4 
4-(HOMe2C-CC)-
C6H4 
32D 58 (60)b,13 
5 30E 4-(HOPh2C-CC)-C6H4 
4-(HOPh2C-CC)-
C6H4 
32E 33 (32)b,13 
6 30F 4-(C6H11-CC)-C6H4 4-(C6H11-CC)-C6H4 32F 23 
7 30G 2-Cl-C6H4 3,4-(MeO)2-C6H4 32G 25 
8 30H 
O O
O
PhPh
32H 
20 (48, r.t.)c,18 
a) Reaction conditions: 30 (1.19 mmol), 31 (1 equiv.), NaOH (1 equiv.), 0.1 M in EtOH, T=70 °C, t=25 min; b) In
parenthesis, literature yields (when available) for the classical thermal procedure (80°C); c) reaction performed at room 
temperature. 
Results evidence that microwave irradiation promotes a significant acceleration of the reaction. In fact, reaction 
times, which typically range from 2 to 16 h in the classic thermal methods for the preparation of 32B-E, are 
shortened to 25 min in the corresponding microwave assisted procedures.  
Likewise conventional methods,16 yields are influenced by the aryl functionalization (Table 1), and the work up 
procedure is particularly convenient when the products are insoluble in EtOH (32A-C, 32F, 32H), in that it 
simply consists of a filtration. Conversely, in the case of soluble products, (32D-E and 32G) purification requires 
column chromatography on silica gel. All the compounds have been characterized by IR, 1H- and 13C-NMR 
spectroscopy and by comparison with literature data, when available. For the new compounds 30F, 32F and 
32G complete characterization is reported in the experimental section. 
8.2 Microwave-assisted synthesis of hydroxycyclopentadienylruthenium hydride dimer 
(Shvo’s type) complexes 
The dinuclear complexes {[3,4-(R-C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) [e.g. R = H, OMe, Cl] are 
typically prepared by heating Ru3(CO)12 and tetraarylcyclopentadienones in MeOH for 40h. An alternative two-
step approach involves the synthesis of the precursor 3,4-(R-C6H4)2-2,5-Ph2(4-C4CO)Ru(CO)3, which is 
subsequently transformed in the corresponding dinuclear Shvo’s type complex by a 48 h long reaction in 
acetone/water in the presence of Na2CO3. The latter method leads to lower yields and more difficult purification 
of the product. 
A drawback of the reported methods 2,15 is the long reaction time that prompted us to explore the potential of 
microwave heating in the organometallic synthesis of Shvo’s type complexes 33. Indeed, microwave irradiation 
has been widely used for transition metal catalyzed reactions, but there are few reports about its application 
in the syntheses of organometallic20 and coordination21 compounds. We have found that this technique 
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impressively reduces the reaction time (from 40 h to 50 min) required for reacting Ru3(CO)12 with 
tetraarylcyclopentadienones in methanol (12 mL) (Scheme 8.2). It is noteworthy that the syntheses of 
complexes 33 can be performed with not-anhydrous solvents in air. 
Scheme 8.2. Microwave assisted synthesis of Shvo’s type complexes 33A-F. 
First we optimized the synthetic procedure for 33A by heating a mixture of 3 eq. of 
tetraphenylcyclopentadienone 32A with Ru3(CO)12 in MeOH (12 mL) in a teflon closed reaction vessel at 
variable temperatures and times. Best reaction conditions have been found at 110 °C for 50 min, leading to 
the complete conversion of Ru3(CO)12 and subsequent isolation of microcrystalline Shvo’s complex 33A by 
precipitation, filtration and washing with MeOH. Complex 33A was obtained in about 75% yield.  
The substrate scope has been then extended to several tetraarylcyclopentadienones with different R 
substituents leading to yields comparable or higher with respect to classical methods (Table 8.2). Yields above 
70% have been obtained for complexes 33A, 33B, 33C and 33F (entry 1-3, 6 in Table 8.2), which can be easily 
separated by precipitation in methanol, whereas complexes containing propargyl substituents (33D, 33E) 
require separation by column chromatography, leading to lower yields (22-25%: entry 4 and 5 in Table 8.2). 
Table 8.2 Scope of the microwave assisted Shvo’s complexes synthesis.a 
Entry Cyclopentadienone R Product Yield (%)b,c 
1 32A H- 33A 75 (67) 
2 32B MeO- 33B 73 (70) 
3 32C Br- 33C 72 (62) 
4 32D (HOMe2C-CC)- 33D 24 (22) 
5 32E (HOPh2C-CC)- 33E 23 (25) 
6 32F (C6H11-CC)- 33F 74 (72) 
a) Reaction conditions: Ru3(CO)12 (0.16mmol), 32 (0.48 mmol), MeOH (12 mL), T=110 °C, t=50 min; b) In parenthesis
yields for the classical thermal procedure in our hands – in agreement with literature procedures when available
(methanol reflux, 40 h); c) 33H has been also obtained by 32H in 15% yield, the poor yield is ascribable to the instability 
of 32H at high temperatures.18 
FT-IR spectra of compounds 33 show the typical pattern in the region of CO stretching (e.g. for 33C: ν(CO): 
2041, 2010, 1982 cm-1). 1H NMR spectra exhibit the diagnostic signal of the bridging hydride, at about -18 ppm 
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in CDCl3 (e.g. for 33C: -18.40), and 13C-NMR spectra are consistent with typical resonances that involve 
terminal CO (at about 200.20-201.12 ppm), and quaternary carbons of hydroxycyclopentadienyl ligands (e.g. 
C1-OH = 154.49-155.63; C2,5 = 101.88-102.75; C3,4 = 87.78-87.88). Signals of alkyne-containing substituents 
in 33D-33F present a negligible shift if compared with the corresponding resonances of not coordinated 
cyclopentadienones (e.g. for 32D vs 33D the quaternary carbons of the group -CCC(CH3)2OH resonate at 
95.21, 81.79, 65.6313 and 94,93, 81,59, 65,52 respectively) indicating that formation of the complexes has a 
little influence on the substituents placed on the five-member ring. ESI-MS allowed to identify the molecular 
ion of 33C-33H (see Experimental section). 
Suitable crystals for X-Ray analysis have been obtained for 33B as its 33B·CH2Cl2 solvate, and for the new 
complex 33C (Figures 8.1 and 8.2). Since structural data for complex 33B have not been reported previously, 
its crystallographic structure is herein reported. The structures of 33B and 33C are very similar to those 
previously reported for analogous complexes, for what concern their geometries and bonding parameters and, 
therefore, they will not be discussed any further.1a, 15b,d  
 
Figure 8.1. ORTEP drawing of 33B with key atoms labelled. Thermal ellipsoids are at the 30% probability level. H-atoms, 
apart from H(1) and H(3), have been omitted for clarity. Selected bond lengths (Å) and angles (°): Ru(1)-H(1) 1.68(2); 
Ru(2)-H(1) 1.68(2); Ru(1)-Cp(av) 2.256(18); Ru(2)-Cp(av) 2.69(2); Ru(1)-CO(av) 1.886(15); Ru(2)-CO(av) 1.880(16); 
O(3)-H(3) 1.276(18); O(53)-H(3) 1.248(18); Ru(1)-H(1)-Ru(2) 149.8(8); O(3)-H(3)-O(53) 158(7). 
 
 
Figure 8.2 ORTEP drawing of 33C with key atoms labelled. Thermal ellipsoids are at the 30% probability level. H-atoms, 
apart from H(1) and H(3), have been omitted for clarity. Selected bond lengths (Å) and angles (°): Ru(1)-H(1) 1.724(13); 
Ru(1)-Cp(av) 2.264(4); Ru(1)-CO(av) 1.895(4); O(3)-H(3) 1.2676(19); Ru(1)-H(1)-Ru(1_1) 140.0(2); O(3)- H(3)-O(3_3) 
178(4). Symmetry transformations used to generate equivalent atoms Ru(1_1) and O(53_1): -x,y,-z+1/2. 
 
  
Chapter VIII 
 
161 
Conclusions 
In this chapter a very efficient procedure for the synthesis of variously functionalized 
tetraarylcyclopentadienones and the corresponding dinuclear ruthenium hydride Shvo’s type complexes based 
on microwave irradiation has been described. This class of complexes are of great interest in modern 
homogeneous catalytic processes, with promising applications in biomass conversion into chemicals and bio-
fuel. The new synthetic procedure, designed to obtain Shvo complexes provided with different substituents 
and functional groups, has demonstrated to tolerate various functionalities, avoiding protection and 
deprotection steps, with consequent advantages in terms of atom economy. The reaction needs a relatively 
low amount of solvent, and, with few exceptions, does not require long and solvent consuming purification 
steps. The most relevant advantage is reduction of the reaction time, which in the case of complexes 33, goes 
from days (40 h) to minutes (50 min) without affecting the reaction yields. Also the ligand synthesis takes 
advantage of a significant reduction of solvent used and reaction time, which goes from 2-16 h, under the 
classic refluxing method, to 25 min under microwave heating. Functionalization toward novel complexes of 
type 33 containing alkyne and -OH groups should be exploited for Shvo’s catalysts immobilization on solid 
support by means of “click” or “coupling” reactions. In principle, catalyst heterogenization should make easier 
recover and recycling of the catalyst for industrial applications. 
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Experimental section 
Materials and procedures. Solvents: THF was dried and distilled under nitrogen prior to use, ethanol (EtOH), 
methanol (MeOH), dichloromethane (CH2Cl2), ethyl acetate, diethyl ether, petroleum ether referring to a 
fraction of bp 60-80 °C, CDCl3 (Sigma Aldrich) and reagents: 1,3-diphenylacetone, benzil, NaOH, 4,4’-
dimethoxybenzil, 2-chloro-3′,4′-dimethoxybenzil, 9,10-phenanthrenequinone, 2-methyl-3-butin-2-ol, 1,1-
diphenyl-2-propyn-2-ol, triethylamine (Et3N), 2,3-butanedione, 2,3-pentanedione, 1-phenyl-1,2-propanedione, 
(Sigma Aldrich) 4,4’-dibromobenzil, (Alfa Aesar) dichlorobis-(triphenylphosphine)palladium(II), copper iodide 
(CuI), triruthenium- dodecacarbonil (Ru3(CO)12) (Strem) have been used as purchased, 4,4’-bis(2-methyl-3-
butin-2-ol)-benzil and 4,4’-bis(2-phenyl-3-butin-2-ol)-benzil, have been prepared as previously reported.13 The 
prepared derivatives were characterized by spectroscopic methods. 1H and 13C NMR were measured at rt with 
399.9  MHz and 100.6 MHz NMR spectrometer; chemical shifts were referenced internally to residual solvent 
peaks for 1H (CDCl3: 7.26 ppm) and 13C NMR (CDCl3: 77.00 ppm); infrared spectra were recorded at 298 K 
with a FT-IR spectrophotometer. ESI-MS spectra were recorded with samples dissolved in MeOH or CH3CN.  
General procedure for microwave experiments 
Microwave reactions were carried out in a “high throughput rotor” microwave oven using Teflon vessels 
equipped with temperature sensor and pressure control. The instrument power has been set at maximum 600 
W. The instrument has been programmed in order to reach the reaction temperature within 5 min and to keep 
it for the required reaction time. Thereafter the irradiation was stopped and the sample cooled down to room 
temperature. 
All the experiments have been followed by temperature and pressure control while the power of pulsed 
microwave irradiation is automatically modulated by the instrument in order to follow the desired temperature 
program. All the experiments herein discussed registered a microwave power plot in the range between 0 and 
100 W. 
General procedure for the microwave assisted synthesis of cyclopentadienones (32). 
Into a 75 mL Teflon vessel with a magnetic stirrer were placed -diketone 30 (1.19 mmol), 1,3-diphenylacetone 
31 (0.250 g, 1.19 mmol), 12 mL of EtOH and NaOH (0.0479 g, 1.19 mmol). The vessel was sealed with a lid 
equipped with a temperature sensor and placed in the microwave oven. The reaction mixture was heated for 
25 min at 70 °C. The dark-purple product was purified by filtration when solid, or by column chromatography. 
Spectral data for new compounds are reported. 
Tetraphenylcyclopentadienone (32A) Reactants: benzil (30A) (0.250 g, 1.19 mmol), 1,3-diphenylacetone 
31 (0.250 g, 1.19 mmol), 12 mL of EtOH and NaOH (0.0479 g, 1.19 mmol). The dark-purple crystalline solid 
was purified by filtration and washed three times with 5 mL of EtOH (0.357 g, 78% yield).  
3,4-Bis(4-methoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone (32B) Reactants: 4,4’-dimethoxybenzil 
(30B) (0.490 g, 1.81 mmol), 1,3-diphenylacetone 31 (0.380 g, 1.81 mmol), NaOH (0.0724 g, 1.81 mmol). Dark-
purple crystalline solid purified by filtration (0.607 g, 75% yield). 
3,4-Bis(4-Bromophenyl)-2,5-diphenylcyclopenta-2,4-dienone (32C) Reactants: 4,4’-dibromobenzil (30C) 
(0.452 g, 1.23 mmol), 1,3-diphenylacetone 31 (0.261 g, 1.23 mmol), NaOH (0.0492 g, 1.23 mmol). Dark-purple 
crystalline solid purified by filtration (0.471g, 70% yield). 
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3,4-Bis(4-(3-hydroxy-3-methylbut-1-ynyl)phenyl)-2,5-diphenylcyclopenta-2,4-dienone (32D) Reactants: 
4,4’-bis(2-methyl-3-butin-2-ol)-benzil (30D) (0.307 g, 0.820 mmol), 1,3-diphenylacetone 31 (0.172 g, 0.820 
mmol), NaOH (0.0328 g, 0.820 mmol). Dark-purple solid: purified by chromatography on silica gel 
(CH2Cl2/ethylacetate: 95/5) (0.261 g, 58% yield). 
3,4-Bis(4-(3-hydroxy-3,3-diphenyl-prop-1-ynyl)phenyl)-2,5-diphenylcyclopenta-2,4-dienone (32E) 
Reactants: 4,4’-bis(2-phenyl-3-butin-2-ol)-benzil (30E) (0.761 g, 1.22 mmol), 1,3-diphenylacetone 2 (0.262 g, 
1.22 mmol), NaOH (0.0490 g, 1.22 mmol). Dark-purple solid: purified by chromatography on silica gel (CH2Cl2) 
(0.320 g, 33% yield). 
4,4’-bis(cyclohexylethynyl)benzil (30F) 4,4’-dibromobenzil (30B) (0.500 g, 1.22 mmol) and 
cyclohexylacetylene (0.385 mL, 2.99 mmol) were dissolved in 50 mL of THF in a two neck round bottom flask 
under nitrogen atmosphere. Dichlorobis-(triphenylphosphine)palladium(II) (0.168 g, 0.240 mmol), CuI (0.0473 
g, 0.251 mmol) and Et3N (5 mL) were added and the mixture was stirred for 1 h at room temperature. Then 
the solvent was removed under vacuum and the crude was purified by chromatography on silica gel (petroleum 
ether/Et2O=95/5) giving the desired product 4,4’-bis(cyclohexylethynyl)benzil (30F) (0.478 g, 82% yields) as a 
pale yellow solid. 1H-NMR (399.9 MHz, CDCl3) δ 7.79 (d, JH,H=8.7, 4H, CHaryl), 7.49 (d, JH,H=8.7, 4H, CHaryl), 
2.60-2.45 (m, 2H), 1.85-1.55 (m, 8H), 1.55-1.15 (m, 12H); 13C-1HNMR (100.6 MHz, CDCl3) δ 193.8 (C=O), 
132.0 (CH), 131.4 (C), 131.2 (C), 129.7 (CH), 100.0 (C), 80.1 (C), 32.4 (CH2), 29.8 (CH), 25.8 (CH2), 24.8 
(CH2). IR (CH2Cl2): υ(C=O): 1673 cm-1. GC-MS: 423 (M+1). Anal. Calcd (%) for C30H30O2: C, 85.27; H, 7.16. 
Found: C, 85.23; H 7.18. 
3,4-bis-[4-(cyclohexylethynyl)phenyl]-2,5-diphenylcyclopenta-2,4-dienone (32F) Reactants: 4,4’-
bis(cyclohexylethynyl)benzil (30F) (0.100 g, 0.240 mmol), 1,3-diphenylacetone 2 (0.0494 g, 0.240 mmol), 
NaOH (0.0096 mg, 0.240 mmol). Dark purple solid purified by filtration (0.0330 g, 23% yield). 1H-NMR (399.9 
MHz, CDCl3) δ 7.20–7.10 (m, 14H, CHaryl), 6.76 (d, JH,H=8.7, 4H, CHaryl), 2.55-2.45 (m, 2H), 1.85-1.60 (m, 8H), 
1.55-1.20 (m, 12H); 13C-1HNMR (100.6 MHz, CDCl3) δ 199.9 (C=O), 153.6 (C), 132.0 (C), 131.3 (CH), 130.5 
(C), 130.1 (CH), 129.3 (CH), 128.1 (CH), 127.6 (CH), 125.5 (C), 124.3 (C), 96.1 (C), 80.3 (C), 32.6 (CH2), 29.7 
(CH), 25.9 (CH2), 24.9 (CH2). IR (CH2Cl2): υ(C=O): 1712 cm-1. GC-MS: 598 (M+1). Anal. Calcd for C45H40O: 
C, 90.56; H, 6.76. Found: C, 90.50; H, 6.75. 
3-(2-chlorophenyl)-4-(3,4-dimethoxyphenyl)-2,5-diphenylcyclopenta-2,4-dienone (32G) Reactants: 2-
chloro-3′,4′-dimethoxybenzil (30G) (0.366 g, 1.19 mmol), 1,3-diphenylacetone 31 (0.250 g, 1.19 mmol), NaOH 
(0.0479 g, 1.19 mmol). Dark purple solid purified by chromatography on silica gel (CH2Cl2/petroleum ether=9/1) 
(0.142 g, 25% yield). 1H-NMR (399.9 MHz, CDCl3) δ 7.30–7.00 (m, 17H, CHaryl), 3.71 (s, 3H, OMe), 3.30 (s, 
3H, OMe); 13C-1HNMR (100.6 MHz, CDCl3) δ 200.0 (C=O), 154.4 (C), 152.3 (C), 149.3 (C), 148.0 (C), 134.1 
(C), 133.7 (C), 131.1 (C), 130.6 (C), 130.3 (CH), 130.2 (CH), 129.8 (CH), 129.7 (CH), 129.3 (CH), 128.13 (CH), 
128.09 (CH), 127.9 (C), 127.8 (CH), 127.4 (CH), 126.9 (CH), 125.4 (C), 123.6 (C), 122.4 (CH), 112.0 (CH), 
110.5 (CH), 55.7 (CH3), 55.4 (CH3). IR (CH2Cl2): υ(C=O): 1713 cm-1. GC-MS: 480 (M+1). Anal. Calcd for 
C31H23ClO3: C, 77.74; H, 4.84. Found: C, 77.82; H, 4.85. 
1,3-Diphenyl-2H-cyclopenta[l]phenanthrene-2-one (32H) Reactants: 9,10-Phenanthrenequinone (30H) 
(0.248 g, 1.19 mmol), 1,3-diphenylacetone 31 (0.250 g, 1.19 mmol), NaOH (0.0479 g, 1.19 mmol). The dark-
green crystalline solid (0.0909 g, 20% yield) was purified by filtration. 
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General procedure for the microwave assisted synthesis of Shvo’s type complexes {[3,4-(R-
C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) (4). 
Into a 75 mL Teflon vessel with a magnetic stirrer were placed tetraarylcyclopentadienone 32 (3 eq.), 
Ru3(CO)12 (1 eq.), methanol (12 mL). The vessel was sealed with a lid equipped with a temperature sensor 
and placed in the microwave oven. The reaction mixture was heated for 50 min at 110 °C. 
{[2,3,4,5-Ph4(η5-C4CO)]2H}Ru2(CO)4(μ-H) (33A) Reactants: tetraphenylcyclopentadienone 32A (0.180 g, 0.48 
mmol), Ru3(CO)12 (0.100g, 0.16mmol), methanol (12 mL). The complex 33A was purified by filtration (0.260 g, 
75% yield). The purity of the product was verified by comparison of 1H, 13C-NMR and IR spectra with literature 
data.15 The same reaction was performed under classic heating method (methanol, 80°C, 40 h) leading to a 
yield of 67%. 
{[3,4-(OMe-C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) (33B) Reactants: 3,4-Bis(4-methoxyphenyl)-2,5-
diphenylcyclopenta-2,4-dienone 32B (0.213g, 0.48 mmol), Ru3(CO)12 (0.100g, 0.16mmol), methanol (12 mL). 
The complex 33B was purified by filtration (0.211 g, 73% yield). The purity of the product was verified by 
comparison of 1H, 13C-NMR and IR spectra with literature data.15 Suitable crystals of 33B were obtained by 
precipitation from MeOH. The same reaction was performed under classic heating method (methanol, 80°C, 
40 h) leading to a yield of 70%. 
{[3,4-(Br-C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) (33C) Reactants: 3,4-Bis(4-Bromophenyl)-2,5-
diphenylcyclopenta-2,4-dienone 32C (0.260g, 0.48 mmol), Ru3(CO)12 (0.100g, 0.16mmol), methanol (12 mL). 
The complex 33C was purified by filtration (0.242 g, 72% yield). Suitable crystal of 33C were obtained by 
precipitation from MeOH. 1H-NMR (399.9 MHz, CDCl3) δ 7.45-6.85 (m, 36H, CHaryl), 3.43 (s, 1H, OH), -18.40 
(s, 1H, RuHRu); 13C-1HNMR (100.6 MHz, CDCl3)  200.20 (CO), 154.49 (C1-OH, Cp), 130.96-127.13 (Cqaryl 
and CHaryl), 101.88 (C2,5; Cp), 87.84 (C3,4; Cp); IR (CH2Cl2) ν(CO): 2041, 2010, 1982 cm-1; ESI-MS (CH3OH, 
m/z) =1399 [M+H]+, 1421 [M+Na]+. Anal. Calcd (%) for C62H38Br4O6Ru2: C, 53,22; H, 2.78. Found: C, 53,34; 
H, 2,76. The same reaction was performed under classic heating method (methanol, 80°C, 40 h) leading to a 
yield in 33C of 62%. 
{[3,4-(4-CCC(CH3)2OH-C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) (33D) Reactants: 3,4-bis(4-(3-hydroxy-
3-methylbut-1-ynyl)phenyl)-2,5-diphenylcyclopenta-2,4-dienone 32D (0.263 g, 0.48 mmol), Ru3(CO)12 (0.100g, 
0.16mmol), methanol (12 mL). The complex {[3,4-(4-CCC(CH3)2OH-C6H4)2-2,5-Ph2(5-
C4CO)]2H}Ru2(CO)4(μ-H) (33D), soluble in MeOH, was purified by column chromatography on silica gel 
(eluent: CH2Cl2/EtOAc 95:5), (0,081 g, 24% yield). 1H-NMR (399.9 MHz, CDCl3) δ 7,62-6,89 (m, 36H, CHaryl); 
1,55 (s, 24H, CH3); -18,38 (s, 1H, RuHRu); OH variable. 13C-1HNMR (100.6 MHz, CDCl3) δ 201,12 (CO); 
155,52 (C1-OH, Cp); 131,81-126,75 (CHaryl and Cqaryl); 102,48 (C2,5; Cp); 94,93 (-CCC(CH3)2OH); 87,78 (C3,4; 
Cp); 81,59 (-CCC(CH3)2OH); 65,52 (-CCC(CH3)2OH); 31,37 (CH3). IR (CH2Cl2) ν(CO): 2040; 2011; 1981 
cm-1. ESI-MS (m/z) (-) = 1413 [M - H]-. Anal. Calcd (%) for C82H66O10Ru2: C, 69.59; H, 4.67. Found: C, 69.69; 
H, 4,65. 
The same reaction was performed under classic heating conditions (methanol, 80°C, 40 h) leading to a yield 
in 33D of 22%. 
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{[3,4-(4-CCC(Ph)2OH-C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) (33E) Reactants: 3,4-bis(4-(3-hydroxy-
3,3-diphenyl-prop-1-ynyl)phenyl)-2,5-diphenylcyclopenta-2,4-dienone 32E (0.382 g, 0.48 mmol), Ru3(CO)12 
(0.100g, 0.16mmol), methanol (12 mL). The complex {[3,4-(4-CCC(Ph)2OH-C6H4)2-2,5-Ph2(5-
C4CO)]2H}Ru2(CO)4(μ-H) (33E), soluble in MeOH, was purified by column chromatography on silica gel 
(eluent: CH2Cl2/EtOAc 95:5), (0,105 g, 23% yield). 1H-NMR (399.9 MHz, CDCl3) δ (ppm): 8.08-6.72 (m, 76H, 
CHaryl); -18.42 (s, 1H, RuHRu); OH variable. 13C-1HNMR (100.6 MHz, CDCl3) δ 201,32 (CO); 155,63 (C1-
OH, Cp); 144,82 (Cipso, -(Ph)2OH) 133,30-126,02 (CHaryl and Cqaryl); 102,75 (C2,5; Cp); 94,22 (-
CCC(CH3)2OH); 87,88 (C3,4; Cp); 86,92 (-CCC(Ph)2OH); 74,85 (-CCC(Ph)2OH). IR (CH2Cl2) ν(CO): 2039; 
2010; 1981 cm-1. ESI-MS (m/z) (-) = 1909 [M - H]-. Anal. Calcd (%) for C122H82O10Ru2: C, 76.65; H, 4.29. Found: 
C, 76.58; H, 4,32. The same reaction was performed under classic heating method (methanol, 80°C, 40 h) 
leading to a yield in 33E of 25%. 
{[3,4-(4-(C6H11-CC)-C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) (33F) Reactants: 3,4-bis-[4-
(cyclohexylethynyl)phenyl]-2,5-diphenylcyclopenta-2,4-dienone 33F (0.287 g, 0.48 mmol), Ru3(CO)12 (0.100g, 
0.16mmol), methanol (12 mL). The complex {[3,4-(4-(C6H11-CC)-C6H4)2-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) 
(33F) was purified by filtration (0.268 g, 74% yield). 1H-NMR (399.9 MHz, CDCl3) δ (ppm): 7.41-6.82 (m, 36H, 
CHaryl); 2.52-1.05 (m, 44H, cyclohexane), -18.46 (s, 1H, RuHRu); OH variable. 13C-1HNMR (100.6 MHz, 
CDCl3) δ 201,04 (CO); 155,11 (C1-OH, Cp); 132.0 -124.3 (CHaryl and Cqaryl), 102,63 (C2,5; Cp); 95.7, 81.0 (-
CC-), 88,01 (C3,4; Cp); 33.0 (CH2), 29.7 (CH), 26.0 (CH2), 24.9 (CH2). IR (CH2Cl2) ν(CO): 2037; 2019; 1976 
cm-1. ESI-MS (m/z) (+) = 1511 [M + H]+. Anal. Calcd (%) for C94H82O6Ru2: C, 74.70; H, 5.43. Found: C, 74.77; 
H, 5.38. The same reaction was performed under classic heating method (methanol, 80°C, 40 h) leading to a 
yield in 33Fof 72%. 
{[3,4-phenanthren-2,5-Ph2(5-C4CO)]2H}Ru2(CO)4(μ-H) (33H) Reactants: 1,3-Diphenyl-2H-
cyclopenta[l]phenanthren-2-one 32H (0.183 g, 0.48 mmol), Ru3(CO)12 (0.100g, 0.16mmol), methanol (12 mL). 
The complex 33H was purified by filtration (0.039 g, 15% yield). 1H-NMR (399.9 MHz, CDCl3)δ 8.83-7.17 (m, 
36H, CHaryl), -19.68 (s, 1H, RuHRu), OH variable; IR (CH2Cl2) ν(CO): 2037, 2008, 1981cm-1; ESI-MS (CH3OH, 
m/z) =1083 [M+H]+. Anal. Calcd (%) for C62H38O6Ru2: C, 68.76; H, 3.51. Found: C, 68.88; H, 3.49. 
X-ray Crystallography 
Crystal data and collection details for 33B·CH2Cl2 and 33C are reported in Table 8.3. The diffraction 
experiments were carried out on a diffractometer equipped with a CCD detector using Mo–K radiation. Data 
were corrected for Lorentz polarization and absorption effects (empirical absorption correction SADABS).22 
Structures were solved by direct methods and refined by full-matrix least-squares based on all data using F2.23 
All hydrogen atoms were fixed at calculated positions and refined by a riding model, except H(1) and H(3) in 
both structures which were located in the Fourier map and refined isotropically using the 1.2 fold Uiso value of 
the parent atoms. All non-hydrogen atoms were refined with anisotropic displacement parameters. 
33B·CH2Cl2: The asymmetric unit of the unit cell contains one 33B complex and one CH2Cl2 molecule (all 
located on general positions). The CH2Cl2 molecule is disordered over three independent positions and, 
therefore, it has been split and refined isotropically using one occupancy parameter per disordered group; the 
sum of the site occupation factors of the three images has been restrained to unit (SUMP 1.0 0.001 1.0 2 1.0 
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3 1.0 4 line in SHELXL). Some C and O atoms of 33B have been restrained to isotropic behaviour (ISOR line 
in SHELXL, s.u. 0.01). The Ru(1)-H(1) and Ru(2)-H(1) distances have been restrained to be similar (SADI line 
in SHELXL, s.u. 0.01); the same restraint has been applied also to the O(3)-H(3) and O(53)-H(3) distances. 
The three images of CH2Cl2 have been restrained to have similar geometries (SAME line in SHELXL, s.u. 
0.02) and similar U parameters (SIMU line in SHELXL, s.u. 0.02). Restraints to bond distances were applied 
as follow (s.u. 0.02): 1.75 Å for C–Clin CH2Cl2. 
33C: The asymmetric unit of the unit cell contains half of a complex molecule located on a 2-fold axis passing 
through H(1) and H(3). 
Table8.3. Crystal data and experimental details for 33B·CH2Cl2 and 33C. 
 33B·CH2Cl2 33C 
Formula C67H52Cl2O10Ru2 C62H38Br4O6Ru2 
Fw 1290.13 1400.70 
T, K 293(2) 294(2) 
, Å 0.71073 0.71073 
Crystal system Triclinic Monoclinic 
Space group P  C2/c 
a, Å 11.5361(19) 27.2316(18) 
b, Å 17.408(3) 9.6582(6) 
c, Å 17.936(5) 20.5820(13) 
,  118.895(3) 90 
,  97.620(3) 100.8750(10) 
,  101.411(2) 90 
Cell Volume, Å3 2979.9(10) 5316.0(6) 
Z 2 4 
Dc, g cm-3 1.438 1.750 
, mm-1 0.655 3.628 
F(000) 1312 2744 
Crystal size, mm 0.190.160.12 0.210.160.14 
 limits,  1.34–25.03 1.52–25.99 
Reflections collected 28343 26736 
Independent reflections 10500 [Rint= 0.0942] 5212 [Rint= 0.0222] 
Data / restraints /parameters 10500 / 148 / 748 5212 / 0 / 336 
Goodness on fit on F2 0.978 1.025 
R1 (I> 2(I)) 0.0726 0.0266 
wR2 (all data) 0.2177 0.0722 
Largest diff. peak and hole, e Å-3 1.295 / –0.516 0.728 / –0.679 
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CHAPTER IV 
Oxidant free one-pot transformation of bio-based 2,5-bis-hydroxymethylfuran into α-
6-hydroxy-6-methyl-4-enyl-2H-pyran-3-one in water 
Abstract 
A new synthetic route for obtaining α-6-hydroxy-6-methyl-4-enyl-2H-pyran-3-one, a useful synthon for the 
preparation of biologically active compounds, has been developed from the bio-based platform derivative 
(2,5-bis-hydroxymethylfuran) BHMF. The reaction occurs with good selectivity in water, under mild conditions 
and employing a heterogeneous recyclable acid (Amberlyst 15®) as catalyst, avoiding the use of oxidizing 
agents. The reaction provides access to poly-oxygenated compounds characterized by a molecular motif 
commonly found in many natural products. 
Introduction 
As already stated in the conclusion of the previous chapter, Shvo’s type complexes are promising catalysts for 
application of in the valorization of bio-oil and biomass derivatives. Indeed the research group in which I 
performed my PhD, has developed a new process for the quantitative reduction of 5-hydroxymethylfurfural 
(HMF) to BHMF exploiting the selective behavior of Shvo catalyst in the hydrogenation of aldehyde to alcohol.1 
Biomass and biomass-derived chemicals hold promise in transitioning to a more sustainable bio-based 
economy displaying a new portfolio of products, not equivalent to those presently manufactured by classical 
synthetic routes from hydrocarbons.2 In particular, furans (e.g. 5-hydroxymethylfurfural HMF) are important  
biomass-derived molecules which can be used as starting materials for the synthesis of a variety of potentially 
useful compounds.3 The structural moieties present in HMF allow synthetic transformations to other target 
molecules by means of selective reactions such as: oxidation of the formyl group,4 reduction of the formyl 
group and/or the furan ring,5 deoxygenation of the hydroxyl groups to 2,5-dimethylfuran,6 etherification and 
carbonylation,7 and hydrogenolysis transformations.8 In particular, selective reduction of 5-
hydroxymethylfurfural (HMF) provides access to the diol 2,5-bishydroxymethylfuran (BHMF), a valuable 
building block for the production of polymers and polyurethane foams.3c,9,HMF reduction to BHMF can be 
performed under stoichiometric conditions in the presence of NaBH410 or by using aqueous solutions of HCHO 
and NaOH,11 in the presence of catalysts such as: copper chromite,12 Ni Raney,13 Pt-, Pd- or Ru-supported 
catalysts.5,14 Main drawbacks are the toxicity of some of the catalysts employed, and the high temperature 
(140-200 °C) and pressure (70-75 bar) required.1e Therefore, the development of novel processes for biomass 
derived building blocks transformation employing lower temperature, ,low hydrogen pressure and exploiting 
less toxic catalysts, such as the one above cited,1 is indeed of great interest. 
Aimed at developing a heterogeneous bi-functional redox/acidic catalyst for the transformation of HMF in a 
linear bis-alcohol with terminal –OH groups, we first tested the heterogeneous acid catalyst Amberlyst 15® on 
BHMF in order to favor concomitant hydrolysis and the opening of the furan ring. In our plan The subsequent 
planned step would be to modify the acidic support by adding the Shvo catalyst. In particular, by using the 
complexes 33 described in the previous chapter, we planned to insert the redox catalyst for the reduction 
steps. Nonetheless, we found out that the acid catalyst allows a series of unexpected rearrangements that led 
to the formation of a secondary alcohol function, making almost useless the incorporation of the Shvo catalyst. 
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Anyway, the compound obtained is interesting by itself and this is the reason why we decided to study in more 
detail the effect of acid catalysis on BHMF. In this final chapter then, the transformation of BHMF into α-6-
hydroxy-6-methyl-4-enyl-2H-pyran-3-one upon treatment with a heterogeneous acid catalyst (Amberlyst 15®) 
in water and in the absence of oxidizing agent is described. The same treatment in alcohol leads to 
etherification of the OH functionalities and no rearrangements are observed.15 Amberlyst 15® is non-hazardous 
in nature and easily separable from reaction mixture.  Thus, on the basis of its physical properties such as high 
H- exchange capacity (4.7 meq/g) and surface area (42 m2/g) it combines very useful acidic properties, with 
benign environmental character, reusability and commercial availability.16 The present reaction is consistent 
with most requirements typical of green methodologies, in that it is atom economic,17 one-pot reaction18 and 
performed in water as solvent,19 with the possibility to recycle the catalyst. Furthermore, the product obtained 
represents an attractive synthon for the preparation of sugar analogues and compounds showing biological 
activity.20 
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Result and discussion 
9.1 Catalyst screening 
The substrate BHMF has been treated in the presence of different heterogeneous acid catalysts such as 
Amberlite IRC50® and Amberlyst 15®. Amberlite IRC50® did not produce any conversion of BHMF at 100 °C, 
even upon different catalyst loading (up to 1gCAT/mmolBHMF). Concerning the reaction with Amberlyst 15®, no 
conversion occurred with 0.1g/mmolBHMF, while with a loading of 0.8gCAT/mmolBHMF decomposition of BHMF 
was detected by the formation of an insoluble black product. Lowering the catalyst/substrate ratio to 
0.5gCAT/mmolBHMF, a complete conversion of BHMF was observed within 30 minutes at 70 °C, leading to the 
formation of a mixture of products. The high catalyst loading (actually one H+ sites each BHMF) suggests that 
a high acid content for the catalyst is required in order to promote the reaction as confirmed by the inactivity 
of Amberlite IRC 50® (0.43 meq H+/g vs Amberlyst 15® 4.7 meq H+/g). 1H-NMR and 13C-NMR (g-HSQC e g-
HMBC) allowed the identification of α-6-hydroxy-6-methyl-4-enyl-2H-pyran-3-one (34) (Scheme 9.1) as major 
product. 
 
Scheme 9.1. Reaction of BHMF in water with Amberlyst 15® (t = 30 min; T = 70 °C, H2O = 20 mL). 
The 1H-NMR signals, assigned to the pyranone 34 (Figure 9.3), are consistent with those reported for the same 
product obtained by a different synthetic approach,21 better known as the Achmatowicz rearrangement[68] 
which is the oxidative rearrangement of 2-(α-hydroxyalkyl) furan, to form 6-hydroxy-3(2H)-pyranones (Scheme 
9.2). The Achmatowicz rearrangement occurs under a variety of conditions, including treatment with: 
Br2/MeOH,22 peracids (e.g. m-CPBA,23 magnesium monoperoxypthalate24), NBS,25 dioxiranes (DMDO26), 
metal-based oxidations (PCC,27 VO(acac)2/t-BuOOH28 and titanium(IV) silicalite (TS-1)/H2O229). 
 
Scheme 9.2. Some example of Achmatowicz rearrangement. 
Analogies between the reaction of BHMF (Scheme 9.1) and the Achmatowicz rearrangement are obviously 
based on the similar nature of the pyranone products. However, there are relevant and peculiar differences, in 
that our reaction provides access to 34 without oxidants. On the other hand, the Achmatowicz rearrangements 
shown in Scheme 9.2 do not take place when the reactions occur under the conditions shown in Scheme 1. 
For example, treatment of furfuryl alcohol with Amberlyst 15® (0.5gCAT/mmolFurfuryl alcohol, H2O 20 mL, T = 70°C, 
t = 30 min) does not lead to the formation of pyranone products. A further observation is that BHMF, under 
Achmatowicz conditions is transformed into a more oxidized product (see Scheme 9.2, R= CH2OH), compared 
to 34, which is instead obtained from 2-methyl-5-hydroxymethylfuran. 
It has to be underlined that the number of methods developed to undertake the oxidative Achmatowicz 
rearrangement accounts for both the usefulness 6-hydroxy-3(2H)-pyranones, and the lack of a single, very 
effective and reliable synthetic route. Methods proposed so far exhibit limits mostly arising from the harshness 
of the reaction conditions and the lack of selectivity associated. Drawbacks include tedious work-up, use of 
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expensive reagents or high energy-demand, non-scalability, formation of salt waste or low catalyst recyclability. 
For example, although the NBS and peroxyacid mediated reactions usually offer simple procedures, it was 
found that these methods are unreliable and unsuitable for all but very small-scale work. On the other hand, 
the bromomethoxylation procedure is highly sensitive to temperature and produces stoichiometric amounts of 
NaBr. In contrast to the above-mentioned methods, using TS-1 as a heterogeneous catalyst and aqueous 
H2O2 as an inexpensive oxygen source, small-sized furfuryl alcohols are readily converted into 6-hydroxy-2H-
pyran-3(6H)-ones with high yield and high oxidant efficiency. Moreover, the use of other Ti-substituted 
molecular sieves possessing larger pores, such as zeolite Ti-Beta or mesoporous Ti-MCM-41, provide access 
to the oxidation of more bulky furfuryl alcohols.30 More recently, it has been reported a greener method based 
on non-toxic singlet oxygen (1O2), run in MeOH in the presence of a reducing agent,31 and in water exploiting 
light and spirulina as the photosensitizer.32 In our reaction, the presence of two hydroxyl groups on the furan 
ring makes the oxidant source unnecessary, and results in a greener approach to pyranones. 
9.2 Screening of the reaction conditions 
The reaction has been performed also under nitrogen atmosphere. Both GC-MS and NMR spectra (1H and 
13C-NMR) confirm the formation of α-6-hydroxy-6-methyl-4-enyl-2H-pyran-3-one (34) as well as of the by-
products 1,3-dihydroxyhexan-2,5-dione (35) and 1,4-dihydroxyhexan-2,5-dione (36). (Scheme 9.3 and 
Figure 9.6). 
 
Scheme 9.3. Reaction conditions: 0.5gCAT/mmolBHMF, N2, degassed water, 70°C, t = 30 min. 
Conversion, yield and selectivity were established on the crude from 1H-NMR spectra, once identified all the 
products in the mixture which are solely 34, 35 and 36. As reported in Table 9.1 the reaction under nitrogen 
atmosphere (entry 2) shows a better selectivity in the formation of 34 than in the presence of air (entry 1). It is 
worth noting that lower temperatures (e.g. 50 °C, entry 3) have a detrimental effect on both yield and selectivity. 
Product 34 has been purified by column chromatography on deactivated silica (treated with a Et2O solution of 
NEt3). The product was eluted with Et2O and isolated with a 25% yield. 
Table 9.1. Acid catalyzed BHMF conversion to 34. Reaction conditions: 0.5gCAT/mmolBHMF, t=30 min. 
Entry Atmosphere T (°C) Conversion (%) Yield (%) Selectivity (%) 
1 Air 70 91 45 49 
2 N2 70 76 50 70 
3 N2 50 12 5 46 
Finally, the reaction behavior in function of the reaction time is reported in Figure 9.1. The reaction reaches 
complete conversion within 60 minutes and the selectivity results lower than 100% already at the beginning of 
the reaction suggesting that a parallel reaction is involved, with formation of the side products 35 and 36. 
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Figure 9.1. BHMF conversion, yield and selectivity of 34 in function of time. Reaction conditions: 0.5gCAT/mmolBHMF, T = 
70°C, under N2. 
9.3 Catalyst recycling 
The resin employed under the reaction conditions of Table 9.1 - entry 2 (T = 70 °C, t = 30 min) was washed 
with water and dried for 14 h, then was further employed for recycling tests maintaining the same activity for 
four cycles (Figure 9.2). FT-IR (KBr) analysis of the resin before and after use and comparison with the spectra 
of BHMF and 34 indicates that neither reagents nor products remain absorbed over the resin. 
 
Figure 9.2. Recycling of Amberlyst 15®. Reaction conditions: 0.5gCAT/mmolBHMF T = 70 °C, t = 30 min, under N2. 
9.4 Reaction mechanism 
Based on the nature of the reaction products, a tentative reaction mechanism has been depicted (Scheme 
9.4). It consists of a hydration of one C=C double bond of BHMF followed by a dehydration that involve the 
hydroxymethyl group on the other side of the ring. Then the ring of 2-hydroxymethyl-5-methylen-2,5-
dihydrofuran-2-ol undergoes ring opening giving rise to a keto-enol equilibrium. When the linear molecule is in 
its ketonic form a nucleophilic attack of the hydroxyl group on the terminal carbon lead to the ring closure and 
to the formation of compound 34 which is the major compound. The side products 35 and 36 are likely derived 
from parallel hydration of the ketonic intermediate before ring closure. However, following the reaction up to 5 
h the complete conversion of the product 34 into 35 and 36 is observed (GC-MS e 1H-NMR) that means that 
a consecutive hydration/ring opening of compound 34 also contributes to the formation of 35 and 36. 
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Scheme 9.4. Proposed mechanism for the reaction of BHMF in water with Amberlyst 15®. 
In order to validate the proposed mechanism, the reaction has been also performed in D2O with the same 
reaction conditions (0.5gCAT/mmolBHMF; T = 70 °C, t = 30 min). 1H-NMR spectrum of the mixture shows the 
appearance of signals due to H/D coupling in the range in which signals attributable to CH3 (δ 1.4-1.5 ppm) 
and to CH2 (δ 2.0-2.2 ppm) are found, which is consistent with the hydration and dehydration steps in the 
proposed mechanism (see Scheme 9.5 and Figure 9.3). 
 
Scheme 9.5: Mechanism proposed for the reaction of BHMF with Amberlyst 15 in D2O. Sites involved in the hydration 
and subsequently in the deuterium insertion are highlighted. 
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Below a portion of the NMR spectrum in which H-D coupling have been detected: 
 
Figure 9.3 Portion of the 1H-NMR spectrum in D2O. Reaction conditions: Amberlyst 15/BHMF (5:1) in D2O at 70°C, t = 
30 min. 
9.5 Homogeneous vs. heterogeneous acid catalysis 
The reactivity of BHMF with a homogeneous acid catalyst (HCl) has been investigated in water at 70 °C for 30 
minutes by varying the solution pH (Table 9.2). The formation of a mixtures of compounds 34, 35 and 36 with 
a general behavior similar to that found for the Amberlyst 15® resin (entry 1) is observed, however lower yields 
and selectivity in 34 are obtained in the case of the homogeneous system (HCl, entries 2-5). Data in Table 9.3 
also evidence that a low pH favors the conversion. 
Table 9.2. Reaction of BHMF with HCl at different pH. 
Entry Cat [H+] Conversion (%) Yield of 34 (%) Selectivity of 34 (%) 
1 Amberlyst 15 (0.5gCAT/mmolBHMF) 76 53 70 
2 HCl (pH 1) 99 16 16 
3 HCl (pH 2) 76 14 18 
4 HCl (pH 3) 49 13 27 
5 HCl (pH 4) 19 6 29 
Employing H2SO4 instead of HCl as acid led to complete decomposition probably due to the oxidizing 
properties of the acid. The latter experiments confirm the role of acid in the formation of 34 from BHMF, as 
well as the need of a strong acidity in order to obtain complete conversion in due time (pH=1 for a complete 
conversion in 30 min). Moreover, the heterogeneous catalyst results, by far, more effective in terms of 
selectivity, which is not obvious to explain. The heterogeneous catalyst might provide both a very high acid 
concentration, necessary to promote hydration-dehydration steps, and some selectivity effects due to the lower 
availability of the acid sites, which should favor the formation of 34. Indeed, due to steric reasons, the ketonic 
form in equilibrium with 34 (Scheme 9.4) should have easier access to the acidic sites, compared to 34, making 
ring opening reaction less favorable compared to the reverse reaction and resulting in the observed selectivity. 
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Conclusions 
In this novel and efficient acid-mediated BHMF rearrangement to α-6-hydroxy-6-methyl-4-enyl-2H-pyran-3-on 
in water neither ungreen oxidizing agents nor harsh conditions are required. The heterogeneous recyclable 
acid catalyst Amberlyst 15® allows good selectivity and mild conditions. The new method starts from a bio-
based platform derivative such as BHMF and the protocol employs green, nontoxic reagents and conditions. 
Furthermore, it is highly step-economic and highly efficient from the perspective of atom economy. The product 
obtained represents an attractive synthon for the preparation of biologically active compounds, making the 
protocol a step forward in the direction of the green approach to pharmaceuticals from biomasses. Mechanistic 
investigation opens the street for the development of a general method for the transformation of variously 
functionalized dihydroxy-furans. 
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Experimental section 
Materials. Solvents: water has been freshly distilled; diethylether, methanol (MeOH), toluene, CDCl3, toluene-
d8, CD3CN, (Sigma Aldrich), reagents: H2SO4, HCl, furfuryl alcohol (Sigma Aldrich), 5-hydroxymethylfurfural 
(HMF) (SAFC), and resins Amberlite IRC50®, Amberlyst 15® wet, have been employed as purchased, 2,5-
bishydroxymethylfuran (BHMF) has been prepared as described in the literature.1 
Analytical methods. The NMR spectra were recorded using Varian Inova 300 (1H, 300.1; 13C, 75.5 MHz), 
Varian Mercury 400 (1H, 399.9; 13C, 100.6 MHz), Varian Inova 600 (1H, 599.7, 13C, 150.8 MHz) spectrometers. 
Infrared spectra were recorded at 298 K on a Perkin-Elmer Spectrum 2000 FT-IR spectrophotometer. GC 
analyses have been performed on an Agilent Technologies 6890N instrument (column: Agilent 19091J-433 
HP-5). HPLC analyses where performed on an Agilent Technologies 1260 Infinity instrument, equipped with a 
C-18 core shell column 50x4.6mm employing a solution of 80% of 0.01 M H3PO4 and 20% acetonitrile as 
mobile phase. 
BHMF rearrangement 
Amberlyst 15®. BHMF (54.8 mg, 0.43 mmol) is dissolved in a suspension of Amberlyst 15® (256 mg) in water 
(20 mL). For reactions performed under nitrogen atmosphere the aqueous suspension of Amberlyst 15® is 
degassed and purged with nitrogen. The mixture is warmed to the desired temperature and the suspension 
maintained under stirring for the time requested and then cooled in a water bath. The catalyst is filtered off and 
the solvent removed under vacuum (at a temperature lower than 40 °C). The reaction crude is analysed by 
GC-MS, 1H- and 13C-NMR and HPLC. From those analyses the following products are identified in variable 
mixtures. BHMF, α-6-hydroxy-6-methyl-4-enyl-2H-pyran-3-one (34), 1,3-dihydroxyhexan-2,5-dione (35), 1,4-
dihydroxyhexan-2,5-dione (36). 
HCl or H2SO4. BHMF (54.8 mg, 0.43 mmol) is dissolved in a water (20 mL) solution of the desired quantity of 
HCl or H2SO4. The reaction mixture is stirred at 70 °C for 30 min. Then it is cooled to room temperature and 
neutralized with NaOH. Water is removed under vacuum and the crude dissolved in CH2Cl2. After 
anhydrification on Na2SO4 the solution is filtered and the solvent removed under vacuum. The crude has been 
analyzed by 1H-NMR. 
Characterization of 2,5-hydroxymethylfuran (BHMF) 
 
1H NMR (399.9 MHz, CD3CN): δ 3.19 (s, 2H, -OH); 4.44 (s, 4H, -CH2OH); 6.20 (s, 2H, -CH). 13C NMR (100.6 
MHz, CD3CN): δ 57.87 (s, 2C, -CH2OH); 109.50 (s, 2C, -CH); 156.37 (s, 2C, -Cq)  
1H NMR (399.9 MHz, D2O): δ 4.56 (s, 4H, -CH2OH); 4.79 (s, 2H, -OH); 6.36 (s, 2H, -CH).13C NMR (100.6 MHz, 
D2O): δ 58.37 (s, 2C, -CH2OH); 111.59 (s, 2C, -CH); 156.17 (s, 2C, -Cq)  
1H NMR (399.9 MHz, CDCl3): δ 4.60 (s, 4H, -CH2OH); 6.25 (s, 2H, -CH); –OH variable. 13C NMR (100.6 MHz, 
CDCl3): δ 58.00 (-CH2OH); 108.45 (CH); 155.08 (Cq). 
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1H NMR (399.9 MHz, Toluene-d8): δ 4.18 (CH2-OH); 5.89 (-CH); 4.32 (-OH).13C NMR (100.6 MHz, Toluene-
d8): δ 58.13 (-CH2OH); 108.65 (CH); 155.31 (Cq). 
GC-MS t.r.: 10.77 min - 128 [M+]; 109 [M+-OH]; 97 [M+-CHO]. HPLC r.t.: 1,7 minutes  
NMR spectra of selected reaction mixtures 
 
Figure 9.4. 1H-NMR spectrum in CD3CN. Reaction conditions: Amberlyst 15/BHMF (5:1), T = 70 °C, t = 30 min, air, 
water. 
 
Figure 9.5. 1H-NMR in CDCl3. Reaction conditions: Amberlyst 15/BHMF (5:1), N2, degassed water, 70°C, t = 30 min. 
 
Figura 9.6. 13C-NMR in CDCl3. Reaction conditions: Amberlyst 15/BHMF (5:1), N2, degassed water, 70°C, t = 30 min. 
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Characterization of α-6-hydroxy-6-methyl-4-enyl-2H-pyran-3-one (34) 
 
1H NMR (399.9 MHz, CD3CN): δ 1.51 (s, 3H, CH3); 4.01, 4.45 (d, 2J (H,H) = 17.2 Hz, 2H -CH2); 5.96 (d, 2J 
(H,H) = 10.4 Hz, 2H -CHCO); 6.93 (d, 2J (H,H) = 10.4 Hz -CHC(OH)CH3); OH variable;13C NMR (100.6 MHz, 
CD3CN): δ 27.70 (CH3); 67, (-CH2-); 93.40 (-C(OH)CH3); 126.37 (-CHCO); 151.36-CHC(OH)CH3; 196.31 (CO). 
1H NMR (399.9 MHz, CDCl3): δ 1.65 (s, 3H, CH3); 4.12, 4.57 (d, 2J (H,H) = 17.1 Hz, 2H -CH2); 6.08 (d, 2J (H,H) 
= 10.2 Hz, 2H -CHCO); 6.87 (d, 2J (H,H) = 10.2 Hz -CHC(OH)CH3); OH variable; 
1H NMR (399.9 MHz, D2O): δ 1.67 (s, 3H, CH3); 4.34, 4.63 (d, 2J (H,H) = 23.2 Hz, 2H -CH2); 6.22, 7.18 (d, 2J 
(H,H) = 10.4 Hz, 2H -CHCO); 6.87 (d, 2J (H,H) = 10.2 Hz -CHC(OH)CH3); OH variable; 
IR (CH2Cl2): ν(C=O) = 1706 cm-1. IR (KBr): ν(C=O) = 1704 cm-1. 
GC-MS t.r.: 8.38 min - 128 [M+]; 113 [M+-CH3]; 111 [M+-OH]; 98 [M+-CH2O]. 
HPLC r.t.: 4,7 minutes 
Characterization of 1,3-dihydroxyhexan-2,5-dione (3) e 1,4-dihydroxyhexan-2,5-dione (4)  
 
1H NMR (399.9 MHz, CD3CN): 2.14, 2.19 (s, 3H + 3H, CH3 (35 and 36)); 3.00-2.50 (m, 2H + 2H –CH2CO- (35 
and 36)); 4.18, 4.44 (s, 2H, CH2OH (35 and 36)); 4.41, 4.46 (m, 1H, CH (35 and 36)); OH variable.  13C NMR 
(100.6 MHz, CD3CN): 25.84, 30.58 (CH3 (35 and 36); 42.38, 47.56 (CH2CO (35 and 36); 66.68, 69.43 (CH2OH 
(35 and 36); 72.36, 73.98 (CH (35 and 36); 207.62, 209.18, 210.63, 212.96 (CO (35 and 36). 
1H NMR (399.9 MHz, CDCl3): 2.17, 2.24 (s, 3H + 3H, CH3 (3 and 4)); 3.00-2.60 (m, 2H + 2H –CH2CO- (35 and 
36)); 4.22, 4.50 (s, 2H, CH2OH (35 and 36)); 4.43, 4.44 (m, 1H, CH (35 and 36)); OH variable. 
HPLC (35 and 36): r.t.: 1,0 e 1,2 minutes 
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